Stress-Induced NN O
Sleep NN O
After IN O
Exposure NN O
to IN O
Ultraviolet NNP O
Light NNP O
Is VBZ O
Promoted VBN O
by IN O
p53 NN O
in IN O
Caenorhabditis NNP O
elegans NNS O
. . O

Stress-induced NN O
sleep NN O
( -LRB- O
SIS NNP O
) -RRB- O
in IN O
C. NNP O
elegans NNS O
is VBZ O
important JJ O
for IN O
restoration NN O
of IN O
cellular JJ O
homeostasis NN O
and CC O
is VBZ O
a DT O
useful JJ O
model NN O
to TO O
study VB O
the DT O
function NN O
and CC O
regulation NN O
of IN O
sleep NN O
. . O

SIS NNP O
is VBZ O
triggered VBN O
when WRB O
epidermal JJ O
growth NN O
factor NN O
( -LRB- O
EGF NNP O
) -RRB- O
activates VBZ O
the DT O
ALA NNP O
neuron NN O
, , O
which WDT O
then RB O
releases VBZ O
neuropeptides NNS O
to TO O
promote VB O
sleep NN O
. . O

To TO O
further RB O
understand VB O
this DT O
behavior NN O
, , O
we PRP O
established VBD O
a DT O
new JJ O
model NN O
of IN O
stress-induced NN O
sleep NN O
using VBG O
irradiation NN O
by IN O
ultraviolet NN O
C NNP O
( -LRB- O
UVC NNP O
) -RRB- O
light NN O
. . O

While IN O
UVC NNP O
irradiation NN O
requires VBZ O
ALA NNP O
signaling NN O
and CC O
leads VBZ O
to IN O
a DT O
sleep NN O
state NN O
similar JJ O
to IN O
that DT O
induced VBN O
by IN O
heat NN O
and CC O
other JJ O
stressors NNS O
, , O
it PRP O
does VBZ O
not RB O
induce VB O
the DT O
proteostatic JJ O
stress NN O
seen VBN O
with IN O
heat NN O
exposure NN O
. . O

Based VBN O
on IN O
the DT O
known VBN O
genotoxic JJ O
effects NNS O
of IN O
UVC NNP O
irradiation NN O
, , O
we PRP O
tested VBD O
two CD O
genes-atl-1 NNS O
and CC O
cep-1-which NN O
encode JJ O
proteins NNS O
that WDT O
act VBP O
in IN O
the DT O
DNA NN O
damage NN O
response NN O
pathway NN O
. . O

Loss NN O
of IN O
function NN O
mutants NNS O
of IN O
atl-1 NNS O
had VBD O
no DT O
defect NN O
in IN O
UVC NNP O
induced VBD O
SIS NNP O
but CC O
a DT O
partial JJ O
loss NN B-NegReg
of IN I-NegReg
function NN I-NegReg
mutant JJ B-Var
of IN O
cep-1 NNP B-Gene
, , O
gk138 NNP O
, , O
had VBD O
decreased VBN B-NegReg
movement NN B-MPA
quiescence NN I-MPA
following VBG O
UVC NNP O
irradiation NN O
. . O

Germline JJ O
ablation NN O
experiments NNS O
and CC O
tissue-specific NN O
RNA NNP O
interference NN O
experiments NNS O
showed VBD O
that IN O
cep-1 NNP O
is VBZ O
required VBN O
somatically RB O
in IN O
neurons NNS O
for IN O
its PRP$ O
effect NN O
on IN O
SIS NNP O
. . O

The DT O
cep-1(gk138 NN B-Gene
) -RRB- O
mutant JJ B-Var
suppressed VBN B-NegReg
body NN B-MPA
movement NN I-MPA
quiescence NN I-MPA
controlled VBN I-MPA
by IN I-MPA
EGF NNP I-MPA
PCSK9 NNS B-Gene
deficiency NN B-Var
results NNS O
in IN O
increased VBN B-PosReg
ectopic NN B-MPA
fat JJ I-MPA
accumulation NN I-MPA
in IN O
experimental JJ O
models NNS O
and CC O
in IN O
humans NNS O
. . O

Background NNP O
Proprotein NNP O
convertase NN O
subtilisin JJ O
kexin NN O
type NN O
9 CD O
( -LRB- O
PCSK9 NNS O
) -RRB- O
regulates VBZ O
low-density JJ O
lipoprotein NN O
and CC O
very RB O
low-density JJ O
lipoprotein NN O
receptor NN O
expression NN O
in IN O
several JJ O
tissues NNS O
. . O

Here RB O
we PRP O
evaluated VBD O
whether IN O
PCSK9 NNS O
may MD O
modulate VB O
the DT O
handling NN O
of IN O
triglycerides NNS O
in IN O
the DT O
liver NN O
and CC O
peripheral JJ O
tissues NNS O
. . O

Methods NNS O
Subjects NNS O
from IN O
the DT O
PLIC NNP O
cohort NN O
were VBD O
genotyped VBN O
for IN O
the DT O
loss-of-function NN O
PCSK9 NNS O
R46L NN O
variant NN O
and CC O
characterized VBD O
for IN O
clinical JJ O
and CC O
biochemical JJ O
parameters NNS O
, , O
total JJ O
and CC O
android JJ O
fat JJ O
mass NN O
, , O
hepatic JJ O
steatosis NN O
and CC O
epicardial NN O
fat JJ O
thickness NN O
. . O

Visceral NNP O
adipose JJ O
tissue NN O
and CC O
subcutaneous JJ O
adipose JJ O
tissue NN O
in IN O
PCSK9 NNP O
KO NNP O
and CC O
wild JJ O
type NN O
mice NNS O
were VBD O
quantified VBN O
by IN O
nuclear JJ O
magnetic JJ O
resonance NN O
imaging NN O
. . O

Results NNS O
Carriers NNPS O
of IN O
the DT O
R46L NN O
variant NN O
( -LRB- O
n CC O
  _SP O
= SYM O
  _SP O
13 CD O
) -RRB- O
had VBD O
lower JJR O
low-density JJ O
lipoprotein NN O
cholesterol NN O
levels NNS O
, , O
higher JJR O
body NN O
mass NN O
index NN O
and CC O
increased VBD O
percentage NN O
of IN O
total JJ O
and CC O
android JJ O
fat JJ O
masses NNS O
compared VBN O
with IN O
non-carriers AFX O
( -LRB- O
n CC O
  _SP O
= SYM O
  _SP O
521 CD O
) -RRB- O
. . O

R46L NN B-Gene
variant NN B-Var
associated VBN O
with IN O
a DT O
two-fold CD O
increase NN B-PosReg
prevalence NN O
of IN O
hepatic JJ B-MPA
steatosis NN I-MPA
and CC I-MPA
higher JJR I-MPA
epicardial NN I-MPA
fat JJ I-MPA
thickness NN I-MPA
. . O

These DT O
observations NNS O
were VBD O
replicated VBN O
in IN O
PCSK9 NNS O
KO NNP O
mice NNS O
, , O
which WDT O
showed VBD O
increased VBN O
visceral JJ O
adipose DT O
tissue NN O
( -LRB- O
but CC O
not RB O
subcutaneous JJ O
adipose JJ O
tissue NN O
) -RRB- O
when WRB O
fed JJ O
chow NN O
or CC O
high-fat JJ O
diet NN O
for IN O
20 CD O
weeks NNS O
, , O
compared VBN O
with IN O
wild JJ O
type NN O
mice NNS O
. . O

Conclusions NNS O
These DT O
data NNS O
suggest VBP O
that IN O
genetically RB O
determined VBN O
PCSK9 NNS B-Gene
deficiency NN B-Var
might MD O
be VB O
associated VBN B-Reg
with IN O
ectopic JJ B-MPA
fat JJ I-MPA
accumulation NN I-MPA
A DT O
Braf NNP B-Gene
kinase-inactive NN O
mutant JJ B-Var
induces NNS B-Reg
lung NN B-Disease
adenocarcinoma NN I-Disease
. . O

The DT O
initiating VBG O
oncogenic JJ O
event NN O
in IN O
almost RB O
half NN O
of IN O
human JJ O
lung NN O
adenocarcinomas NNS O
is VBZ O
still RB O
unknown JJ O
, , O
a DT O
fact NN O
that WDT O
complicates VBZ O
the DT O
development NN O
of IN O
selective JJ O
targeted VBN O
therapies NNS O
. . O

Yet RB O
these DT O
tumours NNS O
harbour VBP O
a DT O
number NN O
of IN O
alterations NNS O
without IN O
obvious JJ O
oncogenic JJ O
function NN O
including VBG O
BRAF-inactivating NNP O
mutations NNS O
. . O

Inactivating VBG O
BRAF NNP O
mutants NNS O
in IN O
lung NN O
predominate NN O
over IN O
the DT O
activating VBG O
V600E JJ O
mutant NN O
that WDT O
is VBZ O
frequently RB O
observed VBN O
in IN O
other JJ O
tumour NN O
types NNS O
. . O

Here RB O
we PRP O
demonstrate VBP O
that IN O
the DT O
expression NN O
of IN O
an DT O
endogenous JJ O
Braf(D631A NN O
) -RRB- O
kinase-inactive NN O
isoform NN O
in IN O
mice NNS O
( -LRB- O
corresponding VBG O
to IN O
the DT O
human JJ O
BRAF(D594A NN O
) -RRB- O
mutation NN O
) -RRB- O
triggers VBZ O
lung NN O
adenocarcinoma NN O
in IN O
vivo NN O
, , O
indicating VBG O
that IN O
BRAF-inactivating NNP O
mutations NNS O
are VBP O
initiating VBG O
events NNS O
in IN O
lung NN O
oncogenesis NN O
. . O

Moreover RB O
, , O
inactivating VBG O
BRAF NN O
mutations NNS O
have VBP O
also RB O
been VBN O
identified VBN O
in IN O
a DT O
subset NN O
of IN O
KRAS-driven NNP O
human JJ O
lung NN O
tumours NNS O
. . O

Co-expression NN O
of IN O
Kras(G12V NNP B-Gene
) -RRB- O
and CC O
Braf(D631A NNP O
) -RRB- O
in IN O
mouse NN O
lung NN O
cells NNS O
markedly RB O
enhances VBZ O
tumour NN O
initiation NN O
, , O
a DT O
phenomenon NN O
mediated VBN O
by IN O
Craf NNP O
kinase NN O
activity NN O
, , O
and CC O
effectively RB O
accelerates VBZ O
tumour NN O
progression NN O
when WRB O
activated VBN O
in IN O
advanced JJ O
lung NN O
adenocarcinomas NNS O
. . O

We PRP O
also RB O
report VBP O
a DT O
key JJ O
role NN O
for IN O
the DT O
wild-type JJ O
Braf NNP O
kinase NN O
in IN O
sustaining VBG O
Kras(G12V)/Braf(D631A)-driven JJ O
tumours NNS O
. . O

Ablation NN O
of IN O
the DT O
wild-type JJ O
Braf NNP O
allele NN O
prevents VBZ O
the DT O
development NN O
of IN O
lung NN O
adenocarcinoma NN O
by IN O
inducing VBG O
a DT O
further JJ O
increase NN O
in IN O
MAPK NN O
signalling NN O
that WDT O
results VBZ O
in IN O
oncogenic JJ O
toxicity NN O
; : O
this DT O
effect NN O
can MD O
be VB O
abolished VBN O
by IN O
pharmacological JJ O
inhibition NN O
of IN O
Mek NNP O
to TO O
restore VB O
tumour NN O
growth NN O
. . O

However RB O
, , O
the DT O
loss NN O
of IN O
wild-type JJ O
Braf NNP O
also RB O
induces VBZ O
transdifferentiation NN O
of IN O
club NN O
cells NNS O
, , O
which WDT O
leads VBZ O
to IN O
the DT O
rapid JJ O
development NN O
of IN O
lethal JJ O
intrabronchiolar JJ O
lesions NNS O
. . O

These DT O
observations NNS O
indicate VBP O
that IN O
the DT O
signal NN O
intensity NN O
of IN O
the DT O
MAPK JJ O
pathway NN O
is VBZ O
a DT O
critical JJ O
determinant NN O
not RB O
only RB O
in IN O
tumour NN O
development NN O
, , O
but CC O
also RB O
in IN O
dictating VBG O
the DT O
nature NN O
of IN O
the DT O
cancer-initiating NN O
cell NN O
and CC O
ultimately RB O
the DT O
resulting VBG O
tumour NN O
phenotype NN O
. . O

Enpp1 NN O
is VBZ O
an DT O
anti-aging RB O
factor NN O
that WDT O
regulates VBZ O
Klotho NNP O
under IN O
phosphate JJ O
overload NN O
conditions NNS O
. . O

Control NNP O
of IN O
phosphate JJ O
metabolism NN O
is VBZ O
crucial JJ O
to TO O
regulate VB O
aging VBG O
in IN O
mammals NNS O
. . O

Klotho NNP O
is VBZ O
a DT O
well-known RB O
anti-aging RB O
factor NN O
that WDT O
regulates VBZ O
phosphate VBP O
metabolism NN O
: : O
mice NNS O
mutant JJ O
or CC O
deficient JJ O
in IN O
Klotho NNP O
exhibit NN O
phenotypes NNS O
resembling VBG O
human JJ O
aging NN O
. . O

Here RB O
we PRP O
show VBP O
that IN O
ectonucleotide NN O
pyrophosphatase NN O
/ SYM O
phosphodiesterase NN O
1 CD O
( -LRB- O
Enpp1 NN O
) -RRB- O
is VBZ O
required VBN O
for IN O
Klotho NNP O
expression NN O
under IN O
phosphate JJ O
overload NN O
conditions NNS O
. . O

Loss-of-function NN B-Var
Enpp1 NNP B-Gene
( -LRB- O
ttw NN O
/ SYM O
ttw NN O
) -RRB- O
mice NNS O
under IN O
phosphate JJ O
overload NN O
conditions NNS O
exhibited VBD B-Reg
phenotypes NNS O
resembling VBG O
human JJ O
aging NN O
and CC O
Klotho NNP O
mutants NNS O
, , O
such JJ O
as IN O
short JJ O
life NN O
span NN O
, , O
arteriosclerosis NN B-Disease
and CC O
osteoporosis NN B-Disease
, , O
with IN O
elevated JJ B-PosReg
serum NN B-MPA
1,25(OH)2D3 CD I-MPA
levels NNS I-MPA
Characterization NN O
of IN O
the DT O
autophagy-related NN O
gene NN O
BmATG8 NN O
in IN O
Bipolaris NNP O
maydis NN O
. . O

Autophagy NNP O
is VBZ O
involved VBN O
in IN O
cellular JJ O
development NN O
and CC O
the DT O
maintenance NN O
of IN O
viability NN O
under IN O
nutrient NN O
deprivation NN O
in IN O
a DT O
wide JJ O
range NN O
of IN O
eukaryotes NNS O
. . O

A DT O
filamentous JJ O
ascomycete JJ O
Bipolaris NNP O
maydis NN O
, , O
responsible JJ O
for IN O
southern JJ O
corn NN O
leaf NN O
blight NN O
, , O
is VBZ O
also RB O
studied VBN O
as IN O
a DT O
model NN O
fungus NN O
for IN O
sexual JJ O
reproduction NN O
in IN O
filamentous JJ O
ascomycetes NNS O
that WDT O
form VBP O
filiform NN O
ascospores NNS O
. . O

In IN O
order NN O
to TO O
clarify VB O
the DT O
roles NNS O
of IN O
autophagy NN O
in IN O
various JJ O
stages NNS O
of IN O
the DT O
life NN O
cycle NN O
of IN O
B. NNP O
maydis NN O
, , O
we PRP O
constructed VBD O
null JJ O
mutants NNS O
of IN O
BmATG8 NNP O
, , O
an DT O
orthologue NN O
of IN O
the DT O
Saccharomyces NNPS O
cerevisiae VBP O
autophagy NN O
gene NN O
ATG8 NNP O
in IN O
B. NNP O
maydis NN O
. . O

Deletion NN B-Var
of IN O
BmATG8 NNP B-Gene
impaired JJ B-NegReg
localization NN B-MPA
of IN O
cytosolic JJ O
components NNS O
to IN O
the DT O
vacuole NN O
under IN O
nitrogen NN O
starvation NN O
, , O
suggesting VBG O
that DT O
autophagy NN B-CPA
was VBD O
deficient JJ B-NegReg
in IN O
the DT O
null JJ O
mutants NNS O
. . O

Additionally RB O
, , O
fluorescent JJ O
microscopic JJ O
observations NNS O
on IN O
a DT O
eGFP-fused NN O
BmATG8 NNS O
expressing VBG O
strain NN O
showed VBD O
that IN O
BmATG8 NNP O
is VBZ O
associated VBN O
with IN O
autophagy-related NN O
structures NNS O
. . O

In IN O
vegetative JJ O
growth NN O
, , O
ΔBmATG8 NNP B-Var
strains NNS O
showed VBD O
a DT O
reduction NN O
in IN O
conidiation NN O
and CC O
aerial JJ O
mycelial JJ O
growth NN O
. . O

Interestingly RB O
, , O
the DT O
mutant JJ O
conidia NN O
indicated VBD O
loss NN O
of IN O
the DT O
germination NN O
rate NN O
under IN O
starvation NN O
conditions NNS O
and CC O
affected JJ O
longevity NN O
. . O

However RB O
, , O
germinated VBD O
mutant JJ O
conidia NN O
were VBD O
still RB O
capable JJ O
of IN O
infecting VBG O
the DT O
host NN O
plant NN O
via IN O
appressoria NN O
. . O

In IN O
sexual JJ O
reproduction NN O
, , O
ascospores NNS O
with IN O
ΔBmATG8 NNP O
genetic JJ O
background NN O
were VBD O
aborted VBN O
. . O

Our PRP$ O
results NNS O
revealed VBD O
that IN O
autophagy NN O
plays VBZ O
a DT O
crucial JJ O
role NN O
in IN O
the DT O
function NN O
of IN O
conidia NN O
, , O
not RB O
in IN O
host NN O
infection NN O
via IN O
appressoria NN O
in IN O
B. NNP O
maydis NN O
. . O

In IN O
addition NN O
, , O
conservation NN O
of IN O
the DT O
importance NN O
of IN O
autophagy NN O
in IN O
ascospore NN O
development NN O
is VBZ O
suggested VBN O
among IN O
ascomycetes NNS O
including VBG O
species NNS O
that WDT O
form VBP O
bitunicate JJ O
ascus NN O
. . O

Impairment NN O
of IN O
different JJ O
protein NN O
domains NNS O
causes VBZ O
variable JJ O
clinical JJ O
presentation NN O
within IN O
Pitt-Hopkins NNP O
syndrome NN O
and CC O
suggests VBZ O
intragenic JJ O
molecular JJ O
syndromology NN O
of IN O
TCF4 NNP O
. . O

Pitt-Hopkins NNP B-Disease
syndrome NN I-Disease
is VBZ O
a DT O
neurodevelopmental JJ O
disorder NN O
characterized VBN O
by IN O
severe JJ O
intellectual JJ O
disability NN O
and CC O
a DT O
distinctive JJ O
facial JJ O
gestalt NN O
. . O

It PRP O
is VBZ O
caused VBN B-Reg
by IN I-Reg
haploinsufficiency NN B-Var
of IN O
the DT O
TCF4 NNP B-Gene
gene NN O
. . O

The DT O
TCF4 NNP O
protein NN O
has VBZ O
different JJ O
functional JJ O
domains NNS O
, , O
with IN O
the DT O
NLS NNP O
( -LRB- O
nuclear JJ O
localization NN O
signal NN O
) -RRB- O
domain NN O
coded VBN O
by IN O
exons NNS O
7-8 CD O
and CC O
the DT O
bHLH NN O
( -LRB- O
basic JJ O
Helix-Loop-Helix NNP O
) -RRB- O
domain NN O
coded VBN O
by IN O
exon NN O
18 CD O
. . O

Several JJ O
alternatively RB O
spliced VBN O
TCF4 NNP O
variants NNS O
have VBP O
been VBN O
described VBN O
, , O
allowing VBG O
for IN O
translation NN O
of IN O
variable JJ O
protein NN O
isoforms NNS O
. . O

Typical JJ O
PTHS NNP O
patients NNS O
have VBP O
impairment NN O
of IN O
at IN O
least JJS O
the DT O
bHLH NN O
domain NN O
. . O

To TO O
which WDT O
extent NN O
impairment NN O
of IN O
the DT O
remaining VBG O
domains NNS O
contributes VBZ O
to IN O
the DT O
final JJ O
phenotype NN O
is VBZ O
not RB O
clear JJ O
. . O

There EX O
is VBZ O
recent JJ O
evidence NN O
that IN O
certain JJ O
loss-of-function NN O
variants NNS B-Var
disrupting VBG B-NegReg
TCF4 NNP B-Gene
are VBP O
associated VBN O
with IN O
mild JJ B-Disease
ID NN I-Disease
, , O
but CC O
not RB O
with IN O
typical JJ O
PTHS NNP O
. . O

We PRP O
describe VBP O
a DT O
frameshift-causing NN B-Var
partial JJ O
gene NN O
deletion NN O
encompassing VBG O
exons NNS O
4-6 CD O
of IN O
TCF4 NNP O
in IN O
an DT O
adult NN O
patient NN O
with IN O
mild JJ O
ID NNP O
and CC O
nonspecific JJ O
facial JJ O
dysmorphisms NNS O
but CC O
without IN O
the DT O
typical JJ O
features NNS O
of IN O
PTHS NNP O
, , O
and CC O
a DT O
c.520C NN O
   O
> XX O
   O
T NNP O
nonsense NN O
variant NN O
within IN O
exon NN O
8 CD O
in IN O
a DT O
child NN O
presenting VBG O
with IN O
a DT O
severe JJ O
phenotype NN O
largely RB O
mimicking VBG O
PTHS NNP O
, , O
but CC O
lacking VBG O
the DT O
typical JJ O
facial JJ O
dysmorphism NN O
. . O

Investigation NN O
on IN O
mRNA NNS O
, , O
along IN O
with IN O
literature NN O
review NN O
, , O
led VBD O
us PRP O
to TO O
suggest VB O
a DT O
preliminary JJ O
phenotypic NN O
map NN O
of IN O
loss-of-function NN O
variants NNS O
affecting VBG O
TCF4 NNP O
. . O

An DT O
intragenic JJ O
phenotypic NN O
map NN O
of IN O
loss-of-function NN O
variants NNS O
in IN O
TCF4 NNP O
is VBZ O
suggested VBN O
here RB O
for IN O
the DT O
first JJ O
time NN O
: : O
variants NNS O
within IN O
exons NNS O
1-4 CD O
and CC O
exons NNS O
4-6 CD O
give NN O
rise NN O
to IN O
a DT O
recurrent JJ O
phenotype NN O
with IN O
mild JJ O
ID NNP O
not RB O
in IN O
the DT O
spectrum NN O
of IN O
Pitt-Hopkins NNP O
syndrome NN O
( -LRB- O
biallelic JJ O
preservation NN O
of IN O
both CC O
the DT O
NLS NNP O
and CC O
bHLH NN O
domains NNS O
) -RRB- O
; : O
variants NNS O
within IN O
exons NNS O
7-8 CD O
cause NN O
a DT O
severe JJ O
phenotype NN O
resembling VBG O
PTHS NNP O
but CC O
in IN O
absence NN O
of IN O
the DT O
typical JJ O
facial JJ O
dysmorphism NN O
( -LRB- O
impairment NN O
limited VBN O
to IN O
the DT O
NLS NNP O
domain NN O
) -RRB- O
; : O
variants NNS O
within IN O
exons NNS O
9-19 CD O
cause NN O
typical JJ O
Pitt-Hopkins NNP O
syndrome NN O
( -LRB- O
impairment NN O
of IN O
at IN O
least JJS O
the DT O
bHLH NN O
domain NN O
) -RRB- O
. . O

Understanding VBG O
the DT O
TCF4 NNP O
molecular JJ O
syndromology NN O
can MD O
allow VB O
for IN O
proper JJ O
nosology NN O
in IN O
the DT O
current JJ O
era NN O
of IN O
whole JJ O
genomic JJ O
investigations NNS O
. . O

ARHGAP29 NNP O
Mutation NNP O
Is VBZ O
Associated VBN O
with IN O
Abnormal NNP O
Oral NNP O
Epithelial NNP O
Adhesions NNPS O
. . O

Nonsyndromic NNP O
cleft NN O
lip NN O
and/or CC O
palate NN O
( -LRB- O
NSCL NNP O
/ SYM O
P NN O
) -RRB- O
is VBZ O
a DT O
prevalent JJ O
birth NN O
defect NN O
of IN O
complex JJ O
etiology NN O
. . O

Previous JJ O
studies NNS O
identified VBD O
mutations NNS B-Var
in IN O
ARHGAP29 NNP B-Gene
associated VBN B-Reg
with IN O
an DT O
increased VBN O
risk NN O
for IN O
NSCL NNP B-Disease
/ SYM O
P. NNP O
To TO O
investigate VB O
the DT O
effects NNS O
of IN O
ARHGAP29 NNP O
in IN O
vivo NN O
, , O
we PRP O
generated VBD O
a DT O
novel JJ O
murine NN O
allele NN O
by IN O
inserting VBG O
a DT O
point NN O
mutation NN O
identified VBN O
in IN O
a DT O
patient NN O
with IN O
NSCL NNP O
/ SYM O
P. NNP O
This DT O
single-nucleotide JJ B-Var
variation NN I-Var
of IN O
ARHGAP29 JJ B-Gene
translates NNS O
to IN O
an DT O
early JJ O
nonsense NN O
mutation NN O
( -LRB- O
K326X NN B-Var
) -RRB- O
, , O
presumably RB O
resulting VBG O
in IN O
loss-of-function NN B-NegReg
( -LRB- O
LoF NNP O
) -RRB- O
. . O

Embryos NNS O
from IN O
Arhgap29(K326X/+ NNPS O
) -RRB- O
intercrosses NNS O
were VBD O
harvested VBN O
at IN O
various JJ O
time NN O
points NNS O
. . O

No DT O
homozygous JJ O
Arhgap29(K326X NN O
) -RRB- O
animals NNS O
were VBD O
found VBN O
in IN O
the DT O
45 CD O
analyzed VBN O
litters NNS O
, , O
assessed VBN O
as RB O
early RB O
as IN O
embryonic JJ O
day NN O
8.5 CD O
( -LRB- O
e8.5 RB O
) -RRB- O
. . O

Coronal JJ O
sectioning NN O
of IN O
e13.5 NN O
and CC O
e14.5 VBZ O
heads NNS O
revealed VBD O
that IN O
59 CD O
% NN O
of IN O
Arhgap29(K326X/+ NNPS O
) -RRB- O
mice NNS O
( -LRB- O
n CC O
= SYM O
37 CD O
) -RRB- O
exhibited VBN O
improper JJ O
epithelial JJ O
contact NN O
between IN O
developing VBG O
oral JJ O
structures NNS O
, , O
while IN O
none NN O
were VBD O
observed VBN O
in IN O
wild JJ O
types NNS O
( -LRB- O
n CC O
= SYM O
10 CD O
) -RRB- O
. . O

In IN O
addition NN O
, , O
Arhgap29(K326X/+ NNPS O
) -RRB- O
embryos NNS O
exhibited VBD O
a DT O
significantly RB O
higher JJR O
percentage NN O
of IN O
maxillary JJ O
epithelium NN O
in IN O
contact NN O
with IN O
mandibular JJ O
epithelium NN O
. . O

Immunofluorescent JJ O
analyses NNS O
of IN O
the DT O
periderm NN O
and CC O
oral JJ O
adhesions NNS O
revealed VBD O
the DT O
presence NN O
of IN O
Arhgap29 NNP O
in IN O
periderm NN O
cells NNS O
. . O

These DT O
cells NNS O
were VBD O
p63 VBN O
negative JJ O
, , O
keratin NNP O
17 CD O
positive JJ O
, , O
and CC O
keratin VB O
6 CD O
positive JJ O
and CC O
present JJ O
at IN O
sites NNS O
of IN O
adhesion NN O
, , O
although IN O
occasionally RB O
disorganized JJ O
. . O

Oral JJ O
adhesions NNS O
did VBD O
not RB O
appear VB O
to TO O
impair VB O
palatogenesis NN O
, , O
as IN O
all DT O
analyzed VBN O
Arhgap29(K326X/+ NNPS O
) -RRB- O
embryos NNS O
showed VBD O
confluent JJ O
palatal JJ O
mesenchyme NNS O
and CC O
epithelium NN O
at IN O
e18.5 NN O
( -LRB- O
n CC O
= SYM O
16 CD O
) -RRB- O
, , O
and CC O
no DT O
mice NNS O
were VBD O
found VBN O
with IN O
a DT O
cleft NN O
at IN O
birth NN O
. . O

Collectively RB O
, , O
our PRP$ O
data NNS O
demonstrate VBP O
that IN O
ARHGAP29 NNP O
is VBZ O
required VBN O
for IN O
embryonic JJ O
survival NN O
and CC O
that IN O
heterozygosity NN O
for IN O
LoF NN B-NegReg
variants NNS B-Var
of IN O
Arhgap29 NNP B-Gene
increases VBZ B-PosReg
the DT O
incidence NN B-CPA
and CC I-CPA
length NN I-CPA
of IN I-CPA
oral JJ I-CPA
adhesions NNS I-CPA
at IN I-CPA
a DT I-CPA
critical JJ I-CPA
time NN I-CPA
point NN I-CPA
during IN I-CPA
orofacial JJ I-CPA
development NN I-CPA
. . O

In IN O
conclusion NN O
, , O
we PRP O
validate VBP O
the DT O
LoF NNP B-NegReg
nature NN O
of IN O
the DT O
human JJ O
K326X NN B-Var
mutation NN I-Var
in IN O
vivo NN O
and CC O
reveal VB O
a DT O
previously RB O
unknown JJ O
effect NN O
of IN O
Arhgap29 NNP B-Gene
in IN O
murine NN O
craniofacial NN B-CPA
development NN I-CPA
Deciphering VBG O
the DT O
molecular JJ O
basis NN O
of IN O
ferroportin NN O
resistance NN O
to IN O
hepcidin NN O
: : O
Structure NN O
/ SYM O
function VBP O
analysis NN O
of IN O
rare JJ O
SLC40A1 NN B-Gene
missense NN B-Var
mutations NNS I-Var
found VBN B-Reg
in IN O
suspected VBN O
hemochromatosis NN B-Disease
type NN I-Disease
4 CD I-Disease
Loss-of-function NN O
mutations NNS O
in IN O
filaggrin NN O
gene NN O
and CC O
malignant JJ O
melanoma NN O
: : O
a DT O
case NN O
control NN O
study NN O
. . O

BACKGROUND NNP O
: : O
Loss-of-function NNP B-NegReg
mutations NNS B-Var
in IN O
filaggrin NN O
gene NN O
( -LRB- O
FLG NNP B-Gene
) -RRB- O
have VBP O
been VBN O
suggested VBN O
to TO O
increase VB O
the DT O
susceptibility NN O
of IN O
skin NN B-Disease
malignancies NNS I-Disease
due IN O
to IN O
reduced JJ B-NegReg
levels NNS B-MPA
of IN I-MPA
epidermal JJ I-MPA
filaggrin NN I-MPA
and CC O
its PRP$ O
degradation NN B-MPA
products NNS I-MPA
, , O
urocanic JJ B-MPA
acid NN I-MPA
A DT O
gain-of-function JJ B-PosReg
mutation NN B-Var
in IN O
TNFRSF13B NNP B-Gene
is VBZ O
a DT O
candidate NN O
for IN O
predisposition NN O
to IN O
familial JJ B-Disease
or CC I-Disease
sporadic JJ I-Disease
immune JJ I-Disease
thrombocytopenia NN I-Disease
. . O

BACKGROUND NNP O
: : O
Most RBS O
immune JJ B-Disease
thrombocytopenia NN I-Disease
( -LRB- O
ITP NNP O
) -RRB- O
is VBZ O
sporadic JJ O
but CC O
a DT O
positive JJ O
family NN O
history NN O
of IN O
ITP NNP O
in IN O
some DT O
patients NNS O
suggests VBZ O
that IN O
hereditary JJ O
forms NNS O
exist VBP O
. . O

Due IN O
to IN O
the DT O
rarity NN O
of IN O
familial JJ O
ITP NNP O
families NNS O
available JJ O
for IN O
study NN O
and CC O
the DT O
heterogeneity NN O
of IN O
sporadic JJ O
ITP NNP O
, , O
family NN O
linkage NN O
analysis NN O
or CC O
genome DT O
wide JJ O
association NN O
studies NNS O
are VBP O
limited VBN O
. . O

OBJECTIVES NNPS O
: : O
Based VBN O
on IN O
one CD O
ITP NNP O
pedigree NN O
, , O
we PRP O
try VBP O
to TO O
identify VB O
the DT O
predisposing VBG O
gene NN O
in IN O
familial JJ O
or CC O
sporadic JJ O
ITP NNP O
and CC O
reveal VB O
the DT O
way NN O
in IN O
which WDT O
it PRP O
causes VBZ O
thrombocytopenia JJ O
. . O

METHODS NNS O
: : O
Gene NN O
expression NN O
profiling VBG O
analysis NN O
and CC O
whole-exome JJ O
sequencing NN O
was VBD O
performed VBN O
on IN O
samples NNS O
from IN O
familial JJ O
ITP NNP O
members NNS O
, , O
sporadic JJ O
ITP NNP O
cases NNS O
and CC O
healthy JJ O
individuals NNS O
. . O

We PRP O
also RB O
evaluated VBD O
the DT O
influence NN O
of IN O
potential JJ O
pathogenic JJ O
mutation NN O
on IN O
immune JJ O
function NN O
and CC O
megakaryocyte NN O
apoptosis NN O
. . O

RESULTS NNP O
: : O
Whole-exome JJ O
sequencing NN O
identified VBD O
a DT O
potential JJ O
pathologic NN B-Reg
p NN B-Var
. . O

G76S VBZ O
heterozygous JJ O
mutation NN O
on IN O
the DT O
TNFRSF13B NNP B-Gene
gene NN O
in IN O
familial JJ B-Disease
ITP NNP I-Disease
patients NNS O
. . O

ITP NNP O
patients NNS O
harboring VBG O
G76S VBZ B-Var
mutation NN O
displayed VBD O
upregulated JJ B-PosReg
" `` B-MPA
cytokine-cytokine NN I-MPA
receptor NN I-MPA
interaction NN I-MPA
" `` O
signal NN O
, , O
increased VBN B-PosReg
serum NN B-MPA
TNFα NNS I-MPA
, , I-MPA
IL-17α NNP I-MPA
, , I-MPA
IFNγ NNS I-MPA
and CC I-MPA
BAFF NNP O
levels NNS O
, , O
and CC O
enhanced VBN B-PosReg
binding JJ B-Interaction
capacity NN I-Interaction
of IN I-Interaction
APRIL NNP I-Interaction
ligand NN I-Interaction
to IN I-Interaction
B NN I-Interaction
cells NNS I-Interaction
. . O

Additionally RB O
, , O
EBV-transformed NNP O
B NN O
cells NNS O
with IN O
the DT O
G76S NN B-Var
mutation NN O
could MD O
induce VB B-PosReg
human JJ B-CPA
megakaryocyte NN I-CPA
line NN I-CPA
( -LRB- I-CPA
Meg-01 NNP I-CPA
) -RRB- O
apoptosis NN O
significantly RB O
. . O

CONCLUSION NN O
: : O
p LS B-Var
. . O

G76S VBZ O
mutation NN O
on IN O
TNFRSF13B NNP B-Gene
gene NN O
is VBZ O
responsible JJ B-Reg
for IN O
ITP NNP B-Disease
A DT O
single JJ O
active JJ O
site NN O
mutation NN O
in IN O
the DT O
pikromycin NNS O
thioesterase NN O
generates VBZ O
a DT O
more RBR O
effective JJ O
macrocyclization NN O
catalyst NN O
. . O

Macrolactonization NNP O
of IN O
natural JJ O
product NN O
analogs NNS O
presents VBZ O
a DT O
significant JJ O
challenge NN O
to IN O
both DT O
biosynthetic JJ O
assembly NN O
and CC O
synthetic JJ O
chemistry NN O
. . O

In IN O
the DT O
preceding VBG O
paper NN O
, , O
we PRP O
identified VBD O
a DT O
thioesterase NN O
( -LRB- O
TE NNP O
) -RRB- O
domain NN O
catalytic JJ O
bottleneck NN O
in IN O
the DT O
processing NN O
of IN O
un-natural NN O
substrates NNS O
in IN O
the DT O
pikromycin NNS O
( -LRB- O
Pik NNP O
) -RRB- O
system NN O
, , O
preventing VBG O
the DT O
formation NN O
of IN O
epimerized VBN O
macrolactones NNS O
. . O

Here RB O
, , O
we PRP O
perform VBP O
molecular JJ O
dynamics NNS O
( -LRB- O
MD NNP O
) -RRB- O
simulations NNS O
showing VBG O
the DT O
epimerized VBN O
hexaketide NN O
was VBD O
accommodated VBN O
within IN O
the DT O
Pik NNP O
TE NNP O
active JJ O
site NN O
; : O
however RB O
, , O
intrinsic JJ O
conformational JJ O
preferences NNS O
of IN O
the DT O
substrate NN O
resulted VBD O
in IN O
predominately RB O
unproductive JJ O
conformations NNS O
, , O
in IN O
agreement NN O
with IN O
the DT O
observed JJ O
hydrolysis NN O
. . O

Accordingly RB O
, , O
we PRP O
engineered VBD O
the DT O
stereospecific NN O
Pik NNP O
TE NNP O
to TO O
yield VB O
a DT O
variant NN O
( -LRB- O
TES148C LS O
) -RRB- O
with IN O
improved JJ O
reaction NN O
kinetics NNS O
and CC O
gain-of-function NN O
processing NN O
of IN O
an DT O
unnatural JJ O
, , O
epimerized VBN O
hexaketide NN O
. . O

Quantum NNP O
mechanical JJ O
( -LRB- O
QM NNP O
) -RRB- O
comparison NN O
of IN O
model NN O
TES148C CD O
and CC O
TEWT NNP O
reaction NN O
coordinate NN O
diagrams NNS O
revealed VBD O
a DT O
change NN O
in IN O
mechanism NN O
from IN O
a DT O
stepwise NN O
addition-elimination NN O
( -LRB- O
TEWT NNP O
) -RRB- O
to IN O
a DT O
lower JJR O
energy NN O
concerted JJ O
acyl JJ O
substitution NN O
( -LRB- O
TES148C LS O
) -RRB- O
, , O
accounting VBG O
for IN O
the DT O
gain-of-function JJ O
and CC O
improved JJ O
reaction NN O
kinetics NNS O
. . O

Finally RB O
, , O
we PRP O
introduced VBD O
the DT O
S148C NN B-Var
mutation NN O
into IN O
a DT O
polyketide NN O
synthase NN O
module NN O
( -LRB- O
PikAIII-TE NNP O
) -RRB- O
to TO O
impart VB O
increased VBN B-PosReg
substrate NN B-MPA
flexibility NN I-MPA
, , O
enabling VBG B-PosReg
the DT O
production NN B-MPA
of IN I-MPA
diastereomeric JJ I-MPA
macrolactones NNS I-MPA
A DT O
comprehensive JJ O
functional JJ O
assessment NN O
of IN O
carboxylesterase NN O
1 CD O
nonsynonymous JJ O
polymorphisms NNS O
. . O

Carboxylesterase NNP O
1 CD O
( -LRB- O
CES1 NNP O
) -RRB- O
is VBZ O
the DT O
predominant JJ O
human JJ O
hepatic JJ O
hydrolase NN O
responsible JJ O
for IN O
the DT O
metabolism NN O
of IN O
many JJ O
clinically RB O
important JJ O
medications NNS O
. . O

CES1 NNP O
expression NN O
and CC O
activity NN O
vary VBP O
markedly RB O
among IN O
individuals NNS O
; : O
and CC O
genetic JJ O
variation NN O
is VBZ O
a DT O
major JJ O
contributing JJ O
factor NN O
to IN O
CES1 NNP O
interindividual JJ O
variability NN O
. . O

In IN O
the DT O
present JJ O
study NN O
, , O
we PRP O
comprehensively RB O
examined VBD O
the DT O
functions NNS O
of IN O
CES1 NNP O
nonsynonymous JJ O
single JJ O
nucleotide NN O
polymorphisms NNS O
( -LRB- O
nsSNPs NNP O
) -RRB- O
and CC O
haplotypes NNS O
using VBG O
transfected VBN O
cell NN O
lines NNS O
and CC O
individual JJ O
human JJ O
liver NN O
tissues NNS O
. . O

The DT O
20 CD O
candidate NN O
variants NNS O
include VBP O
CES1 NNP O
nsSNPs NNP O
with IN O
a DT O
minor JJ O
allele NN O
frequency NN O
( -LRB- O
MAF NNP O
) -RRB- O
> XX O
0.5 CD O
% NN O
in IN O
a DT O
given VBN O
population NN O
or CC O
located VBN O
in IN O
close JJ O
proximity NN O
to IN O
the DT O
CES1 NNP O
active JJ O
site NN O
. . O

Five CD O
nsSNPs NN O
including VBG O
L40Ter NNP O
( -LRB- O
rs151291296 NNP B-Var
) -RRB- O
, , O
G142E NNP O
( -LRB- O
rs121912777 NNP B-Var
) -RRB- O
, , O
G147C NN O
( -LRB- O
rs146456965 NNP B-Var
) -RRB- O
, , O
Y170D NNP O
( -LRB- O
rs148947808 NNP B-Var
) -RRB- O
, , O
and CC O
R171C NNP O
( -LRB- O
rs201065375 NN B-Var
) -RRB- O
were VBD O
found VBN O
to TO O
be VB O
loss-of-function NN B-NegReg
variants NNS O
for IN O
metabolizing VBG B-MPA
the DT O
CES1 NNP B-Enzyme
substrates NNS O
clopidogrel NN O
, , O
enalapril NN O
, , O
and CC O
sacubitril NN O
. . O

Additionally RB O
, , O
the DT O
A158V NNP O
( -LRB- O
rs202121317 NNP B-Var
) -RRB- O
, , O
R199H NNP O
( -LRB- O
rs2307243 NN B-Var
) -RRB- O
, , O
E220 NNP O
G NNP O
( -LRB- O
rs200707504 NNP B-Var
) -RRB- O
, , O
and CC O
T290 NNP O
M NN O
( -LRB- O
rs202001817 NNP B-Var
) -RRB- O
decreased VBD B-NegReg
CES1 NNP B-Enzyme
activity NN B-MPA
to IN O
a DT O
lesser JJR O
extent NN O
in IN O
a DT O
substrate-dependent NN O
manner NN O
. . O

Several JJ O
nsSNPs NNP O
including VBG O
the DT O
L40Ter NNP O
( -LRB- O
rs151291296 NNP B-Var
) -RRB- O
, , O
G147C NN O
( -LRB- O
rs146456965 NNP B-Var
) -RRB- O
, , O
Y170D NNP O
( -LRB- O
rs148947808 NNP B-Var
) -RRB- O
, , O
and CC O
R171C NNP O
( -LRB- O
rs201065375 NN B-Var
) -RRB- O
significantly RB O
reduced VBD B-NegReg
CES1 NNP B-Protein
protein NN I-Protein
and/or CC O
mRNA NNS B-MPA
expressions NNS I-MPA
Progranulin JJ B-Protein
haploinsufficiency NN B-Var
reduces VBZ B-NegReg
amyloid JJ B-MPA
beta NN I-MPA
deposition NN I-MPA
in IN O
Alzheimer NNP B-Disease
's POS I-Disease
disease NN O
model NN O
mice NNS O
. . O

Granulin NNP O
( -LRB- O
Grn NNP O
) -RRB- O
mutations NNS O
were VBD O
identified VBN O
in IN O
familial JJ O
frontotemporal JJ B-Disease
lobar NN I-Disease
degeneration NN I-Disease
( -LRB- O
FTLD NNP O
) -RRB- O
patients NNS O
with IN O
TAR NNP O
DNA-binding NN O
protein NN O
of IN O
43 CD O
kd NNP O
( -LRB- O
TDP-43 NN O
) -RRB- O
pathology NN O
. . O

Grn NN B-Protein
transcript NN O
haploinsufficiency NN B-Var
is VBZ O
proposed VBN O
as IN O
a DT O
disease NN O
mechanism NN O
that WDT O
leads VBZ O
to IN O
the DT O
loss NN B-NegReg
of IN I-NegReg
functional JJ I-NegReg
progranulin NNS O
( -LRB- O
PGRN NNP B-Protein
) -RRB- O
protein NN O
. . O

Thus RB O
, , O
these DT O
mutations NNS B-Var
are VBP O
strongly RB O
involved VBN B-Reg
in IN O
FTLD NNP B-Disease
pathogenesis NN O
. . O

Moreover RB O
, , O
recent JJ O
findings NNS O
indicate VBP O
that IN O
Grn NNP B-Protein
mutations NNS B-Var
are VBP O
associated VBN B-Reg
with IN O
other JJ O
neurodegenerative JJ O
disorders NNS O
with IN O
tau CD O
pathology NN O
, , O
including VBG O
Alzheimer NNP B-Disease
's POS I-Disease
disease NN O
. . O

To TO O
investigate VB O
the DT O
influence NN O
of IN O
PGRN NNP O
on IN O
amyloid NN O
beta NN O
( -LRB- O
Aβ NN O
) -RRB- O
accumulation NN O
, , O
amyloid NN O
precursor NN O
protein NN O
( -LRB- O
APP NNP O
) -RRB- O
transgenic JJ O
mice NNS O
were VBD O
interbred VBN O
with IN O
Grn-deficient NNP O
mice NNS O
, , O
producing VBG O
APP NNP O
transgenic JJ O
mice NNS O
harboring VBG O
the DT O
Grn NNP O
hemizygote NN O
( -LRB- O
APP NNP O
/ SYM O
Grn+/- NNP O
) -RRB- O
. . O

Brains NNS O
were VBD O
collected VBN O
from IN O
16-18-month-old CD O
APP NNP O
and CC O
APP NNP O
/ SYM O
Grn+/- NN O
mice NNS O
and CC O
sequential JJ O
extraction NN O
of IN O
proteins NNS O
, , O
immunoblotting NN O
and CC O
immunohistochemical JJ O
analysis NN O
were VBD O
performed VBN O
. . O

Immunohistochemical JJ O
analysis NN O
showed VBD O
that IN O
the DT O
number NN O
and CC O
area NN O
of IN O
Aβ NNP O
plaque NN O
was VBD O
significantly RB O
decreased VBN O
in IN O
APP NNP O
/ SYM O
Grn+/- NN O
mice NNS O
as IN O
compared VBN O
to IN O
APP NNP O
mice NNS O
. . O

Immunoblotting VBG O
analysis NN O
revealed VBD O
that IN O
Aβ NNP O
was VBD O
reduced VBN O
in IN O
the DT O
sarkosyl-insoluble NN O
fraction NN O
of IN O
16-18-month-old CD O
APP NNP O
/ SYM O
Grn+/- NN O
mice NNS O
as IN O
compared VBN O
with IN O
that DT O
of IN O
APP NNP O
transgenic JJ O
mice NNS O
. . O

Our PRP$ O
data NNS O
suggest VBP O
that IN O
PGRN NNP B-Protein
haploinsufficiency NN B-Var
may MD O
decrease VB B-NegReg
accumulation NN B-MPA
of IN I-MPA
Aβ. NNP I-MPA
Identification NN O
of IN O
distinct JJ O
mutational JJ O
patterns NNS O
and CC O
new JJ O
driver NN O
genes NNS O
in IN O
oesophageal NN O
squamous JJ O
cell NN O
carcinomas NNS O
and CC O
adenocarcinomas NNS O
. . O

OBJECTIVES NNPS O
: : O
Oesophageal NN B-Disease
squamous JJ I-Disease
cell NN I-Disease
carcinoma NN I-Disease
( -LRB- O
OSCC NNS O
) -RRB- O
and CC O
adenocarcinoma NN O
( -LRB- O
OAC NNP O
) -RRB- O
are VBP O
distinct JJ O
cancers NNS O
in IN O
terms NNS O
of IN O
a DT O
number NN O
of IN O
clinical JJ O
and CC O
epidemiological JJ O
characteristics NNS O
, , O
complicating VBG O
the DT O
design NN O
of IN O
clinical JJ O
trials NNS O
and CC O
biomarker NN O
developments NNS O
. . O

We PRP O
analysed VBD O
1048 CD O
oesophageal NN O
tumour-germline NN O
pairs NNS O
from IN O
both DT O
subtypes NNS O
, , O
to TO O
characterise VB O
their PRP$ O
genomic JJ O
features NNS O
, , O
and CC O
biological JJ O
and CC O
clinical JJ O
significance NN O
. . O

DESIGN NNP O
: : O
Previously RB O
exome-sequenced RB O
samples NNS O
were VBD O
re-analysed NN O
to TO O
identify VB O
significantly RB O
mutated VBN O
genes NNS O
( -LRB- O
SMGs NNPS O
) -RRB- O
and CC O
mutational JJ O
signatures NNS O
. . O

The DT O
biological JJ O
functions NNS O
of IN O
novel JJ O
SMGs NNS O
were VBD O
investigated VBN O
using VBG O
cell NN O
line NN O
and CC O
xenograft NN O
models NNS O
. . O

We PRP O
further RB O
performed VBD O
whole-genome JJ O
bisulfite JJ O
sequencing NN O
and CC O
chromatin NN O
immunoprecipitation NN O
( -LRB- O
ChIP)-seq NNP O
to TO O
characterise VB O
epigenetic JJ O
alterations NNS O
. . O

RESULTS NNS O
: : O
OSCC NNS O
and CC O
OAC NNP O
displayed VBD O
nearly RB O
mutually RB O
exclusive JJ O
sets NNS O
of IN O
driver NN O
genes NNS O
, , O
indicating VBG O
that IN O
they PRP O
follow VBP O
independent JJ O
developmental JJ O
paths NNS O
. . O

The DT O
combined JJ O
sample NN O
size NN O
allowed VBD O
the DT O
statistical JJ O
identification NN O
of IN O
a DT O
number NN O
of IN O
novel JJ O
subtype-specific NN O
SMGs NNS O
, , O
mutational JJ O
signatures NNS O
and CC O
prognostic JJ O
biomarkers NNS O
. . O

Particularly RB O
, , O
we PRP O
identified VBD O
a DT O
novel JJ O
mutational JJ O
signature NN O
similar JJ O
to IN O
Catalogue NNP O
Of IN O
Somatic NNP O
Mutations NNPS O
In IN O
Cancer NNP O
( -LRB- O
COSMIC)signature NN O
16 CD O
, , O
which WDT O
has VBZ O
prognostic JJ O
value NN O
in IN O
OSCC NNS O
. . O

Two CD O
newly RB O
discovered VBN O
SMGs NNS O
, , O
CUL3 NNP O
and CC O
ZFP36L2 NNP O
, , O
were VBD O
validated VBN O
as IN O
important JJ O
tumour-suppressors NN O
specific JJ O
to IN O
the DT O
OSCC NNS O
subtype VBP O
. . O

We PRP O
further RB O
identified VBD O
their PRP$ O
additional JJ O
loss-of-function NN O
mechanisms NNS O
. . O

CUL3 NNP B-Gene
was VBD O
homozygously RB O
deleted VBN B-Var
specifically RB O
in IN B-Reg
OSCC NNS B-Disease
and CC O
other JJ O
squamous JJ B-Disease
cell NN I-Disease
cancers NNS I-Disease
Gait JJ O
disturbance NN O
and CC O
lower JJR O
limb NN O
pain NN O
in IN O
a DT O
patient NN O
with IN O
PIK3CA-related NNP O
disorder NN O
. . O

Post-zygotic NNP O
activating VBG O
mutations NNS O
in IN O
PIK3CA JJ O
and CC O
other JJ O
genes NNS O
encoding VBG O
members NNS O
of IN O
PI3K-AKT-mTOR NNP O
pathway NN O
have VBP O
been VBN O
found VBN O
in IN O
various JJ O
overgrowth NN O
syndromes NNS O
that WDT O
have VBP O
been VBN O
grouped VBN O
together RB O
as IN O
PIK3CA-related NNP O
overgrowth NN O
spectrum NN O
( -LRB- O
PROS NNP O
) -RRB- O
. . O

We PRP O
report VBP O
a DT O
female JJ O
patient NN O
with IN O
gait NN O
disturbance NN O
, , O
leg NN O
pain NN O
, , O
isolated JJ O
macrodactyly NNS O
of IN O
the DT O
foot NN O
, , O
and CC O
mild JJ O
intellectual JJ O
disability NN O
. . O

Imaging NN O
of IN O
the DT O
lower JJR O
limb NN O
showed VBD O
a DT O
lipoblastoma NN O
of IN O
the DT O
right JJ O
thigh NN O
. . O

A DT O
mosaic JJ O
gain-of-function NN B-PosReg
mutation NN O
in IN O
the DT O
catalytic JJ O
domain NN O
of IN O
PIK3CA NNP B-Gene
( -LRB- O
c.3140 NFP B-Var
A DT I-Var
   O
> XX O
   O
G NN O
; : O
p NN B-Var
Loss-of-Function NN O
GRHL3 NNP O
Variants NNS O
Detected VBN O
in IN O
African JJ O
Patients NNPS O
with IN O
Isolated NNP O
Cleft NNP O
Palate NNP O
. . O

In IN O
contrast NN O
to IN O
the DT O
progress NN O
that WDT O
has VBZ O
been VBN O
made VBN O
toward IN O
understanding VBG O
the DT O
genetic JJ O
etiology NN O
of IN O
cleft NN O
lip NN O
with IN O
or CC O
without IN O
cleft NN O
palate NN O
, , O
relatively RB O
little JJ O
is VBZ O
known VBN O
about IN O
the DT O
genetic JJ O
etiology NN O
for IN O
cleft NN B-Disease
palate NN I-Disease
only RB I-Disease
( -LRB- O
CPO NNP O
) -RRB- O
. . O

A DT O
common JJ O
coding NN O
variant NN O
of IN O
grainyhead NN O
like IN O
transcription NN O
factor NN O
3 CD O
( -LRB- O
GRHL3 NN O
) -RRB- O
was VBD O
recently RB O
shown VBN O
to TO O
be VB O
associated VBN O
with IN O
risk NN O
for IN O
CPO NNP O
in IN O
Europeans NNPS O
. . O

Mutations NNS O
in IN O
this DT O
gene NN O
were VBD O
also RB O
reported VBN O
in IN O
families NNS O
with IN O
Van NNP O
der VB O
Woude NNP O
syndrome NN O
. . O

To TO O
identify VB O
rare JJ O
mutations NNS O
in IN O
GRHL3 NN O
that WDT O
might MD O
explain VB O
the DT O
missing VBG O
heritability NN O
for IN O
CPO NNP O
, , O
we PRP O
sequenced VBD O
GRHL3 NN O
in IN O
cases NNS O
of IN O
CPO NNP O
from IN O
Africa NNP O
. . O

We PRP O
recruited VBD O
participants NNS O
from IN O
Ghana NNP O
, , O
Ethiopia NNP O
, , O
and CC O
Nigeria NNP O
. . O

This DT O
cohort NN O
included VBD O
case-parent NN O
trios NNS O
, , O
cases NNS O
and CC O
other JJ O
family NN O
members NNS O
, , O
as RB O
well RB O
as IN O
controls NNS O
. . O

We PRP O
sequenced VBD O
exons NNS O
of IN O
this DT O
gene NN O
in IN O
DNA NN O
from IN O
a DT O
total NN O
of IN O
134 CD O
nonsyndromic JJ O
cases NNS O
. . O

When WRB O
possible JJ O
, , O
we PRP O
sequenced VBD O
them PRP O
in IN O
parents NNS O
to TO O
identify VB O
de FW O
novo NN O
mutations NNS O
. . O

Five CD O
novel NN O
mutations NNS O
were VBD O
identified VBN O
: : O
2 CD O
missense NN O
( -LRB- O
c.497C NN O
> XX O
A NN O
; : O
p NN O
. . O

Pro166His NN O
and CC O
c.1229A VBP O
> XX O
G NN O
; : O
p NN O
. . O

Asp410Gly NNP O
) -RRB- O
, , O
1 CD O
splice NN O
site NN O
( -LRB- O
c.1282A NNP O
> XX O
C NN O
p NN O
. . O

Ser428Arg NNP O
) -RRB- O
, , O
1 CD O
frameshift NN O
( -LRB- O
c.470delC NN O
; : O
p LS O
. . O

Gly158Alafster55 NN O
) -RRB- O
, , O
and CC O
1 CD O
nonsense NN O
( -LRB- O
c.1677C NN O
> XX O
A DT O
; : O
p NN O
. . O

Tyr559Ter NNP O
) -RRB- O
. . O

These DT O
mutations NNS O
were VBD O
absent JJ O
from IN O
270 CD O
sequenced JJ O
controls NNS O
and CC O
from IN O
all DT O
public JJ O
exome NN O
and CC O
whole JJ O
genome JJ O
databases NNS O
, , O
including VBG O
the DT O
1000 CD O
Genomes NNS O
database NN O
( -LRB- O
which WDT O
includes VBZ O
data NNS O
from IN O
Africa NNP O
) -RRB- O
. . O

However RB O
, , O
4 CD O
of IN O
the DT O
5 CD O
mutations NNS O
were VBD O
present JJ O
in IN O
unaffected JJ O
mothers NNS O
, , O
indicating VBG O
that IN O
their PRP$ O
penetrance NN O
is VBZ O
incomplete JJ O
. . O

Interestingly RB O
, , O
1 CD O
mutation NN B-Var
damaged VBD B-NegReg
a DT O
predicted VBN O
sumoylation NN B-MPA
site NN I-MPA
, , O
and CC O
another DT O
disrupted VBD B-NegReg
a DT O
predicted VBN O
CK1 NNP B-MPA
phosphorylation NN I-MPA
site NN O
. . O

Overexpression NN O
assays NNS O
in IN O
zebrafish NN O
and CC O
reporter NN O
assays NNS O
in IN O
vitro FW O
indicated VBN O
that IN O
4 CD O
variants NNS O
were VBD O
functionally RB O
null JJ O
or CC O
hypomorphic JJ O
, , O
while IN O
1 CD O
was VBD O
dominant JJ O
negative JJ O
. . O

This DT O
study NN O
provides VBZ O
evidence NN O
that IN O
, , O
as IN O
in IN O
Caucasian JJ O
populations NNS O
, , O
mutations NNS B-Var
in IN O
GRHL3 NN B-Gene
contribute VBP O
to IN O
the DT O
risk NN B-Reg
of IN O
nonsyndromic JJ O
CPO NNP B-Disease
The DT O
apolipoprotein NN B-Protein
C-III NNP I-Protein
( -LRB- O
Gln38Lys NN B-Var
) -RRB- O
variant NN O
associated VBN O
with IN O
human JJ B-Disease
hypertriglyceridemia NN I-Disease
is VBZ O
a DT O
gain-of-function JJ B-PosReg
mutation NN O
. . O

Recent JJ O
cell NN O
culture NN O
and CC O
animal NN O
studies NNS O
have VBP O
suggested VBN O
that IN O
expression NN O
of IN O
human JJ O
apo NN O
C-III NNP O
in IN O
the DT O
liver NN O
has VBZ O
a DT O
profound JJ O
impact NN O
on IN O
the DT O
triacylglycerol NN O
( -LRB- O
TAG)-rich RB O
VLDL1 NNP O
production NN O
under IN O
lipid-rich NN O
conditions NNS O
. . O

The DT O
apoC-III NNP O
Gln38Lys NN O
variant NN O
was VBD O
identified VBN O
in IN O
subjects NNS O
of IN O
Mexican JJ O
origin NN O
with IN O
moderate JJ O
hypertriglyceridemia NN O
. . O

We PRP O
postulated VBD O
that IN O
Gln38Lys NNP O
( -LRB- O
C3QK NNP O
) -RRB- O
, , O
being VBG O
a DT O
gain-of-function JJ O
mutation NN O
, , O
promotes VBZ O
hepatic JJ O
VLDL1 NNP O
assembly NN O
/ SYM O
secretion NN O
. . O

To TO O
test VB O
this DT O
hypothesis NN O
, , O
we PRP O
expressed VBD O
C3QK NNP O
in IN O
McA-RH7777 NNP O
cells NNS O
and CC O
apoc3-null JJ O
mice NNS O
to TO O
contrast VB O
its PRP$ O
effect NN O
with IN O
WT NNP O
apoC-III NNP O
( -LRB- O
C3WT NNP O
) -RRB- O
. . O

In IN O
both DT O
model NN O
systems NNS O
, , O
C3QK CD O
expression NN O
increased VBD O
the DT O
secretion NN O
of IN O
VLDL1-TAG NNP O
( -LRB- O
by IN O
230 CD O
% NN O
) -RRB- O
under IN O
lipid-rich NN O
conditions NNS O
. . O

Metabolic JJ O
labeling NN O
experiments NNS O
with IN O
C3QK NNP O
cells NNS O
showed VBD O
an DT O
increase NN O
in IN O
de FW B-MPA
novo NN I-MPA
lipogenesis NN I-MPA
( -LRB- O
DNL NNP O
) -RRB- O
. . O

Fasting VBG O
plasma NN O
concentration NN O
of IN O
TAG NNP O
, , O
cholesterol NN O
, , O
cholesteryl NN O
ester NN O
, , O
and CC O
FA NNP O
were VBD O
increased VBN O
in IN O
C3QK CD O
mice NNS O
as IN O
compared VBN O
with IN O
C3WT JJ O
mice NNS O
. . O

Liver NNP O
of IN O
C3QK NNP B-Var
mice NNS O
also RB O
displayed VBD O
an DT O
increase NN B-PosReg
in IN O
DNL NNP B-MPA
and CC O
expression NN B-MPA
of IN O
lipogenic JJ B-Gene
genes NNS I-Gene
as IN O
compared VBN O
with IN O
that DT O
in IN O
C3WT JJ O
mice NNS O
. . O

These DT O
results NNS O
suggest VBP O
that IN O
C3QK CD B-Var
variant NN O
is VBZ O
a DT O
gain-of-function JJ O
mutation NN O
that WDT O
can MD O
stimulate VB B-PosReg
VLDL1 NNP B-MPA
production NN I-MPA
, , O
through IN O
enhanced VBN B-PosReg
DNL NNP B-MPA
The DT O
Impact NNP O
of IN O
Heterozygous NNP O
KCNK3 NNP O
Mutations NNPS O
Associated NNP O
With IN O
Pulmonary NNP O
Arterial NNP O
Hypertension NNP O
on IN O
Channel NNP O
Function NNP O
and CC O
Pharmacological NNP O
Recovery NNP O
. . O

BACKGROUND NNP O
: : O
Heterozygous JJ O
loss NN O
of IN O
function NN O
mutations NNS B-Var
in IN O
the DT O
KCNK3 NNP B-Gene
gene NN O
cause IN B-Reg
hereditary JJ O
pulmonary JJ B-Disease
arterial JJ I-Disease
hypertension NN I-Disease
( -LRB- O
PAH NNP O
) -RRB- O
. . O

KCNK3 NN O
encodes NNS O
an DT O
acid-sensitive NN O
potassium NN O
channel NN O
, , O
which WDT O
contributes VBZ O
to IN O
the DT O
resting VBG O
potential NN O
of IN O
human JJ O
pulmonary JJ O
artery NN O
smooth JJ O
muscle NN O
cells NNS O
. . O

KCNK3 NNP O
is VBZ O
widely RB O
expressed VBN O
in IN O
the DT O
body NN O
, , O
and CC O
dimerizes NNS O
with IN O
other JJ O
KCNK3 NNP O
subunits NNS O
, , O
or CC O
the DT O
closely RB O
related JJ O
, , O
acid-sensitive NN O
KCNK9 NN O
channel NN O
. . O

METHODS NNS O
AND CC O
RESULTS NNS O
: : O
We PRP O
engineered VBD O
homomeric JJ O
and CC O
heterodimeric JJ O
mutant JJ O
and CC O
nonmutant JJ O
KCNK3 NNP O
channels NNS O
associated VBN O
with IN O
PAH NNP O
. . O

Using VBG O
whole-cell JJ O
patch-clamp NN O
electrophysiology NN O
in IN O
human JJ O
pulmonary JJ O
artery NN O
smooth JJ O
muscle NN O
and CC O
COS7 NNP O
cell NN O
lines NNS O
, , O
we PRP O
determined VBD O
that IN O
homomeric JJ O
and CC O
heterodimeric JJ O
mutant JJ O
channels NNS O
in IN O
heterozygous JJ O
KCNK3 NNP O
conditions NNS O
lead VBP O
to IN O
mutation-specific NN O
severity NN O
of IN O
channel NN O
dysfunction NN O
. . O

Both DT O
wildtype NN O
and CC O
mutant JJ O
KCNK3 NNP O
channels NNS O
were VBD O
activated VBN O
by IN O
ONO-RS-082 NNP O
( -LRB- O
10 CD O
   O
μmol NN O
/ SYM O
L NNP O
) -RRB- O
, , O
causing VBG O
cell NN O
hyperpolarization NN O
. . O

We PRP O
observed VBD O
robust JJ O
gene NN O
expression NN O
of IN O
KCNK3 NNP O
in IN O
healthy JJ O
and CC O
familial JJ O
PAH NNP O
patient NN O
lungs NNS O
, , O
but CC O
no DT O
quantifiable JJ O
expression NN O
of IN O
KCNK9 NN O
, , O
and CC O
demonstrated VBD O
in IN O
functional JJ O
studies NNS O
that WDT O
KCNK9 VBP O
minimizes NNS O
the DT O
impact NN O
of IN O
select JJ O
KCNK3 NNP O
mutations NNS O
when WRB O
the DT O
2 CD O
channel NN O
subunits NNS O
co-assemble NN O
. . O

CONCLUSIONS NNS O
: : O
Heterozygous JJ O
KCNK3 NNP B-Gene
mutations NNS B-Var
in IN O
PAH NNP O
lead NN O
to IN O
variable JJ O
loss NN B-NegReg
of IN O
channel NN B-MPA
function NN I-MPA
Modifiers NNS O
of IN O
GRN-Associated NNP O
Frontotemporal NNP O
Lobar NNP O
Degeneration NNP O
. . O

Heterozygous JJ O
loss-of-function NN B-NegReg
( -LRB- O
LOF NNP O
) -RRB- O
mutations NNS O
in IN O
the DT O
human JJ O
progranulin NN O
gene NN O
( -LRB- O
GRN NNP O
) -RRB- O
cause VB O
frontotemporal JJ O
lobar NN O
degeneration NN O
( -LRB- O
FTLD NNP O
) -RRB- O
by IN O
a DT O
mechanism NN O
of IN O
haploinsufficiency NN O
. . O

Patients NNS O
present VBP O
most RBS O
frequently RB O
with IN O
frontotemporal JJ O
dementia NN O
, , O
which WDT O
is VBZ O
the DT O
second JJ O
most RBS O
common JJ O
neurodegenerative JJ O
dementia NN O
at IN O
young JJ O
age NN O
. . O

Currently RB O
, , O
no DT O
disease-modifying NN O
therapies NNS O
are VBP O
available JJ O
for IN O
these DT O
patients NNS O
. . O

Stimulating VBG O
GRN NNP O
protein NN O
expression NN O
or CC O
inhibiting VBG O
its PRP$ O
breakdown NN O
is VBZ O
an DT O
obvious JJ O
therapeutic JJ O
strategy NN O
, , O
and CC O
is VBZ O
indeed RB O
the DT O
focus NN O
of IN O
current JJ O
preclinical JJ O
research NN O
and CC O
clinical JJ O
trials NNS O
. . O

Multiple JJ O
studies NNS O
have VBP O
demonstrated VBN O
the DT O
heterogeneity NN O
in IN O
clinical JJ O
presentation NN O
and CC O
wide JJ O
variability NN O
in IN O
age NN O
of IN O
onset NN O
in IN O
patients NNS O
carrying VBG O
a DT O
GRN NNP O
LOF NNP O
mutation NN O
. . O

Recently RB O
, , O
this DT O
heterogeneity NN O
became VBD O
an DT O
opportunity NN O
to TO O
identify VB O
disease NN O
modifiers NNS O
, , O
considering VBG O
that IN O
these DT O
might MD O
constitute VB O
suitable JJ O
targets NNS O
for IN O
developing VBG O
disease-modifying NN O
or CC O
disease-delaying NN O
therapies NNS O
. . O

De NNP O
novo NN O
SETD5 NNP B-Gene
loss-of-function NN B-NegReg
variant NN B-Var
as IN O
a DT O
cause NN O
for IN O
intellectual JJ B-Disease
disability NN I-Disease
in IN O
a DT O
10-year CD O
old JJ O
boy NN O
with IN O
an DT O
aberrant NN O
blind JJ O
ending NN O
bronchus RB O
. . O

Although IN O
rare JJ O
, , O
3p CD O
microdeletion NN O
cases NNS O
have VBP O
been VBN O
well RB O
described VBN O
in IN O
the DT O
clinical JJ O
literature NN O
. . O

The DT O
clinical JJ O
phenotype NN O
includes VBZ O
; : O
intellectual JJ O
disability NN O
( -LRB- O
ID NNP O
) -RRB- O
, , O
growth NN O
retardation NN O
, , O
facial JJ O
dysmorphism NN O
, , O
and CC O
cardiac JJ O
malformations NNS O
. . O

Advances NNS O
in IN O
chromosome NN O
microarray NN O
( -LRB- O
CMA NNP O
) -RRB- O
testing NN O
narrowed VBD O
the DT O
3p25 CD O
critical JJ O
region NN O
to IN O
a DT O
124 CD O
  _SP O
kb IN O
region NN O
, , O
and CC O
recent JJ O
Whole NNP O
Exome NNP O
Sequencing NNP O
( -LRB- O
WES NNP O
) -RRB- O
studies NNS O
have VBP O
suggested VBN O
that IN O
the DT O
SETD5 NNP O
gene NN O
contributes VBZ O
significantly RB O
to IN O
the DT O
3p25 CD O
phenotype NN O
. . O

Loss-of-Function NN B-NegReg
( -LRB- O
LoF NN O
) -RRB- O
variants NNS B-Var
in IN O
SETD5 NNP B-Gene
are VBP O
now RB O
considered VBN O
a DT O
likely JJ O
cause NN O
of IN O
ID NNP B-Disease
Signal JJ O
transducer NN O
and CC O
activator NN O
of IN O
transcription NN O
gain-of-function NN O
primary JJ O
immunodeficiency NN O
/ SYM O
immunodysregulation NN O
disorders NNS O
. . O

PURPOSE NN O
OF IN O
REVIEW NNS O
: : O
To TO O
describe VB O
primary JJ B-Disease
immunodeficiencies NNS I-Disease
caused VBN O
by IN O
gain-of-function NN B-PosReg
( -LRB- O
GOF NN O
) -RRB- O
mutations NNS B-Var
of IN O
signal NN O
transducer NN O
and CC O
activator NN O
of IN O
transcription NN O
( -LRB- O
STAT NN B-Gene
) -RRB- O
genes NNS O
, , O
a DT O
group NN O
of IN O
genetically RB O
determined VBN O
disorders NNS O
characterized VBN O
by IN O
susceptibility NN O
to IN O
infections NNS O
and CC O
, , O
in IN O
many JJ O
cases NNS O
, , O
autoimmune JJ O
manifestations NNS O
. . O

RECENT JJ O
FINDINGS NNS O
: : O
GOF NN O
mutations NNS B-Var
affecting VBG O
STAT1 NNP B-Gene
result NN O
in IN O
increased VBN B-PosReg
STAT NNP B-MPA
tyrosine NN I-MPA
phosphorylation NN I-MPA
and CC O
secondarily RB O
increased VBN B-PosReg
response NN B-MPA
to IN I-MPA
STAT1-signaling VBG I-MPA
cytokines NNS I-MPA
GNPTAB NNP O
missense NN O
mutations NNS O
cause VBP O
loss NN O
of IN O
GlcNAc-1-phosphotransferase NN O
activity NN O
in IN O
mucolipidosis NN O
type NN O
II CD O
through IN O
distinct JJ O
mechanisms NNS O
. . O

Mucolipidoses NNP O
( -LRB- O
ML NNP O
) -RRB- O
II NNP O
and CC O
III CD O
alpha NN O
/ SYM O
beta NN O
are VBP O
lysosomal JJ O
storage NN O
diseases NNS O
caused VBN O
by IN O
pathogenic JJ O
mutations NNS O
in IN O
GNPTAB NNP O
encoding VBG O
the DT O
α⁄β-subunit NN O
precursor NN O
of IN O
GlcNAc-1-phosphotransferase NN O
. . O

To TO O
determine VB O
genotype-phenotype NN O
correlation NN O
and CC O
functional JJ O
analysis NN O
of IN O
mutant JJ O
GlcNAc-1-phosphotransferase NN O
, , O
13 CD O
Brazilian JJ O
patients NNS O
clinically RB O
and CC O
biochemical JJ O
diagnosed VBN O
for IN O
MLII NNP O
or CC O
III CD O
alpha NN O
/ SYM O
beta NN O
were VBD O
studied VBN O
. . O

By IN O
sequencing NN O
of IN O
genomic JJ O
GNPTAB NNS B-Gene
of IN O
the DT O
MLII NNP O
and CC O
MLIII NNP O
alpha NN O
/ SYM O
beta NN O
patients NNS O
we PRP O
identified VBD O
six CD O
novel NN O
mutations NNS O
: : O
p LS B-Var
. . O

D76 NNP O
G NNP O
, , O
p NN B-Var
. . O

S385L NNP O
, , O
p UH B-Var
. . O

Q278Kfs*3 NNP O
, , O
p NN B-Var
. . O

H588Qfs*27 NNP O
, , O
p NN B-Var
. . O

N642Lfs*10 NNP O
and CC O
p NN B-Var
. . O

Y1111*. NNP O
Expression NNP O
analysis NN O
by IN O
western JJ O
blotting NN O
and CC O
immunofluorescence NN O
microscopy NN O
revealed VBN O
that IN O
the DT O
mutant JJ O
α⁄β-subunit NN O
precursor NN O
p NN B-Var
. . O

D76 NNP O
G NNP O
is VBZ O
retained VBN O
in IN O
the DT O
endoplasmic JJ O
reticulum NN O
whereas IN O
the DT O
mutant JJ O
p NN B-Var
. . O

S385L NN O
is VBZ O
correctly RB O
transported VBN O
to IN O
the DT O
cis-Golgi NN O
apparatus NN O
and CC O
proteolytically RB O
processed VBN O
. . O

Both DT O
mutations NNS O
lead VBP O
to TO O
complete JJ O
loss NN B-NegReg
of IN O
GlcNAc-1-phosphotransferase NN B-Enzyme
activity NN B-MPA
Altered JJ O
Cav1.2 JJ O
function NN O
in IN O
the DT O
Timothy NNP O
syndrome NN O
mouse NN O
model NN O
produces VBZ O
ascending VBG O
serotonergic NN O
abnormalities NNS O
. . O

Polymorphism NNP O
in IN O
the DT O
gene NN O
CACNA1C NN O
, , O
encoding VBG O
the DT O
pore-forming NN O
subunit NN O
of IN O
Cav1.2 NNP O
L-type NN O
calcium NN O
channels NNS O
, , O
has VBZ O
one CD O
of IN O
the DT O
strongest JJS O
genetic JJ O
linkages NNS O
to IN O
schizophrenia NN O
, , O
bipolar JJ O
disorder NN O
and CC O
major JJ O
depressive JJ O
disorder NN O
: : O
psychopathologies NNS O
in IN O
which WDT O
serotonin NN O
signaling NN O
has VBZ O
been VBN O
implicated VBN O
. . O

Additionally RB O
, , O
a DT O
gain-of-function JJ B-PosReg
mutation NN B-Var
in IN O
CACNA1C NNP B-Gene
is VBZ O
responsible JJ O
for IN O
the DT O
neurodevelopmental JJ O
disorder NN O
Timothy NNP B-Disease
syndrome NN I-Disease
Localization NN O
of IN O
Cdc7 NNP O
Protein NNP O
Kinase NNP O
During IN O
DNA NNP O
Replication NN O
in IN O
Saccharomyces NNP O
cerevisiae VBP O
. . O

DDK NNP O
, , O
a DT O
conserved JJ O
serine-threonine JJ O
protein NN O
kinase NN O
composed VBN O
of IN O
a DT O
regulatory JJ O
subunit NN O
, , O
Dbf4 NNS O
, , O
and CC O
a DT O
catalytic JJ O
subunit NN O
, , O
Cdc7 NNP O
, , O
is VBZ O
essential JJ O
for IN O
DNA NN O
replication NN O
initiation NN O
during IN O
S NNP O
phase NN O
of IN O
the DT O
cell NN O
cycle NN O
through IN O
MCM2-7 NNP O
helicase NN O
phosphorylation NN O
. . O

The DT O
biological JJ O
significance NN O
of IN O
DDK NNP O
is VBZ O
well RB O
characterized VBN O
, , O
but CC O
the DT O
full JJ O
mechanism NN O
of IN O
how WRB O
DDK NNP O
associates VBZ O
with IN O
substrates NNS O
remains VBZ O
unclear JJ O
. . O

Cdc7 NNP O
is VBZ O
bound VBN O
to TO O
chromatin VB O
in IN O
the DT O
Saccharomyces NNP O
cerevisiae VBP O
genome RB O
throughout IN O
the DT O
cell NN O
cycle NN O
, , O
but CC O
there EX O
is VBZ O
little JJ O
empirical JJ O
evidence NN O
as IN O
to IN O
specific JJ O
Cdc7 NN O
binding VBG O
locations NNS O
. . O

Using VBG O
biochemical JJ O
and CC O
genetic JJ O
techniques NNS O
, , O
this DT O
study NN O
investigated VBD O
the DT O
specific JJ O
localization NN O
of IN O
Cdc7 NNP O
on IN O
chromatin NN O
. . O

The DT O
Calling NNP O
Cards NNP O
method NN O
, , O
using VBG O
Ty5 JJ O
retrotransposons NNS O
as IN O
a DT O
marker NN O
for IN O
DNA-protein NN O
binding NN O
, , O
suggests VBZ O
Cdc7 NNP O
kinase NN O
is VBZ O
preferentially RB O
bound VBN O
to TO O
genomic JJ O
DNA NN O
known VBN O
to TO O
replicate VB O
early RB O
in IN O
S NNP O
phase NN O
, , O
including VBG O
centromeres NNS O
and CC O
origins NNS O
of IN O
replication NN O
. . O

We PRP O
also RB O
discovered VBD O
Cdc7 NN O
binding VBG O
throughout IN O
the DT O
genome NN O
, , O
which WDT O
may MD O
be VB O
necessary JJ O
to TO O
initiate VB O
other JJ O
cellular JJ O
processes NNS O
, , O
including VBG O
meiotic JJ O
recombination NN O
and CC O
translesion CD O
synthesis NN O
. . O

A DT O
kinase NN O
dead JJ O
Cdc7 NNP B-Gene
point NN B-Var
mutation NN I-Var
increases VBZ B-PosReg
the DT O
Ty5 JJ B-MPA
retrotransposon NN I-MPA
integration NN I-MPA
efficiency NN I-MPA
and CC O
a DT O
55-amino CD B-MPA
acid NN I-MPA
C-terminal NNP I-MPA
truncation NN I-MPA
of IN O
Cdc7 NNP B-Gene
, , O
unable JJ B-NegReg
to TO O
bind VB B-Interaction
Dbf4 JJ B-Gene
, , O
reduces VBZ B-NegReg
Cdc7 NN B-Gene
binding VBG B-Interaction
Gain-of-function NN B-PosReg
mutation NN B-Var
in IN O
PTPN11 NN B-Gene
in IN O
histiocytic JJ B-Disease
sarcomas NNS I-Disease
of IN O
Bernese NNP O
Mountain NNP O
Dogs NNP O
. . O

Histiocytic JJ O
sarcoma NN O
( -LRB- O
HS NNP O
) -RRB- O
is VBZ O
an DT O
aggressive JJ O
malignant JJ O
neoplasm NN O
of IN O
dendritic JJ O
cell NN O
origin NN O
that WDT O
is VBZ O
common JJ O
in IN O
certain JJ O
breeds NNS O
of IN O
dogs NNS O
. . O

High JJ O
prevalence NN O
of IN O
fatal JJ O
, , O
disseminated JJ O
HS NNP O
has VBZ O
been VBN O
described VBN O
in IN O
Bernese NNP O
Mountain NNP O
Dogs NNS O
( -LRB- O
BMDs NNPS O
) -RRB- O
. . O

Support NN O
for IN O
genetic JJ O
predisposition NN O
to TO O
develop VB O
HS NNP O
has VBZ O
been VBN O
presented VBN O
in IN O
several JJ O
studies NNS O
, , O
but CC O
to IN O
date NN O
, , O
causative JJ O
genetic JJ O
events NNS O
have VBP O
not RB O
been VBN O
reported VBN O
. . O

In IN O
addition NN O
, , O
no DT O
driver NN O
mutations NNS O
have VBP O
been VBN O
identified VBN O
in IN O
tumours NNS O
. . O

Recently RB O
, , O
E76 NNP B-Var
K NNP O
gain-of-function NN B-PosReg
mutation NN O
in IN O
SHP2 NNP O
encoded VBN O
by IN O
the DT O
PTPN11 NN B-Gene
gene NN O
has VBZ O
been VBN O
described VBN O
in IN O
human JJ O
histiocytic JJ B-Disease
malignancies NNS I-Disease
Homozygous NNP O
KIDINS220 NNP B-Gene
loss-of-function NN B-NegReg
variants NNS B-Var
in IN O
fetuses NNS O
with IN O
cerebral JJ B-CPA
ventriculomegaly NNS I-CPA
and CC O
limb NN B-CPA
contractures NNS I-CPA
. . O

Heterozygous JJ B-Var
mutations NNS I-Var
in IN O
KIDINS220 NNP B-Gene
were VBD O
recently RB O
suggested VBN O
a DT O
cause NN B-Reg
of IN O
spastic JJ B-Disease
paraplegia NNS I-Disease
, , O
intellectual JJ B-Disease
disability NN I-Disease
, , O
nystagmus NN B-Disease
and CC O
obesity NN B-Disease
The DT O
GNASR201C DT O
mutation NN O
associated VBN O
with IN O
clonal JJ O
hematopoiesis NN O
supports VBZ O
transplantable JJ O
hematopoietic JJ O
stem NN O
cell NN O
activity NN O
. . O

Genome NNP O
sequencing NN O
efforts NNS O
have VBP O
identified VBN O
virtually RB O
all DT O
of IN O
the DT O
important JJ O
mutations NNS O
in IN O
adult NN O
myeloid NN O
malignancies NNS O
. . O

More RBR O
recently RB O
, , O
population NN O
studies NNS O
have VBP O
identified VBN O
cancer-associated NN O
variants NNS O
in IN O
the DT O
blood NN O
of IN O
otherwise RB O
healthy JJ O
individuals NNS O
as IN O
they PRP O
age VBP O
, , O
a DT O
phenomenon NN O
termed VBD O
clonal JJ O
hematopoiesis NN O
of IN O
indeterminate JJ O
potential JJ O
( -LRB- O
CHIP NN O
) -RRB- O
. . O

This DT O
suggests VBZ O
that IN O
these DT O
mutations NNS O
may MD O
occur VB O
in IN O
hematopoietic JJ O
stem NN O
cells NNS O
( -LRB- O
HSCs NNS O
) -RRB- O
long RB O
before IN O
any DT O
clinical JJ O
presentation NN O
but CC O
are VBP O
not RB O
necessarily RB O
harbingers NNS O
of IN O
transformation NN O
because IN O
only RB O
a DT O
fraction NN O
of IN O
individuals NNS O
with IN O
CHIP NN O
develop VBP O
hematopoietic JJ O
pathologies NNS O
. . O

Delineation NN O
between IN O
CHIP JJ O
variants NNS O
that WDT O
predispose VBP O
for IN O
disease NN O
versus IN O
those DT O
that WDT O
are VBP O
more RBR O
benign JJ O
could MD O
be VB O
used VBN O
as IN O
a DT O
prognostic JJ O
factor NN O
to TO O
identify VB O
individuals NNS O
at IN O
greater JJR O
risk NN O
for IN O
transformation NN O
. . O

To TO O
achieve VB O
this DT O
, , O
the DT O
biological JJ O
impact NN O
of IN O
CHIP JJ O
variants NNS O
on IN O
HSC NNP O
function NN O
must MD O
be VB O
validated VBN O
. . O

One CD O
variant NN O
that WDT O
has VBZ O
been VBN O
identified VBN O
recurrently RB O
in IN O
CHIP NN B-CPA
is VBZ O
a DT O
gain-of-function JJ B-PosReg
missense NN B-Var
mutation NN I-Var
in IN O
the DT O
imprinted JJ O
gene NN O
GNAS NNP B-Gene
( -LRB- O
Guanine NNP O
Nucleotide NN O
Binding NNP O
Protein NNP O
, , O
Alpha NNP O
Stimulating NNP O
) -RRB- O
. . O

In IN O
this DT O
study NN O
, , O
we PRP O
examined VBD O
the DT O
effect NN O
of IN O
the DT O
GNASR201C NN O
variant NN O
on IN O
HSC NNP O
function NN O
. . O

Ectopic JJ O
expression NN O
of IN O
GNASR201C DT B-Gene
supported VBN O
transplantable JJ O
HSC NNP O
activity NN O
and CC O
improved JJ O
lymphoid JJ O
output NN O
in IN O
secondary JJ O
recipients NNS O
. . O

Because IN O
declining VBG O
lymphoid JJ O
output NN O
is VBZ O
a DT O
hallmark NN O
of IN O
aging NN O
, , O
GNASR201C NN O
mutations NNS O
may MD O
sustain VB O
lymphoid-biased NN O
HSCs NNS O
over IN O
time NN O
and CC O
maintain VB O
them PRP O
in IN O
a DT O
developmental JJ O
state NN O
favorable JJ O
for IN O
transformation NN O
. . O

N1366S DT O
mutation NN O
of IN O
human JJ O
skeletal JJ O
muscle NN O
sodium NN O
channel NN O
causes VBZ O
paramyotonia NN O
congenita NN O
. . O

KEY JJ O
POINTS NNS O
: : O
Paramyotonia NNP B-Disease
congenita NN I-Disease
is VBZ O
a DT O
hereditary JJ O
channelopathy NN O
caused VBN B-Reg
by IN O
missense NN B-Var
mutations NNS I-Var
in IN O
the DT O
SCN4A NNP B-Gene
gene NN O
, , O
which WDT O
encodes VBZ O
the DT O
α NN O
subunit NN O
of IN O
the DT O
human JJ O
skeletal JJ O
muscle NN O
voltage-gated NN O
sodium NN O
channel NN O
NaV1.4 NNS O
. . O

Affected VBN O
individuals NNS O
suffered VBN O
from IN O
myotonia NN O
and CC O
paralysis NN O
of IN O
muscles NNS O
, , O
which WDT O
were VBD O
aggravated VBN O
by IN O
exposure NN O
to IN O
cold JJ O
. . O

We PRP O
report VBP O
a DT O
three-generation CD O
Chinese JJ O
family NN O
with IN O
patients NNS O
presenting VBG O
paramyotonia NN O
congenita NN O
and CC O
identify VB O
a DT O
novel JJ O
N1366S NNP O
mutation NN O
of IN O
NaV1.4 NNS O
. . O

Whole-cell JJ O
electrophysiological JJ O
recordings NNS O
of IN O
the DT O
N1366S NNP O
channel NN O
reveal VB O
a DT O
gain-of-function JJ O
change NN O
of IN O
gating VBG O
in IN O
response NN O
to IN O
cold JJ O
. . O

Modelling NN O
and CC O
molecular JJ O
dynamic JJ O
simulation NN O
data NNS O
suggest VBP O
that IN O
an DT O
arginine-to-serine NN O
substitution NN O
at IN O
position NN O
1366 CD O
increases VBZ O
the DT O
distance NN O
from IN O
N1366 NNP O
to IN O
R1454 NNP O
and CC O
disrupts VBZ O
the DT O
hydrogen NN O
bond NN O
formed VBN O
between IN O
them PRP O
at IN O
low JJ O
temperature NN O
. . O

We PRP O
demonstrate VBP O
that IN O
N1366S NNP O
is VBZ O
a DT O
disease-causing NN O
mutation NN O
and CC O
that IN O
the DT O
temperature-sensitive NN O
alteration NN O
of IN O
N1366S NNP O
channel NN O
activity NN O
may MD O
be VB O
responsible JJ O
for IN O
the DT O
pronounced VBN O
paramyotonia NN O
congenita NN O
symptoms NNS O
of IN O
these DT O
patients NNS O
. . O

ABSTRACT NNP O
: : O
Paramyotonia NNP B-Disease
congenita NN I-Disease
is VBZ O
an DT O
autosomal NN O
dominant JJ O
skeletal JJ O
muscle NN O
channelopathy NN O
caused VBN B-Reg
by IN O
missense NN B-Var
mutations NNS I-Var
in IN O
SCN4A NNS B-Gene
, , O
the DT O
gene NN O
encoding VBG O
the DT O
α NN O
subunit NN O
of IN O
the DT O
human JJ O
skeletal JJ O
muscle NN O
voltage-gated NN O
sodium NN O
channel NN O
NaV1.4 NNS O
. . O

We PRP O
report VBP O
a DT O
three-generation CD O
family NN O
in IN O
which WDT O
six CD O
members NNS O
present VBP O
clinical JJ O
symptoms NNS O
of IN O
paramyotonia NN O
congenita NN O
characterized VBN O
by IN O
a DT O
marked VBN O
worsening NN O
of IN O
myotonia NN O
by IN O
cold JJ O
and CC O
by IN O
the DT O
presence NN O
of IN O
clear JJ O
episodes NNS O
of IN O
paralysis NN O
. . O

We PRP O
identified VBD O
a DT O
novel JJ O
mutation NN O
in IN O
SCN4A NNS O
( -LRB- O
Asn1366Ser NN O
, , O
N1366S NNP O
) -RRB- O
in IN O
all DT O
patients NNS O
in IN O
the DT O
family NN O
but CC O
not RB O
in IN O
healthy JJ O
relatives NNS O
or CC O
in IN O
500 CD O
normal JJ O
control NN O
subjects NNS O
. . O

Functional JJ O
analysis NN O
of IN O
the DT O
channel NN O
protein NN O
expressed VBN O
in IN O
HEK293 NNP O
cells NNS O
by IN O
whole-cell JJ O
patch NN O
clamp NN O
recording NN O
revealed VBD O
that IN O
the DT O
N1366S NNP O
mutation NN O
led VBD O
to IN O
significant JJ O
alterations NNS O
in IN O
the DT O
gating NN O
process NN O
of IN O
the DT O
NaV1.4 NN O
channel NN O
. . O

The DT O
N1366S NNP B-Var
mutant NN O
displayed VBD O
a DT O
cold-induced RB O
hyperpolarizing NN O
shift NN O
in IN O
the DT O
voltage NN O
dependence NN O
of IN O
activation NN O
and CC O
a DT O
depolarizing NN O
shift NN O
in IN O
fast JJ O
inactivation NN O
, , O
as RB O
well RB O
as IN O
a DT O
reduced JJ B-NegReg
rate NN B-MPA
of IN O
fast JJ B-MPA
inactivation NN I-MPA
and CC O
accelerated JJ B-PosReg
recovery NN B-MPA
from IN O
fast JJ B-MPA
inactivation NN I-MPA
. . O

In IN O
addition NN O
, , O
homology NN O
modelling NN O
and CC O
molecular JJ O
dynamic JJ O
simulation NN O
of IN O
N1366S NNP O
and CC O
wild-type JJ O
NaV1.4 NN O
channels NNS O
indicated VBD O
that IN O
the DT O
arginine-to-serine NN O
substitution NN O
disrupted VBD O
the DT O
hydrogen NN O
bond NN O
formed VBN O
between IN O
N1366 NNP O
and CC O
R1454 NNP O
. . O

Together RB O
, , O
our PRP$ O
results NNS O
suggest VBP O
that IN O
N1366S NNP B-Var
is VBZ O
a DT O
gain-of-function JJ B-PosReg
mutation NN O
of IN O
NaV1.4 NNS O
at IN O
low JJ O
temperature NN O
and CC O
the DT O
mutation NN O
may MD O
be VB O
responsible JJ O
for IN O
the DT O
clinical JJ O
symptoms NNS O
of IN O
paramyotonia NN B-Disease
congenita NN I-Disease
Loss-of-function NN B-NegReg
variants NNS B-Var
in IN O
NFIA NNP B-Gene
provide VBP O
further JJ O
support NN O
that WDT O
NFIA NNP O
is VBZ O
a DT O
critical JJ O
gene NN O
in IN O
1p32-p31 CD B-Disease
deletion NN I-Disease
syndrome NN I-Disease
Clcn7F318L/+ NNP O
as IN O
a DT O
new JJ O
mouse NN O
model NN O
of IN O
Albers-Schönberg NNPS O
disease NN O
. . O

Dominant JJ O
negative JJ B-NegReg
mutations NNS B-Var
in IN O
CLCN7 NNP B-Gene
, , O
which WDT O
encodes VBZ O
a DT O
homodimeric JJ O
chloride JJ O
channel NN O
needed VBN O
for IN O
matrix NN O
acidification NN O
by IN O
osteoclasts NNS O
, , O
cause IN O
Albers-Schönberg NNPS B-Disease
disease NN I-Disease
( -LRB- O
also RB O
known VBN O
as IN O
autosomal NN O
dominant JJ O
osteopetrosis NN O
type NN O
2 CD O
) -RRB- O
. . O

More JJR O
than IN O
25 CD O
different JJ O
CLCN7 NN O
mutations NNS O
have VBP O
been VBN O
identified VBN O
in IN O
patients NNS O
affected VBN O
with IN O
Albers-Schönberg NNPS O
disease NN O
, , O
but CC O
only RB O
one CD O
mutation NN O
( -LRB- O
Clcn7G213R NNP O
) -RRB- O
has VBZ O
been VBN O
introduced VBN O
in IN O
mice NNS O
to TO O
create VB O
an DT O
animal NN O
model NN O
of IN O
this DT O
disease NN O
. . O

Here RB O
we PRP O
describe VBP O
a DT O
mouse NN O
with IN O
a DT O
different JJ O
osteopetrosis-causing NN O
mutation NN O
( -LRB- O
Clcn7F318L NNP O
) -RRB- O
. . O

Compared VBN O
to IN O
Clcn7+/+ JJ O
mice NNS O
, HYPH O
12-week-old CD O
Clcn7F318L/+ NN O
mice NNS O
have VBP O
significantly RB O
increased VBN B-PosReg
trabecular NN B-CPA
bone NN I-CPA
volume NN I-CPA
, , O
consistent JJ O
with IN O
Clcn7F318L NN B-Gene
acting VBG O
as IN O
a DT O
dominant JJ O
negative JJ O
mutation NN O
. . O

Clcn7F318L NNP O
/ SYM O
F318L NN O
and CC O
Clcn7F318L NNP O
/ SYM O
G213R WP O
mice NNS O
die VBP O
by IN O
1month CD O
of IN O
age NN O
and CC O
resemble VB O
Clcn7 NNP O
knockout NN O
mice NNS O
, , O
which WDT O
indicate VBP O
that DT O
p XX O
. . O

F318L VB O
mutant JJ O
protein NN O
is VBZ O
non-functional AFX O
and CC O
p NN O
. . O

F318L VB O
and CC O
p NN O
. . O

G213R JJS O
mutant JJ O
proteins NNS O
do VBP O
not RB O
complement VB O
one CD O
another DT O
. . O

Since IN O
it PRP O
has VBZ O
been VBN O
reported VBN O
that IN O
treatment NN O
with IN O
interferon NN O
gamma NN O
( -LRB- O
IFN-G NNP O
) -RRB- O
improves VBZ O
bone NN O
properties NNS O
in IN O
Clcn7G213R/+ NNP O
mice NNS O
, , O
we PRP O
treated VBD O
Clcn7F318L/+ NNP O
mice NNS O
with IN O
IFN-G NNP O
and CC O
observed VBD O
a DT O
decrease NN O
in IN O
osteoclast JJ O
number NN O
and CC O
mineral NN O
apposition NN O
rate NN O
, , O
but CC O
no DT O
overall JJ O
improvement NN O
in IN O
bone NN O
properties NNS O
. . O

Our PRP$ O
results NNS O
suggest VBP O
that IN O
the DT O
benefits NNS O
of IN O
IFN-G NNP O
therapy NN O
in IN O
patients NNS O
with IN O
Albers-Schönberg NNPS O
disease NN O
may MD O
be VB O
mutation-specific NN O
. . O

Highlighting NNP O
Interleukin-36 NNP O
Signalling NNP O
in IN O
Plaque NNP O
Psoriasis NNP O
and CC O
Pustular NNP O
Psoriasis NNP O
. . O

Plaque NNP O
psoriasis NN O
and CC O
pustular NN O
psoriasis NN O
are VBP O
overlapping VBG O
, , O
but CC O
distinct JJ O
, , O
disorders VBZ O
. . O

The DT O
therapeutic JJ O
response NN O
to IN O
biologics NNS O
supports VBZ O
the DT O
pivotal JJ O
role NN O
of IN O
the DT O
tumour NN O
necrosis NN O
alpha NN O
( -LRB- O
TNF-?)/ NN O
interleukin FW O
( -LRB- O
IL)-23/IL-17/IL-22 NNS O
axis JJ O
in IN O
the DT O
pathogenesis NN O
of IN O
these DT O
disorders NNS O
. . O

Recently RB O
, , O
functional JJ O
activation NN O
of IN O
the DT O
IL-36 NNP O
receptor NN O
( -LRB- O
IL-36R NNP O
) -RRB- O
was VBD O
discovered VBN O
to TO O
be VB O
another DT O
driving VBG O
force NN O
in IN O
the DT O
pathogenesis NN O
of IN O
psoriasis NN O
. . O

This DT O
was VBD O
first RB O
highlighted VBN O
by IN O
the DT O
discovery NN O
that WDT O
a DT O
loss-of-function NN B-NegReg
mutation NN B-Var
of IN O
the DT O
IL-36R NNP O
antagonist NN O
( -LRB- O
IL-36Ra NNP B-Gene
) -RRB- O
causes VBZ O
pustular NN B-Disease
psoriasis NN I-Disease
CCR5Δ32 JJ O
( -LRB- O
rs333 NN O
) -RRB- O
polymorphism NN O
is VBZ O
associated VBN O
with IN O
decreased VBN O
risk NN O
of IN O
chronic JJ O
and CC O
aggressive JJ O
periodontitis NN O
: : O
A DT O
case-control NN O
analysis NN O
based VBN O
in IN O
disease NN O
resistance NN O
and CC O
susceptibility NN O
phenotypes NNS O
. . O

Chronic NNP O
and CC O
aggressive JJ O
periodontitis NN O
are VBP O
infectious JJ O
diseases NNS O
characterized VBN O
by IN O
the DT O
irreversible JJ O
destruction NN O
of IN O
periodontal JJ O
tissues NNS O
, , O
which WDT O
is VBZ O
mediated VBN O
by IN O
the DT O
host NN O
inflammatory JJ O
immune JJ O
response NN O
triggered VBN O
by IN O
periodontal JJ O
infection NN O
. . O

The DT O
chemokine NN O
receptor NN O
CCR5 NNP O
play VBP O
an DT O
important JJ O
role NN O
in IN O
disease NN O
pathogenesis NN O
, , O
contributing VBG O
to IN O
pro-inflammatory JJ O
response NN O
and CC O
osteoclastogenesis NN O
. . O

CCR5Δ32 RB O
( -LRB- O
rs333 NNP B-Var
) -RRB- O
is VBZ O
a DT O
loss-of-function NN B-NegReg
mutation NN O
in IN O
the DT O
CCR5 NNP B-Gene
gene NN O
, , O
which WDT O
can MD O
potentially RB O
modulate VB B-Reg
the DT O
host NN B-CPA
response NN I-CPA
and CC O
, , O
consequently RB O
periodontitis JJ O
outcome NN O
. . O

Thus RB O
, , O
we PRP O
investigated VBD O
the DT O
effect NN O
of IN O
the DT O
CCR5Δ32 JJ O
mutation NN O
over IN O
the DT O
risk NN O
to TO O
suffer VB O
periodontitis NN O
in IN O
a DT O
cohort NN O
of IN O
Brazilian JJ O
patients NNS O
( -LRB- O
total JJ O
N=699 NN O
) -RRB- O
, , O
representative NN O
of IN O
disease NN O
susceptibility NN O
( -LRB- O
chronic JJ O
periodontitis NN O
, , O
N=197 NN O
; : O
and CC O
aggressive JJ O
periodontitis NN O
, , O
N=91 NNP O
) -RRB- O
or CC O
resistance NN O
( -LRB- O
chronic JJ O
gingivitis NNS O
, , O
N=193 NNP O
) -RRB- O
phenotypes NNS O
, , O
and CC O
healthy JJ O
subjects NNS O
( -LRB- O
N=218 NNP O
) -RRB- O
. . O

Additionally RB O
, , O
we PRP O
assayed VBD O
the DT O
influence NN O
of IN O
CCR5Δ32 RB O
in IN O
the DT O
expression NN O
of IN O
the DT O
biomarkers NNS O
TNFα NNS O
, , O
IL-1β NNP O
, , O
IL-10 NNP O
, , O
IL-6 NNP O
, , O
IFN-γ NNP O
and CC O
T-bet NNP O
, , O
and CC O
key JJ O
periodontal JJ O
pathogens NNS O
P. NN O
gingivalis NNS O
, , O
T. JJ O
forsythia NNS O
, , O
and CC O
T. NNP O
denticola NN O
. . O

In IN O
the DT O
association NN O
analysis NN O
of IN O
resistant JJ O
versus IN O
susceptible JJ O
subjects NNS O
, , O
CCR5Δ32 JJ O
mutant JJ O
allele-carriers NN O
proved VBD O
significantly RB O
protected VBN O
against IN O
chronic JJ O
( -LRB- O
OR CC O
0.49 CD O
; : O
95 CD O
% NN O
CI NNP O
0.29-0.83 CD O
; : O
p-value NN O
0.01 CD O
) -RRB- O
and CC O
aggressive JJ O
( -LRB- O
OR CC O
0.46 CD O
; : O
95 CD O
% NN O
CI NNP O
0.22-0.94 CD O
; : O
p-value NN O
0.03 CD O
) -RRB- O
periodontitis NN O
. . O

Further RB O
, , O
heterozygous JJ O
subjects NNS O
exhibited VBD O
significantly RB O
decreased VBN B-NegReg
expression NN B-MPA
of IN O
TNFα NNS B-Protein
in IN O
periodontal JJ O
tissues NNS O
, , O
pointing VBG O
to IN O
a DT O
functional JJ O
effect NN O
of IN O
the DT O
mutation NN B-Var
Tacrolimus NN O
rescues VBZ O
the DT O
signaling NN O
and CC O
gene NN O
expression NN O
signature NN O
of IN O
endothelial JJ O
ALK1 NNP O
loss-of-function NN O
and CC O
improves VBZ O
HHT NNP O
vascular JJ O
pathology NN O
. . O

Hereditary NNP B-Disease
hemorrhagic JJ I-Disease
telangiectasia NN I-Disease
( -LRB- O
HHT NNP O
) -RRB- O
is VBZ O
a DT O
highly RB O
debilitating VBG O
and CC O
life-threatening NN O
genetic JJ O
vascular JJ O
disorder NN O
arising VBG O
from IN O
endothelial JJ O
cell NN O
( -LRB- O
EC NNP O
) -RRB- O
proliferation NN O
and CC O
hypervascularization NN O
, , O
for IN O
which WDT O
no DT O
cure NN O
exists VBZ O
. . O

Because IN O
HHT NNP B-Disease
is VBZ O
caused VBN O
by IN O
loss-of-function NN B-NegReg
mutations NNS B-Var
in IN O
bone NN O
morphogenetic JJ O
protein NN O
9 CD O
( -LRB- B-MPA
BMP9)-ALK1-Smad1/5/8 NN I-MPA
Zebrafish JJ O
cdc6 NN O
hypomorphic JJ O
mutation NN O
causes VBZ O
Meier-Gorlin NNP O
syndrome-like NN O
phenotype NN O
. . O

Cell NNP O
Division NNP O
Cycle NNP O
6 CD O
( -LRB- O
Cdc6 NNP O
) -RRB- O
is VBZ O
a DT O
component NN O
of IN O
pre-replicative AFX O
complex NN O
( -LRB- O
preRC NNP O
) -RRB- O
forming VBG O
on IN O
DNA NN O
replication NN O
origins NNS O
in IN O
eukaryotes NNS O
. . O

Recessive VB O
mutations NNS B-Var
in IN O
ORC1 NNP B-Gene
, , O
ORC4 NNP B-Gene
, , O
ORC6 NNP B-Gene
, , O
CDT1 NNP B-Gene
or CC O
CDC6 NNP B-Gene
of IN O
the DT O
preRC NN O
in IN O
human JJ O
cause IN B-Reg
Meier-Gorlin NNP B-Disease
syndrome NN I-Disease
( -LRB- O
MGS NNP O
) -RRB- O
that WDT O
is VBZ O
characterized VBN O
by IN O
impaired JJ O
post-natal NN O
growth NN O
, , O
short JJ O
stature NN O
and CC O
microcephaly NN O
. . O

However RB O
, , O
vertebrate NN O
models NNS O
of IN O
MGS NNP O
have VBP O
not RB O
been VBN O
reported VBN O
. . O

Through IN O
N-ethyl-N-nitrosourea NN O
mutagenesis NN O
and CC O
Cas9 PRP$ O
knockout NN O
, , O
we PRP O
generate VBP O
several JJ O
cdc6 NN O
mutant JJ O
lines NNS O
in IN O
zebrafish NN O
. . O

Loss-of-function NN B-NegReg
mutations NNS B-Var
of IN O
cdc6 NN B-Gene
, , O
as IN O
manifested VBN O
by IN O
cdc6tsu4305 JJ O
and CC O
cdc6tsu7cd NNP O
mutants NNS O
, , O
lead VBP O
to IN O
embryonic JJ B-CPA
lethality NN I-CPA
due JJ O
to IN O
cell NN B-CPA
cycle NN I-CPA
arrest NN I-CPA
at IN I-CPA
the DT I-CPA
S NNP I-CPA
phase NN I-CPA
and CC O
extensive JJ O
apoptosis NN B-CPA
. . O

Embryos NNS O
homozygous JJ O
for IN O
a DT O
cdc6 FW O
hypomorphic JJ O
mutation NN O
, , O
cdc6tsu21cd NN O
, , O
develop VB O
normally RB O
during IN O
embryogenesis NN O
. . O

Later RB O
on RB O
, , O
compared VBN O
with IN O
their PRP$ O
wild-type JJ O
( -LRB- O
WT NNP O
) -RRB- O
siblings NNS O
, , O
cdc6tsu21cd JJ B-Var
mutant JJ I-Var
fish NN O
show VBP O
growth NN O
retardation NN O
, , O
and CC O
their PRP$ O
body NN B-CPA
weight NN I-CPA
and CC I-CPA
length NN I-CPA
in IN O
adulthood NN O
are VBP O
greatly RB O
reduced VBN B-NegReg
, , O
which WDT O
resemble VBP O
human JJ O
MGS NNP O
. . O

Surprisingly RB O
, , O
cdc6tsu21cd JJ B-Var
mutant JJ I-Var
fish NN O
become VBP O
males NNS O
with IN O
a DT O
short JJ O
life NN O
and CC O
fail VB O
to TO O
mate VB O
with IN O
WT NNP O
females NNS O
, , O
suggesting VBG O
defective JJ B-NegReg
reproduction NN B-CPA
. . O

Overexpression NN O
of IN O
Cdc6 NNP O
mutant JJ O
forms NNS O
, , O
which WDT O
mimic VBP O
human JJ O
CDC6(T323R NNP B-Gene
) -RRB- O
mutation NN B-Var
found VBD O
in IN O
a DT O
MGS NNP O
patient NN O
, , O
in IN O
zebrafish JJ O
cdc6tsu4305 JJ O
mutant JJ O
embryos NNS O
partially RB O
represses VBZ B-NegReg
cell NN B-CPA
death NN I-CPA
phenotype NN I-CPA
Three CD O
Cases NNS O
of IN O
KCNT1 NNP O
Mutations NNPS O
: : O
Malignant NNP O
Migrating NNP O
Partial NNP O
Seizures NNPS O
in IN O
Infancy NNP O
with IN O
Massive NNP O
Systemic NNP O
to IN O
Pulmonary NNP O
Collateral NNP O
Arteries NNPS O
. . O

KCNT1 NNP B-Gene
mutations NNS B-Var
are VBP O
gain-of-function NN B-PosReg
mutations NNS O
in IN O
potassium NN O
channels NNS O
resulting VBG O
in IN O
severe JJ O
infantile JJ B-Disease
epilepsy NN I-Disease
Homozygous JJ B-Var
indel JJ I-Var
mutation NN I-Var
in IN O
CDH11 NNP B-Gene
as IN O
the DT O
probable JJ O
cause NN B-Reg
of IN O
Elsahy-Waters NNP B-Disease
syndrome NN I-Disease
. . O

Two CD O
sisters NNS O
from IN O
a DT O
consanguineous JJ O
couple NN O
were VBD O
seen VBN O
in IN O
genetics NNS O
department NN O
for IN O
facial JJ O
dysmorphic JJ O
features NNS O
and CC O
glaucoma JJ O
. . O

They PRP O
both DT O
had VBD O
broad JJ O
foreheads NNS O
, , O
hypertelorism NN O
, , O
megalocorneas NNS O
, , O
thick JJ O
eyebrows NNS O
with IN O
synophrys NNS O
, , O
flat JJ O
malar JJ O
regions NNS O
, , O
broad JJ O
and CC O
bulbous JJ O
noses NNS O
, , O
and CC O
mild JJ O
prognathism NN O
. . O

Both DT O
had VBD O
glaucoma JJ O
, , O
younger JJR O
one NN O
also RB O
had VBD O
cataracts NNS O
and CC O
phthisis NN O
bulbi NN O
. . O

Other JJ O
findings NNS O
included VBD O
bilateral JJ O
partial JJ O
cutaneous JJ O
syndactyly NNS O
of IN O
2nd JJ O
and CC O
3rd JJ O
fingers NNS O
, , O
history NN O
of IN O
impacted VBN O
teeth NNS O
with IN O
dentigerous JJ O
cyst NN O
in IN O
the DT O
elder JJR O
one NN O
, , O
and CC O
intellectual JJ O
disability NN O
( -LRB- O
mild JJ O
and CC O
borderline NN O
) -RRB- O
. . O

The DT O
sisters NNS O
were VBD O
considered VBN O
to TO O
have VB O
Elsahy-Waters NNP O
syndrome NN O
. . O

In IN O
order NN O
to TO O
elucidate VB O
the DT O
underlying JJ O
molecular JJ O
cause NN O
, , O
sisters NNS O
and CC O
their PRP$ O
healthy JJ O
parents NNS O
were VBD O
genotyped VBN O
by IN O
SNP NNP O
arrays NNS O
, , O
followed VBN O
by IN O
homozygosity NN O
mapping NN O
. . O

Homozygous JJ O
regions NNS O
were VBD O
further RB O
analyzed VBN O
by IN O
exome NN O
sequencing NN O
in IN O
one CD O
affected JJ O
individual NN O
. . O

A DT O
homozygous JJ O
indel NN O
variant NN O
segregating VBG O
with IN O
the DT O
condition NN O
was VBD O
detected VBN O
in IN O
CDH11 NNP O
( -LRB- O
c.1116_1117delinsGATCATCAG NNP O
, , O
p.(Ile372MetfsTer9 NN O
) -RRB- O
) -RRB- O
, , O
which WDT O
was VBD O
then RB O
validated VBN O
by IN O
using VBG O
Sanger NNP O
sequencing NN O
. . O

CDH11 NNS O
encodes NNS O
cadherin NN O
11 CD O
( -LRB- O
osteo-cadherin NN O
) -RRB- O
that WDT O
regulates VBZ O
cell-cell NN O
adhesion NN O
, , O
cell NN O
polarization NN O
and CC O
migration NN O
, , O
as RB O
well RB O
as IN O
osteogenic JJ O
differentiation NN O
. . O

Further JJ O
experiments NNS O
revealed VBD O
that IN O
CDH11 NNP O
expression NN O
was VBD O
decreased VBN O
in IN O
patient-derived NN O
fibroblasts NNS O
as IN O
compared VBN O
to IN O
the DT O
heterozygous JJ O
parent NN O
and CC O
another DT O
healthy JJ O
donor NN O
. . O

Immunostaining NN O
showed VBD O
absence NN O
of IN O
the DT O
protein NN O
expression NN O
in IN O
patient JJ O
fibroblasts NNS O
. . O

In IN O
addition NN O
, , O
cell NN B-CPA
proliferation NN I-CPA
rate NN I-CPA
was VBD O
slow JJ B-NegReg
and CC O
osteogenic JJ B-CPA
differentiation NN I-CPA
potential NN I-CPA
was VBD O
delayed VBN B-NegReg
. . O

We PRP O
consider VBP O
that IN O
this DT O
study NN O
reveals VBZ O
loss-of-function NN O
mutations NNS B-Var
in IN O
CDH11 NNP B-Gene
Effect NN B-Reg
of IN O
Mutant NNP B-Var
p53 VBP B-Gene
Proteins NNS B-Protein
on IN O
Glycolysis NNP B-MPA
and CC O
Mitochondrial NNP B-MPA
Metabolism NNP I-MPA
. . O

TP53 NNP O
is VBZ O
one CD O
of IN O
the DT O
most RBS O
commonly RB O
mutated VBN O
genes NNS O
in IN O
human JJ O
cancers NNS O
. . O

Unlike IN O
other JJ O
tumor NN O
suppressors NNS O
that WDT O
are VBP O
frequently RB O
deleted VBN O
or CC O
acquire VB O
loss-of-function NN O
mutations NNS O
, , O
the DT O
majority NN O
of IN O
TP53 NNP B-Gene
mutations NNS B-Var
in IN O
tumors NNS O
are VBP O
missense NN B-Var
substitutions NNS I-Var
, , O
which WDT O
lead VBP O
to IN O
the DT O
expression NN B-MPA
of IN O
full-length JJ O
mutant JJ B-Var
proteins NNS B-Protein
that WDT O
accumulate VBP B-PosReg
in IN O
cancer NN O
cells NNS O
and CC O
may MD O
confer VB O
unique JJ O
gain-of-function NN B-PosReg
( -LRB- O
GOF NN O
) -RRB- O
activities NNS B-MPA
to TO O
promote VB B-PosReg
tumorigenic JJ B-CPA
events NNS I-CPA
. . O

Recently RB O
, , O
mutant JJ B-Var
p53 NN B-Gene
proteins NNS B-Protein
have VBP O
been VBN O
shown VBN O
to TO O
mediate VB O
metabolic JJ B-CPA
changes NNS I-CPA
as IN O
a DT O
novel JJ O
GOF NN B-PosReg
to TO O
promote VB B-PosReg
tumor NN B-CPA
development NN I-CPA
The DT O
Roles NNPS O
of IN O
the DT O
Sole NNP O
Activator-Type NNP O
Auxin NNP O
Response NNP O
Factor NNP O
in IN O
Pattern NNP O
Formation NNP O
of IN O
Marchantia NNP O
polymorpha NN O
. . O

Cell NNP O
division NN O
patterning NN O
is VBZ O
important JJ O
to TO O
determine VB O
body NN O
shape NN O
in IN O
plants NNS O
. . O

Nuclear JJ O
auxin NN O
signaling NN O
mediated VBN O
by IN O
AUXIN NNP O
RESPONSE NNP O
FACTOR NNP O
( -LRB- O
ARF NNP O
) -RRB- O
transcription NN O
factors NNS O
affects VBZ O
plant NN O
growth NN O
and CC O
development NN O
through IN O
regulation NN O
of IN O
cell NN O
division NN O
, , O
elongation NN O
and CC O
differentiation NN O
. . O

The DT O
evolutionary JJ O
origin NN O
of IN O
the DT O
ARF-mediated NNP O
pathway NN O
dates VBZ O
back RB O
to IN O
at IN O
least JJS O
the DT O
common JJ O
ancestor NN O
of IN O
bryophytes NNS O
and CC O
other JJ O
land NN O
plants NNS O
. . O

The DT O
liverwort NN O
Marchantia NNP O
polymorpha NN O
has VBZ O
three CD O
phylogenetically RB O
distinct JJ O
ARFs NNS O
: : O
MpARF1 NNP O
, , O
the DT O
sole NN O
' `` O
activator NN O
' '' O
ARF NNP O
; : O
and CC O
MpARF2 NNP O
and CC O
MpARF3 NNP O
, , O
two CD O
' `` O
repressor NN O
' POS O
ARFs NNS O
. . O

Genetic JJ O
screens NNS O
for IN O
auxin-resistant NN O
mutants NNS O
revealed VBD O
that IN O
loss NN O
of IN O
MpARF1 JJ O
function NN O
conferred VBD O
auxin NN O
insensitivity NN O
. . O

Mparf1 NN B-Gene
mutants NNS B-Var
showed VBD O
reduced JJ B-NegReg
auxin-inducible NN B-Gene
gene NN I-Gene
expression NN B-MPA
and CC O
various JJ O
developmental JJ B-CPA
defects NNS I-CPA
Loss NN O
of IN O
the DT O
nutrient NN O
sensor NN O
TAS1R3 DT O
leads VBZ O
to IN O
reduced JJ O
bone NN O
resorption NN O
. . O

The DT O
taste NN O
receptor NN O
type NN O
1 CD O
( -LRB- O
TAS1R NN O
) -RRB- O
family NN O
of IN O
heterotrimeric JJ O
G NNP O
protein-coupled NN O
receptors NNS O
participates NNS O
in IN O
monitoring VBG O
energy NN O
and CC O
nutrient NN O
status NN O
. . O

TAS1R NN O
member NN O
3 CD O
( -LRB- O
TAS1R3 DT O
) -RRB- O
is VBZ O
a DT O
bi-functional NNP O
protein NN O
that WDT O
recognizes VBZ O
amino NN O
acids NNS O
such JJ O
as IN O
L-glycine NN O
and CC O
L-glutamate NN O
or CC O
sweet JJ O
molecules NNS O
such JJ O
as IN O
sucrose NN O
and CC O
fructose NN O
when WRB O
dimerized VBN O
with IN O
TAS1R NN O
member NN O
1 CD O
( -LRB- O
TAS1R1 NN O
) -RRB- O
or CC O
TAS1R NN O
member NN O
2 CD O
( -LRB- O
TAS1R2 NNP O
) -RRB- O
, , O
respectively RB O
. . O

It PRP O
was VBD O
recently RB O
reported VBN O
that DT O
deletion NN B-Var
of IN O
TAS1R3 DT B-Gene
expression NN O
in IN O
Tas1R3 DT O
mutant JJ O
mice NNS O
leads VBZ O
to IN O
increased VBN B-PosReg
cortical JJ B-CPA
bone NN I-CPA
mass NN I-CPA
but CC O
the DT O
underlying JJ O
cellular JJ O
mechanism NN O
leading VBG O
to IN O
this DT O
phenotype NN O
remains VBZ O
unclear JJ O
. . O

Here RB O
, , O
we PRP O
independently RB O
corroborate VBP O
the DT O
increased VBN B-PosReg
thickness NN B-CPA
of IN I-CPA
cortical JJ I-CPA
bone NN I-CPA
in IN O
femurs NNS O
of IN O
20-week-old CD O
male NN O
Tas1R3 DT B-Gene
mutant JJ B-Var
mice NNS O
and CC O
confirm VBP O
that IN O
Tas1R3 DT O
is VBZ O
expressed VBN O
in IN O
the DT O
bone NN O
environment NN O
. . O

Tas1R3 DT O
is VBZ O
expressed VBN O
in IN O
undifferentiated JJ O
bone NN O
marrow NN O
stromal JJ O
cells NNS O
( -LRB- O
BMSCs NNPS O
) -RRB- O
in FW O
vitro FW O
and CC O
its PRP$ O
expression NN O
is VBZ O
maintained VBN O
during IN O
BMP2-induced VBN O
osteogenic JJ O
differentiation NN O
. . O

However RB O
, , O
levels NNS O
of IN O
the DT O
bone NN O
formation NN O
marker NN O
procollagen NN O
type NN O
I PRP O
N-terminal NN O
propeptide NN O
( -LRB- O
PINP NNP O
) -RRB- O
are VBP O
unchanged JJ O
in IN O
the DT O
serum NN O
of IN O
20-week-old CD O
Tas1R3 DT O
mutant JJ O
mice NNS O
as IN O
compared VBN O
to IN O
controls NNS O
. . O

In IN O
contrast NN O
, , O
levels NNS B-MPA
of IN I-MPA
the DT I-MPA
bone NN I-MPA
resorption NN I-MPA
marker NN I-MPA
collagen NN I-MPA
type NN I-MPA
I PRP I-MPA
C-telopeptide NN I-MPA
are VBP O
reduced VBN B-NegReg
greater JJR O
than IN O
60 CD O
% NN O
in IN O
Tas1R3 DT B-Gene
mutant JJ B-Var
mice NNS O
. . O

Consistent JJ O
with IN O
this DT O
, , O
Tas1R3 DT O
and CC O
its PRP$ O
putative JJ O
signaling NN O
partner NN O
Tas1R2 NNP O
are VBP O
expressed VBN O
in IN O
primary JJ O
osteoclasts NNS O
and CC O
their PRP$ O
expression NN O
levels NNS O
positively RB O
correlate VBP O
with IN O
differentiation NN O
status NN O
. . O

Collectively RB O
, , O
these DT O
findings NNS O
suggest VBP O
that IN O
high JJ B-PosReg
bone NN B-CPA
mass NN I-CPA
in IN O
Tas1R3 DT B-Gene
mutant JJ B-Var
mice NNS O
is VBZ O
due JJ O
to IN O
uncoupled JJ O
bone NN O
remodeling VBG O
with IN O
reduced VBN B-NegReg
osteoclast JJ B-CPA
function NN I-CPA
Molecular JJ O
characterization NN O
of IN O
the DT O
llama NN O
FGF5 NN O
gene NN O
and CC O
identification NN O
of IN O
putative JJ O
loss NN O
of IN O
function NN O
mutations NNS O
. . O

Llama NNP O
, , O
the DT O
most RBS O
numerous JJ O
domestic JJ O
camelid NN O
in IN O
Argentina NNP O
, , O
has VBZ O
good JJ O
fiber-production NN O
ability NN O
. . O

Although IN O
a DT O
few JJ O
genes NNS O
related VBN O
to IN O
other JJ O
productive JJ O
traits NNS O
have VBP O
been VBN O
characterized VBN O
, , O
the DT O
molecular JJ O
genetic JJ O
basis NN O
of IN O
fiber NN O
growth NN O
control NN O
in IN O
camelids NNS O
is VBZ O
still RB O
poorly RB O
understood VBN O
. . O

Fibroblast JJ O
growth NN O
factor NN O
5 CD O
( -LRB- O
FGF5 NN O
) -RRB- O
is VBZ O
a DT O
secreted JJ O
signaling NN O
protein NN O
that WDT O
controls VBZ O
hair NN O
growth NN O
in IN O
humans NNS O
and CC O
other JJ O
mammals NNS O
. . O

Mutations NNS O
in IN O
the DT O
FGF5 NNP O
gene NN O
have VBP O
been VBN O
associated VBN O
with IN O
long-hair JJ O
phenotypes NNS O
in IN O
several JJ O
species NNS O
. . O

Here RB O
, , O
we PRP O
sequenced VBD O
the DT O
llama NN O
FGF5 NN O
gene NN O
, , O
which WDT O
consists VBZ O
of IN O
three CD O
exons NNS O
encoding VBG O
813 CD O
   O
bp NNP O
. . O

cDNA CD O
analysis NN O
from IN O
hair NN O
follicles NNS O
revealed VBD O
the DT O
expression NN O
of IN O
two CD O
FGF5 NNP O
alternative NN O
spliced VBN O
transcripts NNS O
, , O
in IN O
one CD O
of IN O
which WDT O
exon NN O
2 CD O
is VBZ O
absent JJ O
. . O

DNA NN O
variation NN O
analysis NN O
showed VBD O
four CD O
polymorphisms NNS O
in IN O
the DT O
coding NN O
region NN O
: : O
a DT O
synonymous JJ O
SNP NNP O
( -LRB- O
c.210A NN O
> XX O
G NN O
) -RRB- O
, , O
a DT O
single JJ O
base NN O
deletion NN O
( -LRB- O
c.348delA NN B-Var
) -RRB- O
, , O
a DT O
12-bp CD O
insertion NN O
( -LRB- O
c.351_352insCATATAACATAG FW O
) -RRB- O
and CC O
a DT O
non-sense AFX O
mutation NN O
( -LRB- O
c.499C NN O
> XX O
T NNP O
) -RRB- O
. . O

The DT O
deletion NN O
was VBD O
always RB O
found VBN O
together RB O
with IN O
the DT O
insertion NN O
forming VBG O
a DT O
haplotype NN O
and CC O
producing VBG O
a DT O
putative JJ O
truncated VBN O
protein NN O
of IN O
123 CD O
amino NN O
acids NNS O
. . O

The DT O
c.499C NN B-Var
> XX O
T NNP O
mutation NN O
also RB O
leads VBZ O
to IN O
a DT O
premature JJ O
stop NN O
codon VBN O
at IN O
position NN O
168 CD O
. . O

In IN O
both DT O
cases NNS O
, , O
critical JJ B-MPA
functional JJ I-MPA
domains NNS I-MPA
of IN O
FGF5 NNP B-Gene
, , O
including VBG O
one CD O
heparin JJ B-MPA
binding VBG I-MPA
site NN I-MPA
, , O
are VBP O
lost VBN B-NegReg
Differential JJ O
regulation NN O
of IN O
two CD O
FLNA NNP O
transcripts NNS O
explains VBZ O
some DT O
of IN O
the DT O
phenotypic NN O
heterogeneity NN O
in IN O
the DT O
loss-of-function NN O
filaminopathies NNS O
. . O

Loss-of-function NNP B-NegReg
mutations NNS B-Var
in IN O
the DT O
X-linked NN O
gene NN O
FLNA NNP B-Gene
can MD O
lead VB O
to IN O
abnormal JJ B-CPA
neuronal JJ I-CPA
migration NN I-CPA
, , O
vascular NN B-CPA
and CC I-CPA
cardiac JJ I-CPA
defects NNS I-CPA
, , O
and CC O
congenital JJ B-Disease
intestinal JJ I-Disease
pseudo-obstruction NN I-Disease
A DT O
disulfide NN O
bond NN O
A-like NN O
oxidoreductase NN O
is VBZ O
a DT O
strong JJ O
candidate NN O
gene NN O
for IN O
self-incompatibility NN O
in IN O
apricot NN O
( -LRB- O
Prunus NNP O
armeniaca NNP O
) -RRB- O
pollen NN O
. . O

S-RNase NNP O
based VBD O
gametophytic JJ O
self-incompatibility NN O
( -LRB- O
SI NNP O
) -RRB- O
is VBZ O
a DT O
widespread JJ O
prezygotic JJ O
reproductive JJ O
barrier NN O
in IN O
flowering VBG O
plants NNS O
. . O

In IN O
the DT O
Solanaceae NNP O
, , O
Plantaginaceae NNP O
and CC O
Rosaceae NNP O
gametophytic JJ O
SI NN O
is VBZ O
controlled VBN O
by IN O
the DT O
pistil-specific VBN O
S-RNases NNP O
and CC O
the DT O
pollen NN O
S-locus NNP O
F-box NNP O
proteins NNS O
but CC O
non-S-specific AFX O
factors NNS O
, , O
namely RB O
modifiers NNS O
, , O
are VBP O
also RB O
required VBN O
. . O

In IN O
apricot NN O
, , O
Prunus NNP O
armeniaca NNP O
( -LRB- O
Rosaceae NNP O
) -RRB- O
, , O
we PRP O
previously RB O
mapped VBD O
two CD O
pollen-part NN O
mutations NNS B-Var
that WDT O
confer VBP B-Reg
self-compatibility NN B-MPA
in IN O
cultivars NNS O
Canino NNP O
and CC O
Katy NNP O
at IN O
the DT O
distal JJ O
end NN O
of IN O
chromosome NN O
3 CD O
( -LRB- O
M-locus CD O
) -RRB- O
unlinked JJ O
to IN O
the DT O
S-locus NNP O
. . O

Here RB O
, , O
we PRP O
used VBD O
high-resolution JJ O
mapping NN O
to TO O
identify VB O
the DT O
M-locus NNP O
with IN O
an DT O
~134 NN O
kb FW O
segment NN O
containing VBG O
ParM-1-16 NN O
genes NNS O
. . O

Gene NN O
expression NN O
analysis NN O
identified VBD O
four CD O
genes NNS O
preferentially RB O
expressed VBD O
in IN O
anthers NNS O
as IN O
modifier JJR O
gene NN O
candidates NNS O
, , O
ParM-6 NNP O
, , O
-7 JJ O
, , O
-9 : O
and CC O
-14 NN O
. . O

Variant JJ O
calling VBG O
of IN O
WGS NNP O
Illumina NNP O
data NNS O
from IN O
Canino NNP O
, , O
Katy NNP O
, , O
and CC O
10 CD O
self-incompatible NN O
cultivars NNS O
detected VBD O
a DT O
358 CD O
bp NNP O
miniature JJ O
inverted-repeat VBN O
transposable JJ O
element NN O
( -LRB- O
MITE NNP O
) -RRB- O
insertion NN O
in IN O
ParM-7 NNP O
shared VBN O
only RB O
by IN O
self-compatible NN O
apricots NNS O
, , O
supporting VBG O
ParM-7 NN O
as RB O
strong JJ O
candidate NN O
gene NN O
required VBN O
for IN O
SI NNP O
. . O

ParM-7 VB O
encodes NNS O
a DT O
disulfide NN O
bond NN O
A-like NN O
oxidoreductase NN O
protein NN O
, , O
which WDT O
we PRP O
named VBD O
ParMDO NN O
. . O

The DT O
MITE NNP B-Gene
insertion NN B-Var
truncates VBZ B-NegReg
the DT O
ParMDO NNP B-MPA
ORF NNP I-MPA
and CC O
produces VBZ O
a DT O
loss NN B-NegReg
of IN O
SI NN B-MPA
function NN I-MPA
The DT O
Gain-of-Function NN B-PosReg
Integrin NNP O
β3 VBP O
Pro33 NNP O
Variant NNP B-Var
Alters NNPS O
the DT O
Serotonin NNP B-MPA
System NNP I-MPA
in IN O
the DT O
Mouse NNP O
Brain NNP O
. . O

Engagement NNP O
of IN O
integrins NNS O
by IN O
the DT O
extracellular JJ O
matrix NN O
initiates VBZ O
signaling VBG O
cascades NNS O
that WDT O
drive VBP O
a DT O
variety NN O
of IN O
cellular JJ O
functions NNS O
, , O
including VBG O
neuronal JJ O
migration NN O
and CC O
axonal JJ O
pathfinding NN O
in IN O
the DT O
brain NN O
. . O

Multiple JJ O
lines NNS O
of IN O
evidence NN O
link VBP O
the DT O
ITGB3 NNP O
gene NN O
encoding VBG O
the DT O
integrin NN O
β3 VBP O
subunit NN O
with IN O
the DT O
serotonin NN O
( -LRB- O
5-HT CD O
) -RRB- O
system NN O
, , O
likely JJ O
via IN O
its PRP$ O
modulation NN O
of IN O
the DT O
5-HT CD O
transporter NN O
( -LRB- O
SERT NNP O
) -RRB- O
. . O

The DT O
ITGB3 NNP B-Gene
coding VBG O
polymorphism NN O
Leu33Pro NN B-Var
( -LRB- O
rs5918 NN O
, , O
PlA2 NNS O
) -RRB- O
produces VBZ O
hyperactive JJ B-PosReg
αvβ3 VBP B-Protein
receptors NNS I-Protein
that WDT O
influence VBP B-Reg
whole-blood JJ B-MPA
5-HT CD I-MPA
levels NNS I-MPA
and CC O
may MD O
influence VB B-Reg
the DT O
risk NN O
for IN O
autism NN B-Disease
spectrum NN I-Disease
disorder NN I-Disease
( -LRB- O
ASD NN O
) -RRB- O
. . O

Using VBG O
a DT O
phenome-wide JJ O
scan NN O
of IN O
psychiatric JJ O
diagnoses NNS O
, , O
we PRP O
found VBD O
significant JJ O
, , O
male-specific JJ O
associations NNS O
between IN O
the DT O
Pro33 JJ O
allele NN O
and CC O
attention-deficit NN O
hyperactivity NN O
disorder NN O
and CC O
ASDs NNS O
. . O

Here RB O
, , O
we PRP O
used VBD O
knock-in VB O
( -LRB- O
KI NNP O
) -RRB- O
mice NNS O
expressing VBG O
an DT O
Itgb3 NNP B-Gene
variant NN B-Var
that WDT O
phenocopies VBZ O
the DT O
human JJ O
Pro33 PRP$ O
variant NN O
to TO O
elucidate VB O
the DT O
consequences NNS O
of IN O
constitutively RB O
enhanced JJ B-PosReg
αvβ3 NN B-MPA
signaling VBG I-MPA
to IN I-MPA
the DT I-MPA
5-HT CD I-MPA
system NN I-MPA
Parkin NN B-Gene
absence NN B-Var
accelerates VBZ B-PosReg
microtubule VBP B-MPA
aging VBG I-MPA
in IN I-MPA
dopaminergic JJ I-MPA
neurons NNS I-MPA
. . O

Loss-of-function NNP B-NegReg
caused VBN O
by IN O
mutations NNS B-Var
in IN O
the DT O
parkin NN O
gene NN O
( -LRB- O
PARK2 NNP B-Gene
) -RRB- O
lead VBP O
to IN O
early-onset JJ B-Disease
familial JJ I-Disease
Parkinson NNP I-Disease
's POS I-Disease
disease NN O
. . O

Recently RB O
, , O
mechanistic JJ O
studies NNS O
proved VBD O
the DT O
ability NN O
of IN O
parkin NN O
in IN O
regulating VBG O
mitochondria NN O
homeostasis NN O
and CC O
microtubule JJ O
( -LRB- O
MT NNP O
) -RRB- O
stability NN O
. . O

Looking VBG O
at IN O
these DT O
systems NNS O
during IN O
aging VBG O
of IN O
PARK2 NNP O
knockout NN O
mice NNS O
, , O
we PRP O
found VBD O
that IN O
loss NN B-Var
of IN O
parkin NN B-Gene
induced VBD O
an DT O
accelerated JJ B-PosReg
( -LRB- O
over)acetylation NN O
of IN O
MT NNP O
system NN O
both CC O
in IN O
dopaminergic JJ O
neuron NN O
cell NN O
bodies NNS O
and CC O
fibers NNS O
, , O
localized VBN O
in IN O
the DT O
substantia NN O
nigra NN O
and CC O
corpus NN O
striatum NN O
, , O
respectively RB O
. . O

Interestingly RB O
, , O
in IN O
PARK2 NNP O
knockout NN O
mice NNS O
, , O
changes NNS O
of IN O
MT NNP O
stability NN O
preceded VBD O
the DT O
alteration NN O
of IN O
mitochondria NN O
transport NN O
. . O

Moreover RB O
, , O
in-cell IN O
experiments NNS O
confirmed VBD O
that IN O
loss NN O
of IN O
parkin NN O
affects VBZ O
mitochondria NN O
mobility NN O
and CC O
showed VBD O
that IN O
this DT O
defect NN O
depends VBZ O
on IN O
MT NNP O
system NN O
as IN O
it PRP O
is VBZ O
rescued VBN O
by IN O
paclitaxel NN O
, , O
a DT O
well-known RB O
MT-targeted NNP O
agent NN O
. . O

Furthermore RB O
, , O
both CC O
in IN O
PC12 NNP O
neuronal JJ O
cells NNS O
and CC O
in IN O
patients NNS O
' POS O
induced VBN O
pluripotent NN O
stem NN O
cell-derived NN O
midbrain NN O
neurons NNS O
, , O
we PRP O
observed VBD O
that DT O
parkin NN O
deficiencies NNS O
cause VBP O
the DT O
fragmentation NN O
of IN O
stable JJ O
MTs NNS O
. . O

Therefore RB O
, , O
we PRP O
suggest VBP O
that DT O
parkin NN O
acts NNS O
as IN O
a DT O
regulator NN O
of IN O
MT NNP O
system NN O
during IN O
neuronal JJ O
aging NN O
, , O
and CC O
we PRP O
endorse VBP O
the DT O
hypothesis NN O
that WDT O
MT NNP O
dysfunction NN O
may MD O
be VB O
crucial JJ O
in IN O
the DT O
pathogenesis NN O
of IN O
Parkinson NNP O
's POS O
disease NN O
. . O

Parkinson NNP B-Disease
's POS I-Disease
Disease-Associated NNP O
LRRK2 NNP B-Gene
Hyperactive NNP O
Kinase NNP O
Mutant NNP B-Var
Disrupts NNP B-NegReg
Synaptic NNP B-MPA
Vesicle NNP I-MPA
Trafficking NN I-MPA
in IN I-MPA
Ventral NNP I-MPA
Midbrain NNP I-MPA
Neurons NNPS I-MPA
. . O

Parkinson NNP O
's POS O
disease NN O
( -LRB- O
PD NNP O
) -RRB- O
is VBZ O
characterized VBN O
pathologically RB O
by IN O
the DT O
selective JJ O
loss NN O
of IN O
substantia NN O
nigra NN O
( -LRB- O
SN NNP O
) -RRB- O
dopaminergic JJ O
( -LRB- O
DAergic NN O
) -RRB- O
neurons NNS O
. . O

Recent JJ O
evidence NN O
has VBZ O
suggested VBN O
a DT O
role NN O
of IN O
LRRK2 NNS O
, , O
linked VBN O
to IN O
the DT O
most RBS O
frequent JJ O
familial JJ O
PD NN O
, , O
in IN O
regulating VBG O
synaptic JJ O
vesicle NN O
( -LRB- O
SV NNP O
) -RRB- O
trafficking NN O
. . O

However RB O
, , O
the DT O
mechanism NN O
whereby WRB O
LRRK2 NNP B-Gene
mutants NNS B-Var
contribute VBP B-Reg
to IN O
nigral JJ B-MPA
vulnerability NN I-MPA
remains VBZ O
unclear JJ O
. . O

Here RB O
we PRP O
show VBP O
that IN O
the DT O
most RBS O
common JJ O
PD NNP O
mutation NN B-Var
LRRK2 NNS B-Gene
G2019S NNP O
impairs NNS B-NegReg
SV NNP B-MPA
endocytosis NN I-MPA
in IN I-MPA
ventral JJ I-MPA
midbrain NN I-MPA
( -LRB- I-MPA
MB NNP I-MPA
) -RRB- I-MPA
neurons NNS I-MPA
, , I-MPA
including VBG O
DA NNP O
neurons NNS O
, , O
and CC O
the DT O
slowed JJ O
endocytosis NN O
can MD O
be VB O
rescued VBN O
by IN O
inhibition NN O
of IN O
LRRK2 NNS O
kinase VBP O
activity NN O
. . O

A DT O
similar JJ O
endocytic JJ O
defect NN O
, , O
however RB O
, , O
was VBD O
not RB O
observed VBN O
in IN O
LRRK2 NNS O
mutant JJ O
neurons NNS O
from IN O
the DT O
neocortex NN O
( -LRB- O
hereafter JJ O
, , O
cortical JJ O
neurons NNS O
) -RRB- O
or CC O
the DT O
hippocampus NN O
, , O
suggesting VBG O
a DT O
brain NN O
region-specific NN O
vulnerability NN O
to IN O
the DT O
G2019S JJ O
mutation NN O
. . O

Additionally RB O
, , O
we PRP O
found VBD O
MB-specific NN O
impairment NN B-NegReg
of IN O
SV NNP B-MPA
endocytosis NN I-MPA
in IN I-MPA
neurons NNS I-MPA
carrying VBG O
heterozygous JJ O
deletion NN B-Var
of IN O
SYNJ1 NNP B-Gene
( -LRB- O
PARK20 NN O
) -RRB- O
, , O
a DT O
gene NN O
that WDT O
is VBZ O
associated VBN O
with IN O
recessive JJ O
Parkinsonism NN O
. . O

Combining VBG O
SYNJ1+/- NN B-Var
and CC O
LRRK2 NNP B-Var
G2019S NNP I-Var
does VBZ O
not RB O
exacerbate VB O
SV NNP O
endocytosis NN O
but CC O
impairs NNS B-NegReg
sustained VBD B-MPA
exocytosis NN I-MPA
in IN I-MPA
MB NN I-MPA
neurons NNS I-MPA
and CC O
alters NNS B-Reg
specific JJ B-MPA
motor NN I-MPA
functions NNS I-MPA
of IN O
1-year-old JJ O
male JJ O
mice NNS O
. . O

Interestingly RB O
, , O
we PRP O
show VBP O
that IN O
LRRK2 NNS B-Var
directly RB O
phosphorylates VBZ O
synaptojanin1 NN O
in IN O
vitro FW O
, , O
resulting VBG B-Reg
in IN I-Reg
the DT O
disruption NN B-MPA
of IN I-MPA
endophilin-synaptojanin1 NN I-MPA
interaction NN I-MPA
required VBN I-MPA
for IN I-MPA
SV NNP I-MPA
endocytosis NN I-MPA
. . O

Our PRP$ O
work NN O
suggests VBZ O
a DT O
merge NN O
of IN O
LRRK2 NNS O
and CC O
SYNJ1 VBN O
pathogenic JJ O
pathways NNS O
in IN O
deregulating VBG O
SV NNP O
trafficking NN O
in IN O
MB NN O
neurons NNS O
as IN O
an DT O
underlying JJ O
molecular JJ O
mechanism NN O
of IN O
early JJ O
PD NNP O
pathogenesis NN O
. . O

SIGNIFICANCE NNP O
STATEMENT NNP O
Understanding NNP O
midbrain NN O
dopaminergic JJ O
( -LRB- O
DAergic NN O
) -RRB- O
neuron-selective NN O
vulnerability NN O
in IN O
PD NNP O
is VBZ O
essential JJ O
for IN O
the DT O
development NN O
of IN O
targeted VBN O
therapeutics NNS O
. . O

We PRP O
report VBP O
, , O
for IN O
the DT O
first JJ O
time NN O
, , O
a DT O
nerve NN O
terminal NN O
impairment NN O
in IN O
SV NNP O
trafficking NN O
selectively RB O
in IN O
MB NN O
neurons NNS O
but CC O
not RB O
cortical JJ O
neurons NNS O
caused VBN O
by IN O
two CD O
PARK NNP O
genes NNS O
: : O
LRRK2 NNP O
( -LRB- O
PARK8 NNP O
) -RRB- O
and CC O
SYNJ1 NN O
( -LRB- O
PARK20 NN O
) -RRB- O
. . O

We PRP O
demonstrate VBP O
that IN O
the DT O
enhanced JJ B-PosReg
kinase NN B-MPA
activity NN I-MPA
resulting VBG O
from IN O
the DT O
most RBS O
frequent JJ O
G2019S JJ B-Var
mutation NN O
in IN O
LRRK2 NNP B-Gene
is VBZ O
the DT O
key NN O
to IN O
this DT O
impairment NN O
. . O

We PRP O
provide VBP O
evidence NN O
suggesting VBG O
that IN O
LRRK2 NNP B-Gene
G2019S NNP B-Var
and CC O
SYNJ1 NN B-Gene
loss NN B-NegReg
of IN I-NegReg
function NN I-NegReg
share VBP O
a DT O
similar JJ O
pathogenic JJ O
pathway NN O
in IN O
deregulating VBG B-MPA
DAergic NN I-MPA
neuron NN I-MPA
SV NNP I-MPA
endocytosis NN I-MPA
and CC O
that IN O
they PRP O
play VBP B-Reg
additive JJ I-Reg
roles NNS I-Reg
in IN O
facilitating VBG O
each DT O
other JJ O
's POS O
pathogenic JJ O
functions NNS O
in IN O
PD NNP B-Disease
From IN O
mutational JJ O
inactivation NN O
to TO O
aberrant NN O
gain-of-function NN O
: : O
Unraveling VBG O
the DT O
structural JJ O
basis NN O
of IN O
mutant JJ O
p53 NN O
oncogenic JJ O
transition NN O
. . O

Various JJ O
evidence NN O
has VBZ O
revealed VBN O
that IN O
mutations NNS B-Var
in IN O
p53 NN B-Gene
exert NN O
activities NNS O
that WDT O
go VBP O
beyond IN O
simply RB O
inactivation NN B-PosReg
of IN O
wildtype NN B-MPA
functions NNS I-MPA
but CC O
rather RB O
elicits VBZ B-Reg
downstream JJ O
interactions NNS B-Interaction
that WDT O
promote VBP B-PosReg
malignancy NN B-Disease
described VBN O
as IN O
mutant JJ B-Var
p53 NN B-Gene
gain-of-function JJ B-PosReg
( -LRB- O
GOF NN O
) -RRB- O
. . O

Here RB O
we PRP O
report VBP O
the DT O
first JJ O
account NN O
of IN O
the DT O
dynamics NNS O
of IN O
mutation-induced NN O
structural JJ O
transition NN O
of IN O
native JJ O
p53 NN O
to IN O
an DT O
aberrant JJ O
gain-of-function NN O
state NN O
, , O
studying VBG O
the DT O
wildtype NN O
( -LRB- O
WT NNP O
) -RRB- O
and CC O
high JJ O
incidence NN O
contact NN O
( -LRB- O
R273C NNP B-Var
) -RRB- O
and CC O
structural JJ O
( -LRB- O
R175H NNP B-Var
) -RRB- O
mutant JJ O
p53 NN B-Gene
( -LRB- O
mutp53 NN O
) -RRB- O
through IN O
molecular JJ O
dynamics NNS O
simulation NN O
. . O

Result NN O
analysis NN O
revealed VBD O
that IN O
both DT O
mutants NNS O
exhibited VBD B-Reg
structural JJ B-Var
distortion NN I-Var
and CC O
reduced VBN B-NegReg
flexibility NN B-MPA
, , O
indicative JJ O
of IN O
rigidity NN O
and CC O
kinetic JJ O
stability NN O
. . O

In IN O
addition NN O
, , O
surface NN O
analysis NN O
revealed VBD O
an DT O
increase NN O
in IN O
the DT O
accessible JJ O
surface NN O
area NN O
in IN O
the DT O
p53 NN O
mutants NNS O
. . O

This DT O
suggests VBZ O
that IN O
the DT O
GOF NN O
transition NN O
involves VBZ O
protein NN O
unfolding NN O
and CC O
exposure NN O
of IN O
buried VBN O
hydrophobic JJ O
surface NN O
essential JJ O
for IN O
interaction NN O
with IN O
HSF-1 NNP O
oncogenic JJ O
partner NN O
and CC O
wildtype NN O
p63 NN O
, , O
and CC O
p73 NN O
homologs NNS O
. . O

Further JJ O
validation NN O
revealed VBD O
binding VBG O
cavities NNS O
, , O
similar JJ O
in IN O
the DT O
mutants NNS O
but CC O
dissimilar JJ O
to IN O
the DT O
WT NNP O
. . O

Taken VBN O
together RB O
, , O
this DT O
study NN O
complements VBZ O
experimental JJ O
findings NNS O
and CC O
reveals VBZ O
the DT O
interplay NN O
between IN O
mutation-induced NN B-Var
structural JJ O
distortion NN O
, , O
loss NN O
of IN O
flexibility NN O
, , O
rigidity NN O
, , O
enhanced JJ O
stability NN O
, , O
protein NN O
unfolding NN O
and CC O
ultimately RB O
, , O
exposure NN O
of IN O
binding JJ O
surfaces NNS O
as IN O
conformational JJ O
attributes NNS O
that WDT O
characterize VBP O
mutP53 CD O
structure-GOF NN O
activities NNS O
. . O

This DT O
insight NN O
is VBZ O
, , O
therefore RB O
, , O
of IN O
great JJ O
importance NN O
as IN O
it PRP O
opens VBZ O
up RP O
a DT O
novel JJ O
therapeutic JJ O
approach NN O
toward IN O
the DT O
structure NN O
based VBN O
targeting NN O
of IN O
mutP53 NNP O
oncogenic JJ O
involvement NN O
beyond IN O
wildtype NN O
inactivation NN O
. . O

Furthermore RB O
, , O
" `` O
exposed VBD O
" '' O
binding JJ O
site NN O
information NN O
obtained VBN O
from IN O
this DT O
study NN O
can MD O
be VB O
explored VBN O
for IN O
structure-based NN O
design NN O
of IN O
substances NNS O
best RB O
described VBN O
as IN O
" `` O
destabilizers NNS O
" '' O
to TO O
disrupt VB O
the DT O
GOF NN O
interaction NN O
of IN O
mutp53 NN O
. . O

Gain-of-function NN B-PosReg
HCN2 NNP B-Gene
variants NNS B-Var
in IN O
genetic JJ O
epilepsy NN B-Disease
. . O

Genetic NNP O
generalized VBD O
epilepsy NN O
( -LRB- O
GGE NNP O
) -RRB- O
is VBZ O
a DT O
common JJ O
epilepsy NN O
syndrome NN O
that WDT O
encompasses VBZ O
seizure NN O
disorders NNS O
characterized VBN O
by IN O
spike-and-wave NN O
discharges NNS O
( -LRB- O
SWDs NNPS O
) -RRB- O
. . O

Pacemaker NNP O
hyperpolarization-activated NN O
cyclic JJ O
nucleotide-gated NN O
channels NNS O
( -LRB- O
HCN NNP O
) -RRB- O
are VBP O
considered VBN O
integral JJ O
to IN O
SWD NNP O
genesis NN O
, , O
making VBG O
them PRP O
an DT O
ideal JJ O
gene NN O
candidate NN O
for IN O
GGE NNP O
. . O

We PRP O
identified VBD O
HCN2 NNP O
missense NN O
variants NNS O
from IN O
a DT O
large JJ O
cohort NN O
of IN O
585 CD O
GGE NNP O
patients NNS O
, , O
recruited VBN O
by IN O
the DT O
Epilepsy NNP O
Phenome-Genome NNP O
Project NNP O
( -LRB- O
EPGP NNP O
) -RRB- O
, , O
and CC O
performed VBD O
functional JJ O
analysis NN O
using VBG O
two-electrode CD O
voltage NN O
clamp NN O
recordings NNS O
from IN O
Xenopus NNP O
oocytes NNS O
. . O

The DT O
p NN O
. . O

S632W NN O
variant NN O
was VBD O
identified VBN O
in IN O
a DT O
patient NN O
with IN O
idiopathic JJ O
photosensitive JJ O
occipital JJ O
epilepsy NN O
and CC O
segregated VBN O
in IN O
the DT O
family NN O
. . O

This DT O
variant NN O
was VBD O
also RB O
independently RB O
identified VBN O
in IN O
an DT O
unrelated JJ O
patient NN O
with IN O
childhood NN O
absence NN O
seizures NNS O
from IN O
a DT O
European JJ O
cohort NN O
of IN O
238 CD O
familial JJ O
GGE NNP O
cases NNS O
. . O

The DT O
p NN O
. . O

V246 NNP O
M NNP O
variant NN O
was VBD O
identified VBN O
in IN O
a DT O
patient NN O
with IN O
photo-sensitive NN O
GGE NNP O
and CC O
his PRP$ O
father NN O
diagnosed VBD O
with IN O
juvenile JJ O
myoclonic JJ O
epilepsy NN O
. . O

Functional JJ O
studies NNS O
revealed VBD O
that IN O
both DT O
p NN B-Var
. . O

S632W VB O
and CC O
p NN B-Var
. . O

V246 NNP O
M NNP O
had VBD O
an DT O
identical JJ O
functional JJ O
impact NN O
including VBG O
a DT O
depolarizing VBG B-MPA
shift NN I-MPA
in IN I-MPA
the DT I-MPA
voltage NN I-MPA
dependence NN I-MPA
of IN O
activation NN B-PosReg
that WDT O
is VBZ O
consistent JJ O
with IN O
a DT O
gain-of-function JJ O
. . O

In IN O
contrast NN O
, , O
no DT O
biophysical JJ O
changes NNS O
resulted VBD O
from IN O
the DT O
introduction NN O
of IN O
common JJ O
population NN O
variants NNS O
, , O
p NN O
. . O

E280 NNP O
K NNP O
and CC O
p NN O
. . O

A705 NNP O
T NNP O
, , O
and CC O
the DT O
p NN O
. . O

R756C JJ O
variant NN O
from IN O
EPGP NNP O
that WDT O
did VBD O
not RB O
segregate VB O
with IN O
disease NN O
. . O

Our PRP$ O
data NNS O
suggest VBP O
that IN O
HCN2 NNP B-Gene
variants NNS B-Var
can MD O
confer VB O
susceptibility NN B-MPA
to IN O
GGE NNP O
via IN O
a DT O
gain-of-function JJ B-PosReg
Polymorphism NN O
of IN O
glutathione NN O
S-transferase NNP O
M1 NNP O
and CC O
T1 NNP O
genes NNS O
and CC O
susceptibility NN O
to IN O
psoriasis NN O
disease NN O
: : O
A DT O
study NN O
from IN O
North NNP O
India NNP O
. . O

BACKGROUND NNP O
: : O
Increased VBN O
oxidative JJ O
stress NN O
and CC O
resulting VBG O
inflammation NN O
has VBZ O
been VBN O
emphasized VBN O
as IN O
a DT O
factor NN O
in IN O
the DT O
pathogenesis NN O
of IN O
many JJ O
diseases NNS O
including VBG O
psoriasis NN O
. . O

Glutathione NNP O
S-transferases NNP O
( -LRB- O
GSTs NNS O
) -RRB- O
protect VB O
against IN O
oxidative JJ O
stress NN O
, , O
inflammation NN O
, , O
and CC O
genotoxicity NN O
. . O

Polymorphisms NNS B-Var
in IN O
the DT O
GST NNP B-Gene
genes NNS O
may MD O
lead VB B-Reg
to IN I-Reg
an DT O
imbalance NN B-MPA
in IN I-MPA
pro- AFX I-MPA
and CC I-MPA
antioxidant NN I-MPA
systems NNS I-MPA
resulting VBG O
in IN O
the DT O
increased VBN B-PosReg
production NN B-MPA
of IN I-MPA
reactive JJ I-MPA
oxygen NN I-MPA
species NNS I-MPA
that WDT O
could MD O
influence VB B-Reg
the DT O
pathogenesis NN O
of IN O
psoriasis NN B-Disease
. . O

AIM NNP O
: : O
The DT O
aim NN O
of IN O
this DT O
study NN O
was VBD O
to TO O
investigate VB O
the DT O
association NN O
between IN O
GSTs NNP O
( -LRB- O
GSTM1 VB O
and CC O
GSTT1 NNP O
) -RRB- O
gene NN O
polymorphism NN O
in IN O
patients NNS O
with IN O
chronic JJ O
plaque NN O
psoriasis NN O
as IN O
a DT O
factor NN O
in IN O
the DT O
susceptibility NN O
and CC O
development NN O
of IN O
psoriasis NN O
. . O

MATERIALS NNS O
AND CC O
METHODS NNS O
: : O
We PRP O
assessed VBD O
128 CD O
patients NNS O
with IN O
psoriasis NN O
and CC O
250 CD O
age- NN O
and CC O
sex-matched NN O
healthy JJ O
controls NNS O
. . O

Genomic JJ O
DNA NNP O
was VBD O
extracted VBN O
from IN O
peripheral JJ O
blood NN O
by IN O
the DT O
phenol NN O
chloroform NN O
method NN O
. . O

The DT O
null JJ O
GSTT1 NN O
and CC O
GSTM1 VB O
genotypes NNS O
were VBD O
identified VBN O
by IN O
multiplex JJ O
polymerase NN O
chain NN O
reaction NN O
( -LRB- O
PCR NN O
) -RRB- O
method NN O
. . O

RESULTS NNS O
: : O
The DT O
null JJ O
genotype NN O
of IN O
GSTM1 NNP O
and CC O
GSTT1 NN O
was VBD O
seen VBN O
in IN O
45.3 CD O
% NN O
and CC O
40.6 CD O
% NN O
in IN O
psoriasis NN O
patients NNS O
whereas IN O
in IN O
the DT O
controls NNS O
it PRP O
was VBD O
34.4 CD O
% NN O
and CC O
20.0 CD O
% NN O
, , O
respectively RB O
. . O

A DT O
significant JJ O
association NN O
was VBD O
seen VBN O
between IN O
the DT O
null JJ O
alleles NNS O
of IN O
the DT O
GSTT1 NN O
( -LRB- O
OR CC O
= SYM O
2.74 CD O
) -RRB- O
and CC O
GSTM1 NNP O
( -LRB- O
OR CC O
= SYM O
1.58 CD O
) -RRB- O
alone RB O
or CC O
in IN O
combination NN O
with IN O
tobacco NN O
use NN O
( -LRB- O
P NN O
< XX O
0.001 CD O
) -RRB- O
and CC O
psoriasis NN O
risk NN O
. . O

The DT O
presence NN B-Var
of IN O
both DT O
null JJ O
genotypes NNS O
of IN O
GSTM1 NNP B-Gene
and CC O
GSTT1 NNP B-Gene
further RB O
increased VBD B-PosReg
the DT O
risk NN O
of IN O
psoriasis NN B-Disease
Loss-of-function NN O
of IN O
ASPARTIC NNP O
PEPTIDASE NNP O
NODULE-INDUCED NNP O
1 CD O
( -LRB- O
APN1 NNP O
) -RRB- O
in IN O
Lotus NNP O
japonicus NN O
restricts VBZ O
efficient JJ O
nitrogen-fixing NN O
symbiosis NN O
with IN O
specific JJ O
Mesorhizobium NNP O
loti NN O
strains NNS O
. . O

The DT O
nitrogen-fixing NN O
symbiosis NN O
of IN O
legumes NNS O
and CC O
Rhizobium NNP O
bacteria NNS O
is VBZ O
established VBN O
by IN O
complex JJ O
interactions NNS O
between IN O
the DT O
two CD O
symbiotic JJ O
partners NNS O
. . O

Legume NN O
Fix- NNP O
mutants NNS O
form VBP O
apparently RB O
normal JJ O
nodules NNS O
with IN O
endosymbiotic JJ O
rhizobia NN O
but CC O
fail VB O
to TO O
induce VB O
rhizobial JJ O
nitrogen NN O
fixation NN O
. . O

These DT O
mutants NNS O
are VBP O
useful JJ O
for IN O
identifying VBG O
the DT O
legume NN O
genes NNS O
involved VBN O
in IN O
the DT O
interactions NNS O
essential JJ O
for IN O
symbiotic JJ O
nitrogen NN O
fixation NN O
. . O

We PRP O
describe VBP O
here RB O
a DT O
Fix- NNP O
mutant NN O
of IN O
Lotus NNP O
japonicus NN O
, , O
apn1 NNP O
, , O
which WDT O
showed VBD O
a DT O
very RB O
specific JJ O
symbiotic JJ O
phenotype NN O
. . O

It PRP O
formed VBD O
ineffective JJ O
nodules NNS O
when WRB O
inoculated VBN O
with IN O
the DT O
Mesorhizobium NNP O
loti NN O
strain NN O
TONO NN O
. . O

In IN O
these DT O
nodules NNS O
, , O
infected JJ O
cells NNS O
disintegrated VBN O
and CC O
successively RB O
became VBD O
necrotic JJ O
, , O
indicating VBG B-Reg
premature JJ B-MPA
senescence NN I-MPA
typical JJ O
of IN O
Fix- NNP B-Var
mutants NNS I-Var
[ -LRB- O
FILAGGRIN NNP O
GENE NNP O
NULL-MUTATIONS NNP O
AND CC O
ATOPIC NNP O
DISEASES NNP O
] -RRB- O
. . O

Null-mutations NNP B-Var
which WDT O
cause VBP O
loss NN B-NegReg
of IN I-NegReg
function NN I-NegReg
of IN O
the DT O
gene NN O
encoding NN O
filaggrin NN O
( -LRB- O
FLG NNP B-Gene
) -RRB- O
have VBP O
been VBN O
strongly RB O
linked VBN B-Reg
to IN O
the DT O
development NN O
of IN O
atopic JJ O
disorders NNS O
, , O
predominantly RB O
atopic JJ B-Disease
eczema NN I-Disease
/ SYM I-Disease
dermatitis NN O
syndrome NN O
( -LRB- O
AEDS NNP O
) -RRB- O
. . O

Filaggrin NNP O
plays VBZ O
a DT O
key JJ O
role NN O
in IN O
epidermal JJ O
barrier NN O
function NN O
by IN O
upholding VBG O
epidermal JJ O
structure NN O
and CC O
moisturization NN O
. . O

Up IN O
to IN O
now RB O
, , O
around RB O
40 CD O
variants NNS O
of IN O
FLG NNP O
null-mutations NN O
have VBP O
been VBN O
genotyped VBN O
among IN O
different JJ O
world NN O
populations NNS O
. . O

FLG NNP O
null-mutations NN O
are VBP O
present JJ O
in IN O
up IN O
to TO O
10 CD O
% NN O
of IN O
the DT O
Caucasian JJ O
population NN O
in IN O
Western NNP O
Europe NNP O
and CC O
North NNP O
America NNP O
, , O
with IN O
R05X NNP O
and CC O
2282del4 CD O
as IN O
the DT O
most RBS O
common JJ O
null-mutations NN O
. . O

Epidemiological JJ O
studies NNS O
conducted VBN O
in IN O
Europe NNP O
indicate VBP O
a DT O
latitude NN O
dependent JJ O
distribution NN O
of IN O
common JJ O
FLG NNP O
null-mutations NN O
with IN O
a DT O
decreasing VBG O
north-south JJ O
gradient NN O
of IN O
R501X NNP O
and CC O
2282del4 CD O
mutation NN O
frequencies NNS O
. . O

FLG NNP B-Gene
null-mutation JJ B-Var
carriers NNS O
are VBP O
prone JJ O
to TO O
develop VB B-PosReg
unspecific JJ B-Disease
skin NN I-Disease
symptoms NNS I-Disease
related VBN O
to IN O
atopic JJ O
and CC O
non-atopic AFX O
skin NN O
disorders NNS O
due IN O
to IN O
their PRP$ O
defect NN O
of IN O
epidermal JJ O
barrier NN O
function NN O
, , O
which WDT O
allows VBZ O
greater JJR O
skin NN O
penetration NN O
of IN O
various JJ O
hazards NNS O
. . O

Epidemiological JJ O
studies NNS O
indicate VBP O
an DT O
association NN B-Interaction
of IN O
FLG NNP B-Gene
null-mutations NN B-Var
with IN O
AEDS NNP B-Disease
FGF-FGFR NNP O
Mediates NNP O
the DT O
Activity-Dependent NNP O
Dendritogenesis NNP O
of IN O
Layer NNP O
IV NNP O
Neurons NNP O
during IN O
Barrel NNP O
Formation NNP O
. . O

Fibroblast NNP O
growth NN O
factors NNS O
( -LRB- O
FGFs NNS O
) -RRB- O
and CC O
FGF NNP O
receptors NNS O
( -LRB- O
FGFRs NNS O
) -RRB- O
are VBP O
known VBN O
for IN O
their PRP$ O
potent JJ O
effects NNS O
on IN O
cell NN O
proliferation NN O
/ SYM O
differentiation NN O
and CC O
cortical JJ O
patterning NN O
in IN O
the DT O
developing VBG O
brain NN O
. . O

However RB O
, , O
little JJ O
is VBZ O
known VBN O
regarding VBG O
the DT O
roles NNS O
of IN O
FGFs NNS O
/ SYM O
FGFRs NNS O
in IN O
cortical JJ O
circuit NN O
formation NN O
. . O

Here RB O
we PRP O
show VBP O
that IN O
Fgfr1/2/3 NN O
and CC O
Fgf7/9/10/22 NNS O
mRNAs JJ O
are VBP O
expressed VBN O
in IN O
the DT O
developing VBG O
primary JJ O
somatosensory NN O
( -LRB- O
S1 NN O
) -RRB- O
barrel NN O
cortex NN O
. . O

Barrel NN O
cortex NN O
layer NN O
IV NNP O
spiny JJ O
stellate NN O
cells NNS O
( -LRB- O
bSCs RB O
) -RRB- O
are VBP O
the DT O
primary JJ O
recipients NNS O
of IN O
ascending VBG O
sensory JJ O
information NN O
via IN O
thalamocortical JJ O
axons NNS O
( -LRB- O
TCAs NNS O
) -RRB- O
. . O

Detail NN O
quantification NN O
revealed VBD O
distinctive JJ O
phases NNS O
for IN O
bSC CD O
dendritogenesis NN O
: : O
orienting VBG O
dendrites NNS O
toward IN O
TCAs NNS O
, , O
adding VBG O
de IN O
novo NN O
dendritic JJ O
segments NNS O
, , O
and CC O
elongating VBG O
dendritic JJ O
length NN O
, , O
while IN O
maintaining VBG O
dendritic JJ O
patterns NNS O
. . O

Deleting VBG O
Fgfr1/2/3 NN O
in IN O
bSCs JJ O
had VBD O
minimal JJ O
impact NN O
on IN O
dendritic JJ O
polarity NN O
but CC O
transiently RB O
increased VBD O
the DT O
number NN O
of IN O
dendritic JJ O
segments NNS O
. . O

However RB O
, , O
6 CD O
d XX O
later RB O
, , O
FGFR1/2/3 NN O
loss NN O
of IN O
function NN O
reduced VBN O
dendritic JJ O
branch NN O
numbers NNS O
. . O

These DT O
data NNS O
suggest VBP O
that IN O
FGFs NNS O
/ SYM O
FGFRs NNS O
have VBP O
a DT O
role NN O
in IN O
stabilizing VBG O
dendritic JJ O
patterning NN O
. . O

Depolarization NN O
of IN O
cultured JJ O
mouse NN O
cortical JJ O
neurons NNS O
upregulated VBD O
the DT O
levels NNS O
of IN O
several JJ O
Fgf NNP O
/ SYM O
Fgfr NNP O
mRNAs JJ O
within IN O
2 CD O
h. NN O
In IN O
vivo NN O
, , O
within IN O
6 CD O
h NN O
of IN O
systemic JJ O
kainic JJ O
acid NN O
administration NN O
at IN O
postnatal JJ O
day NN O
6 CD O
, , O
mRNA NNS O
levels NNS O
of IN O
Fgf9 NNP O
, , O
Fgf10 NNP O
, , O
Fgfr2c NNP O
, , O
and CC O
Fgfr3b NNP O
in IN O
S1 NN O
cortices NNS O
were VBD O
enhanced VBN O
, , O
and CC O
this DT O
was VBD O
accompanied VBN O
by IN O
exuberant JJ O
dendritogenesis NN O
of IN O
bSCs RB O
by IN O
24 CD O
h. NN O
Deleting NNP O
Fgfr1/2/3 NNP O
abolished VBD O
kainic JJ O
acid-induced NN O
bSC CD O
dendritic JJ O
overgrowth NN O
. . O

Finally RB O
, , O
FGF9/10 JJ O
gain NN O
of IN O
function NN O
also RB O
resulted VBD O
in IN O
extensive JJ O
dendritogenesis NN O
. . O

Together RB O
, , O
our PRP$ O
data NNS O
suggest VBP O
that IN O
FGFs NNS O
/ SYM O
FGFRs NNS O
can MD O
be VB O
regulated VBN O
by IN O
glutamate JJ O
transmission NN O
to TO O
modulate VB O
/ SYM O
stabilize VB O
bSC CD O
dendritic JJ O
complexity NN O
. . O

Both DT O
male JJ O
and CC O
female JJ O
mice NNS O
were VBD O
used VBN O
for IN O
our PRP$ O
study NN O
. . O

SIGNIFICANCE NNP O
STATEMENT NNP O
Glutamatergic NNP O
transmission NN O
plays VBZ O
critical JJ O
roles NNS O
in IN O
cortical JJ O
circuit NN O
formation NN O
. . O

Its PRP$ O
dysregulation NN O
has VBZ O
been VBN O
proposed VBN O
as IN O
a DT O
core JJ O
factor NN O
in IN O
the DT O
etiology NN O
of IN O
many JJ O
neurological JJ O
diseases NNS O
. . O

We PRP O
found VBD O
that IN O
excessive JJ O
glutamate JJ O
transmission NN O
upregulated JJ O
mRNA NNS O
expression NN O
of IN O
Fgfrs NNP O
and CC O
their PRP$ O
ligands NNS O
Fgfs NNP O
Deleting NNP B-Var
Fgfr1/2/3 NN B-Gene
not RB O
only RB O
impaired VBD B-NegReg
bSC JJ B-MPA
dendritogenesis NN I-MPA
but CC O
also RB O
abolished VBD B-NegReg
glutamate JJ B-MPA
transmission-induced NN I-MPA
dendritic JJ I-MPA
overgrowth NN I-MPA
Why WRB O
are VBP O
there EX O
hotspot JJ O
mutations NNS O
in IN O
the DT O
TP53 NNP O
gene NN O
in IN O
human JJ O
cancers NNS O
? . O
The DT O
p53 NN O
gene NN O
contains VBZ O
homozygous JJ O
mutations NNS O
in IN O
~50-60 NNP O
% NN O
of IN O
human JJ O
cancers NNS O
. . O

About RB O
90 CD O
% NN O
of IN O
these DT O
mutations NNS O
encode VBP O
missense NN O
mutant JJ O
proteins NNS O
that WDT O
span VBP O
~190 NFP O
different JJ O
codons NNS O
localized VBN O
in IN O
the DT O
DNA-binding NN O
domain NN O
of IN O
the DT O
gene NN O
and CC O
protein NN O
. . O

These DT O
mutations NNS B-Var
produce VBP O
a DT O
protein NN O
with IN O
a DT O
reduced VBN O
capacity NN O
to TO O
bind VB O
to IN O
a DT O
specific JJ O
DNA NN O
sequence NN O
that WDT O
regulates VBZ B-Reg
the DT O
p53 NN B-Pathway
transcriptional JJ I-Pathway
pathway NN I-Pathway
. . O

Eight CD O
of IN O
these DT O
mutations NNS O
are VBP O
localized VBN O
in IN O
codons NNS O
that WDT O
account VBP O
for IN O
~28 CD O
% NN O
of IN O
the DT O
total JJ O
p53 NN O
mutations NNS O
and CC O
these DT O
alleles NNS O
appear VBP O
to TO O
be VB O
selected VBN O
for IN O
preferentially RB O
in IN O
human JJ O
cancers NNS O
of IN O
many JJ O
tissue NN O
types NNS O
. . O

This DT O
article NN O
explores VBZ O
the DT O
question NN O
' '' O
Why WRB O
are VBP O
there EX O
hotspot JJ O
mutations NNS O
in IN O
the DT O
p53 NN O
gene NN O
in IN O
human JJ O
cancers NNS O
? . O
' '' O
Four CD O
possible JJ O
reasons NNS O
for IN O
this DT O
are VBP O
considered VBN O
; : O
( -LRB- O
1 LS O
) -RRB- O
the DT O
hotspot JJ O
mutant JJ B-Var
alleles NNS O
produce VBP O
a DT O
protein NN O
that WDT O
has VBZ O
a DT O
highly RB O
altered JJ B-Reg
structure NN B-MPA
, , O
( -LRB- O
2 LS O
) -RRB- O
environmental JJ O
mutagens NNS O
produce VBP O
allele-specific NN O
changes NNS O
in IN O
the DT O
p53 NN O
gene NN O
, , O
( -LRB- O
3 LS O
) -RRB- O
these DT O
mutations NNS O
arise VBP O
at IN O
selected VBN O
sites NNS O
in IN O
the DT O
gene NN O
due IN O
to IN O
a DT O
specific JJ O
DNA NN O
sequence NN O
, , O
such JJ O
as IN O
a DT O
methylated VBN O
cytosine NN O
residue NN O
in IN O
a DT O
CpG NN O
dinucleotide NN O
, , O
which WDT O
has VBZ O
a DT O
higher JJR O
mutation NN O
rate NN O
changing VBG O
C NN O
to IN O
T NNP O
nucleotides NNS O
, , O
( -LRB- O
4 LS O
) -RRB- O
along IN O
with IN O
the DT O
observed JJ O
change NN O
in IN O
mutant JJ O
p53 NN O
proteins NNS O
, , O
which WDT O
produce VBP O
a DT O
loss NN O
of IN O
function NN O
( -LRB- O
DNA NN O
binding NN O
and CC O
transcription NN O
) -RRB- O
, , O
some DT O
mutant JJ B-Var
proteins NNS B-Protein
have VBP O
an DT O
allele-specific NN O
gain NN B-PosReg
of IN I-PosReg
function NN I-PosReg
that WDT O
promotes VBZ O
cancer NN B-Disease
Mutant JJ O
p53 VBP O
partners NNS O
in IN O
crime NN O
. . O

Mutant NNP B-Var
p53 VBP B-Gene
proteins NNS B-Protein
impart JJ O
changes NNS B-Reg
in IN O
cellular JJ B-MPA
behavior NN I-MPA
and CC O
function NN B-MPA
through IN O
interactions NNS B-Interaction
with IN O
proteins NNS B-Protein
that WDT O
alter VBP O
gene NN O
expression NN O
. . O

The DT O
milieu NN O
of IN O
intracellular JJ O
proteins NNS O
available JJ O
to TO O
interact VB O
with IN O
mutant JJ O
p53 NN O
is VBZ O
context NN O
specific JJ O
and CC O
changes NNS O
with IN O
disease NN O
, , O
cell NN O
type NN O
, , O
and CC O
environmental JJ O
conditions NNS O
. . O

Varying VBG O
conformations NNS O
of IN O
mutant JJ B-Var
p53 NN B-Gene
largely RB O
dictate VBP B-Reg
protein-protein NN B-MPA
interactions NNS I-MPA
as IN O
different JJ O
point NN O
mutations NNS O
within IN O
protein-coding NN O
regions NNS O
greatly RB O
alter VBP O
the DT O
extent NN O
and CC O
array NN O
of IN O
gain-of-function NN O
( -LRB- O
GOF NN O
) -RRB- O
activities NNS O
. . O

Given VBN O
such JJ O
variables NNS O
, , O
how WRB O
can MD O
knowledge VB O
regarding VBG O
p53 NN O
missense NN O
mutations NNS O
be VB O
translated VBN O
into IN O
predicting VBG O
or CC O
altering VBG O
biologic JJ O
activity NN O
for IN O
therapy NN O
? . O
How WRB O
may MD O
knowledge VB O
regarding VBG O
mutant JJ O
p53 NN O
functions NNS O
within IN O
certain JJ O
disease NN O
contexts NNS O
be VB O
harnessed VBN O
to TO O
blunt VB O
or CC O
ablate NN O
mutant JJ O
p53 NN O
GOF NN O
for IN O
therapy NN O
? . O
In IN O
this DT O
article NN O
, , O
we PRP O
review VBP O
known VBN O
proteins NNS O
that WDT O
interact VBP O
with IN O
mutant JJ B-Var
p53 NN B-Gene
and CC O
result VB O
in IN O
the DT O
activation NN B-PosReg
of IN O
genes NNS B-Gene
Exceptional JJ O
Response NNP O
to IN O
Temsirolimus NNP O
in IN O
a DT O
Metastatic NNP O
Clear NNP O
Cell NNP O
Renal NNP O
Cell NNP O
Carcinoma NNP O
With IN O
an DT O
Early JJ O
Novel NNP O
MTOR-Activating NNP O
Mutation NNP O
. . O

mTOR NN O
pathway NN O
inhibitors NNS O
are VBP O
important JJ O
drugs NNS O
for IN O
the DT O
treatment NN O
of IN O
advanced JJ O
renal JJ O
cell NN O
carcinoma NN O
( -LRB- O
RCC NNP O
) -RRB- O
. . O

However RB O
, , O
no DT O
valid JJ O
predictive JJ O
markers NNS O
have VBP O
been VBN O
identified VBN O
to TO O
guide VB O
treatment NN O
selection NN O
and CC O
identify VB O
patients NNS O
who WP O
are VBP O
sensitive JJ O
to IN O
these DT O
drugs NNS O
. . O

Mutations NNS O
activating VBG O
the DT O
mTOR NN O
pathway NN O
have VBP O
been VBN O
suggested VBN O
to TO O
predict VB O
response NN O
; : O
however RB O
, , O
their PRP$ O
predictive JJ O
value NN O
is VBZ O
still RB O
unclear JJ O
. . O

Here RB O
, , O
we PRP O
present VBP O
the DT O
genomic JJ O
and CC O
functional JJ O
characterization NN O
of IN O
a DT O
patient NN O
with IN O
metastatic JJ O
clear JJ O
cell NN O
RCC NNP O
( -LRB- O
ccRCC NNP O
) -RRB- O
who WP O
experienced VBD O
a DT O
partial JJ O
response NN O
to TO O
temsirolimus VB O
after IN O
a DT O
poor JJ O
response NN O
to IN O
2 CD O
previous JJ O
lines NNS O
of IN O
treatment NN O
. . O

At IN O
the DT O
time NN O
of IN O
publication NN O
, , O
the DT O
patient NN O
was VBD O
disease-free NN O
8 CD O
years NNS O
after IN O
temsirolimus NN O
treatment NN O
. . O

Multiregion NNP O
whole-exome JJ O
sequencing NN O
( -LRB- O
WES NNP O
) -RRB- O
on IN O
3 CD O
regions NNS O
of IN O
the DT O
primary JJ O
tumor NN O
, , O
1 CD O
metastasis NN O
, , O
and CC O
blood NN O
revealed VBD O
tumor NN O
mutations NNS O
in IN O
driver NN O
genes NNS O
in IN O
ccRCC NNP O
: : O
a DT O
missense NN O
mutation NN O
in IN O
VHL NNP O
( -LRB- O
p NN O
. . O

W88L NNS O
) -RRB- O
, , O
a DT O
loss-of-function NN O
mutation NN O
in IN O
BAP1 NNP O
( -LRB- O
p NN O
. . O

E454Rfs*15 NNP O
) -RRB- O
, , O
and CC O
a DT O
novel JJ O
missense NN O
mutation NN O
in IN O
MTOR NNP O
( -LRB- O
p NN O
. . O

Y1974H NNP O
) -RRB- O
. . O

The DT O
MTOR NNP O
mutation NN O
was VBD O
present JJ O
in IN O
all DT O
tumor NN O
regions NNS O
, , O
with IN O
similar JJ O
allele NN O
frequency NN O
as IN O
the DT O
VHL NNP O
mutation NN O
, , O
and CC O
in IN O
vitro FW O
functional JJ O
assessment NN O
of IN O
the DT O
MTOR NNP B-Gene
variant NN B-Var
demonstrated VBD O
that IN O
it PRP O
increased VBD B-PosReg
mTORC1 NN B-MPA
activity NN I-MPA
. . O

Consistently RB O
, , O
immunohistochemistry NN O
in IN O
the DT O
tumor NN O
samples NNS O
demonstrated VBD O
increased JJ O
levels NNS O
of IN O
phospho-S6 NN O
. . O

In IN O
conclusion NN O
, , O
multiregion NN O
WES NNP O
identified VBD O
a DT O
novel JJ O
MTOR NNP B-Gene
mutation NN B-Var
acquired VBD O
early RB O
during IN O
tumor NN O
development NN O
as IN O
the DT O
event NN O
leading VBG B-Reg
to IN I-Reg
a DT O
high JJ B-MPA
sensitivity NN I-MPA
to TO I-MPA
temsirolimus VB I-MPA
treatment NN I-MPA
Loss NN O
of IN O
function NN O
JAK1 NNP O
mutations NNS O
occur VBP O
at IN O
high JJ O
frequency NN O
in IN O
cancers NNS O
with IN O
microsatellite NN O
instability NN O
and CC O
are VBP O
suggestive JJ O
of IN O
immune JJ O
evasion NN O
. . O

Immune NNP O
evasion NN O
is VBZ O
a DT O
well-recognized RB O
hallmark NN O
of IN O
cancer NN O
and CC O
recent JJ O
studies NNS O
with IN O
immunotherapy JJ O
agents NNS O
have VBP O
suggested VBN O
that IN O
tumors NNS O
with IN O
increased VBN O
numbers NNS O
of IN O
neoantigens NNS O
elicit VBP O
greater JJR O
immune JJ O
responses NNS O
. . O

We PRP O
hypothesized VBD O
that IN O
the DT O
immune JJ O
system NN O
presents VBZ O
a DT O
common JJ O
selective JJ O
pressure NN O
on IN O
high JJ O
mutation NN O
burden NN O
tumors NNS O
and CC O
therefore RB O
immune JJ O
evasion NN O
mutations NNS O
would MD O
be VB O
enriched VBN O
in IN O
high JJ O
mutation NN O
burden NN O
tumors NNS O
. . O

The DT O
JAK NNP O
family NN O
of IN O
kinases NNS O
is VBZ O
required VBN O
for IN O
the DT O
signaling NN O
of IN O
a DT O
host NN O
of IN O
immune JJ O
modulators NNS O
in IN O
tumor NN O
, , O
stromal JJ O
, , O
and CC O
immune JJ O
cells NNS O
. . O

Therefore RB O
, , O
we PRP O
analyzed VBD O
alterations NNS O
in IN O
this DT O
family NN O
for IN O
the DT O
hypothesized VBN O
signature NN O
of IN O
an DT O
immune JJ O
evasion NN O
mutation NN O
. . O

Here RB O
, , O
we PRP O
searched VBD O
a DT O
database NN O
of IN O
61,704 CD O
unique JJ O
solid JJ O
tumors NNS O
for IN O
alterations NNS O
in IN O
the DT O
JAK NNP O
family NN O
kinases VBZ O
( -LRB- O
JAK1/2/3 NNP O
, , O
TYK2 NNP O
) -RRB- O
. . O

We PRP O
used VBD O
The DT O
Cancer NNP O
Genome NNP O
Atlas NNP O
and CC O
Cancer NNP O
Cell NNP O
Line NNP O
Encyclopedia NNP O
data NNS O
to TO O
confirm VB O
and CC O
extend VB O
our PRP$ O
findings NNS O
by IN O
analyzing VBG O
gene NN O
expression NN O
patterns NNS O
. . O

Recurrent JJ O
frameshift NN B-Var
mutations NNS I-Var
in IN O
JAK1 NNP B-Gene
were VBD O
associated VBN B-Reg
with IN O
high JJ B-MPA
mutation NN I-MPA
burden NN I-MPA
and CC O
microsatellite NN B-MPA
instability NN I-MPA
. . O

These DT O
mutations NNS B-Var
occurred VBD B-Reg
in IN O
multiple JJ O
tumor NN O
types NNS O
including VBG O
endometrial NN B-Disease
, , O
colorectal NN B-Disease
, , O
stomach NN B-Disease
, , O
and CC O
prostate VB B-Disease
carcinomas NNS B-Disease
. . O

Analyzing VBG O
gene NN O
expression NN O
signatures NNS O
in IN O
endometrial NN O
and CC O
stomach NN O
adenocarcinomas NNS O
revealed VBD O
that IN O
tumors NNS O
with IN O
a DT O
JAK1 NNP O
frameshift NN O
exhibited VBD O
reduced JJ O
expression NN O
of IN O
interferon NN O
response NN O
signatures NNS O
and CC O
multiple JJ O
anti-tumor RB O
immune JJ O
signatures NNS O
. . O

Importantly RB O
, , O
endometrial JJ O
cancer NN O
cell NN O
lines NNS O
exhibited VBD O
similar JJ O
gene NN O
expression NN O
changes NNS O
that WDT O
were VBD O
expected VBN O
to TO O
be VB O
tumor NN O
cell NN O
intrinsic JJ O
( -LRB- O
e.g. RB O
interferon NN O
response NN O
) -RRB- O
but CC O
not RB O
those DT O
expected VBN O
to TO O
be VB O
tumor NN O
cell NN O
extrinsic NN O
( -LRB- O
e.g. RB O
NK NNP O
cells NNS O
) -RRB- O
. . O

From IN O
these DT O
data NNS O
, , O
we PRP O
derive VBP O
two CD O
primary JJ O
conclusions NNS O
: : O
1 LS O
) -RRB- O
JAK1 NNP O
frameshifts NNS O
are VBP O
loss NN O
of IN O
function NN O
alterations NNS O
that WDT O
represent VBP O
a DT O
potential JJ O
pan-cancer NN O
adaptation NN O
to IN O
immune JJ O
responses NNS O
against IN O
tumors NNS O
with IN O
microsatellite NN O
instability NN O
; : O
2 LS O
) -RRB- O
The DT O
mechanism NN O
by IN O
which WDT O
JAK1 NNP B-Var
loss NN B-NegReg
of IN I-NegReg
function NN I-NegReg
contributes VBZ O
to IN O
tumor NN B-MPA
immune JJ I-MPA
evasion NN I-MPA
Gain NN B-PosReg
of IN I-PosReg
function NN I-PosReg
of IN O
TMEM16E NN B-Gene
/ SYM O
ANO5 NNP O
scrambling VBG B-MPA
activity NN I-MPA
caused VBN O
by IN O
a DT O
mutation NN B-Var
associated VBN O
with IN O
gnathodiaphyseal JJ B-Disease
dysplasia NN I-Disease
. . O

Mutations NNPS B-Var
in IN O
the DT O
human JJ O
TMEM16E NN B-Gene
( -LRB- O
ANO5 NNP O
) -RRB- O
gene NN O
are VBP O
associated VBN B-Reg
both DT O
with IN O
the DT O
bone NN B-Disease
disease NN I-Disease
gnathodiaphyseal NN B-Disease
dysplasia NN I-Disease
( -LRB- O
GDD NN O
; : O
OMIM NN O
: : O
166260 CD O
) -RRB- O
and CC O
muscle NN B-Disease
dystrophies NNS I-Disease
Multiple NNP O
Legionella NNP O
pneumophila NN O
effector NN O
virulence NN O
phenotypes NNS O
revealed VBN O
through IN O
high-throughput JJ O
analysis NN O
of IN O
targeted VBN O
mutant JJ O
libraries NNS O
. . O

Legionella NNP O
pneumophila NN O
is VBZ O
the DT O
causative JJ O
agent NN O
of IN O
a DT O
severe JJ O
pneumonia NN O
called VBD O
Legionnaires NNPS O
' POS O
disease NN O
. . O

A DT O
single JJ O
strain NN O
of IN O
L. NNP O
pneumophila NN O
encodes NNS O
a DT O
repertoire NN O
of IN O
over IN O
300 CD O
different JJ O
effector NN O
proteins NNS O
that WDT O
are VBP O
delivered VBN O
into IN O
host NN O
cells NNS O
by IN O
the DT O
Dot NNP O
/ SYM O
Icm NNP O
type NN O
IV NNP O
secretion NN O
system NN O
during IN O
infection NN O
. . O

The DT O
large JJ O
number NN O
of IN O
L. NNP O
pneumophila NN O
effectors NNS O
has VBZ O
been VBN O
a DT O
limiting VBG O
factor NN O
in IN O
assessing VBG O
the DT O
importance NN O
of IN O
individual JJ O
effectors NNS O
for IN O
virulence NN O
. . O

Here RB O
, , O
a DT O
transposon NN O
insertion NN O
sequencing NN O
technology NN O
called VBN O
INSeq NNP O
was VBD O
used VBN O
to TO O
analyze VB O
replication NN O
of IN O
a DT O
pool NN O
of IN O
effector NN O
mutants NNS O
in IN O
parallel NN O
both CC O
in IN O
a DT O
mouse NN O
model NN O
of IN O
infection NN O
and CC O
in IN O
cultured JJ O
host NN O
cells NNS O
. . O

Loss-of-function NN B-NegReg
mutations NNS B-Var
in IN O
genes NNS O
encoding VBG O
effector NN O
proteins NNS O
resulted VBD O
in IN O
host-specific NN B-MPA
or CC O
broad JJ B-MPA
virulence NN I-MPA
phenotypes NNS I-MPA
. . O

Screen NN O
results NNS O
were VBD O
validated VBN O
for IN O
several JJ O
effector NN O
mutants NNS O
displaying VBG O
different JJ O
virulence NN O
phenotypes NNS O
using VBG O
genetic JJ O
complementation NN O
studies NNS O
and CC O
infection NN O
assays NNS O
. . O

Specifically RB O
, , O
loss-of-function NN B-NegReg
mutations NNS B-Var
in IN O
the DT O
gene NN O
encoding NN O
LegC4 NNP B-Gene
resulted VBD O
in IN O
enhanced JJ B-PosReg
L. NNP B-CPA
pneumophila NN I-CPA
in IN O
the DT O
lungs NNS O
of IN O
infected JJ O
mice NNS O
but CC O
not RB O
within IN O
cultured JJ O
host NN O
cells NNS O
, , O
which WDT O
indicates VBZ O
LegC4 NNP B-Var
augments NNS B-PosReg
bacterial JJ B-CPA
clearance NN I-CPA
A DT O
Partial NNP O
Loss-of-Function NNP B-NegReg
Variant NNP B-Var
in IN O
AKT2 NNP B-Gene
Is VBZ O
Associated VBN O
With IN O
Reduced NNP B-NegReg
Insulin-Mediated NNP B-CPA
Glucose NNP I-CPA
Uptake NNP I-CPA
in IN O
Multiple NNP O
Insulin-Sensitive NNP O
Tissues NNPS O
: : O
A DT O
Genotype-Based NNP O
Callback NNP O
Positron NNP O
Emission NNP O
Tomography NNP O
Study NNP O
. . O

Rare NNP O
fully RB O
penetrant JJ O
mutations NNS O
in IN O
AKT2 NNP O
are VBP O
an DT O
established VBN O
cause NN O
of IN O
monogenic JJ O
disorders NNS O
of IN O
glucose NN O
metabolism NN O
. . O

Recently RB O
, , O
a DT O
novel JJ O
partial JJ O
loss-of-function NN O
AKT2 NNP O
coding NN O
variant NN O
( -LRB- O
p NN O
. . O

Pro50Thr NN O
) -RRB- O
was VBD O
identified VBN O
that WDT O
is VBZ O
nearly RB O
specific JJ O
to IN O
Finns NNP O
( -LRB- O
frequency NN O
1.1 CD O
% NN O
) -RRB- O
, , O
with IN O
the DT O
low-frequency JJ O
allele NN O
associated VBN O
with IN O
an DT O
increase NN O
in IN O
fasting VBG O
plasma NN O
insulin NN O
level NN O
and CC O
risk NN O
of IN O
type NN O
2 CD O
diabetes NNS O
. . O

The DT O
effects NNS O
of IN O
the DT O
p NN O
. . O

Pro50Thr NNP O
AKT2 NNP O
variant NN O
( -LRB- O
p NN O
. . O

P50T NNP O
/ SYM O
AKT2 NNP O
) -RRB- O
on IN O
insulin-stimulated NN O
glucose NN O
uptake NN O
( -LRB- O
GU NNP O
) -RRB- O
in IN O
the DT O
whole JJ O
body NN O
and CC O
in IN O
different JJ O
tissues NNS O
have VBP O
not RB O
previously RB O
been VBN O
investigated VBN O
. . O

We PRP O
identified VBD O
carriers NNS O
( -LRB- O
N NNP O
= SYM O
20 CD O
) -RRB- O
and CC O
matched VBN O
noncarriers NNS O
( -LRB- O
N NN O
= SYM O
25 CD O
) -RRB- O
for IN O
this DT O
allele NN O
in IN O
the DT O
population-based NN O
Metabolic NNP O
Syndrome NNP O
in IN O
Men NNP O
( -LRB- O
METSIM)study NN O
and CC O
invited VBN O
these DT O
individuals NNS O
back RB O
for IN O
positron NN O
emission NN O
tomography NN O
study VB O
with IN O
[ -LRB- O
18F]-fluorodeoxyglucose CD O
during IN O
euglycemic NN O
hyperinsulinemia NN O
. . O

When WRB O
we PRP O
compared VBD O
p XX O
. . O

P50T NNP O
/ SYM O
AKT2 NNP O
carriers NNS O
to IN O
noncarriers NNS O
, , O
we PRP O
found VBD O
a DT O
39.4 CD O
% NN O
reduction NN O
in IN O
whole-body JJ O
GU NNP O
( -LRB- O
P NN O
= SYM O
0.006 CD O
) -RRB- O
and CC O
a DT O
55.6 CD O
% NN O
increase NN O
in IN O
the DT O
rate NN O
of IN O
endogenous JJ O
glucose NN O
production NN O
( -LRB- O
P NN O
= SYM O
0.038 CD O
) -RRB- O
. . O

We PRP O
found VBD O
significant JJ O
reductions NNS O
in IN O
GU NNP O
in IN O
multiple JJ O
tissues-skeletal NNS O
muscle NN O
( -LRB- O
36.4 CD O
% NN O
) -RRB- O
, , O
liver NN O
( -LRB- O
16.1 CD O
% NN O
) -RRB- O
, , O
brown JJ O
adipose DT O
( -LRB- O
29.7 CD O
% NN O
) -RRB- O
, , O
and CC O
bone NN O
marrow NN O
( -LRB- O
32.9%)-and CD O
increases NNS O
of IN O
16.8-19.1 CD O
% NN O
in IN O
seven CD O
tested VBN O
brain NN O
regions NNS O
. . O

These DT O
data NNS O
demonstrate VBP O
that IN O
the DT O
p NN B-Var
. . O

P50 NNP O
T NNP O
substitution NN O
of IN O
AKT2 NNP B-Gene
influences VBZ B-Reg
insulin-mediated NN B-MPA
GU NNP I-MPA
Common JJ O
and CC O
rare JJ O
TBK1 NNP B-Gene
variants NNS B-Var
in IN B-Reg
early-onset JJ B-Disease
Alzheimer NNP I-Disease
disease NN I-Disease
in IN O
a DT O
European JJ O
cohort NN O
. . O

TANK-binding NN O
kinase NN O
1 CD O
( -LRB- O
TBK1 NNP B-Gene
) -RRB- O
loss-of-function NN B-NegReg
( -LRB- O
LoF NN O
) -RRB- O
mutations NNS B-Var
are VBP O
known VBN O
to TO O
cause VB O
frontotemporal JJ B-Disease
dementia NN I-Disease
( -LRB- O
FTD NNP O
) -RRB- O
and CC O
amyotrophic JJ B-Disease
lateral JJ I-Disease
sclerosis NN I-Disease
Polymorphisms NNS O
in IN O
inflammasome JJ O
genes NNS O
and CC O
risk NN O
of IN O
asthma NN O
in IN O
Brazilian JJ O
children NNS O
. . O

Considering VBG O
its PRP$ O
role NN O
in IN O
inflammation NN O
and CC O
recently RB O
described VBN O
" `` O
alternative NN O
" '' O
roles NNS O
in IN O
epithelial JJ O
homeostasis NN O
and CC O
Th1/Th2 VBN O
balance NN O
, , O
we PRP O
hypothesize VBP O
that DT O
inflammasome JJ O
genetics NNS O
could MD O
contribute VB O
to IN O
the DT O
development NN O
of IN O
asthma NN O
. . O

Selected VBN O
functional JJ O
polymorphisms NNS O
in IN O
inflammasome JJ O
genes NNS O
are VBP O
evaluated VBN O
in IN O
a DT O
cohort NN O
of IN O
asthmatic JJ O
children NNS O
and CC O
their PRP$ O
families NNS O
. . O

Gain-of-function NN B-PosReg
NLRP1 NN B-Gene
variants NNS B-Var
rs11651270 RB B-Var
, , O
rs12150220 NN B-Var
and CC O
rs2670660 NNP B-Var
resulted VBD O
significantly RB O
associated VBN O
to IN O
asthma VB B-Disease
in IN O
trios NNS O
( -LRB- O
TDT NNP O
) -RRB- O
analysis NN O
; : O
and CC O
rs11651270 RB B-Var
and CC O
rs2670660 VBZ B-Var
also RB O
with IN B-Reg
asthma NN B-Disease
severity NN O
and CC O
total JJ O
IgE NNP B-MPA
level NN I-MPA
in IN O
asthmatic JJ O
children NNS O
. . O

NLRP1 NN O
activators NNS O
in IN O
humans NNS O
are VBP O
still RB O
unknown JJ O
, , O
however RB O
we PRP O
hypothesized VBD O
that IN O
individuals NNS O
with IN O
gain-of-function NN B-PosReg
SNPs NNS B-Var
in IN O
NLRP1 NNP B-Gene
could MD O
be VB O
more RBR O
prone JJ B-PosReg
in IN O
activating VBG B-MPA
inflammasome NN I-MPA
in IN O
the DT O
presence NN O
of IN O
asthma-related NN O
cell NN O
stressors NNS O
( -LRB- O
i.e. FW O
ER NNP O
stress NN O
or CC O
ROS NN O
) -RRB- O
, , O
and CC O
this DT O
activation NN O
contribute VBP O
to TO O
exacerbate VB B-PosReg
inflammatory JJ B-CPA
response NN I-CPA
and CC O
asthma NN B-CPA
development NN I-CPA
. . O

Gain-of-function NN O
IL1A NNP B-Gene
rs17561 NNP B-Var
resulted VBD O
significantly RB O
associated VBN O
with IN O
a DT O
reduced JJ B-NegReg
pulmonary JJ B-CPA
capacity NN I-CPA
in IN O
asthmatic JJ O
children NNS O
. . O

IL18 NNP B-Gene
rs5744256 NNP B-Var
which WDT O
lead VBP O
to IN O
lower JJR B-NegReg
serum NN B-MPA
level NN I-MPA
of IN I-MPA
IL-18 NNP I-MPA
MED13L VB B-Gene
loss-of-function NN B-NegReg
variants NNS B-Var
in IN O
two CD O
patients NNS O
with IN O
syndromic JJ O
Pierre NNP B-Disease
Robin NNP I-Disease
sequence NN I-Disease
. . O

We PRP O
report VBP O
two CD O
unrelated JJ O
patients NNS O
with IN O
Pierre NNP O
Robin NNP O
sequence NN O
( -LRB- O
PRS NNP O
) -RRB- O
and CC O
a DT O
strikingly RB O
similar JJ O
combination NN O
of IN O
associated JJ O
features NNS O
. . O

Whole JJ O
exome NN O
sequencing NN O
was VBD O
performed VBN O
for IN O
both DT O
patients NNS O
. . O

No DT O
single JJ O
gene NN O
containing VBG O
likely JJ O
pathogenic JJ O
point NN O
mutations NNS O
in IN O
both DT O
patients NNS O
could MD O
be VB O
identified VBN O
, , O
but CC O
the DT O
finding NN O
of IN O
an DT O
essential JJ O
splice NN O
site NN O
mutation NN O
in IN O
mediator NN O
complex NN O
subunit NN O
13 CD O
like IN O
( -LRB- O
MED13L NN O
) -RRB- O
in IN O
one CD O
patient NN O
prompted VBD O
the DT O
investigation NN O
of IN O
copy JJ O
number NN O
variants NNS O
in IN O
MED13L NNP O
in IN O
the DT O
other JJ O
, , O
leading VBG O
to IN O
the DT O
identification NN O
of IN O
an DT O
intragenic JJ O
deletion NN O
. . O

Disruption NN B-Var
of IN O
MED13L NNP B-Gene
, , O
encoding VBG O
a DT O
component NN O
of IN O
the DT O
Mediator NNP O
complex NN O
, , O
is VBZ O
increasingly RB O
recognized VBN O
as IN O
the DT O
cause NN B-Reg
of IN O
an DT O
intellectual JJ B-Disease
disability NN I-Disease
syndrome NN I-Disease
with IN O
associated VBN O
facial JJ B-Disease
dysmorphism NN I-Disease
Loss-of-activity-mutation NN B-NegReg
in IN O
the DT O
cardiac JJ O
chloride-bicarbonate NN O
exchanger NN O
AE3 NNP O
causes VBZ O
short JJ O
QT NNP O
syndrome NN O
. . O

Patients NNPS O
with IN O
short JJ O
QT NNP O
syndrome NN O
( -LRB- O
SQTS NNP O
) -RRB- O
may MD O
present VB O
with IN O
syncope NN O
, , O
ventricular JJ O
fibrillation NN O
or CC O
sudden JJ O
cardiac JJ O
death NN O
. . O

Six CD O
SQTS JJ O
susceptibility NN O
genes NNS O
, , O
encoding VBG O
cation NN O
channels NNS O
, , O
explain VB O
< XX O
25 CD O
% NN O
of IN O
SQTS NNP O
cases NNS O
. . O

Here RB O
we PRP O
identify VBP O
a DT O
missense NN O
mutation NN O
in IN O
the DT O
anion NN O
exchanger NN O
( -LRB- O
AE3)-encoding VBG O
SLC4A3 IN O
gene NN O
in IN O
two CD O
unrelated JJ O
families NNS O
with IN O
SQTS NNP O
. . O

The DT O
mutation NN O
causes VBZ O
reduced VBN O
surface NN O
expression NN O
of IN O
AE3 NNP O
and CC O
reduced VBN O
membrane JJ O
bicarbonate NN O
transport NN O
. . O

Slc4a3 IN O
knockdown VBN O
in IN O
zebrafish JJ O
causes NNS O
increased VBD O
cardiac JJ O
pHi NNP O
, , O
short JJ O
QTc NNS O
, , O
and CC O
reduced VBN O
systolic JJ O
duration NN O
, , O
which WDT O
is VBZ O
rescued VBN O
by IN O
wildtype NN O
but CC O
not RB O
mutated VBN O
SLC4A3 RB O
. . O

Mechanistic JJ O
analyses NNS O
suggest VBP O
that IN O
an DT O
increase NN O
in IN O
pHi NN O
and CC O
decrease NN O
in IN O
[ -LRB- O
Cl-]i NNP O
shortened VBD O
the DT O
action NN O
potential JJ O
duration NN O
. . O

However RB O
, , O
other JJ O
mechanisms NNS O
may MD O
also RB O
play VB O
a DT O
role NN O
. . O

Altered JJ O
anion NN O
transport NN O
represents VBZ O
a DT O
mechanism NN O
for IN O
development NN O
of IN O
arrhythmia NN O
and CC O
may MD O
provide VB O
new JJ O
therapeutic JJ O
possibilities NNS O
. . O

In IN O
Silico NNP O
Approach NNP O
to TO O
Investigate VB O
the DT O
Structural NNP O
and CC O
Functional NNP O
Attributes NNPS O
of IN O
Familial NNP O
Hypercholesterolemia NNP O
Variants NNPS O
Reported VBN O
in IN O
the DT O
Saudi NNP O
Population NNP O
. . O

Familial JJ B-Disease
hypercholesterolemia NN I-Disease
( -LRB- O
FH NNP O
) -RRB- O
is VBZ O
a DT O
metabolic JJ O
disorder NN O
that WDT O
leads VBZ O
primarily RB O
to TO O
premature VB O
cardiovascular JJ O
diseases NNS O
, , O
the DT O
main JJ O
cause NN O
of IN O
mortality NN O
in IN O
Saudi NNP O
Arabia NNP O
( -LRB- O
SA NNP O
) -RRB- O
. . O

FH NNP O
is VBZ O
underreported JJ O
and CC O
underdiagnosed VBN O
in IN O
SA NNP O
with IN O
statistical JJ O
evidence NN O
of IN O
high JJ O
expected VBN O
prevalence NN O
in IN O
such PDT O
a DT O
consanguineous JJ O
community NN O
. . O

Lacking VBG O
knowledge NN O
of IN O
which WDT O
and CC O
how WRB O
these DT O
alterations NNS O
are VBP O
actually RB O
impacting VBG O
lipid NN O
metabolism NN O
is VBZ O
one CD O
of IN O
the DT O
main JJ O
reasons NNS O
why WRB O
FH NNP O
is VBZ O
insufficiently RB O
diagnosed VBN O
in IN O
the DT O
region NN O
. . O

The DT O
aim NN O
of IN O
this DT O
study NN O
was VBD O
to TO O
develop VB O
a DT O
fast JJ O
prediction NN O
approach NN O
using VBG O
an DT O
integrated JJ O
bioinformatics NNS O
method NN O
for IN O
future JJ O
screening NN O
of IN O
the DT O
potential JJ O
causative JJ O
variants NNS O
from IN O
national JJ O
registries NNS O
. . O

A DT O
total NN O
of IN O
21 CD O
variants NNS O
were VBD O
detected VBN O
with IN O
majority NN O
rate NN O
in IN O
LDLR NNP O
( -LRB- O
81 CD O
% NN O
) -RRB- O
. . O

Variants NNS O
were VBD O
classified VBN O
based VBN O
on IN O
the DT O
type NN O
of IN O
mutation NN O
. . O

Missense NN O
variants NNS O
resulting VBG O
in IN O
amino NN O
acid JJ O
changes NNS O
, , O
c.1429G NNS B-Var
> XX O
A DT O
( -LRB- O
p NN O
. . O

D477N NN O
) -RRB- O
, , O
c.1474G UH B-Var
> XX O
A NN O
( -LRB- O
p NN O
. . O

D492N NN O
) -RRB- O
, , O
c.1731G NN B-Var
> XX O
T NNP O
( -LRB- O
p NN O
. . O

W577C NN O
) -RRB- O
, , O
and CC O
c.1783C NNP B-Var
> XX O
T NNP O
( -LRB- O
p NN O
. . O

R595W NNP O
) -RRB- O
in IN O
LDLR NNP B-Gene
gene NN O
, , O
in IN O
addition NN O
to IN O
c.9835A NNP B-Var
> XX O
G NNP O
( -LRB- O
p NN O
. . O

S3279 NN O
G NN O
) -RRB- O
in IN O
APOB NNP B-Gene
, , O
were VBD O
shown VBN O
to TO O
be VB O
deleterious JJ O
by IN O
concordant JJ O
analysis NN O
. . O

Furthermore RB O
, , O
functional JJ B-Interaction
interaction NN I-Interaction
deformities NNS B-Reg
showed VBD O
a DT O
significant JJ O
loss NN B-NegReg
and CC O
gain NN B-PosReg
of IN O
energies NNS B-MPA
in IN I-MPA
the DT I-MPA
mutated VBN I-MPA
proteins NNS I-MPA
Effects NNS O
of IN O
null JJ O
mutation NN O
of IN O
the DT O
heat-shock NN O
gene NN O
htpG NN O
on IN O
the DT O
production NN O
of IN O
virulence NN O
factors NNS O
by IN O
Pseudomonas NNP O
aeruginosa NN O
. . O

AIM NNP O
: : O
Pseudomonas NNP O
aeruginosa NN O
is VBZ O
one CD O
of IN O
the DT O
most RBS O
clinically RB O
important JJ O
opportunistic JJ O
pathogen NN O
in IN O
humans NNS O
. . O

The DT O
aim NN O
of IN O
the DT O
project NN O
was VBD O
to TO O
study VB O
effects NNS O
of IN O
HtpG NNP O
on IN O
the DT O
selected VBN O
virulence NN O
factors NNS O
responsible JJ O
for IN O
pathogenesis NN O
and CC O
biofilm NN O
formation NN O
of IN O
P. NNP O
aeruginosa NN O
. . O

METHODOLOGY NNP O
: : O
By IN O
characterizing VBG O
a DT O
htpG NN O
null JJ O
mutant NN O
of IN O
P. NNP O
aeruginosa NN O
, , O
we PRP O
have VBP O
identified VBN O
the DT O
role NN O
of IN O
HtpG NNP O
in IN O
the DT O
production NN O
of IN O
selected VBN O
factors NNS O
. . O

RESULTS NNS O
: : O
We PRP O
showed VBD O
that IN O
ΔhtpG NNP O
mutant JJ O
affects VBZ O
many JJ O
physiological JJ O
processes NNS O
containing VBG O
: : O
decreased VBN O
activity NN O
of IN O
the DT O
LasA NNS O
protease NN O
, , O
reduction NN O
of IN O
biofilm NN O
formation NN O
, , O
decreased VBD O
motility NN O
, , O
and CC O
diminished VBN O
amount NN O
of IN O
rhamnolipids NNS O
and CC O
pyoverdine NN O
/ SYM O
pyocyanin NN O
. . O

These DT O
defects NNS O
were VBD O
most RBS O
evident JJ O
when WRB O
the DT O
ΔhtpG NNP O
strain NN O
was VBD O
cultured VBN O
at IN O
42 CD O
° NN O
C NNP O
. . O

CONCLUSION NN O
: : O
Our PRP$ O
findings NNS O
demonstrate VBP O
the DT O
unexplored JJ O
role NN O
of IN O
HtpG NNP O
in IN O
the DT O
pathogenicity NN O
of IN O
P. NNP O
aeruginosa NN O
, , O
and CC O
indicate VBP O
potential JJ O
targets NNS O
for IN O
antibacterial JJ O
therapeutics NNS O
. . O

[ -LRB- O
Formula NN O
: : O
see VB O
text NN O
] -RRB- O
. . O

Molecular JJ O
and CC O
cellular JJ O
issues NNS O
of IN O
KMT2A NNP B-Gene
variants NNS B-Var
involved VBN B-Reg
in IN I-Reg
Wiedemann-Steiner NNP B-Disease
syndrome NN I-Disease
. . O

Variants NNPS B-Var
in IN O
KMT2A NNP B-Gene
, , O
encoding VBG O
the DT O
histone NN O
methyltransferase NN O
KMT2A NNP O
, , O
are VBP O
a DT O
growing VBG O
cause NN B-Reg
of IN O
intellectual JJ B-Disease
disability NN I-Disease
( -LRB- O
ID NNP O
) -RRB- O
. . O

Up IN O
to IN O
now RB O
, , O
the DT O
majority NN O
of IN O
KMT2A NNP B-Gene
variants NNS B-Var
are VBP O
non-sense AFX B-Var
and CC O
frameshift NN B-Var
variants NNS O
causing VBG B-Reg
a DT O
typical JJ O
form NN O
of IN O
Wiedemann-Steiner NNP B-Disease
syndrome NN I-Disease
. . O

We PRP O
studied VBD O
KMT2A NNP O
gene NN O
in IN O
a DT O
cohort NN O
of IN O
200 CD O
patients NNS O
with IN O
unexplained JJ O
syndromic JJ O
and CC O
non-syndromic AFX O
ID NN O
and CC O
identified VBD O
four CD O
novel JJ O
variants NNS O
, , O
one CD O
splice NN O
and CC O
three CD O
missense NN O
variants NNS O
, , O
possibly RB O
deleterious JJ O
. . O

We PRP O
used VBD O
primary JJ O
cells NNS O
from IN O
the DT O
patients NNS O
and CC O
molecular JJ O
approaches NNS O
to TO O
determine VB O
the DT O
deleterious JJ O
effects NNS B-Reg
of IN O
those DT O
variants NNS B-Var
on IN O
KMT2A NNP B-Gene
expression NN B-MPA
and CC O
function NN B-MPA
. . O

For IN O
the DT O
putative JJ O
splice NN O
variant NN O
c.11322-1G NN B-Var
> XX O
A NN O
, , O
we PRP O
showed VBD O
that IN O
it PRP O
led VBD O
to IN O
only RB O
one CD O
nucleotide NN O
deletion NN O
and CC O
loss NN B-NegReg
of IN O
the DT O
C-terminal NN B-MPA
part NN I-MPA
of IN I-MPA
the DT I-MPA
protein NN I-MPA
. . O

For IN O
two CD O
studied VBN O
KMT2A NNP B-Gene
missense NN O
variants NNS O
, , O
c.3460C NN B-Var
> XX O
T NNP O
( -LRB- O
p.(Arg1154Trp NNP O
) -RRB- O
) -RRB- O
and CC O
c.8558T JJ B-Var
> XX O
G NN O
( -LRB- O
p.(Met2853Arg NN O
) -RRB- O
) -RRB- O
, , O
located VBN O
at IN O
the DT O
cysteine-rich JJ O
CXXC NNP O
domain NN O
and CC O
the DT O
transactivation NN O
domain NN O
of IN O
the DT O
protein NN O
, , O
respectively RB O
, , O
we PRP O
found VBD O
altered JJ B-Reg
KMT2A NNP O
target NN O
genes NNS O
expression NN B-MPA
in IN O
patient NN O
's POS O
fibroblasts NNS O
compared VBN O
to IN O
controls NNS O
. . O

Furthermore RB O
, , O
we PRP O
found VBD O
a DT O
disturbed JJ B-Reg
subcellular JJ B-MPA
distribution NN I-MPA
of IN O
KMT2A NNP B-Gene
for IN O
the DT O
c.3460C NN B-Var
First NNP O
Report NNP O
of IN O
Prenatal NNP O
Ascertainment NNP O
of IN O
a DT O
Fetus NNP O
With IN O
Homozygous NNP O
Loss NNP O
of IN O
the DT O
SOX10 NNP O
Gene NNP O
and CC O
Phenotypic NNP O
Correlation NNP O
by IN O
Autopsy NNP O
Examination NNP O
. . O

The DT O
SOX10 NNP O
gene NN O
plays VBZ O
a DT O
vital JJ O
role NN O
in IN O
neural JJ O
crest NN O
cell NN O
development NN O
and CC O
migration NN O
. . O

Abnormalities NNS B-Var
in IN O
SOX10 NNP B-Gene
are VBP O
associated VBN B-Reg
with IN O
Waardenburg NNP B-Disease
syndrome NN I-Disease
Types NNP B-Disease
II NNP I-Disease
and CC O
IV NNP B-Disease
A DT O
novel NN O
NR2F2 VB B-Gene
loss-of-function NN B-NegReg
mutation NN B-Var
predisposes VBZ O
to TO O
congenital JJ B-Disease
heart NN I-Disease
defect NN I-Disease
. . O

Congenital JJ O
heart NN O
defect NN O
( -LRB- O
CHD NN O
) -RRB- O
is VBZ O
the DT O
most RBS O
common JJ O
type NN O
of IN O
birth NN O
defect NN O
in IN O
humans NNS O
and CC O
a DT O
leading JJ O
cause NN O
of IN O
infant NN O
morbidity NN O
and CC O
mortality NN O
. . O

Previous JJ O
studies NNS O
have VBP O
demonstrated VBN O
that IN O
genetic JJ O
defects NNS O
play VBP O
a DT O
pivotal JJ O
role NN O
in IN O
the DT O
pathogenesis NN O
of IN O
CHD NNP O
. . O

However RB O
, , O
the DT O
genetic JJ O
basis NN O
of IN O
CHD NNP O
remains VBZ O
poorly RB O
understood VBN O
due JJ O
to IN O
substantial JJ O
genetic JJ O
heterogeneity NN O
. . O

In IN O
this DT O
study NN O
, , O
the DT O
coding VBG O
exons NNS O
and CC O
splicing NN O
boundaries NNS O
of IN O
the DT O
NR2F2 NNP O
gene NN O
, , O
which WDT O
encodes VBZ O
a DT O
pleiotropic JJ O
transcription NN O
factor NN O
required VBN O
for IN O
normal JJ O
cardiovascular JJ O
development NN O
, , O
were VBD O
sequenced VBN O
in IN O
168 CD O
unrelated JJ O
patients NNS O
with IN O
CHD NNP O
, , O
and CC O
a DT O
novel JJ O
mutation NN O
( -LRB- O
c.247 NNP O
G NN O
   O
> XX O
   O
T NNP O
, , O
equivalent JJ O
to IN O
p NN O
. . O

G83X NNP O
) -RRB- O
was VBD O
detected VBN O
in IN O
a DT O
patient NN O
with IN O
double JJ O
outlet NN O
right JJ O
ventricle NN O
as RB O
well RB O
as IN O
ventricular JJ O
septal JJ O
defect NN O
. . O

Genetic JJ O
scanning NN O
of IN O
the DT O
mutation NN O
carrier NN O
's POS O
relatives NNS O
available JJ O
showed VBD O
that IN O
the DT O
mutation NN O
was VBD O
present JJ O
in IN O
all DT O
affected JJ O
family NN O
members NNS O
but CC O
absent JJ O
in IN O
unaffected JJ O
family NN O
members NNS O
. . O

Analysis NN O
of IN O
the DT O
index NN O
patient NN O
's POS O
pedigree NN O
displayed VBD O
that IN O
the DT O
mutation NN O
co-segregated NN O
with IN O
CHD NNP O
, , O
which WDT O
was VBD O
transmitted VBN O
as IN O
an DT O
autosomal NN O
dominant JJ O
trait NN O
with IN O
complete JJ O
penetrance NN O
. . O

The DT O
nonsense NN O
mutation NN O
was VBD O
absent JJ O
in IN O
230 CD O
unrelated JJ O
, , O
ethnically-matched RB O
healthy JJ O
individuals NNS O
used VBN O
as IN O
controls NNS O
. . O

Functional JJ O
deciphers NNS O
by IN O
using VBG O
a DT O
dual-luciferase JJ O
reporter NN O
assay JJ O
system NN O
revealed VBD O
that IN O
the DT O
mutant JJ B-Var
NR2F2 NNP B-Gene
protein NN O
had VBD O
no DT B-NegReg
transcriptional JJ B-MPA
activity NN I-MPA
as IN O
compared VBN O
with IN O
its PRP$ O
wild-type JJ O
counterpart NN O
. . O

Furthermore RB O
, , O
the DT O
mutation NN B-Var
abrogated VBD B-NegReg
the DT O
synergistic JJ B-MPA
transcriptional JJ I-MPA
activation NN I-MPA
between IN O
NR2F2 NNP B-Gene
and CC O
GATA4 NNP B-Gene
Potential JJ O
pathogenic JJ O
mechanisms NNS O
underlying VBG O
Fragile NNP O
X NN O
Tremor NNP O
Ataxia NNP O
Syndrome NNP O
: : O
RAN NNP O
translation NN O
and/or CC O
RNA NNP O
gain-of-function NN O
? . O
Fragile NNP B-Disease
X-associated NN I-Disease
tremor NN I-Disease
/ SYM I-Disease
ataxia NN O
syndrome NN O
( -LRB- O
FXTAS NNP O
) -RRB- O
is VBZ O
an DT O
inherited VBN O
neurodegenerative JJ O
disease NN O
caused VBN B-Reg
by IN I-Reg
an DT O
expansion NN B-Var
of IN I-Var
55-200 CD I-Var
CGG NNP I-Var
repeats NNS I-Var
located VBN O
in IN O
the DT O
FMR1 NNP B-Gene
Deleterious JJ O
variants NNS B-Var
in IN O
DCHS1 NNS B-Gene
are VBP O
prevalent JJ B-Reg
in IN O
sporadic JJ O
cases NNS O
of IN O
mitral JJ B-Disease
valve NN I-Disease
prolapse NN I-Disease
. . O

BACKGROUND NNP O
: : O
A DT O
recent JJ O
study NN O
identified VBD O
DCHS1 VBD O
as IN O
a DT O
causal JJ O
gene NN O
for IN O
mitral JJ O
valve NN O
prolapse NN O
. . O

The DT O
goal NN O
of IN O
this DT O
study NN O
is VBZ O
to TO O
investigate VB O
the DT O
presence NN O
and CC O
frequency NN O
of IN O
known JJ O
and CC O
novel JJ O
variants NNS O
in IN O
this DT O
gene NN O
in IN O
100 CD O
asymptomatic JJ O
patients NNS O
with IN O
moderate JJ O
to IN O
severe JJ O
organic JJ O
mitral NN O
regurgitation NN O
. . O

METHODS NNS O
: : O
DNA NN O
sequencing NN O
assays NNS O
were VBD O
developed VBN O
for IN O
two CD O
previously RB O
identified VBN O
functional JJ O
missense NN O
variants NNS O
, , O
namely RB O
p XX B-Var
. . O

R2330C NN O
and CC O
p NN B-Var
. . O

R2513H JJ O
, , O
and CC O
all DT O
21 CD O
exons NNS O
of IN O
DCHS1 NN B-Gene
Primary JJ B-Disease
Ovarian NNP I-Disease
Insufficiency NNP I-Disease
and CC O
Azoospermia NNP B-Disease
in IN O
Carriers NNPS B-Reg
of IN O
a DT O
Homozygous NNP O
PSMC3IP NN B-Gene
Stop VB O
Gain NNP O
Mutation NNP B-Var
. . O

Context NNP O
: : O
The DT O
etiology NN O
of IN O
primary JJ O
ovarian JJ O
insufficiency NN O
( -LRB- O
POI NNP O
) -RRB- O
remains VBZ O
unknown JJ O
in IN O
most JJS O
cases NNS O
. . O

Objective NN O
: : O
We PRP O
sought VBD O
to TO O
identify VB O
the DT O
genes NNS O
causing VBG O
POI NNP O
. . O

Design NNP O
: : O
The DT O
study NN O
was VBD O
a DT O
familial JJ O
genetic JJ O
study NN O
. . O

Setting NN O
: : O
The DT O
study NN O
was VBD O
performed VBN O
at IN O
two CD O
academic JJ O
institutions NNS O
. . O

Patients NNPS O
: : O
We PRP O
identified VBD O
a DT O
consanguineous JJ O
Yemeni JJ O
family NN O
in IN O
which WDT O
four CD O
daughters NNS O
had VBD O
POI NNP O
. . O

A DT O
brother NN O
had VBD O
azoospermia NN O
. . O

Intervention NN O
: : O
DNA NNP O
was VBD O
subjected VBN O
to IN O
whole JJ O
genome JJ O
sequencing NN O
. . O

Shared JJ O
regions NNS O
of IN O
homozygosity NN O
were VBD O
identified VBN O
using VBG O
Truploidy NNP O
and CC O
prioritized VBN O
using VBG O
the DT O
Variant NNP O
Annotation NNP O
, , O
Analysis NNP O
, , O
and CC O
Search NNP O
Tool NNP O
with IN O
control NN O
data NNS O
from IN O
387 CD O
healthy JJ O
subjects NNS O
. . O

Imaging NN O
and CC O
quantification NN O
of IN O
protein NN O
localization NN O
and CC O
mitochondrial JJ O
function NN O
were VBD O
examined VBN O
in IN O
cell NN O
lines NNS O
. . O

Main NNP O
Outcome NNP O
: : O
Homozygous NNP O
recessive JJ O
gene NN O
variants NNS O
shared VBN O
by IN O
the DT O
four CD O
sisters NNS O
. . O

Results NNS O
: : O
The DT O
sisters NNS O
shared VBD O
a DT O
homozygous JJ O
stop NN O
gain JJ O
mutation NN O
in IN O
exon NN O
6 CD O
of IN O
PSMC3IP NN O
( -LRB- O
c.489 NN O
C NNP O
> XX O
G NN O
, , O
p NN O
. . O

Tyr163Ter NNP O
) -RRB- O
and CC O
a DT O
missense NN O
variant NN O
in IN O
exon NN O
1 CD O
of IN O
CLPP NNP O
( -LRB- O
c.100C NNP B-Var
> XX O
T NNP O
, , O
p NN O
. . O

Pro34Ser JJ O
) -RRB- O
. . O

The DT O
affected JJ O
brother NN O
also RB O
carried VBD O
the DT O
homozygous JJ O
PSMC3IP NN O
mutation NN O
. . O

Functional JJ O
studies NNS O
demonstrated VBD B-Reg
mitochondrial JJ B-CPA
fragmentation NN I-CPA
in IN O
cells NNS O
infected VBN O
with IN O
the DT O
CLPP JJ B-Gene
mutation NN B-Var
HOP-1 JJ O
Presenilin NNP O
Deficiency NNP O
Causes NNP O
a DT O
Late-Onset JJ O
Notch NNP O
Signaling NNP O
Phenotype NNP O
That IN O
Affects VBZ O
Adult NNP O
Germline NNP O
Function NNP O
in IN O
Caenorhabditis NNP O
elegans VBZ O
. . O

Functionally RB O
redundant JJ O
genes NNS O
present VBP O
a DT O
puzzle NN O
as IN O
to IN O
their PRP$ O
evolutionary JJ O
preservation NN O
, , O
and CC O
offer VB O
an DT O
interesting JJ O
opportunity NN O
for IN O
molecular JJ O
specialization NN O
. . O

In IN O
Caenorhabditis NNP O
elegans NNS O
, , O
either CC O
one CD O
of IN O
two CD O
presenilin JJ O
genes NNS O
( -LRB- O
sel-12 NN O
or CC O
hop-1 NNS O
) -RRB- O
facilitate VBP O
Notch NN O
activation NN O
, , O
providing VBG O
the DT O
catalytic JJ O
subunit NN O
for IN O
the DT O
γ NN O
secretase JJ O
proteolytic JJ O
enzyme NN O
complex NN O
. . O

For IN O
all DT O
known VBN O
Notch NN O
signaling NN O
events NNS O
, , O
sel-12 NN O
can MD O
mediate VB O
Notch NN O
activation NN O
, , O
so CC O
the DT O
conservation NN O
of IN O
hop-1 NNS O
remains VBZ O
a DT O
mystery NN O
. . O

Here RB O
, , O
we PRP O
uncover VBP O
a DT O
novel JJ O
" `` O
late-onset JJ O
" '' O
germline JJ O
Notch NN O
phenotype NN O
in IN O
which WDT O
HOP-1-deficient NN O
worms NNS O
fail VBP O
to TO O
maintain VB O
proliferating VBG O
germline NN O
stem NN O
cells NNS O
during IN O
adulthood NN O
. . O

Either CC O
SEL-12 NNP O
or CC O
HOP-1 JJ O
presenilin NN O
can MD O
impart VB O
sufficient JJ O
Notch NN O
signaling VBG O
for IN O
the DT O
establishment NN O
and CC O
expansion NN O
of IN O
the DT O
germline NN O
, , O
but CC O
maintenance NN O
of IN O
an DT O
adult NN O
stem NN O
cell NN O
pool NN O
relies VBZ O
exclusively RB O
on IN O
HOP-1-mediated VBN O
Notch NNP O
signaling NN O
. . O

We PRP O
also RB O
show VBP O
that IN O
HOP-1 JJ O
is VBZ O
necessary JJ O
for IN O
maximum JJ O
fecundity NN O
and CC O
reproductive JJ O
span NN O
. . O

The DT O
low-fecundity JJ B-NegReg
phenotype NN O
of IN O
hop-1 JJ O
mutants NNS O
can MD O
be VB O
phenocopied VBN O
by IN O
switching VBG O
off RP O
glp-1/Notch NN O
function NN O
during IN O
the DT O
last JJ O
stage NN O
of IN O
larval NN O
development NN O
. . O

We PRP O
propose VBP O
that IN O
at IN O
the DT O
end NN O
of IN O
larval NN O
development NN O
, , O
dual JJ O
presenilin NN O
usage NN O
switches VBZ O
exclusively RB O
to IN O
HOP-1 JJ O
, , O
perhaps RB O
offering VBG O
opportunities NNS O
for IN O
differential JJ O
regulation NN O
of IN O
the DT O
germline NN O
during IN O
adulthood NN O
. . O

Additional JJ O
defects NNS O
in IN O
oocyte NN O
size NN O
and CC O
production NN O
rate NN O
in IN O
hop-1 NNS O
and CC O
glp-1 NNS O
mutants NNS O
indicate VBP O
that IN O
the DT O
process NN O
of IN O
oogenesis NN O
is VBZ O
compromised VBN O
when WRB O
germline JJ O
Notch NN O
signaling NN O
is VBZ O
switched VBN O
off RP O
. . O

We PRP O
calculate VBP O
that IN O
in IN O
wild-type JJ O
adults NNS O
, , O
as RB O
much JJ O
as IN O
86 CD O
% NN O
of IN O
cells NNS O
derived VBN O
from IN O
the DT O
stem NN O
cell NN O
pool NN O
function NN O
to TO O
support VB O
oogenesis NN O
. . O

This DT O
work NN O
suggests VBZ O
that IN O
an DT O
important JJ O
role NN O
for IN O
Notch NNP O
signaling VBG O
in IN O
the DT O
adult NN O
germline NN O
is VBZ O
to TO O
furnish VB O
a DT O
large JJ O
and CC O
continuous JJ O
supply NN O
of IN O
nurse NN O
cells NNS O
to TO O
support VB O
the DT O
efficiency NN O
of IN O
oogenesis NN O
. . O

Mild NNP O
Telomere NNP O
Dysfunction NNP O
as IN O
a DT O
Force NNP O
for IN O
Altering VBG O
the DT O
Adaptive NNP O
Potential NNP O
of IN O
Subtelomeric NNP O
Genes NNPS O
. . O

Subtelomeric NNP O
regions NNS O
have VBP O
several JJ O
unusual JJ O
characteristics NNS O
, , O
including VBG O
complex JJ O
repetitive JJ O
structures NNS O
, , O
increased VBN O
rates NNS O
of IN O
evolution NN O
, , O
and CC O
enrichment NN O
for IN O
genes NNS O
involved VBN O
in IN O
niche NN O
adaptation NN O
. . O

The DT O
adaptive JJ O
telomere NN O
failure NN O
hypothesis NN O
suggests VBZ O
that IN O
certain JJ O
environmental JJ O
stresses NNS O
can MD O
induce VB O
a DT O
low JJ O
level NN O
of IN O
telomere JJ O
failure NN O
, , O
potentially RB O
leading VBG O
to IN O
elevated JJ O
subtelomeric JJ O
recombination NN O
that WDT O
could MD O
result VB O
in IN O
adaptive JJ O
mutational JJ O
changes NNS O
within IN O
subtelomeric JJ O
genes NNS O
. . O

Here RB O
, , O
we PRP O
tested VBD O
a DT O
key JJ O
prediction NN O
of IN O
the DT O
adaptive JJ O
telomere NN O
failure NN O
hypothesis-that NN O
telomere JJ O
dysfunction NN O
mild JJ O
enough RB O
to TO O
have VB O
little JJ O
or CC O
no DT O
overall JJ O
effect NN O
on IN O
cell NN O
fitness NN O
could MD O
still RB O
lead VB O
to IN O
substantial JJ O
increases NNS O
in IN O
the DT O
mutation NN O
rates NNS O
of IN O
subtelomeric JJ O
genes NNS O
. . O

Our PRP$ O
results NNS O
show VBP O
that IN O
a DT O
mutant NN O
of IN O
Kluyveromyces NNPS O
lactis JJ O
with IN O
stably RB O
short JJ O
telomeres NNS O
produced VBD O
a DT O
large JJ O
increase NN O
in IN O
the DT O
frequency NN O
of IN O
mutations NNS O
affecting VBG O
the DT O
native JJ O
subtelomeric JJ O
β-galactosidase NN O
( -LRB- O
LAC4 NNP O
) -RRB- O
gene NN O
. . O

All DT O
lac4 NN B-Gene
mutants NNS B-Var
examined VBN O
from IN O
strains NNS O
with IN O
severe JJ O
telomere JJ O
dysfunction NN O
underwent VBD B-Reg
terminal NN B-MPA
deletion NN I-MPA
/ SYM O
duplication NN O
events NNS O
consistent JJ O
with IN O
being VBG O
due JJ O
to IN O
break-induced VB O
replication NN O
. . O

In IN O
contrast NN O
, , O
although IN O
cells NNS O
with IN O
mild JJ O
telomere JJ O
dysfunction NN O
also RB O
exhibited VBD O
similar JJ O
terminal NN O
deletion NN O
and CC O
duplication NN O
events NNS O
, , O
up IN O
to TO O
50 CD O
% NN O
of IN O
lac4 NN B-Gene
mutants NNS B-Var
from IN O
this DT O
background NN O
unexpectedly RB O
contained VBD B-Reg
base JJ B-MPA
changes NNS I-MPA
Patients NNS O
with IN O
a DT O
Kabuki NNP O
syndrome NN O
phenotype NN O
demonstrate VBP O
DNA NN O
methylation NN O
abnormalities NNS O
. . O

Kabuki NNP B-Disease
syndrome NN I-Disease
is VBZ O
a DT O
monogenic JJ O
disorder NN O
caused VBN O
by IN O
loss NN B-NegReg
of IN I-NegReg
function NN I-NegReg
variants NNS B-Var
in IN O
either DT O
of IN O
two CD O
genes NNS O
encoding VBG O
histone-modifying NN O
enzymes NNS O
. . O

We PRP O
performed VBD O
targeted VBN O
sequencing NN O
in IN O
a DT O
cohort NN O
of IN O
27 CD O
probands NNS O
with IN O
a DT O
clinical JJ O
diagnosis NN O
of IN O
Kabuki NNP O
syndrome NN O
. . O

Of IN O
these DT O
, , O
12 CD O
had VBD O
causative JJ O
variants NNS O
in IN O
the DT O
two CD O
known VBN O
Kabuki NNP O
syndrome NN O
genes NNS O
. . O

In IN O
2 CD O
, , O
we PRP O
identified VBD O
presumptive JJ O
loss NN O
of IN O
function NN O
de IN O
novo NN O
variants NNS B-Var
in IN O
KMT2A NNP B-Gene
( -LRB- O
missense NN O
and CC O
splice NN O
site NN O
variants NNS O
) -RRB- O
, , O
a DT O
gene NN O
that WDT O
encodes VBZ O
another DT O
histone NN O
modifying VBG O
enzyme NN O
previously RB O
exclusively RB O
associated VBN B-Reg
with IN O
Wiedermann-Steiner NNP B-Disease
syndrome NN I-Disease
A DT O
novel JJ O
homozygous JJ O
ARL13B JJ B-Gene
variant NN B-Var
in IN O
patients NNS O
with IN O
Joubert NNP O
syndrome NN O
impairs VBZ B-NegReg
its PRP$ O
guanine NN B-MPA
nucleotide-exchange NN I-MPA
factor NN I-MPA
activity NN I-MPA
. . O

ARL13B NNP O
encodes NNS O
for IN O
the DT O
ADP-ribosylation NNP O
factor-like NN O
13B CD O
GTPase NN O
, , O
which WDT O
is VBZ O
required VBN O
for IN O
normal JJ O
cilia NNS O
structure NN O
and CC O
Sonic NNP O
hedgehog JJ O
( -LRB- O
Shh NNP O
) -RRB- O
signaling NN O
. . O

Disruptions NNS O
in IN O
cilia JJ O
structure NN O
or CC O
function NN O
lead NN O
to IN O
a DT O
class NN O
of IN O
human JJ O
disorders NNS O
called VBN O
ciliopathies NNS O
. . O

Joubert NNP O
syndrome NN O
is VBZ O
characterized VBN O
by IN O
a DT O
wide JJ O
spectrum NN O
of IN O
symptoms NNS O
, , O
including VBG O
a DT O
variable JJ O
degree NN O
of IN O
intellectual JJ O
disability NN O
, , O
ataxia NN O
, , O
and CC O
ocular JJ O
abnormalities NNS O
. . O

Here RB O
we PRP O
report VBP O
a DT O
novel JJ O
homozygous JJ O
missense NN O
variant NN O
c.[223G VBZ O
> XX O
A NN O
] -RRB- O
( -LRB- O
p.(Gly75Arg NNP O
) -RRB- O
in IN O
the DT O
ARL13B JJ O
gene NN O
, , O
which WDT O
was VBD O
identified VBN O
by IN O
whole-exome JJ O
sequencing NN O
of IN O
a DT O
trio NN O
from IN O
a DT O
consanguineous JJ O
family NN O
with IN O
multiple-affected JJ O
individuals NNS O
suffering VBG O
from IN O
intellectual JJ O
disability NN O
, , O
ataxia NN O
, , O
ocular JJ O
defects NNS O
, , O
and CC O
epilepsy NN O
. . O

The DT O
same JJ O
variant NN O
was VBD O
also RB O
identified VBN O
in IN O
a DT O
second JJ O
family NN O
. . O

We PRP O
saw VBD O
a DT O
striking JJ O
difference NN O
in IN O
the DT O
severity NN O
of IN O
ataxia NN O
between IN O
affected VBN O
male JJ O
and CC O
female JJ O
individuals NNS O
in IN O
both DT O
families NNS O
. . O

Both DT O
ARL13B JJ O
and CC O
ARL13B-c.[223G NNP O
> XX O
A NN O
] -RRB- O
( -LRB- O
p.(Gly75Arg NNP O
) -RRB- O
expression NN O
rescued VBD O
the DT O
cilia JJ O
length NN O
and CC O
Shh NNP O
defects NNS O
displayed VBN O
by IN O
Arl13b JJ O
hennin NN O
( -LRB- O
null NN O
) -RRB- O
cells NNS O
, , O
indicating VBG O
that IN O
the DT O
variant NN O
did VBD O
not RB O
disrupt VB O
either DT O
ARL13B JJ O
function NN O
. . O

In IN O
contrast NN O
, , O
ARL13B-c.[223G NNP B-Gene
> XX O
A NN O
] -RRB- O
( -LRB- O
p.(Gly75Arg NNP O
) -RRB- O
displayed VBD O
a DT O
marked JJ O
loss NN O
of IN O
ARL3 NNP O
guanine NN O
nucleotide-exchange NN O
factor NN O
activity NN O
, , O
with IN O
retention NN O
of IN O
its PRP$ O
GTPase NNP O
activities NNS O
, , O
highlighting VBG O
the DT O
correlation NN O
between IN O
its PRP$ O
loss NN O
of IN O
function NN O
as IN O
an DT O
ARL3 NNP O
guanine NN O
nucleotide-exchange NN O
factor NN O
and CC O
Joubert NNP O
syndrome NN O
. . O

Cantu NNP O
syndrome-associated NN O
SUR2 NNP O
( -LRB- O
ABCC9 NNS B-Gene
) -RRB- O
mutations NNS B-Var
in IN O
distinct JJ O
structural JJ O
domains NNS O
result VBP O
in IN O
KATP NNP B-MPA
channel NN I-MPA
gain-of-function NN B-PosReg
by IN O
differential JJ O
mechanisms NNS O
. . O

The DT O
complex JJ O
disorder NN O
Cantu NNP B-Disease
syndrome NN I-Disease
( -LRB- O
CS NNP O
) -RRB- O
arises VBZ O
from IN O
gain-of-function NN B-PosReg
mutations NNS B-Var
in IN O
either CC O
KCNJ8 NNP B-Gene
or CC O
ABCC9 NNS B-Gene
, , O
the DT O
genes NNS O
encoding VBG O
the DT O
Kir6.1 NNP O
and CC O
SUR2 NNP O
subunits NNS O
of IN O
ATP-sensitive NNP O
potassium NN O
( -LRB- O
KATP NNP O
) -RRB- O
channels NNS O
, , O
respectively RB O
. . O

Recent JJ O
reports NNS O
indicate VBP O
that IN O
such JJ O
mutations NNS B-Var
can MD O
increase VB B-PosReg
channel NN B-MPA
activity NN I-MPA
by IN O
multiple JJ O
molecular JJ O
mechanisms NNS O
. . O

In IN O
this DT O
study NN O
, , O
we PRP O
determined VBD O
the DT O
mechanism NN O
by IN O
which WDT O
KATP NNP B-MPA
function NN I-MPA
is VBZ O
altered VBN B-Reg
by IN O
several JJ O
substitutions NNS O
in IN O
distinct JJ O
structural JJ O
domains NNS O
of IN O
SUR2 NNP B-Gene
: : O
D207E NN B-Var
in IN O
the DT O
intracellular JJ O
L0-linker NNP O
and CC O
Y985S NN B-Var
, , O
G989E NN B-Var
, , O
M1060I NNP B-Var
, , O
and CC O
R1154Q NNP B-Var
/ SYM O
R1154W NNP B-Var
in IN O
TMD2 NNP O
. . O

We PRP O
engineered VBD O
substitutions NNS O
at IN O
their PRP$ O
equivalent JJ O
positions NNS O
in IN O
rat JJ O
SUR2A NNP O
( -LRB- O
D207E NNP O
, , O
Y981S JJ O
, , O
G985E JJ O
, , O
M1056I NNP O
, , O
and CC O
R1150Q NNP O
/ SYM O
R1150W NNP O
) -RRB- O
and CC O
investigated VBN O
functional JJ O
consequences NNS O
using VBG O
macroscopic JJ O
rubidium NN O
( -LRB- O
86Rb+ NN O
) -RRB- O
efflux NN O
assays NNS O
and CC O
patch-clamp NN O
electrophysiology NN O
. . O

Our PRP$ O
results NNS O
indicate VBP O
that IN O
D207E NN B-Var
increases VBZ B-PosReg
KATP NNP B-MPA
channel NN I-MPA
activity NN I-MPA
by IN O
increasing VBG B-PosReg
intrinsic JJ B-MPA
stability NN I-MPA
of IN I-MPA
the DT I-MPA
open JJ I-MPA
state NN I-MPA
, , O
whereas IN O
the DT O
cluster NN O
of IN O
Y981S NNP B-Var
/ SYM O
G985E NNP B-Var
/ SYM O
M1056I NNP B-Var
substitutions NNS O
, , O
as RB O
well RB O
as IN O
R1150Q NNP B-Var
/ SYM O
R1150W NNP B-Var
, , O
augmented VBD B-PosReg
Mg-nucleotide NNP B-MPA
activation NN I-MPA
Arabidopsis NN O
Phospholipase NNP O
C3 NNP O
is VBZ O
Involved VBN O
in IN O
Lateral NNP O
Root NNP O
Initiation NNP O
and CC O
ABA NNP O
Responses NNS O
in IN O
Seed NNP O
Germination NNP O
and CC O
Stomatal NNP O
Closure NNP O
. . O

Phospholipase NN O
C NNP O
( -LRB- O
PLC NNP O
) -RRB- O
is VBZ O
well RB O
known VBN O
for IN O
its PRP$ O
role NN O
in IN O
animal NN O
signaling NN O
, , O
where WRB O
it PRP O
generates VBZ O
the DT O
second JJ O
messengers NNS O
, , O
inositol NN O
1,4,5-trisphosphate CD O
( -LRB- O
IP3 NNP O
) -RRB- O
and CC O
diacylglycerol NN O
( -LRB- O
DAG NN O
) -RRB- O
, , O
by IN O
hydrolyzing VBG O
the DT O
minor JJ O
phospholipid NN O
, , O
phosphatidylinositol VBP O
4,5-bisphosphate CD O
( -LRB- O
PIP2 NNP O
) -RRB- O
, , O
upon IN O
receptor NN O
stimulation NN O
. . O

In IN O
plants NNS O
, , O
PLC NNP O
's POS O
role NN O
is VBZ O
still RB O
unclear JJ O
, , O
especially RB O
because IN O
the DT O
primary JJ O
targets NNS O
of IN O
both CC O
second JJ O
messengers NNS O
are VBP O
lacking VBG O
, , O
i.e. FW O
the DT O
ligand-gated NN O
Ca2 NN O
+ SYM O
channel NN O
and CC O
protein NN O
kinase NN O
C NNP O
, , O
and CC O
because IN O
PIP2 JJ O
levels NNS O
are VBP O
extremely RB O
low JJ O
. . O

Nonetheless RB O
, , O
the DT O
Arabidopsis NNP O
genome VBP O
encodes NNS O
nine CD O
PLCs NNS O
. . O

We PRP O
used VBD O
a DT O
reversed-genetic JJ O
approach NN O
to TO O
explore VB O
PLC NNP O
's POS O
function NN O
in IN O
Arabidopsis NNP O
, , O
and CC O
report VB O
here RB O
that IN O
PLC3 NNP B-Gene
is VBZ O
required VBN O
for IN O
proper JJ O
root NN O
development NN O
, , O
seed NN O
germination NN O
and CC O
stomatal JJ O
opening NN O
. . O

Two CD O
independent JJ O
knock-down VB B-Var
mutants NNS I-Var
, , O
plc3-2 NN O
and CC O
plc3-3 NN O
, , O
were VBD O
found VBN O
to TO O
exhibit VB O
reduced VBN B-NegReg
lateral JJ B-CPA
root NN I-CPA
densities NNS I-CPA
by IN O
10-20 CD O
% NN O
. . O

Mutant JJ B-Var
seeds NNS O
germinated VBD B-CPA
more RBR O
slowly RB B-NegReg
but CC O
were VBD O
less RBR O
sensitive JJ O
to IN O
ABA NN O
to TO O
prevent VB O
germination NN O
. . O

Guard VB O
cells NNS O
of IN O
plc3 NN O
were VBD O
also RB O
compromised VBN O
in IN O
ABA-dependent NN O
stomatal JJ O
closure NN O
. . O

Promoter-β-glucuronidase NNP O
( -LRB- O
GUS NNP O
) -RRB- O
analyses VBZ O
confirmed VBD O
PLC3 NNP O
expression NN O
in IN O
guard NN O
cells NNS O
and CC O
germinating VBG O
seeds NNS O
, , O
and CC O
revealed VBD O
that IN O
the DT O
majority NN O
is VBZ O
expressed VBN O
in IN O
vascular JJ O
tissue NN O
, , O
most RBS O
probably RB O
phloem JJ O
companion NN O
cells NNS O
, , O
in IN O
roots NNS O
, , O
leaves NNS O
and CC O
flowers NNS O
. . O

In IN O
vivo NN O
32Pi CD O
labeling NN O
revealed VBD O
that IN O
ABA NNP O
stimulated VBD O
the DT O
formation NN B-MPA
of IN I-MPA
PIP2 NNP I-MPA
in IN O
germinating VBG O
seeds NNS O
and CC O
guard VB O
cell-enriched NN O
leaf NN O
peels NNS O
, , O
which WDT O
was VBD O
significantly RB O
reduced VBN B-NegReg
in IN O
plc3 JJ B-Gene
mutants NNS B-Var
Rare JJ O
loss NN B-NegReg
of IN I-NegReg
function NN I-NegReg
mutations NNS B-Var
in IN O
N-methyl-D-aspartate NNP B-Protein
glutamate JJ I-Protein
receptors NNS I-Protein
and CC O
their PRP$ O
contributions NNS O
to IN O
schizophrenia VB B-Disease
susceptibility NN O
. . O

In IN O
schizophrenia NN O
( -LRB- O
SCZ NNP O
) -RRB- O
and CC O
autism NN O
spectrum NN O
disorder NN O
( -LRB- O
ASD NN O
) -RRB- O
, , O
the DT O
dysregulation NN O
of IN O
glutamate JJ O
transmission NN O
through IN O
N-methyl-D-aspartate NN O
receptors NNS O
( -LRB- O
NMDARs NNPS O
) -RRB- O
has VBZ O
been VBN O
implicated VBN O
as IN O
a DT O
potential JJ O
etiological JJ O
mechanism NN O
. . O

Previous JJ O
studies NNS O
have VBP O
accumulated VBN O
evidence NN O
supporting VBG O
NMDAR-encoding NNP O
genes NNS O
' POS O
role NN O
in IN O
etiology NN O
of IN O
SCZ NNP O
and CC O
ASD NNP O
. . O

We PRP O
performed VBD O
a DT O
screening NN O
study NN O
for IN O
exonic JJ O
regions NNS O
of IN O
GRIN1 NNP O
, , O
GRIN2A NNP O
, , O
GRIN2C NNP O
, , O
GRIN2D NNP O
, , O
GRIN3A NNP O
, , O
and CC O
GRIN3B NNP O
, , O
which WDT O
encode JJ O
NMDAR NNP O
subunits VBZ O
, , O
in IN O
562 CD O
participates NNS O
( -LRB- O
370 CD O
SCZ NNP O
and CC O
192 CD O
ASD NNP O
) -RRB- O
. . O

Forty CD O
rare JJ O
variants NNS O
were VBD O
identified VBN O
including VBG O
38 CD O
missense NN O
, , O
1 CD O
frameshift NN O
mutation NN O
in IN O
GRIN2C NNP O
and CC O
1 CD O
splice NN O
site NN O
mutation NN O
in IN O
GRIN2D. NNP O
We PRP O
conducted VBD O
in IN O
silico NN O
analysis NN O
for IN O
all DT O
variants NNS O
and CC O
detected VBD O
seven CD O
missense NN O
variants NNS O
with IN O
deleterious JJ O
prediction NN O
. . O

De NNP O
novo NN O
analysis NN O
was VBD O
conducted VBN O
if IN O
pedigree JJ O
samples NNS O
were VBD O
available JJ O
. . O

The DT O
splice NN O
site NN O
mutation NN O
in IN O
GRIN2D NNP O
is VBZ O
predicted VBN O
to TO O
result VB O
in IN O
intron NN O
retention NN O
by IN O
minigene JJ O
assay JJ O
. . O

Furthermore RB O
, , O
the DT O
frameshift NN O
mutation NN O
in IN O
GRIN2C NNP O
and CC O
splice NN O
site NN O
mutation NN O
in IN O
GRIN2D NNP O
were VBD O
genotyped VBN O
in IN O
an DT O
independent JJ O
sample NN O
set NN O
comprising VBG O
1877 CD O
SCZ NNP O
cases NNS O
, , O
382 CD O
ASD NNP O
cases NNS O
, , O
and CC O
2040 CD O
controls NNS O
. . O

Both DT O
of IN O
them PRP O
were VBD O
revealed VBN O
to TO O
be VB O
singleton NN O
. . O

Our PRP$ O
study NN O
gives VBZ O
evidence NN O
in IN O
support NN O
of IN O
the DT O
view NN O
that IN O
ultra-rare JJ O
variants NNS O
with IN O
loss NN B-NegReg
of IN I-NegReg
function NN I-NegReg
( -LRB- O
frameshift NN B-Var
, , O
nonsense NN B-Var
or CC I-Var
splice NN I-Var
site NN I-Var
) -RRB- O
in IN O
NMDARs VBN B-Gene
genes NNS O
may MD O
contribute VB O
to IN O
possible JJ O
risk NN O
of IN O
SCZ NNP B-Disease
FRUCTOKINASE-LIKE NNP O
PROTEIN NN O
1 CD O
interacts NNS O
with IN O
TRXz NNS O
to TO O
regulate VB O
chloroplast JJ O
development NN O
in IN O
rice NN O
. . O

Chloroplast NNP O
genes NNS O
are VBP O
transcribed VBN O
by IN O
the DT O
plastid-encoded NN O
RNA NNP O
polymerase NN O
( -LRB- O
PEP NN O
) -RRB- O
or CC O
nucleus-encoded NN O
RNA NNP O
polymerase NN O
. . O

FRUCTOKINASE-LIKE NNP O
PROTEINS NNP O
( -LRB- O
FLNs NNS O
) -RRB- O
are VBP O
phosphofructokinase-B NN O
( -LRB- O
PfkB)-type NNP O
carbohydrate NN O
kinases VBZ O
that DT O
act NN O
as IN O
part NN O
of IN O
the DT O
PEP NNP O
complex NN O
; : O
however RB O
, , O
the DT O
molecular JJ O
mechanisms NNS O
underlying VBG O
FLN NNP O
activity NN O
in IN O
rice NN O
remain VBP O
elusive JJ O
. . O

Previously RB O
, , O
we PRP O
identified VBD O
and CC O
characterized VBD O
a DT O
heat-stress NN O
sensitive JJ O
albino NN O
( -LRB- O
hsa1 NNP O
) -RRB- O
mutant NN O
in IN O
rice NN O
. . O

Map-based NNP O
cloning VBG O
revealed VBN O
that IN O
HSA1 NNP O
encodes VBZ O
a DT O
putative JJ O
OsFLN2 NN O
. . O

Here RB O
, , O
we PRP O
further RB O
demonstrated VBD O
that IN O
knockdown NN O
or CC O
knockout NN O
of IN O
the DT O
OsFLN1 NNS O
, , O
a DT O
close JJ O
homolog NN O
of IN O
HSA1/OsFLN2 NNP O
, , O
considerably RB O
inhibits VBZ O
chloroplast JJ O
biogenesis NN O
and CC O
the DT O
fln1 NN O
knockout NN O
mutants NNS O
, , O
created VBN O
by IN O
clustered VBN O
regularly RB O
interspaced VBN O
short JJ O
palindromic JJ O
repeats NNS O
( -LRB- O
CRISPR NNP O
) -RRB- O
and CC O
CRISPR-associate NNP O
protein NN O
9 CD O
, , O
exhibit NN O
severe JJ O
albino JJ O
phenotype NN O
and CC O
seedling NN O
lethality NN O
. . O

Moreover RB O
, , O
OsFLN1 NNS O
localizes VBZ O
to IN O
the DT O
chloroplast NN O
. . O

Yeast NN O
two-hybrid CD O
, , O
pull-down NN O
and CC O
bimolecular JJ O
fluorescence NN O
complementation NN O
experiments NNS O
revealed VBD O
that IN O
OsFLN1 NNS O
and CC O
HSA1/OsFLN2 NNP O
interact NN O
with IN O
THIOREDOXINZ NNP O
( -LRB- O
OsTRXz NNP O
) -RRB- O
to TO O
regulate VB O
chloroplast JJ O
development NN O
. . O

In IN O
agreement NN O
with IN O
this DT O
, , O
knockout NN O
of IN O
OsTRXz NN O
resulted VBD O
in IN O
a DT O
similar JJ O
albino NN O
and CC O
seedling JJ O
lethality NN O
phenotype NN O
to IN O
that DT O
of IN O
the DT O
fln1 JJ O
mutants NNS O
. . O

Quantitative JJ O
reverse JJ O
transcription NN O
polymerase NN O
chain NN O
reaction NN O
and CC O
immunoblot NN O
analysis NN O
revealed VBD O
that IN O
the DT O
transcription NN B-MPA
and CC O
translation NN B-MPA
of IN O
PEP-dependent NN B-Gene
genes NNS I-Gene
were VBD O
strongly RB O
inhibited VBN B-NegReg
in IN O
fln1 NN B-Gene
and CC O
trxz JJ O
mutants NNS B-Var
, , O
indicating VBG O
that IN O
loss NN O
of IN O
OsFLN1 NNS O
, , O
HSA1/OsFLN2 NNP O
, , O
or CC O
OsTRXz NN O
function NN O
perturbs VBZ B-NegReg
the DT O
stability NN B-CPA
of IN I-CPA
the DT I-CPA
transcriptionally RB I-CPA
active JJ I-CPA
chromosome NN I-CPA
complex JJ I-CPA
and CC O
PEP NN B-Enzyme
activity NN B-MPA
The DT O
gain-of-function JJ B-PosReg
mutation NN O
E76 NNP B-Var
K NNP O
in IN O
SHP2 NNP B-Gene
promotes VBZ B-PosReg
CAC NNP B-Disease
tumorigenesis NN B-CPA
and CC O
induces VBZ B-PosReg
EMT NNP B-CPA
via IN O
the DT O
Wnt/β-catenin NNP B-Pathway
signaling NN I-Pathway
pathway NN I-Pathway
. . O

SHP2 NNP O
is VBZ O
encoded VBN O
by IN O
the DT O
protein NN O
tyrosine NN O
phosphatase NN O
11 CD O
( -LRB- O
Ptpn11 NN O
) -RRB- O
gene NN O
. . O

Several JJ O
gain-of-function NN O
( -LRB- O
GOF NN O
) -RRB- O
mutations NNS O
in IN O
Ptpn11 NN O
have VBP O
been VBN O
identified VBN O
in IN O
human JJ O
hematopoietic JJ O
malignancies NNS O
and CC O
solid JJ O
tumors NNS O
. . O

In IN O
addition NN O
, , O
the DT O
mutation NN B-Var
rate NN O
for IN O
SHP2 NNP B-Gene
is VBZ O
the DT O
highest JJS B-Reg
for IN O
colorectal NN B-Disease
cancer NN I-Disease
( -LRB- O
CRC NNP O
) -RRB- O
among IN O
solid JJ O
tumors NNS O
. . O

The DT O
E76 NNP O
K NNP O
GOF NNP O
mutation NN O
is VBZ O
the DT O
most RBS O
common JJ O
and CC O
active JJ O
SHP2 NNP O
mutation NN O
; : O
however RB O
, , O
the DT O
pathogenic JJ O
effects NNS O
and CC O
function NN O
of IN O
this DT O
mutation NN O
in IN O
CRC NNP O
tumor NN O
progression NN O
have VBP O
not RB O
been VBN O
well RB O
characterized VBN O
. . O

The DT O
Wnt/β-catenin NNP O
( -LRB- O
CTNNB1 NNP O
) -RRB- O
signaling NN O
pathway NN O
is VBZ O
crucial JJ O
for IN O
CRC NNP O
, , O
and CC O
excessive JJ O
activation NN O
of IN O
this DT O
pathway NN O
has VBZ O
been VBN O
observed VBN O
in IN O
several JJ O
tumors NNS O
. . O

We PRP O
used VBD O
Ptpn11E76 NNP O
K NNP O
conditional JJ O
knock-in NN O
mice NNS O
to TO O
study VB O
this DT O
GOF NN O
mutation NN O
in IN O
colitis-associated NN O
CRC NNP O
( -LRB- O
CAC NNP O
) -RRB- O
and CC O
used VBD O
the DT O
CRC NNP O
cell NN O
lines NNS O
HT29 NNP O
and CC O
HCT116 NNP O
to TO O
determine VB O
the DT O
relationship NN O
between IN O
SHP2 NNP O
and CC O
Wnt/β-catenin NNP O
signaling NN O
. . O

Ptpn11E76 NNP B-Gene
K NNP O
conditional JJ O
knock-in NN O
mice NNS O
exhibited VBD O
aggravated JJ O
inflammation NN O
and CC O
increased VBN O
CAC NNP O
tumorigenesis NN O
. . O

In IN O
vitro FW O
, , O
SHP2E76 NNP O
K NNP O
and CC O
SHP2WT NNP O
promoted VBD O
malignant JJ O
biological JJ O
behaviors NNS O
of IN O
CRC NNP O
cells NNS O
and CC O
induced VBN O
epithelial-mesenchymal JJ O
transition NN O
( -LRB- O
EMT NNP O
) -RRB- O
via IN O
the DT O
Wnt/β-catenin NNP O
signaling NN O
pathway NN O
. . O

Together RB O
, , O
our PRP$ O
results NNS O
showed VBD O
that IN O
SHP2E76 `` O
K NNP O
acts VBZ O
as IN O
an DT O
oncogene NN O
that WDT O
promotes VBZ O
the DT O
tumorigenesis NN O
and CC O
metastasis NN O
of IN O
CRC NNP O
. . O

Recessive JJ O
loss NN O
of IN O
function NN O
PIGN NN B-Gene
alleles NNS O
, , O
including VBG O
an DT O
intragenic JJ O
deletion NN B-Var
with IN O
founder NN O
effect NN O
in IN O
La NNP O
Réunion NNP O
Island NNP O
, , O
in IN O
patients NNS O
with IN O
Fryns NNP O
syndrome NN O
. . O

Fryns NNP O
syndrome NN O
( -LRB- O
FS NNP O
) -RRB- O
is VBZ O
a DT O
multiple JJ O
malformations NNS O
syndrome NN O
with IN O
major JJ O
features NNS O
of IN O
congenital JJ O
diaphragmatic JJ O
hernia NN O
, , O
pulmonary JJ O
hypoplasia NN O
, , O
craniofacial NN O
dysmorphic JJ O
features NNS O
, , O
distal JJ O
digit NN O
hypoplasia NN O
, , O
and CC O
a DT O
range NN O
of IN O
other JJ O
lower JJR O
frequency NN O
malformations NNS O
. . O

FS NN O
is VBZ O
typically RB O
lethal JJ O
in IN O
the DT O
fetal JJ O
or CC O
neonatal JJ O
period NN O
. . O

Inheritance NN O
is VBZ O
presumed VBN O
autosomal NN O
recessive JJ O
. . O

Although IN O
no DT O
major JJ O
genetic JJ O
cause NN O
has VBZ O
been VBN O
identified VBN O
for IN O
FS NN O
, , O
biallelic JJ B-Var
truncating NN I-Var
variants NNS I-Var
in IN O
PIGN NN B-Gene
, , O
encoding VBG O
a DT O
component NN O
of IN O
the DT O
glycosylphosphatidylinositol NN O
( -LRB- O
GPI)-anchor VB O
biosynthesis NN O
pathway NN O
, , O
have VBP O
been VBN O
identified VBN B-Reg
in IN O
a DT O
limited JJ O
number NN O
of IN O
cases NNS O
with IN O
a DT O
phenotype NN O
compatible JJ O
with IN O
FS NNP B-Disease
. . O

Biallelic JJ O
variants NNS O
in IN O
PIGN NN B-Gene
, , O
typically RB O
missense NN B-Var
or CC O
compound NN B-Var
missense NN I-Var
with IN O
truncating NN B-MPA
, , O
also RB O
cause VB B-Reg
multiple JJ B-Disease
congenital JJ I-Disease
anomalies-hypotonia-seizures NNS I-Disease
syndrome NN I-Disease
1 CD I-Disease
New JJ O
insights NNS O
into IN O
ANGPLT3 NNP O
in IN O
controlling VBG O
lipoprotein NN O
metabolism NN O
and CC O
risk NN O
of IN O
cardiovascular JJ O
diseases NNS O
. . O

Dyslipidemia NNP O
, , O
characterized VBN O
by IN O
elevation NN O
of IN O
plasma NN O
low JJ O
density NN O
lipoprotein NN O
cholesterol NN O
( -LRB- O
LDL-C NNP O
) -RRB- O
, , O
triglyceride NN O
( -LRB- O
TG NNP O
) -RRB- O
and CC O
reduction NN O
of IN O
plasma NN O
high JJ O
density NN O
lipoprotein NN O
cholesterol NN O
( -LRB- O
HDL-C NNP O
) -RRB- O
, , O
has VBZ O
been VBN O
verified VBN O
as IN O
a DT O
causal JJ O
risk NN O
factor NN O
for IN O
cardiovascular JJ O
diseases NNS O
( -LRB- O
CVD NNP O
) -RRB- O
, , O
leading VBG O
to IN O
a DT O
high JJ O
mortality NN O
rate NN O
in IN O
general JJ O
population NN O
. . O

It PRP O
is VBZ O
important JJ O
to TO O
understand VB O
the DT O
molecular JJ O
metabolism NN O
underlying VBG O
dyslipidemia NN O
in IN O
order NN O
to TO O
reduce VB O
the DT O
risk NN O
and CC O
to TO O
develop VB O
effective JJ O
therapeutic JJ O
approaches NNS O
against IN O
CVD NNP O
. . O

ANGPTL3 NNS O
( -LRB- O
human NN O
) -RRB- O
or CC O
Angptl3 NNP O
( -LRB- O
mouse NNP O
) -RRB- O
, , O
one CD O
member NN O
of IN O
the DT O
angiopoietin-like NN O
protein NN O
( -LRB- O
ANGPTL NNP O
) -RRB- O
family NN O
, , O
has VBZ O
been VBN O
identified VBN O
as IN O
an DT O
important JJ O
regulator NN O
of IN O
lipid NN O
metabolism NN O
by IN O
inhibiting VBG O
LPL NNP O
and CC O
EL NNP O
activity NN O
. . O

Results NNS O
have VBP O
demonstrated VBN O
that DT O
inactivation NN O
of IN O
Angptl3 NNS O
in IN O
mice NNS O
could MD O
obviously RB O
reduce VB O
the DT O
level NN O
of IN O
TG NNP O
, , O
LDL-C NNP O
and CC O
the DT O
atherosclerotic JJ O
lesion NN O
size NN O
, , O
leading VBG O
to IN O
a DT O
lower JJR O
risk NN O
for IN O
dyslipidemia NN O
and CC O
CVD NN O
. . O

Additionally RB O
, , O
in IN O
humans NNS O
, , O
carriers NNS O
with IN O
homozygous JJ O
LOF NNP B-NegReg
mutations NNS B-Var
in IN O
ANGPTL3 NNS B-Gene
have VBP O
lower JJR B-NegReg
plasma NN B-MPA
LDL-C NNP I-MPA
, , O
TG NNP B-MPA
levels NNS I-MPA
Clonal JJ O
evolution NN O
mechanisms NNS B-Reg
in IN O
NT5C2 NNP B-Gene
mutant-relapsed NN B-Var
acute JJ O
lymphoblastic JJ O
leukaemia NN O
. . O

Relapsed VBN O
acute JJ O
lymphoblastic JJ O
leukaemia NN O
( -LRB- O
ALL DT O
) -RRB- O
is VBZ O
associated VBN O
with IN O
resistance NN O
to IN O
chemotherapy NN O
and CC O
poor JJ O
prognosis NN O
. . O

Gain-of-function NN O
mutations NNS O
in IN O
the DT O
5'-nucleotidase CD O
, , O
cytosolic JJ O
II NNP O
( -LRB- O
NT5C2 NNP O
) -RRB- O
gene NN O
induce VBP O
resistance NN O
to TO O
6-mercaptopurine VB O
and CC O
are VBP O
selectively RB O
present JJ O
in IN O
relapsed VBN O
ALL DT O
. . O

Yet RB O
, , O
the DT O
mechanisms NNS O
involved VBN O
in IN O
NT5C2 NNP O
mutation-driven NN O
clonal JJ O
evolution NN O
during IN O
the DT O
initiation NN O
of IN O
leukaemia NN O
, , O
disease NN O
progression NN O
and CC O
relapse NN O
remain VBP O
unknown JJ O
. . O

Here RB O
we PRP O
use VBP O
a DT O
conditional-and-inducible JJ O
leukaemia NN O
model NN O
to TO O
demonstrate VB O
that IN O
expression NN O
of IN O
NT5C2(R367Q NNP O
) -RRB- O
, , O
a DT O
highly RB O
prevalent JJ O
relapsed-ALL VBN O
NT5C2 NNP O
mutation NN O
, , O
induces VBZ O
resistance NN O
to TO O
chemotherapy VB O
with IN O
6-mercaptopurine NN O
at IN O
the DT O
cost NN O
of IN O
impaired JJ O
leukaemia NN O
cell NN O
growth NN O
and CC O
leukaemia-initiating NN O
cell NN O
activity NN O
. . O

The DT O
loss-of-fitness NN O
phenotype NN O
of IN O
NT5C2+/R367Q JJ O
mutant JJ O
cells NNS O
is VBZ O
associated VBN O
with IN O
excess JJ O
export NN O
of IN O
purines NNS O
to IN O
the DT O
extracellular JJ O
space NN O
and CC O
depletion NN O
of IN O
the DT O
intracellular JJ O
purine-nucleotide NN O
pool NN O
. . O

Consequently RB O
, , O
blocking VBG O
guanosine NN O
synthesis NN O
by IN O
inhibition NN O
of IN O
inosine-5'-monophosphate JJ O
dehydrogenase NN O
( -LRB- O
IMPDH NNP O
) -RRB- O
induced VBN O
increased VBN O
cytotoxicity NN O
against IN O
NT5C2-mutant JJ O
leukaemia NN O
lymphoblasts NNS O
. . O

These DT O
results NNS O
identify VBP O
the DT O
fitness NN O
cost NN O
of IN O
NT5C2 NNP O
mutation NN O
and CC O
resistance NN O
to TO O
chemotherapy VB O
as IN O
key JJ O
evolutionary JJ O
drivers NNS O
that WDT O
shape VBP O
clonal JJ O
evolution NN O
in IN O
relapsed VBN O
ALL DT O
and CC O
support VB O
a DT O
role NN O
for IN O
IMPDH JJ O
inhibition NN O
in IN O
the DT O
treatment NN O
of IN O
ALL DT O
. . O

The DT O
protective JJ O
role NN O
of IN O
DOT1L NNS O
in IN O
UV-induced NN O
melanomagenesis NN O
. . O

The DT O
DOT1L NNS O
histone NN O
H3 NNP O
lysine NN O
79 CD O
( -LRB- O
H3K79 JJ O
) -RRB- O
methyltransferase NN O
plays VBZ O
an DT O
oncogenic JJ O
role NN O
in IN O
MLL-rearranged NNP O
leukemogenesis NN O
. . O

Here RB O
, , O
we PRP O
demonstrate VBP O
that IN O
, , O
in IN O
contrast NN O
to IN O
MLL-rearranged NNP O
leukemia NN O
, , O
DOT1L NNS O
plays VBZ O
a DT O
protective JJ O
role NN O
in IN O
ultraviolet JJ O
radiation NN O
( -LRB- O
UVR)-induced VBN O
melanoma NN O
development NN O
. . O

Specifically RB O
, , O
the DT O
DOT1L NNS B-Gene
gene NN O
is VBZ O
located VBN O
in IN O
a DT O
frequently RB O
deleted VBN O
region NN O
and CC O
undergoes NNS O
somatic JJ O
mutation NN O
in IN O
human JJ O
melanoma NN O
. . O

Specific JJ O
mutations NNS B-Var
functionally RB O
compromise VBP B-NegReg
DOT1L NNS B-Gene
methyltransferase NN B-Enzyme
enzyme NN I-Enzyme
activity NN B-MPA
leading VBG O
to IN O
reduced VBN B-NegReg
H3K79 JJ B-Protein
methylation NN B-MPA
. . O

Importantly RB O
, , O
in IN O
the DT O
absence NN O
of IN O
DOT1L NNS O
, , O
UVR-induced NNP O
DNA NN O
damage NN O
is VBZ O
inefficiently RB O
repaired VBN O
, , O
so IN O
that IN O
DOT1L NNS B-Gene
loss NN B-NegReg
promotes VBZ B-PosReg
melanoma NN B-CPA
development NN I-CPA
Biallelic JJ B-Var
variants NNS I-Var
in IN O
KIF14 NNP B-Gene
cause VBP B-Reg
intellectual JJ B-Disease
disability NN I-Disease
with IN O
microcephaly NN B-Disease
. . O

Kinesin NNP O
proteins NNS O
are VBP O
critical JJ O
for IN O
various JJ O
cellular JJ O
functions NNS O
such JJ O
as IN O
intracellular JJ O
transport NN O
and CC O
cell NN O
division NN O
, , O
and CC O
many JJ O
members NNS O
of IN O
the DT O
family NN O
have VBP O
been VBN O
linked VBN O
to IN O
monogenic JJ O
disorders NNS O
and CC O
cancer NN O
. . O

We PRP O
report VBP O
eight CD O
individuals NNS O
with IN O
intellectual JJ O
disability NN O
and CC O
microcephaly NN O
from IN O
four CD O
unrelated JJ O
families NNS O
with IN O
parental JJ O
consanguinity NN O
. . O

In IN O
the DT O
affected VBN O
individuals NNS O
of IN O
each DT O
family NN O
, , O
homozygosity NN O
for IN O
likely JJ O
pathogenic JJ B-CPA
variants NNS O
in IN O
KIF14 NNP B-Gene
were VBD O
detected VBN O
; : O
two CD O
loss-of-function NN B-NegReg
( -LRB- O
p NN B-Var
. . O

Asn83Ilefs*3 RB O
and CC O
p NN B-Var
. . O

Ser1478fs NNP O
) -RRB- O
, , O
and CC O
two CD O
missense NN B-Reg
substitutions NNS I-Reg
( -LRB- O
p NN B-Var
. . O

Ser841Phe NN O
and CC O
p NN B-Var
. . O

Gly459Arg NNP O
) -RRB- O
. . O

KIF14 NNP O
is VBZ O
a DT O
mitotic JJ O
motor NN O
protein NN O
that WDT O
is VBZ O
required VBN O
for IN O
spindle NN O
localization NN O
of IN O
the DT O
mitotic JJ O
citron NN O
rho-interacting VBD O
kinase NN O
, , O
CIT NNP B-Gene
, , O
also RB O
mutated VBN B-Var
in IN B-Reg
microcephaly NN B-Disease
APOC3 NNP B-Gene
Loss-of-Function NN B-NegReg
Mutations NNP B-Var
, , O
Remnant NNP O
Cholesterol NNP O
, , O
Low-Density NNP O
Lipoprotein NNP O
Cholesterol NNP O
, , O
and CC O
Cardiovascular NNP O
Risk NN O
: : O
Mediation- NNP O
and CC O
Meta-Analyses NNP O
of IN O
137 CD O
  _SP O
895 CD O
Individuals NNS O
. . O

OBJECTIVE NN O
: : O
Loss-of-function NN B-NegReg
mutations NNS B-Var
in IN O
APOC3 NN B-Gene
associate NN O
with IN O
low JJ B-NegReg
remnant JJ B-MPA
cholesterol NN I-MPA
levels NNS I-MPA
and CC O
low JJ O
risk NN O
of IN O
ischemic JJ O
vascular JJ O
disease NN O
( -LRB- O
IVD NNP O
) -RRB- O
. . O

Because IN O
some DT O
studies NNS O
show VBP O
an DT O
additional JJ O
association NN O
with IN O
low JJ O
levels NNS O
of IN O
low-density JJ O
lipoprotein NN O
cholesterol NN O
( -LRB- O
LDL-C NNP O
) -RRB- O
, , O
low JJ O
LDL-C NNP O
may MD O
explain VB O
the DT O
low JJ O
risk NN O
of IN O
IVD NNP O
in IN O
APOC3 NNP O
loss-of-function NN O
heterozygotes NNS O
. . O

We PRP O
tested VBD O
to IN O
what WDT O
extent NN O
the DT O
low JJ O
risk NN O
of IN O
IVD NNP O
in IN O
APOC3 NNP O
loss-of-function NN O
heterozygotes NNS O
is VBZ O
mediated VBN O
by IN O
low JJ O
plasma NN O
remnant JJ O
cholesterol NN O
and CC O
LDL-C. NNP O
APPROACH NNP O
AND CC O
RESULTS NNP O
: : O
In IN O
APOC3 NN O
loss-of-function NN O
heterozygotes NNS O
versus IN O
noncarriers NNS O
, , O
we PRP O
first RB O
determined VBD O
remnant JJ O
cholesterol NN O
and CC O
LDL-C NNP O
levels NNS O
in IN O
meta-analyses NN O
of IN O
137 CD O
  _SP O
895 CD O
individuals NNS O
. . O

Second RB O
, , O
we PRP O
determined VBD O
whether IN O
the DT O
association NN O
with IN O
LDL-C NNP O
was VBD O
masked VBN O
by IN O
lipid-lowering NN O
therapy NN O
. . O

Finally RB O
, , O
using VBG O
mediation NN O
analysis NN O
, , O
we PRP O
determined VBD O
the DT O
fraction NN O
of IN O
the DT O
low JJ O
risk NN O
of IN O
IVD NNP O
and CC O
ischemic JJ O
heart NN O
disease NN O
mediated VBN O
by IN O
remnant JJ O
cholesterol NN O
and CC O
LDL-C. NNP O
In IN O
meta-analyses NN O
, , O
remnant JJ O
cholesterol NN O
was VBD O
43 CD O
% NN O
lower JJR O
( -LRB- O
95 CD O
% NN O
confidence NN O
interval NN O
, , O
40%-47 CD O
% NN O
) -RRB- O
, , O
and CC O
LDL-C NNP O
was VBD O
4 CD O
% NN O
lower JJR O
( -LRB- O
1%-6 CD O
% NN O
) -RRB- O
in IN O
loss-of-function NN O
heterozygotes NNS O
( -LRB- O
n=776 NNP O
) -RRB- O
versus IN O
noncarriers NNS O
. . O

In IN O
the DT O
general JJ O
population NN O
, , O
LDL-C NNP O
was VBD O
3 CD O
% NN O
lower JJR O
in IN O
loss-of-function NN O
heterozygotes NNS O
versus IN O
noncarriers NNS O
, , O
4 CD O
% NN O
lower JJR O
when WRB O
correcting VBG O
for IN O
lipid-lowering NN O
therapy NN O
, , O
and CC O
3 CD O
% NN O
lower JJR O
in IN O
untreated JJ O
individuals NNS O
( -LRB- O
P NN O
values NNS O
, , O
0.06-0.008 CD O
) -RRB- O
. . O

Remnant JJ O
cholesterol NN O
mediated VBD O
37 CD O
% NN O
of IN O
the DT O
observed JJ O
41 CD O
% NN O
lower JJR O
risk NN O
of IN O
IVD NNP O
and CC O
54 CD O
% NN O
of IN O
the DT O
observed JJ O
36 CD O
% NN O
lower JJR O
risk NN O
of IN O
ischemic JJ O
heart NN O
disease NN O
; , O
corresponding VBG O
values NNS O
mediated VBN O
by IN O
LDL-C NNP O
were VBD O
1 CD O
% NN O
and CC O
2 CD O
% NN O
. . O

CONCLUSIONS NNS O
: : O
The DT O
low JJ O
risk NN O
of IN O
IVD NNP O
observed VBN O
in IN O
APOC3 NN B-Gene
loss-of-function NN B-NegReg
heterozygotes NNS O
is VBZ O
mainly RB O
mediated VBN O
by IN O
the DT O
associated JJ O
low JJ B-NegReg
remnant JJ B-MPA
cholesterol NN I-MPA
Key JJ O
apoptotic JJ B-Gene
genes NNS I-Gene
APAF1 NNP B-Gene
and CC O
CASP9 NNP B-Gene
implicated VBD O
in IN O
recurrent JJ O
folate-resistant JJ O
neural JJ O
tube NN O
defects NNS O
. . O

Neural JJ O
tube NN O
defects NNS O
( -LRB- O
NTDs NNS O
) -RRB- O
remain VBP O
one CD O
of IN O
the DT O
most RBS O
serious JJ O
birth NN O
defects NNS O
, , O
and CC O
although IN O
genes NNS O
in IN O
several JJ O
pathways NNS O
have VBP O
been VBN O
implicated VBN O
as IN O
risk NN O
factors NNS O
for IN O
neural JJ O
tube NN O
defects NNS O
via IN O
knockout NN O
mouse NN O
models NNS O
, , O
very RB O
few JJ O
molecular JJ O
causes NNS O
in IN O
humans NNS O
have VBP O
been VBN O
identified VBN O
. . O

Whole JJ O
exome NN O
sequencing NN O
identified VBN O
deleterious JJ O
variants NNS O
in IN O
key JJ O
apoptotic JJ O
genes NNS O
in IN O
two CD O
families NNS O
with IN O
recurrent JJ O
neural JJ O
tube NN O
defects NNS O
. . O

Functional JJ O
studies NNS O
in IN O
fibroblasts NNS O
indicate VBP O
that IN O
these DT O
variants NNS B-Var
are VBP O
loss-of-function NN B-NegReg
, , O
as IN O
apoptosis NN B-CPA
is VBZ O
significantly RB O
reduced VBN B-NegReg
. . O

This DT O
is VBZ O
the DT O
first JJ O
report NN O
of IN O
variants NNS B-Var
in IN O
apoptotic JJ B-Gene
genes NNS I-Gene
contributing VBG B-Reg
to IN O
neural JJ B-Disease
tube NN I-Disease
defect NN I-Disease
Congenital JJ O
diaphragmatic JJ O
hernia NN O
as IN O
a DT O
part NN O
of IN O
Nance-Horan NNP O
syndrome NN O
? . O
Nance-Horan NNP O
syndrome NN O
is VBZ O
a DT O
rare JJ O
X-linked NN O
developmental JJ O
disorder NN O
characterized VBN O
by IN O
bilateral JJ O
congenital JJ O
cataract NN O
, , O
dental JJ O
anomalies NNS O
, , O
facial JJ O
dysmorphism NN O
, , O
and CC O
intellectual JJ O
disability NN O
. . O

Here RB O
, , O
we PRP O
identify VBP O
a DT O
patient NN O
with IN O
Nance-Horan NNP B-Disease
syndrome NN I-Disease
caused VBN B-Reg
by IN I-Reg
a DT O
new JJ O
nonsense NN B-Var
NHS NNP B-Gene
variant NN O
. . O

In IN O
addition NN O
, , O
the DT O
patient NN O
presented VBD O
congenital JJ B-Disease
diaphragmatic JJ I-Disease
hernia NN I-Disease
. . O

NHS NNP O
gene NN O
expression NN O
in IN O
murine NN O
fetal JJ O
diaphragm NN O
was VBD O
demonstrated VBN O
, , O
suggesting VBG O
a DT O
possible JJ O
involvement NN O
of IN O
NHS NNP O
in IN O
diaphragm NN O
development NN O
. . O

Congenital JJ B-Disease
diaphragmatic JJ I-Disease
hernia NN I-Disease
could MD O
result VB B-Reg
from IN I-Reg
NHS NNP B-Gene
loss NN B-NegReg
of IN I-NegReg
function NN I-NegReg
in IN O
pleuroperitoneal JJ O
fold NN O
or CC O
in IN O
somites-derived NNS O
muscle NN O
progenitor NN O
cells NNS O
leading VBG O
to IN O
an DT O
impairment NN O
of IN O
their PRP$ O
cells NNS B-CPA
migration NN I-CPA
[ -LRB- O
The DT O
formation NN O
of IN O
skin NN O
barrier NN O
and CC O
defective JJ O
barrier-associated NN O
skin NN O
diseases NNS O
] -RRB- O
. . O


   _SP O
Since IN O
the DT O
discovery NN O
of IN O
loss-of-function NN B-NegReg
mutations NNS B-Var
in IN O
filaggrin NN O
( -LRB- O
FLG NNP B-Gene
) -RRB- O
gene NN O
in IN O
atopic JJ B-Disease
dermatitis NN I-Disease
Tryptophan NNP O
hydroxylase NN O
( -LRB- O
TRH NNP B-Gene
) -RRB- O
loss NN B-NegReg
of IN I-NegReg
function NN I-NegReg
mutations NNS B-Var
induce VBP B-PosReg
growth NN B-CPA
and CC O
behavioral JJ B-CPA
defects NNS I-CPA
in IN O
Daphnia NNP O
magna NN O
. . O

Tryptophan NNP O
hydroxylase NN O
( -LRB- O
TRH NNP O
) -RRB- O
is VBZ O
the DT O
rate NN O
limiting VBG O
enzyme NN O
in IN O
the DT O
serotonin NN O
synthesis NN O
. . O

CRISPR-Cas9 NNP O
technology NN O
was VBD O
used VBN O
to TO O
generate VB O
seven CD O
indel IN O
TRH NNP O
mutants NNS O
in IN O
Daphnia NNP O
magna NN O
. . O

Mono-allelic NNP O
indel JJ O
TRH-/+ NNP O
clones NNS O
showed VBD O
normal JJ O
levels NNS O
of IN O
serotonin NN O
, , O
measured VBN O
by IN O
both DT O
immunohistochemistry NN O
and CC O
mass NN O
spectrometry NN O
( -LRB- O
LC-MS NNP O
/ SYM O
MS NNP O
) -RRB- O
, , O
whereas IN O
bi-allelic NNP O
indel NN O
TRH-/- NN O
clones NNS O
showed VBD O
no DT O
detectable JJ O
levels NNS O
of IN O
serotonin NN O
. . O

Life NN O
history NN O
and CC O
behavioral JJ O
responses NNS O
of IN O
TRH-/- NN O
clones NNS O
showed VBD O
the DT O
anti-phenotype RB O
of IN O
those DT O
exposed VBN O
to IN O
selective JJ O
serotonin NN O
reuptake NN O
inhibitors NNS O
( -LRB- O
SSRI NNP O
) -RRB- O
. . O

Mutants NNS B-Var
lacking VBG B-NegReg
serotonin NN B-MPA
grew VBD B-CPA
less JJR B-NegReg
and CC O
hence RB O
reproduced VBN B-CPA
latter JJ O
, , O
produced VBD O
smaller JJR B-NegReg
clutches NNS B-CPA
of IN O
smaller JJR B-NegReg
offspring NN B-CPA
Internal JJ B-Var
tandem NN I-Var
duplication NN I-Var
mutations NNS I-Var
in IN O
the DT O
tyrosine JJ O
kinase NN O
domain NN O
of IN O
FLT3 NNP B-Gene
display NN O
a DT O
higher JJR B-PosReg
oncogenic JJ B-CPA
potential NN I-CPA
than IN O
the DT O
activation NN O
loop NN O
D835Y IN O
mutation NN O
. . O

Acute NNP B-Disease
myeloid NN I-Disease
leukemia NN I-Disease
( -LRB- O
AML NNP O
) -RRB- O
remains VBZ O
the DT O
most RBS O
common JJ O
form NN O
of IN O
acute JJ O
leukemia NN O
among IN O
adults NNS O
and CC O
accounts NNS O
for IN O
a DT O
large JJ O
number NN O
of IN O
leukemia-related NN O
deaths NNS O
. . O

Mutations NNS B-Var
in IN O
FMS-like NNP O
tyrosine NN O
kinase NN O
3 CD O
( -LRB- O
FLT3 NNP B-Gene
) -RRB- O
is VBZ O
one CD O
of IN O
the DT O
most RBS O
prevalent JJ B-Reg
findings NNS O
in IN O
this DT O
heterogeneous JJ O
disease NN O
. . O

The DT O
major JJ O
types NNS O
of IN O
mutations NNS O
in IN O
FLT3 NNP O
can MD O
be VB O
categorized VBN O
as IN O
internal JJ O
tandem NN O
duplications NNS O
( -LRB- O
ITD NNP O
) -RRB- O
and CC O
point NN O
mutations NNS O
. . O

Recent JJ O
studies NNS O
suggest VBP O
that IN O
ITDs NNS O
not RB O
only RB O
occur VBP O
in IN O
the DT O
juxtamembrane NN O
region NN O
as IN O
originally RB O
described VBN O
, , O
but CC O
also RB O
in IN O
the DT O
kinase NN O
domain NN O
. . O

Although IN O
the DT O
juxtamembrane NN O
ITDs NNS O
have VBP O
been VBN O
well RB O
characterized VBN O
, , O
the DT O
tyrosine JJ O
kinase NN O
domain NN O
ITDs NNS O
have VBP O
not RB O
yet RB O
been VBN O
thoroughly RB O
studied VBN O
due IN O
to IN O
their PRP$ O
recent JJ O
discovery NN O
. . O

For IN O
this DT O
reason NN O
, , O
we PRP O
compared VBD O
ITD NNP O
mutations NNS O
in IN O
the DT O
juxtamembrane NN O
domain NN O
with IN O
those DT O
in IN O
the DT O
tyrosine JJ O
kinase NN O
domain NN O
, , O
as RB O
well RB O
as IN O
with IN O
the DT O
most RBS O
common JJ O
activating NN O
point NN O
mutation NN O
in IN O
the DT O
tyrosine JJ O
kinase NN O
domain NN O
, , O
D835Y. VBZ O
The DT O
purpose NN O
of IN O
this DT O
study NN O
was VBD O
to TO O
understand VB O
whether IN O
it PRP O
is VBZ O
the DT O
nature NN O
of IN O
the DT O
mutation NN O
or CC O
the DT O
location NN O
of IN O
the DT O
mutation NN O
that WDT O
plays VBZ O
the DT O
main JJ O
role NN O
in IN O
leukemogenesis NN O
. . O

The DT O
various JJ O
FLT3 NNP O
mutants NNS O
were VBD O
expressed VBN O
in IN O
the DT O
murine NN O
pro-B JJ O
cell NN O
line NN O
Ba NNP O
/ SYM O
F3 NNP O
and CC O
examined VBD O
for IN O
their PRP$ O
capacity NN O
to TO O
form VB O
colonies NNS O
in IN O
semisolid JJ O
medium NN O
. . O

The DT O
size NN O
and CC O
number NN O
of IN O
colonies NNS O
formed VBN O
by IN O
Ba NNP O
/ SYM O
F3 NNP O
cells NNS O
expressing VBG O
either CC O
the DT O
internal JJ O
tandem NN O
duplication NN O
within IN O
juxtamembrane NN O
   O
domain NN O
of IN O
the DT O
receptor NN O
( -LRB- O
JMD-ITD NNP O
) -RRB- O
or CC O
the DT O
tyrosine JJ O
kinase NN O
domain NN O
( -LRB- O
TKD)-ITD NNS O
were VBD O
indistinguishable JJ O
, , O
while IN O
Ba NNP O
/ SYM O
F3 NNP O
cells NNS O
expressing VBG O
D835Y NNP O
/ SYM O
FLT3 NNP O
failed VBD O
to TO O
form VB O
colonies NNS O
. . O

Cell NN B-CPA
proliferation NN I-CPA
and CC O
cell NN B-CPA
survival NN I-CPA
was VBD O
also RB O
significantly RB O
higher JJR B-PosReg
in IN O
TKD-ITD NNP B-Var
expressing VBG O
cells NNS O
, , O
compared VBN O
to IN O
cells NNS O
expressing VBG O
D835Y NNP O
/ SYM O
FLT3 NNP O
. . O

Furthermore RB O
, , O
TKD-ITD NNP B-Var
is VBZ O
capable JJ O
of IN O
inducing VBG B-PosReg
phosphorylation NN B-MPA
of IN O
STAT5 NNP B-Protein
Reversal NN O
of IN O
end-stage NN O
heart NN O
failure NN O
in IN O
juvenile JJ O
hemochromatosis NN O
with IN O
iron NN O
chelation NN O
therapy NN O
: : O
a DT O
case NN O
report NN O
. . O

BACKGROUND NNP O
: : O
Juvenile NNP O
hemochromatosis NN O
is VBZ O
the DT O
most RBS O
severe JJ O
form NN O
of IN O
iron NN O
overloading NN O
phenotype NN O
. . O

Although IN O
rare JJ O
, , O
it PRP O
should MD O
be VB O
suspected VBN O
in IN O
patients NNS O
who WP O
present VBP O
with IN O
hypogonadotropic JJ O
hypogonadism NN O
, , O
diabetes NN O
mellitus NN O
, , O
or CC O
cardiomyopathy NN O
without IN O
a DT O
clear JJ O
cause NN O
. . O

CASE NN O
PRESENTATION NN O
: : O
A DT O
young JJ O
Serbian JJ O
male NN O
presenting VBG O
with IN O
end-stage NN O
heart NN O
failure NN O
was VBD O
referred VBN O
for IN O
extracorporeal JJ O
membrane JJ O
oxygenation NN O
. . O

An DT O
endomyocardial JJ O
biopsy NN O
revealed VBD O
cytoplasmic JJ O
iron NN O
deposits NNS O
in IN O
myocytes NNS O
. . O

His PRP$ O
condition NN O
was VBD O
stabilized VBN O
with IN O
biventricular JJ O
assist NN O
devices NNS O
and CC O
he PRP O
was VBD O
listed VBN O
for IN O
heart NN O
transplantation NN O
. . O

Iron NN O
chelation NN O
therapy NN O
was VBD O
commenced VBN O
and CC O
resulted VBN O
in IN O
rapid JJ O
removal NN O
of IN O
iron NN O
burden NN O
. . O

Serial JJ O
outpatient NN O
echocardiograms NNS O
demonstrated VBD O
myocardial JJ O
recovery NN O
such JJ O
that IN O
a DT O
successful JJ O
biventricular NN O
assist NN O
device NN O
explant NN O
occurred VBD O
131 CD O
days NNS O
after IN O
initial JJ O
implant NN O
. . O

Targeted VBN O
gene NN O
sequencing NN O
revealed VBD O
a DT O
loss-of-function NN B-NegReg
mutation NN B-Var
within IN O
the DT O
HJV NNP B-Gene
gene NN O
, , O
which WDT O
is VBZ O
consistent JJ O
with IN O
juvenile JJ B-Disease
hemochromatosis NN I-Disease
. . O

CONCLUSIONS NNS O
: : O
This DT O
rare JJ O
case NN O
of IN O
a DT O
patient NN O
with IN O
juvenile JJ B-Disease
hemochromatosis NN I-Disease
associated VBN B-Reg
with IN O
a DT O
HJV NNP B-Gene
mutation NN B-Var
TRPV1 DT B-Gene
gain-of-function NN B-PosReg
mutation NN B-Var
impairs NNS B-NegReg
pain NN B-CPA
and CC I-CPA
itch NN I-CPA
sensations NNS I-CPA
in IN I-CPA
mice NNS I-CPA
. . O

Transient NNP O
receptor NN O
potential JJ O
vanilloid NN O
1 CD O
( -LRB- O
TRPV1 NN O
) -RRB- O
is VBZ O
a DT O
non-selective AFX O
cation NN O
channel NN O
, , O
which WDT O
can MD O
detect VB O
various JJ O
noxious JJ O
stimuli NNS O
that WDT O
cause VBP O
pain NN O
, , O
inflammation NN O
, , O
hyperalgesia NN O
, , O
and CC O
itch NN O
. . O

TRPV1 DT O
knock-out VB O
mice NNS O
show VBP O
deficiency NN O
in IN O
nociception NN O
, , O
but CC O
the DT O
in IN O
vivo NN O
effects NNS O
of IN O
persistent JJ O
activation NN O
of IN O
TRPV1 NN O
are VBP O
not RB O
completely RB O
understood VBN O
. . O

Here RB O
, , O
we PRP O
generated VBD O
TRPV1 DT O
knock-in VB O
mice NNS O
with IN O
a DT O
G564S NNP O
mutation NN O
. . O

In IN O
the DT O
heterologous JJ O
expression NN O
system NN O
, , O
an DT O
electrophysiological JJ O
study NN O
showed VBD O
that IN O
the DT O
G564S NNP B-Var
mutation NN I-Var
in IN O
mouse NN O
TRPV1 NNP B-Gene
caused VBD O
increased VBD B-PosReg
basal NN B-CPA
current NN I-CPA
and CC O
a DT O
leftward NN B-CPA
shift NN I-CPA
of IN I-CPA
voltage NN I-CPA
dependence NN I-CPA
. . O

Intriguingly RB O
, , O
using VBG O
behavioral JJ O
analysis NN O
, , O
we PRP O
found VBD O
that IN O
knock-in VB O
mice NNS O
showed VBD O
a DT O
thermosensory NN B-CPA
defect NN B-NegReg
, , O
impaired VBD B-NegReg
inflammatory JJ B-MPA
thermal JJ I-MPA
pain NN I-MPA
, , O
and CC O
capsaicin VBD B-CPA
sensitivity NN I-CPA
. . O

We PRP O
also RB O
demonstrated VBD O
an DT O
attenuated VBN O
behavioral JJ O
response NN O
to IN O
the DT O
pruritic JJ O
agent NN O
histamine NN O
in IN O
the DT O
knock-in VB O
mice NNS O
. . O

Indeed RB O
, , O
calcium NN O
imaging VBG O
together RB O
with IN O
electrophysiology NN O
showed VBD O
that IN O
the DT O
overactive JJ O
mutant NN O
had VBD O
decreased VBN O
capsaicin NNS O
sensitivity NN O
. . O

Western JJ O
blot NN O
analysis NN O
revealed VBD O
that IN O
the DT O
G564S NNP B-Var
mutant NN I-Var
reduced VBD B-NegReg
TRPV1 JJ B-Protein
phosphorylation NN B-MPA
and CC O
cell NN B-CPA
membrane JJ I-CPA
trafficking NN I-CPA
. . O

Together RB O
, , O
we PRP O
have VBP O
generated VBN O
a DT O
mouse NN O
model NN O
with IN O
a DT O
gain-of-function JJ B-PosReg
mutation NN B-Var
in IN O
Trpv1 NNP B-Gene
gene NN O
and CC O
demonstrated VBD O
that IN O
the DT O
pain NN B-CPA
and CC I-CPA
histamine-dependent NN I-CPA
itch NN I-CPA
sensations NNS I-CPA
in IN O
these DT O
mice NNS O
are VBP O
impaired VBN B-NegReg
due IN O
to IN O
a DT O
decreased VBN B-NegReg
phosphorylation NN B-MPA
level NN I-MPA
and CC O
reduced VBN B-NegReg
membrane JJ B-MPA
localization NN I-MPA
of IN O
TRPV1 NN B-Protein
Loss-of-Function NN B-NegReg
Mutations NNPS B-Var
in IN O
UNC45A NNP B-Gene
Cause NNP O
a DT O
Syndrome NNP B-Disease
Associating NNP O
Cholestasis NNP B-Disease
, , O
Diarrhea NNP B-Disease
, , O
Impaired NNP B-Disease
Hearing NNP I-Disease
, , O
and CC O
Bone NNP B-Disease
Fragility NNP I-Disease
. . O

Despite IN O
the DT O
rapid JJ O
discovery NN O
of IN O
genes NNS O
for IN O
rare JJ O
genetic JJ O
disorders NNS O
, , O
we PRP O
continue VBP O
to TO O
encounter VB O
individuals NNS O
presenting VBG O
with IN O
syndromic JJ O
manifestations NNS O
. . O

Here RB O
, , O
we PRP O
have VBP O
studied VBN O
four CD O
affected JJ O
people NNS O
in IN O
three CD O
families NNS O
presenting VBG O
with IN O
cholestasis NN B-Disease
, , O
congenital JJ B-Disease
diarrhea NN I-Disease
, , O
impaired JJ B-Disease
hearing NN I-Disease
, , O
and CC O
bone NN B-Disease
fragility NN I-Disease
. . O

Whole-exome JJ O
sequencing NN O
of IN O
all DT O
affected VBN O
individuals NNS O
and CC O
their PRP$ O
parents NNS O
identified VBD O
biallelic JJ B-Var
mutations NNS I-Var
in IN O
Unc-45 NNP O
Myosin NNP O
Chaperone NNP O
A NNP O
( -LRB- O
UNC45A NNP B-Gene
) -RRB- O
as IN O
a DT O
likely JJ O
driver NN O
for IN O
this DT O
disorder NN O
. . O

Subsequent JJ O
in IN O
   O
vitro FW O
and CC O
in IN O
   O
vivo NN O
functional JJ O
studies NNS O
of IN O
the DT O
candidate NN O
gene NN O
indicated VBD O
a DT O
loss-of-function NN B-NegReg
paradigm NN O
, , O
wherein WRB O
mutations NNS O
attenuated VBD B-NegReg
or CC O
abolished VBN B-NegReg
protein NN B-Protein
activity NN B-MPA
with IN O
concomitant JJ O
defects NNS B-NegReg
in IN O
gut NN B-CPA
development NN I-CPA
Loss-of-function NN O
and CC O
gain-of-function NN O
mutations NNS O
in IN O
PPP3CA NNP O
cause VBP O
two CD O
distinct JJ O
disorders NNS O
. . O

Calcineurin NNP O
is VBZ O
a DT O
calcium NN O
( -LRB- O
Ca2+)/calmodulin-regulated NNP O
protein NN O
phosphatase NN O
that WDT O
mediates VBZ O
Ca2 NN O
+ SYM O
-dependent : O
signal NN O
transduction NN O
. . O

Here RB O
, , O
we PRP O
report VBP O
six CD O
heterozygous JJ O
mutations NNS O
in IN O
a DT O
gene NN O
encoding VBG O
the DT O
alpha NN O
isoform NN O
of IN O
the DT O
calcineurin NN O
catalytic JJ O
subunit NN O
( -LRB- O
PPP3CA NNP O
) -RRB- O
. . O

Notably RB O
, , O
mutations NNS O
were VBD O
observed VBN O
in IN O
different JJ O
functional JJ O
domains NNS O
: : O
in IN O
addition NN O
to IN O
three CD O
catalytic JJ O
domain NN O
mutations NNS O
, , O
two CD O
missense NN O
mutations NNS O
were VBD O
found VBN O
in IN O
the DT O
auto-inhibitory NN O
( -LRB- O
AI NNP O
) -RRB- O
domain NN O
. . O

One CD O
additional JJ O
frameshift NN O
insertion NN O
that WDT O
caused VBD O
premature JJ O
termination NN O
was VBD O
also RB O
identified VBN O
. . O

Detailed JJ O
clinical JJ O
evaluation NN O
of IN O
the DT O
six CD O
individuals NNS O
revealed VBD O
clinically RB O
unexpected JJ O
consequences NNS O
of IN O
the DT O
PPP3CA NNP B-Gene
mutations NNS O
. . O

First RB O
, , O
the DT O
catalytic JJ B-Var
domain NN I-Var
mutations NNS I-Var
and CC O
frameshift NN B-Var
mutation NN I-Var
were VBD O
consistently RB O
found VBN B-Reg
in IN O
patients NNS O
with IN O
nonsyndromic JJ B-Disease
early JJ I-Disease
onset JJ I-Disease
epileptic NN I-Disease
encephalopathy NN I-Disease
. . O

In IN O
contrast NN O
, , O
the DT O
AI NNP B-Var
domain NN I-Var
mutations NNS I-Var
were VBD O
associated VBN B-Reg
with IN O
multiple JJ B-Disease
congenital JJ I-Disease
abnormalities NNS I-Disease
including VBG O
craniofacial JJ B-Disease
dysmorphism NN I-Disease
, , O
arthrogryposis NN B-Disease
and CC O
short JJ B-Disease
stature NN I-Disease
. . O

In IN O
addition NN O
, , O
one CD O
individual NN O
showed VBD O
severe JJ O
skeletal JJ O
developmental JJ O
defects NNS O
, , O
namely RB O
, , O
severe JJ O
craniosynostosis NN O
and CC O
gracile VB O
bones NNS O
( -LRB- O
severe JJ O
bone NN O
slenderness NN O
and CC O
perinatal JJ O
fractures NNS O
) -RRB- O
. . O

Using VBG O
a DT O
yeast NN O
model NN O
system NN O
, , O
we PRP O
showed VBD O
that IN O
the DT O
catalytic JJ O
and CC O
AI NNP B-Var
domain NN I-Var
mutations NNS I-Var
visibly RB O
result VBP O
in IN O
decreased VBD O
and CC O
increased VBN B-PosReg
calcineurin NN B-MPA
signaling NN I-MPA
, , O
respectively RB O
. . O

These DT O
findings NNS O
indicate VBP O
that IN O
different JJ O
functional JJ O
effects NNS O
of IN O
PPP3CA NN B-Gene
Genetic NNP O
Suppression NNP O
of IN O
Basement NNP O
Membrane NNP O
Defects NNP O
in IN O
Caenorhabditis NNP O
elegans VBZ O
by IN O
Gain NN O
of IN O
Function NNP O
in IN O
Extracellular NNP O
Matrix NNP O
and CC O
Cell-Matrix NNP O
Attachment NNP O
Genes NNPS O
. . O

Basement NNP O
membranes NNS O
are VBP O
extracellular JJ O
matrices NNS O
essential JJ O
for IN O
embryonic JJ O
development NN O
in IN O
animals NNS O
. . O

Peroxidasins NNS O
are VBP O
extracellular JJ O
peroxidases NNS O
implicated VBN O
in IN O
the DT O
unique JJ O
sulfilimine JJ O
cross-links NN O
between IN O
type NN O
IV NNP O
basement NN O
membrane NN O
collagens NNS O
. . O

Loss NN B-NegReg
of IN I-NegReg
function NN I-NegReg
in IN O
the DT O
Caenorhabditis NNP B-Enzyme
elegans NNS I-Enzyme
peroxidasin VBP I-Enzyme
PXN-2 NN I-Enzyme
results NNS O
in IN O
fully RB B-CPA
penetrant JJ I-CPA
embryonic JJ I-CPA
or CC O
larval NN B-CPA
lethality NN I-CPA
. . O

Using VBG O
genetic JJ O
suppressor NN O
screening NN O
, , O
we PRP O
find VBP O
that IN O
the DT O
requirement NN O
for IN O
PXN-2 NNP O
in IN O
development NN O
can MD O
be VB O
bypassed VBN O
by IN O
gain NN O
of IN O
function NN O
in IN O
multiple JJ O
genes NNS O
encoding VBG O
other JJ O
basement NN O
membrane JJ O
components NNS O
, , O
or CC O
proteins NNS O
implicated VBN O
in IN O
cell-matrix NN O
attachment NN O
. . O

We PRP O
identify VBP O
multiple JJ O
alleles NNS O
of IN O
let-805 NN O
, , O
encoding VBG O
the DT O
transmembrane NN O
protein NN O
myotactin NN O
, , O
which WDT O
suppress JJ O
phenotypes NNS O
of IN O
pxn-2 JJ O
null JJ O
mutants NNS O
and CC O
of IN O
other JJ O
basement NN O
membrane JJ O
mutants NNS O
such JJ O
as IN O
F-spondin NNP O
/ , O
spon-1 VBP O
These DT O
let-805 NN B-Gene
suppressor NN O
alleles NNS O
cause VBP O
missense NN B-Var
alterations NNS I-Var
in IN O
two CD O
pairs NNS O
of IN O
FNIII NN O
repeats NNS O
in IN O
the DT O
extracellular JJ O
domain NN O
; : O
they PRP O
act VBP O
dominantly RB O
and CC O
have VBP O
no DT O
detectable JJ O
phenotypes NNS O
alone RB O
, , O
suggesting VBG O
they PRP O
cause VBP O
gain NN B-PosReg
of IN I-PosReg
function NN I-PosReg
Biallelic JJ B-Var
inactivating NN I-Var
variants NNS I-Var
in IN O
the DT O
GTPBP2 JJ B-Gene
gene NN O
cause IN B-Reg
a DT O
neurodevelopmental JJ B-Disease
disorder NN I-Disease
with IN O
severe JJ O
intellectual JJ O
disability NN O
. . O

Congenital JJ O
neurological JJ O
disorders NNS O
are VBP O
genetically RB O
highly RB O
heterogeneous JJ O
. . O

Rare JJ O
forms NNS O
of IN O
hereditary JJ O
neurological JJ O
disorders NNS O
are VBP O
still RB O
difficult JJ O
to TO O
be VB O
adequately RB O
diagnosed VBN O
. . O

Pertinent JJ O
studies NNS O
, , O
especially RB O
when WRB O
reporting VBG O
only RB O
single JJ O
families NNS O
, , O
need VBP O
independent JJ O
confirmation NN O
. . O

We PRP O
present VBP O
three CD O
unrelated JJ O
families NNS O
in IN O
which WDT O
whole-exome JJ O
sequencing NN O
identified VBD O
the DT O
homozygous JJ O
non-sense AFX O
variants NNS O
c.430[C VBP B-Var
> XX I-Var
T];[C UH O
> XX O
T NNP O
] -RRB- O
p.(Arg144 NN O
* NFP O
) -RRB- O
, , O
c.1219[C NNS B-Var
> XX I-Var
T];[C UH O
> XX O
T NNP O
] -RRB- O
p.(Gln407 NNP O
* NFP O
) -RRB- O
and CC O
c.1408[C VBD B-Var
> XX I-Var
T];[C UH O
> XX O
T NNP O
] -RRB- O
p.(Arg470 NNP O
* NFP O
) -RRB- O
in IN O
GTPBP2 NNP B-Gene
. . O

Their PRP$ O
clinical JJ O
presentations NNS O
include VBP O
early JJ O
onset NN O
and CC O
apparently RB O
non-progressive AFX B-CPA
motor NN I-CPA
and CC I-CPA
cognitive JJ I-CPA
impairment NN I-CPA
, , O
and CC O
thereby RB O
overlap VB O
with IN O
findings NNS O
in IN O
a DT O
recently RB O
described VBN O
family NN O
harbouring VBG O
a DT O
homozygous JJ O
GTPBP2 JJ O
splice NN O
site NN O
variant NN O
. . O

Notable JJ O
differences NNS O
include VBP O
structural JJ B-CPA
brain NN I-CPA
abnormalities NNS I-CPA
( -LRB- O
e.g. RB O
, , O
agenesis NN B-CPA
of IN I-CPA
the DT I-CPA
corpus NN I-CPA
callosum NN I-CPA
, , O
exclusive JJ O
to IN O
our PRP$ O
patients NNS O
) -RRB- O
, , O
and CC O
evidence NN O
for IN O
brain NN B-CPA
iron NN I-CPA
accumulation NN I-CPA
Bi-allelic NNP B-Var
inactivating NN I-Var
variants NNS I-Var
in IN O
the DT O
COCH NNP B-Gene
gene NN O
cause NN B-Reg
autosomal NN B-Disease
recessive JJ I-Disease
prelingual JJ I-Disease
hearing NN I-Disease
impairment NN I-Disease
. . O

Pathogenic NNP O
variant NN O
in IN O
COCH NNP O
are VBP O
a DT O
known JJ O
cause NN O
of IN O
DFNA9 JJ O
autosomal NN O
dominant JJ O
progressive JJ O
hearing NN O
loss NN O
and CC O
vestibular JJ O
dysfunction NN O
with IN O
adult NN O
onset NN O
. . O

Hitherto RB O
, , O
only RB O
dominant JJ O
nonsynonymous JJ O
variants NNS O
and CC O
in-frame IN O
deletions NNS O
with IN O
a DT O
presumed VBN O
dominant JJ O
negative JJ O
or CC O
gain-of-function VB O
effect NN O
have VBP O
been VBN O
described VBN O
. . O

Here RB O
, , O
we PRP O
describe VBP O
two CD O
brothers NNS O
with IN O
congenital JJ O
prelingual JJ O
deafness NN O
and CC O
a DT O
homozygous JJ O
nonsense NN O
c.292C NN B-Var
> XX O
T(p NNP O
. . O

Arg98 NNP O
* NFP O
) -RRB- O
COCH NN B-Gene
variant NN O
, , O
suggesting VBG O
a DT O
loss-of-function NN B-NegReg
effect NN O
. . O

Vestibular JJ B-Disease
dysfunction NN I-Disease
Serum NNP O
vitamin NN O
C NN O
levels NNS O
modulate VBP O
the DT O
lifespan NN O
and CC O
endoplasmic JJ O
reticulum NN O
stress NN O
response NN O
pathways NNS O
in IN O
mice NNS O
synthesizing VBG O
a DT O
nonfunctional JJ O
mutant JJ O
WRN NNP O
protein NN O
. . O

Werner NNP B-Disease
syndrome NN I-Disease
( -LRB- O
WS NNP O
) -RRB- O
is VBZ O
a DT O
premature JJ O
aging NN O
disorder NN O
caused VBN B-Reg
by IN I-Reg
mutations NNS B-Var
in IN O
a DT O
RecQ-family NNP B-Protein
DNA NN I-Protein
helicase NN I-Protein
CgPDR1 NN B-Gene
gain-of-function NN B-PosReg
mutations NNS B-Var
lead VBP B-Reg
to IN I-Reg
azole-resistance NN B-MPA
and CC O
increased JJ B-PosReg
adhesion NN B-MPA
in IN O
clinical JJ O
Candida NNP O
glabrata NN O
strains NNS O
. . O

Recently RB O
, , O
Candida NNP O
glabrata NN O
has VBZ O
emerged VBN O
as IN O
a DT O
health-threatening NN O
pathogen NN O
and CC O
the DT O
rising VBG O
resistance NN O
to IN O
antifungal JJ O
agent NN O
in IN O
C. NNP O
   O
glabrata NN O
often RB O
leads VBZ O
to IN O
clinical JJ O
treatment NN O
failure NN O
. . O

To TO O
investigate VB O
the DT O
evolution NN O
of IN O
drug NN O
resistance NN O
and CC O
adherence NN O
ability NN O
in IN O
four CD O
paired VBN O
clinical JJ O
isolates NNS O
collected VBN O
before RB O
and CC O
after IN O
antifungal JJ O
treatment NN O
. . O

Sequence NN O
analysis NN O
, , O
gene NN O
disruption NN O
, , O
drug-susceptibility NN O
, , O
adhesion NN O
tests NNS O
and CC O
real-time JJ O
quantitative JJ O
PCR NNP O
were VBD O
performed VBN O
. . O

The DT O
azole-susceptible NN O
strains NNS O
acquired VBD O
azole NN O
resistance NN O
after IN O
antifungal JJ O
therapy NN O
. . O

Four CD O
gain-of-function NN O
( -LRB- O
GOF NN O
) -RRB- O
mutations NNS O
in IN O
CgPDR1 NNP O
were VBD O
revealed VBN O
by IN O
sequence NN O
analysis NN O
, , O
namely RB O
G1099D RB O
, , O
G346D VB O
, , O
L344S NNP O
and CC O
P927S NNS O
, , O
the DT O
last JJ O
being NN O
reported VBN O
for IN O
the DT O
first JJ O
time NN O
. . O

CDR1 NNP B-MPA
, , I-MPA
CDR2 NNP I-MPA
and CC I-MPA
SNQ2 NNP I-MPA
efflux NN I-MPA
pump VBP I-MPA
gene NN I-MPA
expression NN I-MPA
levels NNS O
were VBD O
elevated JJ B-PosReg
in IN O
strains NNS O
harbouring VBG O
GOF NN B-PosReg
mutations NNS B-Var
in IN O
CgPDR1 NN B-Gene
, , O
resulting VBG O
in IN O
decreased VBN B-NegReg
azole NN B-MPA
susceptibility NN I-MPA
. . O

CgPDR1 NN O
alleles NNS O
with IN O
distinct JJ O
GOF NN O
mutations NNS O
displayed VBD O
different JJ O
expression NN O
profiles NNS O
for IN O
the DT O
drug-related NN O
genes NNS O
. . O

CgPDR1GOF NN B-Gene
mutations NNS O
led VBD O
to IN O
increased VBN O
efflux NN O
pumps NNS O
expression NN O
levels NNS O
in IN O
a DT O
strain NN O
background NN O
independent JJ O
way NN O
. . O

Hyperactive NNP O
Pdr1G1099D NNP O
and CC O
Pdr1P927S NNP O
displayed VBD O
strain NN O
background-dependent NN O
increased VBN O
adherence NN O
to IN O
host NN O
cells NNS O
via IN O
upregulation NN O
of IN O
EPA1 NNP O
transcription NN O
. . O

Interestingly RB O
, , O
the DT O
drug NN O
transporter NN O
gene NN O
expression NN O
levels NNS O
did VBD O
not RB O
always RB O
correspond VB O
with IN O
that DT O
of IN O
the DT O
adhesin NN O
EPA1 NNP O
gene NN O
. . O

GOF NN O
mutations NNS O
in IN O
CgPDR1 NN O
conferred VBD O
drug NN O
resistance NN O
and CC O
increased VBN O
adherence NN O
in IN O
the DT O
clinical JJ O
strains NNS O
, , O
possibly RB O
endowing VBG O
C. NNP O
   O
glabrata NN O
with IN O
increased VBN O
viability NN O
and CC O
pathogenicity NN O
. . O

Loss NNP O
of IN O
Function NNP O
of IN O
the DT O
Nuclear NNP O
Receptor NNP O
NR2F2 NNP O
, , O
Encoding VBG O
COUP-TF2 NN O
, , O
Causes NNP O
Testis NNP O
Development NNP O
and CC O
Cardiac NNP O
Defects NNPS O
in IN O
46,XX CD O
Children NNP O
. . O

Emerging NNP O
evidence NN O
from IN O
murine NN O
studies NNS O
suggests VBZ O
that IN O
mammalian JJ O
sex NN O
determination NN O
is VBZ O
the DT O
outcome NN O
of IN O
an DT O
imbalance NN O
between IN O
mutually RB O
antagonistic JJ O
male NN O
and CC O
female JJ O
regulatory JJ O
networks NNS O
that WDT O
canalize VBP O
development NN O
down RB O
one CD O
pathway NN O
while IN O
actively RB O
repressing VBG O
the DT O
other JJ O
. . O

However RB O
, , O
in IN O
contrast NN O
to IN O
testis NN O
formation NN O
, , O
the DT O
gene NN O
regulatory JJ O
pathways NNS O
governing VBG O
mammalian JJ O
ovary JJ O
development NN O
have VBP O
remained VBN O
elusive JJ O
. . O

We PRP O
performed VBD O
exome RB O
or CC O
Sanger NNP O
sequencing NN O
on IN O
79 CD O
46,XX CD O
SRY-negative NNP O
individuals NNS O
with IN O
either DT O
unexplained JJ O
virilization NN O
or CC O
with IN O
testicular JJ O
/ SYM O
ovotesticular NN O
disorders NNS O
/ SYM O
differences NNS O
of IN O
sex NN O
development NN O
( -LRB- O
TDSD NNP O
/ SYM O
OTDSD NNP O
) -RRB- O
. . O

We PRP O
identified VBD O
heterozygous JJ O
frameshift NN O
mutations NNS O
in IN O
NR2F2 NNP B-Gene
, , O
encoding VBG O
COUP-TF2 NN O
, , O
in IN O
three CD O
children NNS O
. . O

One CD O
carried VBD O
a DT O
c.103_109delGGCGCCC NN O
( -LRB- O
p NN B-Var
. . O

Gly35Argfs∗75 NNP O
) -RRB- O
mutation NN O
, , O
while IN O
two CD O
others NNS O
carried VBD O
a DT O
c.97_103delCCGCCCG NN O
( -LRB- O
p NN B-Var
. . O

Pro33Alafs∗77 NN O
) -RRB- O
mutation NN O
. . O

In IN O
two CD O
of IN O
three CD O
children NNS O
the DT O
mutation NN O
was VBD O
de FW O
novo NN O
. . O

All DT O
three CD O
children NNS O
presented VBN B-Reg
with IN I-Reg
congenital JJ B-Disease
heart NN I-Disease
disease NN I-Disease
( -LRB- O
CHD NN O
) -RRB- O
, , O
one CD O
child NN O
with IN O
congenital JJ O
diaphragmatic JJ O
hernia NN O
( -LRB- O
CDH NNP O
) -RRB- O
, , O
and CC O
two CD O
children NNS O
with IN O
blepharophimosis-ptosis-epicanthus NN O
inversus NN O
syndrome NN O
( -LRB- O
BPES NNP O
) -RRB- O
. . O

The DT O
three CD O
children NNS O
had VBD O
androgen JJ O
production NN O
, , O
virilization NN O
of IN O
external JJ O
genitalia NNS O
, , O
and CC O
biochemical JJ O
or CC O
histological JJ O
evidence NN O
of IN O
testicular JJ O
tissue NN O
. . O

We PRP O
demonstrate VBP O
a DT O
highly RB O
significant JJ O
association NN O
between IN O
the DT O
NR2F2 NNP B-Gene
loss-of-function NN B-NegReg
mutations NNS B-Var
and CC O
this DT O
syndromic JJ B-Disease
form NN I-Disease
of IN I-Disease
DSD NNP I-Disease
Biallelic NNP B-Var
Mutations NNPS I-Var
in IN O
ATP5F1D NNP B-Gene
, , O
which WDT O
Encodes VBZ O
a DT O
Subunit NNP O
of IN O
ATP NNP O
Synthase NNP O
, , O
Cause NNP B-Reg
a DT O
Metabolic NNP B-MPA
Disorder NNP I-MPA
. . O

ATP NNP O
synthase NN O
, , O
H+ NNP O
transporting NN O
, , O
mitochondrial JJ O
F1 NNP O
complex NN O
, , O
δ NN O
subunit NN O
( -LRB- O
ATP5F1D RB O
; : O
formerly RB O
ATP5D NNP O
) -RRB- O
is VBZ O
a DT O
subunit NN O
of IN O
mitochondrial JJ O
ATP NNP O
synthase NN O
and CC O
plays VBZ O
an DT O
important JJ O
role NN O
in IN O
coupling NN O
proton NN O
translocation NN O
and CC O
ATP NNP O
production NN O
. . O

Here RB O
, , O
we PRP O
describe VBP O
two CD O
individuals NNS O
, , O
each DT O
with IN O
homozygous JJ O
missense NN B-Var
variants NNS I-Var
in IN O
ATP5F1D NNP B-Gene
, , O
who WP O
presented VBD B-Reg
with IN O
episodic JJ B-MPA
lethargy NN I-MPA
, , O
metabolic JJ B-MPA
acidosis NN I-MPA
, , O
3-methylglutaconic JJ B-MPA
aciduria NN I-MPA
, , O
and CC O
hyperammonemia NN B-Disease
. . O

Subject NN O
1 CD O
, , O
homozygous JJ O
for IN O
c.245C NN O
> XX O
T NNP O
( -LRB- O
p NN O
. . O

Pro82Leu NN O
) -RRB- O
, , O
presented VBN O
with IN O
recurrent JJ O
metabolic JJ O
decompensation NN O
starting VBG O
in IN O
the DT O
neonatal JJ O
period NN O
, , O
and CC O
subject NN O
2 CD O
, , O
homozygous JJ O
for IN O
c.317T NN O
> XX O
G NN O
( -LRB- O
p NN O
. . O

Val106Gly NN O
) -RRB- O
, , O
presented VBN O
with IN O
acute JJ O
encephalopathy NN O
in IN O
childhood NN O
. . O

Cultured JJ O
skin NN O
fibroblasts NNS O
from IN O
these DT O
individuals NNS O
exhibited VBD O
impaired JJ O
assembly NN O
of IN O
F1FO NNP O
ATP NNP O
synthase NN O
and CC O
subsequent JJ O
reduced JJ O
complex JJ O
V NN O
activity NN O
. . O

Cells NNS O
from IN O
subject NN O
1 CD O
also RB O
exhibited VBD O
a DT O
significant JJ O
decrease NN O
in IN O
mitochondrial JJ O
cristae VBN O
. . O

Knockdown NNP O
of IN O
Drosophila NNP O
ATPsynδ NNP O
, , O
the DT O
ATP5F1D JJ O
homolog NN O
, , O
in IN O
developing VBG O
eyes NNS O
and CC O
brains NNS O
caused VBD O
a DT O
near JJ O
complete JJ O
loss NN O
of IN O
the DT O
fly NN O
head NN O
, , O
a DT O
phenotype NN O
that WDT O
was VBD O
fully RB O
rescued VBN O
by IN O
wild-type JJ O
human JJ O
ATP5F1D. NN O
In IN O
contrast NN O
, , O
expression NN O
of IN O
the DT O
ATP5F1D JJ O
c.245C NN O
> XX O
T NN O
and CC O
c.317T NN O
> XX O
G NN O
variants NNS B-Var
rescued VBD B-PosReg
the DT O
head-size NN B-MPA
phenotype NN I-MPA
but CC O
recapitulated VBD B-NegReg
the DT O
eye NN B-MPA
and CC O
antennae NN B-MPA
defects NNS I-MPA
seen VBN O
in IN O
other JJ O
genetic JJ O
models NNS O
of IN O
mitochondrial JJ O
oxidative JJ O
phosphorylation NN O
deficiency NN O
. . O

Our PRP$ O
   O
data NN O
establish NN O
c.245C NN O
> XX O
T NNP O
( -LRB- O
p NN O
. . O

Pro82Leu NN O
) -RRB- O
and CC O
c.317T NN O
> XX O
G NN O
( -LRB- O
p NN O
. . O

Val106Gly NN O
) -RRB- O
in IN O
ATP5F1D IN O
as IN O
pathogenic JJ O
variants NNS B-Var
leading VBG B-Reg
to IN I-Reg
a DT O
Mendelian JJ B-Disease
mitochondrial JJ I-Disease
disease NN I-Disease
Multifocal JJ O
atrial JJ O
and CC O
ventricular JJ O
premature JJ O
contractions NNS O
with IN O
an DT O
increased VBN O
risk NN O
of IN O
dilated VBN B-Disease
cardiomyopathy NN I-Disease
caused VBN O
by IN O
a DT O
Nav1.5 NNP B-Gene
gain-of-function NN B-PosReg
mutation NN O
( -LRB- O
G213D NNP B-Var
) -RRB- O
. . O

BACKGROUND NNP O
: : O
SCN5A NN O
mutations NNS B-Var
can MD O
lead VB B-Reg
to IN I-Reg
different JJ O
cardiac JJ B-Disease
diseases NNS I-Disease
. . O

Recently RB O
, , O
SCN5A JJ O
mutations NNS O
have VBP O
been VBN O
linked VBN O
to IN O
the DT O
clinical JJ O
entity NN O
multifocal JJ O
ectopic NN O
Purkinje-related NNP O
premature JJ O
contractions NNS O
( -LRB- O
MEPPC NNP O
) -RRB- O
characterized VBN O
by IN O
ventricular JJ O
ectopy NN O
and CC O
dilated VBN O
cardiomyopathy NN O
. . O

METHODS NNS O
& CC O
RESULTS NNP O
: : O
A DT O
family NN O
with IN O
a DT O
uniform JJ O
MEPPC-like NNP O
phenotype NN O
, , O
associated VBN O
with IN O
complex JJ O
atrial JJ O
and CC O
ventricular JJ O
arrhythmias NNS O
and CC O
dilated VBN O
cardiomyopathy NN O
caused VBN O
by IN O
a DT O
high JJ O
frequency NN O
of IN O
ventricular JJ O
ectopy NN O
was VBD O
clinically RB O
assessed VBN O
. . O

Screening VBG O
of IN O
the DT O
SCN5A JJ B-Gene
gene NN O
revealed VBD O
a DT O
missense NN B-Var
mutation NN I-Var
in IN O
the DT O
linker NN O
between IN O
segments NNS O
3 CD O
and CC O
4 CD O
in IN O
domain NN O
1 CD O
of IN O
the DT O
Nav1.5 NNP O
protein NN O
, , O
resulting VBG B-Reg
in IN I-Reg
a DT O
glycine NN O
to TO O
aspartate VB O
substitution NN O
at IN O
position NN O
213 CD O
( -LRB- O
G213D NN B-Var
) -RRB- O
. . O

The DT O
phenotype NN O
co-segregated NN O
with IN O
the DT O
missense NN O
mutation NN O
. . O

Electrophysiological JJ O
studies NNS O
of IN O
wild JJ O
type NN O
( -LRB- O
WT NNP O
) -RRB- O
hNav1.5 NN O
and CC O
hNav1.5_G213D NNP O
expressed VBN O
in IN O
CHO-K NNP O
cells NNS O
showed VBD O
that IN O
the DT O
voltage NN O
of IN O
half-maximal JJ O
activation NN O
( -LRB- O
V½ NNP O
) -RRB- O
was VBD O
significantly RB O
more RBR O
negative JJ O
for IN O
hNav1.5_G213D NNP O
compared VBN O
to IN O
WT NNP O
( -LRB- O
V½=-38.7±0.5mV NNS O
for IN O
WT NNP O
and CC O
V½=-42.4±0.5mV NNP O
for IN O
G213D NNP O
; : O
P<0.001 NNP O
) -RRB- O
. . O

This DT O
suggests VBZ O
activation NN O
of IN O
Nav1.5_G231D NNP O
at IN O
more JJR O
negative JJ O
potentials NNS O
. . O

The DT O
V½ NNP O
of IN O
steady-state JJ O
inactivation NN O
was VBD O
significantly RB O
shifted VBN O
towards IN O
more JJR O
positive JJ O
values NNS O
for IN O
Nav1.5_G213D NNP O
( -LRB- O
V½=-86.7±0.2mV NN O
for IN O
WT NNP O
and CC O
-82.2±0.3mV NN O
for IN O
G213D NNP O
; : O
P<0.001 NNP O
) -RRB- O
, , O
also RB O
contributing VBG O
to IN O
a DT O
gain-of-function JJ O
phenotype NN O
. . O

Flecainide NN O
and CC O
amiodarone NN O
markedly RB O
reduced VBD O
premature JJ O
atrial JJ O
and CC O
ventricular JJ O
contractions NNS O
in IN O
four CD O
patients NNS O
. . O

CONCLUSION NN O
: : O
The DT O
Nav1.5_G213D NNP B-Gene
mutation NN O
is VBZ O
associated VBN O
with IN O
a DT O
gain-of-function JJ O
phenotype NN O
, , O
multifocal JJ O
atrial JJ O
and CC O
ventricular JJ O
ectopy NN O
and CC O
dilated VBN O
cardiomyopathy NN O
. . O

Since IN O
patients NNS O
with IN O
a DT O
MEPPC-like NNP O
phenotype NN O
may MD O
specifically RB O
benefit VB O
from IN O
Class-1 JJ O
antiarrhythmic NN O
drugs NNS O
or CC O
amiodarone NN O
, , O
clinical JJ O
identification NN O
of IN O
this DT O
disease NN O
entity NN O
is VBZ O
important JJ O
. . O

The DT O
Molecular NNP O
Chaperone NNP O
HSP90 NNP O
Promotes NNP O
Notch NNP O
Signaling VBG O
in IN O
the DT O
Germline NNP O
of IN O
Caenorhabditis NNP O
elegans VBZ O
. . O

In IN O
a DT O
genetic JJ O
screen NN O
to TO O
identify VB O
genes NNS O
that WDT O
promote VBP O
GLP-1/Notch NN O
signaling VBG O
in IN O
Caenorhabditis NNP O
elegans VBZ O
germline JJ O
stem NN O
cells NNS O
, , O
we PRP O
found VBD O
a DT O
single JJ O
mutation NN O
, , O
om40 NN O
, , O
defining VBG O
a DT O
gene NN O
called VBN O
ego-3 NN O
. . O

ego-3(om40 NNP B-Gene
) -RRB- O
causes VBZ O
several JJ O
defects NNS O
in IN O
the DT O
soma NN O
and CC O
the DT O
germline NN O
, , O
including VBG O
paralysis NN O
during IN O
larval NN O
development NN O
, , O
sterility NN O
, , O
delayed VBN O
proliferation NN O
of IN O
germline JJ O
stem NN O
cells NNS O
, , O
and CC O
ectopic NN O
germline NN O
stem NN O
cell NN O
proliferation NN O
. . O

Whole JJ O
genome NN O
sequencing NN O
identified VBN O
om40 NN O
as IN O
an DT O
allele NN O
of IN O
hsp-90 NNP O
, , O
previously RB O
known VBN O
as IN O
daf-21 NN O
, , O
which WDT O
encodes VBZ O
the DT O
C. NNP O
elegans VBZ O
ortholog NN O
of IN O
the DT O
cytosolic JJ O
form NN O
of IN O
HSP90 NNP O
. . O

This DT O
protein NN O
is VBZ O
a DT O
molecular JJ O
chaperone NN O
with IN O
a DT O
central JJ O
position NN O
in IN O
the DT O
protein NN O
homeostasis NN O
network NN O
, , O
which WDT O
is VBZ O
responsible JJ O
for IN O
proper JJ O
folding NN O
, , O
structural JJ O
maintenance NN O
, , O
and CC O
degradation NN O
of IN O
proteins NNS O
. . O

In IN O
addition NN O
to IN O
its PRP$ O
essential JJ O
role NN O
in IN O
cellular JJ O
function NN O
, , O
HSP90 NNP O
plays VBZ O
an DT O
important JJ O
role NN O
in IN O
stem NN O
cell NN O
maintenance NN O
and CC O
renewal NN O
. . O

Complementation NN O
analysis NN O
using VBG O
a DT O
deletion NN O
allele NN O
of IN O
hsp-90 NNP O
confirmed VBD O
that IN O
ego-3 NN O
is VBZ O
the DT O
same JJ O
gene NN O
. . O

hsp-90(om40 PRP O
) -RRB- O
is VBZ O
an DT O
I→N NNP O
conservative JJ O
missense NN O
mutation NN O
of IN O
a DT O
highly RB O
conserved JJ O
residue NN O
in IN O
the DT O
middle JJ O
domain NN O
of IN O
HSP-90 NNP O
RNA NNP O
interference-mediated NN O
knockdown NN O
of IN O
hsp-90 JJ O
expression NN O
partially RB O
phenocopied VBD O
hsp-90(om40 NN O
) -RRB- O
, , O
confirming VBG O
the DT O
loss-of-function NN O
nature NN O
of IN O
hsp-90(om40 NN O
) -RRB- O
Furthermore RB O
, , O
reduced VBD O
HSP-90 NNP O
activity NN O
enhanced VBD O
the DT O
effect NN O
of IN O
reduced VBN O
function NN O
of IN O
both CC O
the DT O
GLP-1 NNP O
receptor NN O
and CC O
the DT O
downstream JJ O
LAG-1 NNP O
transcription NN O
factor NN O
. . O

Taken VBN O
together RB O
, , O
our PRP$ O
results NNS O
provide VBP O
the DT O
first JJ O
experimental JJ O
evidence NN O
of IN O
an DT O
essential JJ O
role NN O
for IN O
HSP90 NNP O
in IN O
Notch NNP O
signaling VBG O
in IN O
development NN O
. . O

Impact NN O
of IN O
CYP2C19 NNP O
Polymorphisms NNP O
on IN O
Clinical NNP O
Outcomes NNP O
and CC O
Antiplatelet NNP O
Potency NNP O
of IN O
Clopidogrel NNP O
in IN O
Caucasian NNP O
Poststroke NNP O
Survivors NNPS O
. . O

BACKGROUND NNP O
: : O
Variable JJ O
response NN O
after IN O
clopidogrel NN O
is VBZ O
well RB O
documented VBN O
and CC O
may MD O
affect VB O
major JJ O
adverse JJ O
clinical JJ O
events NNS O
after IN O
stroke NN O
. . O

Impact NN O
of IN O
CYP2C19 NNP O
genetic JJ O
polymorphisms NNS O
is VBZ O
an DT O
established VBN O
marker NN O
linked VBN O
to IN O
variable JJ O
response NN O
after IN O
clopidogrel NN O
. . O

However RB O
, , O
the DT O
association NN O
of IN O
certain JJ O
genetic JJ O
polymorphisms NNS O
with IN O
prediction NN O
of IN O
major JJ O
adverse JJ O
clinical JJ O
events NNS O
following VBG O
stroke NN O
still RB O
remains VBZ O
controversial JJ O
, , O
especially RB O
in IN O
Caucasians NNPS O
. . O

STUDY NN O
QUESTION NN O
: : O
The DT O
primary JJ O
aim NN O
was VBD O
to TO O
evaluate VB O
the DT O
impact NN O
of IN O
CYP2C19 NNP O
allele NN O
* NFP O
2 CD O
in IN O
heterozygote NN O
form NN O
on IN O
major JJ O
adverse JJ O
clinical JJ O
events NNS O
in IN O
Caucasian JJ O
poststroke NN O
survivors NNS O
treated VBN O
with IN O
clopidogrel NN O
. . O

The DT O
secondary JJ O
aim NN O
was VBD O
to TO O
analyze VB O
the DT O
potential JJ O
link NN O
between IN O
CYP2C19 NNP O
genetic JJ O
polymorphism NN O
and CC O
variable JJ O
response NN O
after IN O
clopidogrel NN O
. . O

STUDY NN O
DESIGN NN O
: : O
One CD O
hundred CD O
thirty CD O
patients NNS O
of IN O
Caucasian JJ O
origin NN O
following VBG O
documented VBN O
ischemic JJ O
stroke NN O
were VBD O
included VBN O
. . O

Platelet NNP O
reactivity NN O
was VBD O
assessed VBN O
by IN O
light JJ O
transmittance NN O
aggregometry NN O
( -LRB- O
LTA NNP O
) -RRB- O
and CC O
matched VBN O
with IN O
various JJ O
CYP2C19 JJ O
loss-of-function NN O
genetic JJ O
polymorphisms NNS O
and CC O
major JJ O
adverse JJ O
clinical JJ O
events NNS O
( -LRB- O
composite NN O
of IN O
vascular JJ O
deaths NNS O
, , O
stroke NN O
/ SYM O
transient JJ O
ischemic JJ O
attack NN O
, , O
and CC O
myocardial JJ O
infarction NN O
) -RRB- O
. . O

RESULTS NNS O
: : O
Over IN O
the DT O
mean JJ O
follow-up NN O
of IN O
14.9 CD O
months NNS O
, , O
19 CD O
patients NNS O
experienced VBD O
major JJ O
adverse JJ O
clinical JJ O
events NNS O
. . O

The DT O
risk NN O
of IN O
major JJ B-MPA
adverse JJ I-MPA
clinical JJ I-MPA
events NNS I-MPA
was VBD O
nearly RB O
3-fold VBN O
in IN O
loss-of-function NN B-NegReg
allele NN B-Var
carriers NNS O
( -LRB- O
hazard NN O
ratio NN O
= SYM O
2.904 CD O
; : O
95 CD O
% NN O
confidence NN O
interval NN O
, , O
1.083-7.786 CD O
; : O
P NN O
= SYM O
0.013 CD O
) -RRB- O
, , O
whereas IN O
the DT O
risk NN O
of IN O
ischemic JJ B-MPA
stroke NN I-MPA
or CC O
transient JJ B-MPA
ischemic JJ I-MPA
attack NN I-MPA
alone RB I-MPA
was VBD O
also RB O
higher JJR O
( -LRB- O
hazard NN O
ratio NN O
= SYM O
3.170 CD O
; : O
95 CD O
% NN O
confidence NN O
interval NN O
, , O
1.281-7.849 CD O
; : O
P NN O
= SYM O
0.034 CD O
) -RRB- O
. . O

Platelet NNP B-MPA
activity NN I-MPA
was VBD O
strongly RB O
associated VBN B-Interaction
with IN O
allele NN B-Var
* NFP I-Var
2 CD I-Var
status NN O
( -LRB- O
rs NN O
= SYM O
0.21 CD O
, , O
P NN O
= SYM O
0.016 CD O
) -RRB- O
but CC O
not RB O
with IN O
other JJ O
genetic JJ O
polymorphisms NNS O
. . O

Carriers NNS O
of IN O
allele*2 WP O
exhibited VBD O
lower JJR O
platelet NN O
response NN O
to TO O
adenosine VB O
diphosphate-mean NN O
LTA NNP O
( -LRB- O
30.1 CD O
% NN O
vs. IN O
42.0 CD O
% NN O
; : O
P NN O
= SYM O
0.017 CD O
) -RRB- O
. . O

There EX O
were VBD O
no DT O
significant JJ O
differences NNS O
in IN O
LTA NNP O
results NNS O
with IN O
other JJ O
agonists NNS O
. . O

Strong JJ O
association NN O
of IN O
increase NN O
in IN O
adenosine NN O
diphosphate-induced NN O
aggregation NN O
with IN O
diabetes NN O
mellitus NN O
( -LRB- O
rs NN O
= SYM O
0.20 CD O
, , O
P NN O
= SYM O
0.023 CD O
) -RRB- O
, , O
increasing VBG O
age NN O
( -LRB- O
rs NN O
= SYM O
0.23 CD O
, , O
P NN O
= SYM O
0.008 CD O
) -RRB- O
, , O
and CC O
conversely RB O
diminishing VBG O
over RP O
increased VBN O
weight NN O
( -LRB- O
rs NN O
= SYM O
0.23 CD O
, , O
P NN O
= SYM O
0.009 CD O
) -RRB- O
was VBD O
also RB O
detected VBN O
. . O

The DT O
carriers NNS O
of IN O
other JJ O
gene NN O
allele NN O
variants NNS O
lack VBP O
uniformed JJ O
impact NN O
on IN O
variable JJ O
response NN O
after IN O
clopidogrel NN O
. . O

CONCLUSIONS NNS O
: : O
Even RB O
heterozygous JJ O
CYP2C19 NNP B-Gene
* SYM O
2 CD O
allele NN B-Var
carriers NNS O
among IN O
Caucasian JJ O
patients NNS O
after IN O
ischemic JJ O
stroke NN O
had VBD O
a DT O
higher JJR B-PosReg
risk NN O
of IN O
major JJ B-MPA
adverse JJ I-MPA
clinical JJ I-MPA
events NNS I-MPA
The DT O
Arabidopsis NNP O
thaliana NN O
Mediator NNP O
subunit NN O
MED8 NNP O
regulates VBZ O
plant NN O
immunity NN O
to IN O
Botrytis NNP O
Cinerea NNP O
through IN O
interacting VBG O
with IN O
the DT O
basic JJ O
helix-loop-helix NN O
( -LRB- O
bHLH NN O
) -RRB- O
transcription NN O
factor NN O
FAMA NNP O
. . O

The DT O
Mediator NNP O
complex NN O
is VBZ O
at IN O
the DT O
core NN O
of IN O
transcriptional JJ O
regulation NN O
and CC O
plays VBZ O
a DT O
central JJ O
role NN O
in IN O
plant NN O
immunity NN O
. . O

The DT O
MEDIATOR25 NNP O
( -LRB- O
MED25 NNP O
) -RRB- O
subunit NN O
of IN O
Arabidopsis NN O
thaliana NN O
regulates VBZ O
jasmonate-dependent NN O
resistance NN O
to IN O
Botrytis NNP O
cinerea VB O
through IN O
interacting VBG O
with IN O
the DT O
basic JJ O
helix-loop-helix NN O
( -LRB- O
bHLH NN O
) -RRB- O
transcription NN O
factor NN O
of IN O
jasmonate NN O
signaling VBG O
, , O
MYC2 NNP O
. . O

Another DT O
Mediator NNP O
subunit NN O
, , O
MED8 NNP O
, , O
acts VBZ O
independently RB O
or CC O
together RB O
with IN O
MED25 NNP O
in IN O
plant NN O
immunity NN O
. . O

However RB O
, , O
unlike IN O
MED25 NNP O
, , O
the DT O
underlying VBG O
action NN O
mechanisms NNS O
of IN O
MED8 NNP O
in IN O
regulating VBG O
B. NNP O
cinerea JJ O
resistance NN O
are VBP O
still RB O
unknown JJ O
. . O

Here RB O
, , O
we PRP O
demonstrated VBD O
that IN O
MED8 NNP O
regulated JJ O
plant NN O
immunity NN O
to IN O
B. NNP O
cinerea VB O
through IN O
interacting VBG O
with IN O
another DT O
bHLH JJ O
transcription NN O
factor NN O
, , O
FAMA NNP O
, , O
which WDT O
was VBD O
previously RB O
shown VBN O
to TO O
control VB O
the DT O
final JJ O
proliferation NN O
/ SYM O
differentiation NN O
switch NN O
during IN O
stomatal JJ O
development NN O
. . O

Our PRP$ O
research NN O
demonstrates VBZ O
that IN O
FAMA NNP O
is VBZ O
also RB O
an DT O
essential JJ O
component NN O
of IN O
B. NNP O
cinerea JJ O
resistance NN O
. . O

The DT O
fama NN B-Gene
loss-of-function NN B-NegReg
mutants NNS B-Var
( -LRB- O
fama-1 NN O
and CC O
fama-2 NNS O
) -RRB- O
increased VBD B-PosReg
susceptibility NN B-MPA
to IN I-MPA
B. NNP I-MPA
cinerea JJ I-MPA
infection NN I-MPA
and CC O
reduced JJ B-NegReg
defense-gene NN B-MPA
expression NN I-MPA
A DT O
Gain-of-Function NN O
Mutation NNP O
in IN O
EPO NNP O
in IN O
Familial NNP O
Erythrocytosis NNP O
. . O

Familial JJ B-Disease
erythrocytosis NN I-Disease
with IN O
elevated JJ O
erythropoietin NN O
levels NNS O
is VBZ O
frequently RB O
caused VBN B-Reg
by IN O
mutations NNS B-Var
in IN O
genes NNS O
that WDT O
regulate VBP O
oxygen-dependent NN O
transcription NN O
of IN O
the DT O
gene NN O
encoding NN O
erythropoietin NN O
( -LRB- O
EPO NNP B-Gene
) -RRB- O
. . O

We PRP O
identified VBD O
a DT O
mutation NN O
in IN O
EPO NNP O
that WDT O
cosegregated VBD O
with IN O
disease NN O
with IN O
a DT O
logarithm NN O
of IN O
the DT O
odds NNS O
( -LRB- O
LOD NNP O
) -RRB- O
score NN O
of IN O
3.3 CD O
in IN O
a DT O
family NN O
with IN O
autosomal NN O
dominant JJ O
erythrocytosis NN O
. . O

This DT O
mutation NN B-Var
, , O
a DT O
single-nucleotide JJ O
deletion NN O
( -LRB- O
c.32delG NN O
) -RRB- O
, , O
introduces VBZ O
a DT O
frameshift NN O
in IN O
exon NN O
2 CD O
that IN O
interrupts NNS B-NegReg
translation NN O
of IN O
the DT O
main JJ B-MPA
EPO NNP I-MPA
messenger NN I-MPA
RNA NNP I-MPA
( -LRB- I-MPA
mRNA NNS I-MPA
Inactivation NNP B-Var
of IN O
Fgfr2 NNP B-Gene
gene NN O
in IN O
mouse NN O
secondary JJ O
palate JJ O
mesenchymal JJ O
cells NNS O
leads VBZ B-Reg
to IN I-Reg
cleft NN B-Disease
palate NN I-Disease
. . O

Numerous JJ O
studies NNS O
have VBP O
been VBN O
conducted VBN O
to TO O
understand VB O
the DT O
molecular JJ O
mechanisms NNS O
controlling VBG O
mammalian JJ O
secondary JJ O
palate NN O
development NN O
such JJ O
as IN O
growth NN O
, , O
reorientation NN O
and CC O
fusion NN O
. . O

However RB O
, , O
little JJ O
is VBZ O
known VBN O
about IN O
the DT O
signaling NN O
factors NNS O
regulating VBG O
palate NN O
initiation NN O
. . O

Mouse VB O
fibroblast NN O
growth NN O
factor NN O
( -LRB- O
FGF NNP O
) -RRB- O
receptor NN O
2 CD O
gene NN O
( -LRB- O
Fgfr2 NNS O
) -RRB- O
is VBZ O
expressed VBN O
on IN O
E11.5 NNP O
in IN O
the DT O
palate NN O
outgrowth NN O
within IN O
the DT O
maxillary JJ O
process NN O
, , O
in IN O
a DT O
region NN O
that WDT O
is VBZ O
responsible JJ O
for IN O
palate JJ O
cell NN O
specification NN O
and CC O
shelf NN O
initiation NN O
. . O

Fgfr2 NNS O
continues VBZ O
to TO O
express VB O
in IN O
palate NN O
on IN O
E12.5 NNP O
and CC O
E13.5 NN O
in IN O
both CC O
epithelial JJ O
and CC O
mesenchymal JJ O
cells NNS O
, , O
and CC O
inactivation NN B-Var
of IN O
Fgfr2 NNP B-Gene
expression NN O
in IN O
mesenchymal JJ O
cells NNS O
using VBG O
floxed VBN O
Fgfr2 NNP O
allele NN O
and CC O
Osr2-Cre NN O
leads VBZ B-Reg
to IN I-Reg
cleft NN B-Disease
palate NN I-Disease
MIB-1 NNP O
Is VBZ O
Required VBN O
for IN O
Spermatogenesis NNP O
and CC O
Facilitates NNP O
LIN-12 NNP O
and CC O
GLP-1 NNP O
Activity NNP O
in IN O
Caenorhabditis NNP O
elegans VBZ O
. . O

Covalent NNP O
attachment NN O
of IN O
ubiquitin NN O
to TO O
substrate VB O
proteins NNS O
changes NNS O
their PRP$ O
function NN O
or CC O
marks VBZ O
them PRP O
for IN O
proteolysis NN O
, , O
and CC O
the DT O
specificity NN O
of IN O
ubiquitin JJ O
attachment NN O
is VBZ O
mediated VBN O
by IN O
the DT O
numerous JJ O
E3 NN O
ligases NNS O
encoded VBN O
by IN O
animals NNS O
. . O

Mind NNP O
Bomb NNP O
is VBZ O
an DT O
essential JJ O
E3 NN O
ligase NN O
during IN O
Notch NNP O
pathway NN O
signaling VBG O
in IN O
insects NNS O
and CC O
vertebrates NNS O
. . O

While IN O
Caenorhabditis NNP O
elegans VBZ O
encodes VBP O
a DT O
Mind NNP O
Bomb NNP O
homolog NN O
( -LRB- O
mib-1 NN O
) -RRB- O
, , O
it PRP O
has VBZ O
never RB O
been VBN O
recovered VBN O
in IN O
the DT O
extensive JJ O
Notch NNP O
suppressor NN O
/ SYM O
enhancer NN O
screens NNS O
that WDT O
have VBP O
identified VBN O
numerous JJ O
pathway NN O
components NNS O
. . O

Here RB O
, , O
we PRP O
show VBP O
that IN O
C. NNP O
elegans VBZ O
mib-1 NN B-Gene
null JJ O
mutants NNS B-Var
have VBP O
a DT O
spermatogenesis-defective NN B-Disease
phenotype NN I-Disease
that WDT O
results VBZ B-Reg
in IN I-Reg
a DT O
heterogeneous JJ B-MPA
mixture NN I-MPA
of IN I-MPA
arrested VBN I-MPA
spermatocytes NNS I-MPA
, , O
defective JJ O
spermatids NNS O
, , O
and CC O
motility-impaired NN O
spermatozoa NN O
. . O

mib-1 NN O
mutants NNS O
also RB O
have VBP O
chromosome NN O
segregation NN O
defects NNS O
during IN O
meiosis NN O
, , O
molecular JJ O
null JJ O
mutants NNS O
are VBP O
intrinsically RB O
temperature-sensitive NN O
, , O
and CC O
many JJ O
mib-1 NN O
spermatids NNS O
contain VBP O
large JJ O
amounts NNS O
of IN O
tubulin NN O
. . O

These DT O
phenotypic NN O
features NNS O
are VBP O
similar JJ O
to IN O
the DT O
endogenous JJ O
RNA NNP O
intereference NN O
( -LRB- O
RNAi NNPS O
) -RRB- O
mutants NNS O
, , O
but CC O
mib-1 NN O
mutants NNS O
do VBP O
not RB O
affect VB O
RNAi NNS O
. . O

MIB-1 NN O
protein NN O
is VBZ O
expressed VBN O
throughout IN O
the DT O
germ JJ O
line NN O
with IN O
peak JJ O
expression NN O
in IN O
spermatocytes NNS O
followed VBN O
by IN O
segregation NN O
into IN O
the DT O
residual JJ O
body NN O
during IN O
spermatid NN O
formation NN O
. . O

C. NNP O
elegans VBZ O
mib-1 NN O
expression NN O
, , O
while IN O
upregulated JJ O
during IN O
spermatogenesis NN O
, , O
also RB O
occurs VBZ O
somatically RB O
, , O
including VBG O
in IN O
vulva JJ O
precursor NN O
cells NNS O
. . O

Here RB O
, , O
we PRP O
show VBP O
that IN O
mib-1 NN B-Gene
mutants NNS B-Var
suppress VBP B-NegReg
both DT O
lin-12 NN B-Gene
and CC O
glp-1 NNP B-Gene
( -LRB- O
C. NNP O
elegans VBZ O
Notch NNP O
) -RRB- O
gain-of-function VB B-PosReg
mutants NNS B-Var
, , O
restoring VBG B-PosReg
anchor NN B-MPA
cell NN I-MPA
formation NN I-MPA
and CC O
a DT O
functional JJ B-MPA
vulva NN I-MPA
to IN O
the DT O
former JJ O
and CC O
partly RB O
restoring VBG O
oocyte NN B-MPA
production NN I-MPA
The DT O
curious JJ O
case NN O
of IN O
Gαs JJ O
gain-of-function NN O
in IN O
neoplasia NN O
. . O

BACKGROUND NNP O
: : O
Mutations NNS B-Var
activating VBG B-PosReg
the DT O
α NN O
subunit NN O
of IN O
heterotrimeric JJ B-Protein
Gs NNP I-Protein
protein NN I-Protein
are VBP O
associated VBN O
with IN O
a DT O
number NN O
of IN O
highly RB O
specific JJ O
pathological JJ O
molecular JJ O
phenotypes NNS O
. . O

One CD O
of IN O
the DT O
best JJS O
characterized VBN O
is VBZ O
the DT O
McCune NNP B-Disease
Albright NNP I-Disease
syndrome NN I-Disease
. . O

The DT O
disease NN O
presents VBZ O
with IN O
an DT O
increased VBN O
incidence NN O
of IN O
neoplasias NNS O
in IN O
specific JJ O
tissues NNS O
. . O

MAIN NNP O
BODY NN O
: : O
A DT O
similar JJ O
repertoire NN O
of IN O
neoplasms NNS O
can MD O
develop VB O
whether IN O
mutations NNS O
occur VBP O
spontaneously RB O
in IN O
somatic JJ O
tissues NNS O
during IN O
fetal JJ O
development NN O
or CC O
after IN O
birth NN O
. . O

Glands NNS O
are VBP O
the DT O
most RBS O
" `` O
permissive JJ O
" '' O
tissues NNS O
, , O
recently RB O
found VBN O
to TO O
include VB O
the DT O
entire JJ O
gastrointestinal JJ O
tract NN O
. . O

High JJ O
frequency NN O
of IN O
activating VBG B-PosReg
Gαs NNP B-Gene
mutations NNS B-Var
is VBZ O
associated VBN O
with IN O
precise JJ O
diagnoses NNS O
( -LRB- O
e.g. RB O
, , O
IPMN NN B-Disease
, , O
Pyloric NNP B-Disease
gland NN I-Disease
adenoma NN I-Disease
, , O
pituitary JJ B-Disease
toxic JJ I-Disease
adenoma NN I-Disease
) -RRB- O
. . O

Typically RB O
, , O
most JJS O
neoplastic JJ O
lesions NNS O
, , O
from IN O
thyroid NN O
to IN O
pancreas NNS O
, , O
remain VBP O
well RB O
differentiated VBN O
but CC O
may MD O
be VB O
a DT O
precursor NN O
to IN O
aggressive JJ O
cancer NN O
. . O

CONCLUSIONS NNS O
: : O
Here RB O
we PRP O
propose VBP O
the DT O
possibility NN O
that IN O
gain-of-function NN B-PosReg
mutations NNS B-Var
of IN O
Gαs NNP B-Gene
interfere NN B-NegReg
with IN O
signals NNS O
in IN O
the DT O
microenvironment NN B-MPA
of IN I-MPA
permissive JJ I-MPA
tissues NNS O
and CC O
lead NN B-Reg
to IN I-Reg
a DT O
transversal JJ B-MPA
neoplastic JJ I-MPA
phenotype NN I-MPA
Dissecting VBG O
the DT O
genetic JJ O
basis NN O
of IN O
heavy JJ O
panicle NN O
hybrid JJ O
rice NN O
uncovered VBD O
Gn1a NNP O
and CC O
GS3 NNP O
as IN O
key JJ O
genes NNS O
. . O

KEY JJ O
MESSAGE NN O
: : O
Shuhui498 NNP O
( -LRB- O
R498 NNP O
) -RRB- O
is VBZ O
an DT O
elite JJ O
parent NN O
of IN O
heavy JJ O
panicle NN O
hybrid JJ O
rice NN O
by IN O
pyramiding VBG O
the DT O
rare JJ O
gn1a NNS O
and CC O
null VB O
gs3 NN O
alleles NNS O
. . O

This DT O
finding NN O
reveals VBZ O
the DT O
genetic JJ O
basis NN O
and CC O
great JJ O
potential JJ O
application NN O
in IN O
future JJ O
breeding NN O
of IN O
R498 NNP O
. . O

The DT O
heavy JJ O
panicle NN O
trait NN O
, , O
defined VBN O
as IN O
5 CD O
   O
g NN O
or CC O
more JJR O
of IN O
grain NN O
weight NN O
per IN O
panicle NN O
, , O
is VBZ O
one CD O
of IN O
the DT O
target NN O
traits NNS O
in IN O
super-high-yield JJ O
rice NN O
breeding NN O
programs NNS O
. . O

The DT O
use NN O
of IN O
heavy JJ O
panicle-type NN O
hybrid NN O
rice NN O
has VBZ O
been VBN O
shown VBN O
to TO O
be VB O
a DT O
successful JJ O
strategy NN O
for IN O
super-high-yield JJ O
breeding NN O
programs NNS O
, , O
particularly RB O
under IN O
the DT O
environmental JJ O
conditions NNS O
of IN O
high JJ O
humidity NN O
and CC O
deficient JJ O
solar JJ O
radiation NN O
in IN O
southwestern JJ O
China NNP O
. . O

However RB O
, , O
the DT O
genetic JJ O
components NNS O
of IN O
the DT O
heavy JJ O
panicle NN O
trait NN O
in IN O
hybrid JJ O
rice NN O
remain VBP O
elusive JJ O
. . O

Here RB O
, , O
we PRP O
report VBP O
that IN O
the DT O
combination NN O
of IN O
loss-of-function NN B-NegReg
mutations NNS B-Var
in IN O
Grain NN O
number NN O
1a CD O
( -LRB- O
Gn1a NNP B-Gene
) -RRB- O
and CC O
Grain NNP O
Size NNP O
3 CD O
( -LRB- O
GS3 NNP B-Gene
) -RRB- O
is VBZ O
responsible JJ B-Reg
for IN O
the DT O
heavy JJ B-MPA
panicle NN I-MPA
phenotype NN I-MPA
A DT O
Protein-Truncating NN O
HSD17B13 NNP O
Variant NNP O
and CC O
Protection NNP O
from IN O
Chronic NNP O
Liver NNP O
Disease NNP O
. . O

BACKGROUND NNP O
: : O
Elucidation NN O
of IN O
the DT O
genetic JJ O
factors NNS O
underlying VBG O
chronic JJ O
liver NN O
disease NN O
may MD O
reveal VB O
new JJ O
therapeutic JJ O
targets NNS O
. . O

METHODS NNS O
: : O
We PRP O
used VBD O
exome NN O
sequence NN O
data NNS O
and CC O
electronic JJ O
health NN O
records NNS O
from IN O
46,544 CD O
participants NNS O
in IN O
the DT O
DiscovEHR NN O
human JJ O
genetics NNS O
study VBP O
to TO O
identify VB O
genetic JJ O
variants NNS O
associated VBN O
with IN O
serum NN O
levels NNS O
of IN O
alanine NN O
aminotransferase NN O
( -LRB- O
ALT NNP O
) -RRB- O
and CC O
aspartate VB O
aminotransferase NN O
( -LRB- O
AST NN O
) -RRB- O
. . O

Variants NNS B-Var
that WDT O
were VBD O
replicated VBN O
in IN O
three CD O
additional JJ O
cohorts NNS O
( -LRB- O
12,527 CD O
persons NNS O
) -RRB- O
were VBD O
evaluated VBN O
for IN O
association NN B-Interaction
with IN O
clinical JJ O
diagnoses NNS O
of IN O
chronic JJ B-Disease
liver NN I-Disease
disease NN I-Disease
in IN O
DiscovEHR NN O
study NN O
participants NNS O
and CC O
two CD O
independent JJ O
cohorts NNS O
( -LRB- O
total NN O
of IN O
37,173 CD O
persons NNS O
) -RRB- O
and CC O
with IN O
histopathological JJ O
severity NN O
of IN O
liver NN O
disease NN O
in IN O
2391 CD O
human JJ O
liver NN O
samples NNS O
. . O

RESULTS NNS O
: : O
A DT O
splice NN B-Var
variant NN I-Var
( -LRB- O
rs72613567:TA NN O
) -RRB- O
in IN O
HSD17B13 NNP B-Gene
, , O
encoding VBG O
the DT O
hepatic JJ O
lipid NN O
droplet JJ O
protein NN O
hydroxysteroid JJ O
17-beta CD O
dehydrogenase NN O
13 CD O
, , O
was VBD O
associated VBN O
with IN O
reduced JJ B-NegReg
levels NNS O
of IN O
ALT NNP B-MPA
( -LRB- I-MPA
P=4.2×10-12 NNP I-MPA
) -RRB- I-MPA
and CC I-MPA
AST NNP O
( -LRB- O
P=6.2×10-10 NNP O
) -RRB- O
. . O

Among IN O
DiscovEHR JJ O
study NN O
participants NNS O
, , O
this DT O
variant NN B-Var
was VBD O
associated VBN O
with IN O
a DT O
reduced JJ B-NegReg
risk NN O
of IN O
alcoholic JJ B-Disease
liver NN I-Disease
disease NN I-Disease
( -LRB- O
by IN O
42 CD O
% NN O
[ -LRB- O
95 CD O
% NN O
confidence NN O
interval NN O
{ -LRB- O
CI NN O
} -RRB- O
, , O
20 CD O
to IN O
58 CD O
] -RRB- O
among IN O
heterozygotes NNS O
and CC O
by IN O
53 CD O
% NN O
[ -LRB- O
95 CD O
% NN O
CI NN O
, , O
3 CD O
to IN O
77 CD O
] -RRB- O
among IN O
homozygotes NNS O
) -RRB- O
, , O
nonalcoholic JJ B-Disease
liver NN I-Disease
disease NN I-Disease
( -LRB- O
by IN O
17 CD O
% NN O
[ -LRB- O
95 CD O
% NN O
CI NN O
, , O
8 CD O
to IN O
25 CD O
] -RRB- O
among IN O
heterozygotes NNS O
and CC O
by IN O
30 CD O
% NN O
[ -LRB- O
95 CD O
% NN O
CI NN O
, , O
13 CD O
to IN O
43 CD O
] -RRB- O
among IN O
homozygotes NNS O
) -RRB- O
, , O
alcoholic JJ B-Disease
cirrhosis NN I-Disease
( -LRB- O
by IN O
42 CD O
% NN O
[ -LRB- O
95 CD O
% NN O
CI NN O
, , O
14 CD O
to TO O
61 CD O
] -RRB- O
among IN O
heterozygotes NNS O
and CC O
by IN O
73 CD O
% NN O
[ -LRB- O
95 CD O
% NN O
CI NN O
, , O
15 CD O
to IN O
91 CD O
] -RRB- O
among IN O
homozygotes NNS O
) -RRB- O
, , O
and CC O
nonalcoholic JJ B-Disease
cirrhosis NN I-Disease
( -LRB- O
by IN O
26 CD O
% NN O
[ -LRB- O
95 CD O
% NN O
CI NN O
, , O
7 CD O
to IN O
40 CD O
] -RRB- O
among IN O
heterozygotes NNS O
and CC O
by IN O
49 CD O
% NN O
[ -LRB- O
95 CD O
% NN O
CI NN O
, , O
15 CD O
to IN O
69 CD O
] -RRB- O
among IN O
homozygotes NNS O
) -RRB- O
. . O

Associations NNS O
were VBD O
confirmed VBN O
in IN O
two CD O
independent JJ O
cohorts NNS O
. . O

The DT O
rs72613567:TA JJ O
variant NN B-Var
was VBD O
associated VBN O
with IN O
a DT O
reduced JJ B-NegReg
risk NN O
of IN O
nonalcoholic JJ B-Disease
steatohepatitis NN I-Disease
, , O
but CC O
not RB O
steatosis NN O
, , O
in IN O
human JJ O
liver NN O
samples NNS O
. . O

The DT O
rs72613567:TA JJ O
variant NN B-Var
mitigated VBN B-NegReg
liver NN B-Disease
injury NN I-Disease
associated VBN O
with IN O
the DT O
risk-increasing NN O
PNPLA3 NN O
p NN O
. . O

I148 NNP O
M CD O
allele NN O
and CC O
resulted VBD O
in IN O
an DT O
unstable JJ O
and CC O
truncated VBN O
protein NN O
with IN O
reduced VBN O
enzymatic JJ O
activity NN O
. . O

CONCLUSIONS NNS O
: : O
A DT O
loss-of-function NN B-NegReg
variant NN B-Var
in IN O
HSD17B13 NNP B-Gene
was VBD O
associated VBN O
with IN O
a DT O
reduced JJ B-NegReg
risk NN O
of IN O
chronic JJ B-Disease
liver NN I-Disease
disease NN I-Disease
Gain-of-function NN O
mutations NNS O
in IN O
granulocyte NN O
colony-stimulating NN O
factor NN O
receptor NN O
( -LRB- O
CSF3R NNP O
) -RRB- O
reveal VBP O
distinct JJ O
mechanisms NNS O
of IN O
CSF3R JJ O
activation NN O
. . O

Granulocyte NNP O
colony-stimulating NN O
factor NN O
( -LRB- O
G-CSF NNP O
or CC O
CSF3 NNP O
) -RRB- O
and CC O
its PRP$ O
receptor NN O
CSF3R JJ O
regulate VBP O
granulopoiesis NN O
, , O
neutrophil NN O
function NN O
, , O
and CC O
hematopoietic JJ O
stem NN O
cell NN O
mobilization NN O
. . O

Recent JJ O
studies NNS O
have VBP O
uncovered VBN O
an DT O
oncogenic JJ O
role NN O
of IN O
mutations NNS B-Var
in IN O
the DT O
CSF3R JJ B-Gene
gene NN O
in IN O
many JJ O
hematologic JJ B-Disease
malignancies NNS I-Disease
. . O

To TO O
find VB O
additional JJ O
CSF3R JJ O
mutations NNS O
that WDT O
give VBP O
rise NN O
to IN O
cell NN O
transformation NN O
, , O
we PRP O
performed VBD O
a DT O
cellular JJ O
transformation NN O
assay JJ O
in IN O
which WDT O
murine NN O
interleukin VBP O
3 CD O
( -LRB- O
IL-3)-dependent NNP O
Ba NNP O
/ SYM O
F3 NNP O
cells NNS O
were VBD O
transduced VBN O
with IN O
WT NNP O
CSF3R NNP O
plasmid JJ O
and CC O
screened VBN O
for IN O
spontaneous JJ O
growth NN O
in IN O
the DT O
absence NN O
of IN O
IL-3 CD O
. . O

Any DT O
outgrowth JJ O
clones NNS O
were VBD O
sequenced VBN O
to TO O
identify VB O
CSF3R JJ O
mutations NNS O
with IN O
transformation NN O
capacity NN O
. . O

We PRP O
identified VBD O
several JJ O
novel JJ O
mutations NNS B-Var
and CC O
determined VBD O
that IN O
they PRP O
transform VBP B-Reg
cells NNS B-CPA
via IN O
four CD O
distinct JJ O
mechanisms NNS O
: : O
1 LS O
) -RRB- O
cysteine- NN B-MPA
and CC I-MPA
disulfide VB I-MPA
bond-mediated NN I-MPA
dimerization NN I-MPA
( -LRB- O
S581C NNS O
) -RRB- O
; : O
2 LS O
) -RRB- O
polar JJ B-Var
, , I-Var
noncharged VBD I-Var
amino NN I-Var
acid JJ I-Var
substitution NN O
at IN O
the DT O
transmembrane NN O
helix VBP O
dimer NN O
interface NN O
at IN O
residue JJ O
Thr-640 NNP O
; : O
3 LS O
) -RRB- O
increased VBD B-PosReg
internalization NN B-MPA
by IN O
a DT O
Glu-524 JJ O
substitution NN O
that WDT O
mimics VBZ O
a DT O
low JJ O
G-CSF NNP O
dose NN O
; : O
and CC O
4 LS O
) -RRB- O
hydrophobic JJ B-Var
amino NN I-Var
acid NN I-Var
substitutions NNS I-Var
in IN O
the DT O
membrane-proximal JJ O
residues NNS O
Thr-612 NNP O
, , O
Thr-615 NNP O
, , O
and CC O
Thr-618 NNP O
. . O

Furthermore RB O
, , O
the DT O
change NN O
in IN O
signaling VBG O
activation NN O
was VBD O
related VBN O
to IN O
an DT O
altered JJ O
CSF3R JJ O
localization NN O
. . O

We PRP O
also RB O
found VBD O
that IN O
CSF3R-induced NNP O
STAT3 NN O
and CC O
ERK NNP O
activations NNS O
require VBP O
CSF3R JJ O
internalization NN O
, , O
whereas IN O
STAT5 NNP O
activation NN O
occurred VBD O
at IN O
the DT O
cell NN O
surface NN O
. . O

Cumulatively RB O
, , O
we PRP O
have VBP O
expanded VBN O
the DT O
regions NNS O
of IN O
the DT O
CSF3R JJ O
extracellular NN O
and CC O
transmembrane NN O
domains NNS O
in IN O
which WDT O
missense NN B-Var
mutations NNS I-Var
exhibit VBP B-PosReg
leukemogenic NN B-Disease
Biallelic JJ O
loss-of-function NN B-NegReg
WNT5A WRB B-Gene
mutations NNS B-Var
in IN O
an DT O
infant NN O
with IN O
severe JJ O
and CC O
atypical JJ O
manifestations NNS O
of IN O
Robinow NNP B-Disease
syndrome NN I-Disease
. . O

Robinow NNP O
syndrome NN O
( -LRB- O
RS NNP O
) -RRB- O
is VBZ O
a DT O
well-recognized RB O
Mendelian JJ O
disorder NN O
known VBN O
to TO O
demonstrate VB O
both DT O
autosomal NN O
dominant JJ O
and CC O
autosomal NN O
recessive JJ O
inheritance NN O
. . O

Typical JJ O
manifestations NNS O
include VBP O
short JJ O
stature NN O
, , O
characteristic JJ O
facies NNS O
, , O
and CC O
skeletal JJ O
anomalies NNS O
. . O

Recessive JJ O
inheritance NN O
has VBZ O
been VBN O
associated VBN O
with IN O
mutations NNS O
in IN O
ROR2 NNP O
while IN O
dominant JJ O
inheritance NN O
has VBZ O
been VBN O
observed VBN O
for IN O
mutations NNS O
in IN O
WNT5A NNP O
, , O
DVL1 NNP O
, , O
and CC O
DVL3 NNP O
. . O

Through IN O
trio NN O
whole JJ O
genome JJ O
sequencing NN O
, , O
we PRP O
identified VBD O
a DT O
homozygous JJ B-Var
frameshifting VBG I-Var
single JJ I-Var
nucleotide NN I-Var
deletion NN I-Var
in IN O
WNT5A NN B-Gene
in IN O
a DT O
previously RB O
reported VBN O
, , O
deceased JJ O
infant NN O
with IN O
a DT O
unique JJ O
constellation NN O
of IN O
features NNS O
comprising VBG O
a DT O
46,XY CD O
disorder NN O
of IN O
sex NN O
development NN O
with IN O
multiple JJ O
congenital JJ O
malformations NNS O
including VBG O
congenital JJ B-Disease
diaphragmatic JJ I-Disease
hernia NN I-Disease
, , O
ambiguous JJ B-Disease
genitalia NNS I-Disease
, , O
dysmorphic JJ B-Disease
facies NNS I-Disease
, , O
shortened VBN B-Disease
long JJ I-Disease
bones NNS I-Disease
, , O
adactyly RB B-Disease
, , O
and CC O
ventricular JJ B-Disease
septal JJ I-Disease
defect NN I-Disease
Species-conserved NNS O
SYNGAP1 NN O
phenotypes NNS O
associated VBN O
with IN O
neurodevelopmental JJ O
disorders NNS O
. . O

SYNGAP1 NN B-Gene
loss-of-function NN B-NegReg
variants NNS B-Var
are VBP O
causally RB O
associated VBN O
with IN O
intellectual JJ B-Disease
disability NN I-Disease
, , O
severe JJ B-Disease
epilepsy NN I-Disease
, , O
autism NN B-Disease
spectrum NN I-Disease
disorder NN I-Disease
and CC O
schizophrenia NN B-Disease
Loss-of-function NN O
PCSK9 NNS O
mutants NNS O
evade VBP O
the DT O
unfolded JJ O
protein NN O
response NN O
sensor NN O
GRP78 NNP O
and CC O
fail VBP O
to TO O
induce VB O
endoplasmic JJ O
reticulum NN O
stress NN O
when WRB O
retained VBN O
. . O

The DT O
proprotein NN O
convertase NN O
subtilisin NN O
/ SYM O
kexin NN O
type-9 NN O
( -LRB- O
PCSK9 NNS B-Var
) -RRB- O
plays VBZ O
a DT O
central JJ O
role NN O
in IN O
cardiovascular JJ B-Disease
disease NN I-Disease
( -LRB- O
CVD NN O
) -RRB- O
by IN O
degrading VBG B-NegReg
hepatic JJ B-MPA
low-density JJ I-MPA
lipoprotein NN I-MPA
receptor NN I-MPA
( -LRB- O
LDLR NNP O
) -RRB- O
. . O

As IN O
such JJ O
, , O
loss-of-function NN B-NegReg
( -LRB- O
LOF NNP O
) -RRB- O
PCSK9 VBZ B-Gene
variants NNS B-Var
that WDT O
fail VBP O
to TO O
exit VB O
the DT O
endoplasmic JJ O
reticulum NN O
( -LRB- O
ER NNP O
) -RRB- O
increase VB B-PosReg
hepatic JJ B-MPA
LDLR NNP I-MPA
levels NNS I-MPA
and CC O
lower VB B-NegReg
the DT O
risk NN B-MPA
of IN I-MPA
developing VBG I-MPA
CVD NNP I-MPA
. . O

The DT O
retention NN O
of IN O
misfolded JJ O
protein NN O
in IN O
the DT O
ER NNP O
can MD O
cause VB O
ER NNP O
stress NN O
and CC O
activate VBP O
the DT O
unfolded JJ O
protein NN O
response NN O
( -LRB- O
UPR NNP O
) -RRB- O
. . O

In IN O
this DT O
study NN O
, , O
we PRP O
investigated VBD O
whether IN O
a DT O
variety NN O
of IN O
LOF NNP O
PCSK9 NNS O
variants NNS O
that WDT O
are VBP O
retained VBN O
in IN O
the DT O
ER NNP O
can MD O
cause VB O
ER NNP O
stress NN O
and CC O
hepatic JJ O
cytotoxicity NN O
. . O

Although IN O
overexpression NN B-PosReg
of IN O
these DT O
PCSK9 NNS B-Gene
variants NNS B-Var
caused VBD O
an DT O
accumulation NN B-PosReg
in IN O
the DT O
ER NNP B-MPA
of IN I-MPA
hepatocytes NNS I-MPA
CBL NN B-Gene
mutation NN B-Var
and CC O
MEFV NNP B-Gene
single-nucleotide JJ B-Var
variant NN I-Var
are VBP O
important JJ O
genetic JJ O
predictors NNS O
of IN O
tumor NN B-Disease
reduction NN B-NegReg
in IN O
glucocorticoid-treated NN O
patients NNS O
with IN O
chronic JJ B-Disease
myelomonocytic JJ I-Disease
leukemia NN I-Disease
. . O

Glucocorticoid NNP O
( -LRB- O
GC NNP O
) -RRB- O
therapy NN O
occasionally RB O
relieves VBZ O
tumor-related NN O
fever NN O
and CC O
promotes VBZ O
tumor NN O
reduction NN O
in IN O
patients NNS O
with IN O
chronic JJ O
myelomonocytic JJ O
leukemia NN O
( -LRB- O
CMML NNP O
) -RRB- O
. . O

A DT O
mutation NN O
analysis NN O
of IN O
24 CD O
patients NNS O
with IN O
CMML NNP O
revealed VBD O
the DT O
relationship NN O
of IN O
GC NNP O
effectiveness NN O
, , O
defined VBN O
as IN O
a DT O
monocyte JJ O
reduction NN O
of IN O
  _SP O
> XX O
  _SP O
50 CD O
% NN O
within IN O
3 CD O
   O
days NNS O
of IN O
methylprednisolone NN O
administration NN O
, , O
with IN O
the DT O
MEFV NNP O
single-nucleotide JJ O
variant NN O
( -LRB- O
SNV NNP O
) -RRB- O
and CC O
CBL NNP O
mutation NN O
. . O

Lipopolysaccharide-stimulated NN O
monocytes NNS O
harboring VBG O
MEFV NNP O
E148Q RB O
produced VBD O
greater JJR O
amounts NNS O
of IN O
IL-1β NNP O
and CC O
TNF-α NNP O
than IN O
did VBD O
wild-type JJ O
monocytes NNS O
; : O
this DT O
was VBD O
effectively RB O
suppressed VBN O
by IN O
GC NNP O
. . O

Primary JJ O
CMML NNP O
cells NNS O
harboring VBG O
the DT O
MEFV NNP O
SNV NNP O
and CC O
CBL NNP O
mutation NN O
, , O
and CC O
the DT O
myelomonocytic JJ O
leukemia NN O
cell NN O
line NN O
GDM-1 NNP O
, , O
harboring VBG O
the DT O
CBL NNP O
mutation NN O
, , O
were VBD O
both DT O
more RBR O
significantly RB O
suppressed VBN O
than IN O
non-mutated AFX O
cells NNS O
following VBG O
GC NNP O
treatment NN O
in IN O
the DT O
presence NN O
of IN O
GM-CSF NNP O
. . O

A DT O
loss-of-function NN B-NegReg
CBL NN B-Gene
mutation NN B-Var
prolonged VBD B-PosReg
STAT5 JJ B-MPA
phosphorylation NN I-MPA
Identification NN O
of IN O
a DT O
unique JJ O
loss-of-function NN B-NegReg
mutation NN B-Var
in IN O
IGF1R NNP B-Gene
and CC O
a DT O
crosstalk NN B-Reg
between IN O
IGF1R NNP B-Gene
and CC O
Wnt/β-catenin NNP B-Pathway
signaling NN I-Pathway
pathways NNS I-Pathway
Clinical JJ O
variability NN O
and CC O
onset NN O
age NN O
modifiers NNS O
in IN O
an DT O
extended JJ O
Belgian JJ O
GRN NNP O
founder NN O
family NN O
. . O

We PRP O
previously RB O
reported VBD B-Reg
a DT O
granulin NN O
( -LRB- O
GRN NNP B-Gene
) -RRB- O
null VBP B-Var
mutation NN I-Var
, , O
originating VBG O
from IN O
a DT O
common JJ O
founder NN O
, , O
in IN O
multiple JJ O
Belgian JJ O
families NNS O
with IN O
frontotemporal JJ B-Disease
dementia NN I-Disease
A DT O
rare JJ O
variant NN B-Var
in IN O
MLKL NNP B-Gene
confers VBZ O
susceptibility NN B-Reg
to IN O
ApoE RB O
ɛ4-negative NNP O
Alzheimer NNP B-Disease
's POS I-Disease
disease NN O
in IN O
Hong NNP O
Kong NNP O
Chinese JJ O
population NN O
. . O

Alzheimer NNP O
's POS O
disease NN O
( -LRB- O
AD NN O
) -RRB- O
is VBZ O
the DT O
most RBS O
common JJ O
neurodegenerative JJ O
disorders NNS O
in IN O
the DT O
elderly JJ O
. . O

To TO O
identify VB O
rare JJ O
genetic JJ O
factors NNS O
other JJ O
than IN O
apolipoprotein NN O
E NNP O
ɛ4 NNP O
allele NN O
( -LRB- O
ApoE RB O
ɛ4 NNP O
) -RRB- O
contributing VBG O
to IN O
the DT O
pathogenesis NN O
of IN O
late-onset JJ O
AD NN O
( -LRB- O
LOAD NNP O
) -RRB- O
, , O
we PRP O
conducted VBD O
a DT O
whole-exome JJ O
analysis NN O
of IN O
246 CD O
ApoE NNP O
ɛ4-negative NNP O
LOAD NNP O
cases NNS O
and CC O
172 CD O
matched VBD O
controls NNS O
in IN O
Hong NNP O
Kong NNP O
Chinese JJ O
population NN O
. . O

LOAD NNP O
patients NNS O
showed VBD O
a DT O
significantly RB O
higher JJR O
burden NN O
of IN O
rare JJ O
loss-of-function NN O
variants NNS O
in IN O
genes NNS O
related VBN O
to IN O
immune JJ O
function NN O
than IN O
healthy JJ O
controls NNS O
. . O

Among IN O
the DT O
genes NNS O
involved VBN O
in IN O
immune JJ O
function NN O
, , O
we PRP O
identified VBD O
a DT O
rare JJ O
stop-gain VB O
variant NN O
( -LRB- O
p NN O
. . O

Q48X NNP O
) -RRB- O
in IN O
mixed JJ O
lineage NN O
kinase NN O
domain NN O
like IN O
pseudokinase NN O
( -LRB- O
MLKL NNP O
) -RRB- O
gene NN O
present NN O
exclusively RB O
in IN O
6 CD O
LOAD NNP O
cases NNS O
. . O

MLKL NNP B-Gene
is VBZ O
expressed VBN O
in IN O
neurons NNS O
, , O
and CC O
the DT O
its PRP$ O
expression NN B-MPA
levels NNS I-MPA
in IN O
the DT O
p NN B-Var
. . O

Q48X NNP O
carriers NNS O
were VBD O
significantly RB O
lower JJR B-NegReg
than IN O
that DT O
in IN O
age-matched NN O
wild-type JJ O
controls NNS O
. . O

The DT O
ratio NN O
of IN O
Aβ42 NNP O
to IN O
Aβ40 NNS O
significantly RB O
increased VBD O
in IN O
MLKL NNP O
knockdown VBD O
cells NNS O
compared VBN O
to TO O
scramble JJ O
controls NNS O
. . O

MLKL NNS B-Gene
loss-of-function NN B-NegReg
mutation NN B-Var
might MD O
contribute VB O
to IN O
late-onset JJ O
ApoE RB O
ɛ4-negative JJ O
AD NN B-Disease
Investigation NN O
of IN O
TRPV1 JJ O
loss-of-function NN O
phenotypes NNS O
in IN O
TRPV1 JJ O
Leu206Stop NN O
mice NNS O
generated VBN O
by IN O
N-ethyl-N-nitrosourea NN O
mutagenesis NN O
. . O

N-ethyl-N-nitrosourea NN O
( -LRB- O
ENU NNP O
) -RRB- O
random JJ O
mutagenesis NN O
was VBD O
used VBN O
to TO O
generate VB O
a DT O
mouse NN O
model NN O
for IN O
the DT O
analysis NN O
of IN O
the DT O
transient JJ O
receptor NN O
potential JJ O
vanilloid NN O
1 CD O
( -LRB- O
TRPV1 NN B-Gene
) -RRB- O
cation NN O
channel NN O
. . O

A DT O
transversion NN O
from IN O
T→A JJ O
in IN O
exon NN O
4 CD O
led VBD O
to IN O
a DT O
Leu206Stop NN B-Var
mutation NN O
generating VBG O
a DT O
loss-of-function NN B-NegReg
mutant NN O
. . O

The DT O
TRPV1 NN O
agonist JJ O
capsaicin NNS O
was VBD O
used VBN O
to TO O
analyze VB O
functional JJ O
and CC O
nociceptive JJ O
parameters NNS O
in IN O
   O
vitro FW O
and CC O
in IN O
   O
vivo NN O
in IN O
TRPV1 NN O
Leu206Stop NN O
mice NNS O
and CC O
congenic JJ O
C3HeB NN O
/ SYM O
FeJ NN O
controls NNS O
. . O

Capsaicin-induced NNP B-MPA
[ -LRB- I-MPA
Ca2+]i NN O
changes NNS O
in IN O
small JJ O
diameter NN O
DRG NNP B-CPA
neurons NNS I-CPA
were VBD O
significantly RB O
diminished VBN B-NegReg
in IN O
TRPV1 JJ B-Gene
Leu206Stop NN B-Var
mice NNS O
and CC O
administration NN O
of IN O
capsaicin NNS O
induced VBN O
neither DT O
hypothermia NN O
nor CC O
nocifensive JJ O
behaviour NN O
in IN O
   O
vivo NN O
. . O

TRPV1 DT O
Leu206Stop NN O
mice NNS O
were VBD O
tested VBN O
in IN O
the DT O
spinal JJ O
nerve NN O
ligation NN O
of IN O
mononeuropathic JJ O
pain NN O
and CC O
developed VBD O
mechanical JJ O
hypersensitivity NN O
two CD O
weeks NNS O
after IN O
nerve NN O
injury NN O
. . O

In IN O
the DT O
open JJ O
field NN O
test NN O
, , O
a DT O
significant JJ O
increase NN B-PosReg
in IN O
spontaneous JJ B-CPA
locomotion NN I-CPA
was VBD O
detected VBN O
in IN O
TRPV1 JJ B-Gene
Leu206Stop NN B-Var
Biallelic NNP O
TP53 NNP B-Gene
gain NN B-PosReg
of IN I-PosReg
function NN I-PosReg
mutations NNS B-Var
in IN O
rapidly RB B-Disease
progressing VBG I-Disease
solid JJ I-Disease
tumors NNS I-Disease
. . O

Recent JJ O
studies NNS O
are VBP O
discovering VBG O
TP53 NNP B-Gene
mutations NNS B-Var
with IN O
gain NN B-PosReg
of IN I-PosReg
function NN I-PosReg
( -LRB- O
GOF NN O
) -RRB- O
properties NNS O
that WDT O
promote VBP O
tumorigenesis NN B-CPA
via IN O
a DT O
variety NN O
of IN O
mechanisms NNS O
. . O

To IN O
our PRP$ O
knowledge NN O
, , O
all DT O
reported VBD O
compound NN O
mutations NNS O
are VBP O
allelic JJ O
. . O

We PRP O
identified VBD O
two CD O
patients NNS O
with IN O
biallelic JJ O
GOF NN O
TP53 NNP O
mutations NNS O
in IN O
their PRP$ O
tumors NNS O
and CC O
a DT O
third JJ O
with IN O
allelic JJ O
compound NN O
variants NNS O
. . O

The DT O
correlation NN O
with IN O
p53 NN O
expression NN O
was VBD O
also RB O
examined VBN O
. . O

Genomic JJ O
DNA NNP O
was VBD O
extracted VBN O
from IN O
formalin-fixed NN O
, , O
paraffin-embedded NN O
tissue NN O
and CC O
mutational JJ O
analysis NN O
was VBD O
performed VBN O
using VBG O
Ion NNP O
AmpliSeq NNP O
™ NNP O
Cancer NNP O
HotSpot NNP O
Panel NNP O
V2 NN O
. . O

Biallelic JJ O
GOF NNP B-PosReg
mutations NNS O
( -LRB- O
p NN B-Var
. . O

R273H NN O
and CC O
p LS B-Var
. . O

R273C LS O
) -RRB- O
were VBD O
identified VBN O
in IN O
a DT O
19-year-old CD O
male NN O
with IN O
glioblastoma NN B-Disease
( -LRB- O
allele NN O
frequencies NNS O
94 CD O
% NN O
and CC O
48 CD O
% NN O
) -RRB- O
and CC O
a DT O
54-year-old CD O
with IN O
pT3 JJ O
penile JJ O
squamous JJ O
cell NN O
carcinoma NN O
( -LRB- O
allele NN O
frequencies NNS O
19 CD O
% NN O
and CC O
27 CD O
% NN O
) -RRB- O
. . O

Immunohistochemistry NN O
showed VBD O
nuclear JJ O
accumulation NN O
of IN O
p53 NN O
. . O

The DT O
third JJ O
patient NN O
, , O
a DT O
62-year-old CD O
female NN O
with IN O
metastatic JJ B-Disease
lung NN I-Disease
adenocarcinoma NN I-Disease
, , O
had VBD O
allelic JJ O
p NN B-Var
. . O

P278S NNP O
( -LRB- O
GOF NNP B-PosReg
) -RRB- O
and CC O
p LS B-Var
. . O

R283L NNP O
( -LRB- O
non-GOF AFX B-Reg
Germline JJ O
pathogenic JJ O
variants NNS O
in IN O
PALB2 NN O
and CC O
other JJ O
cancer-predisposing NN O
genes NNS O
in IN O
families NNS O
with IN O
hereditary JJ O
diffuse NN O
gastric JJ O
cancer NN O
without IN O
CDH1 NNP O
mutation NN O
: : O
a DT O
whole-exome JJ O
sequencing NN O
study NN O
. . O

BACKGROUND NNP O
: : O
Germline JJ O
pathogenic JJ O
variants NNS B-Var
in IN O
the DT O
E-cadherin NN O
gene NN O
( -LRB- O
CDH1 NNP B-Gene
) -RRB- O
are VBP O
strongly RB O
associated VBN B-Reg
with IN I-Reg
the DT O
development NN O
of IN O
hereditary JJ B-Disease
diffuse NN I-Disease
gastric JJ I-Disease
cancer NN I-Disease
. . O

There EX O
is VBZ O
a DT O
paucity NN O
of IN O
data NNS O
to TO O
guide VB O
risk NN O
assessment NN O
and CC O
management NN O
of IN O
families NNS O
with IN O
hereditary JJ O
diffuse NN O
gastric JJ O
cancer NN O
that WDT O
do VBP O
not RB O
carry VB O
a DT O
CDH1 NNP O
pathogenic JJ O
variant NN O
, , O
making VBG O
it PRP O
difficult JJ O
to TO O
make VB O
informed JJ O
decisions NNS O
about IN O
surveillance NN O
and CC O
risk-reducing NN O
surgery NN O
. . O

We PRP O
aimed VBD O
to TO O
identify VB O
new JJ O
candidate NN O
genes NNS O
associated VBN O
with IN O
predisposition NN O
to IN O
hereditary JJ O
diffuse NN O
gastric JJ O
cancer NN O
in IN O
affected VBN O
families NNS O
without IN O
pathogenic JJ O
CDH1 NNP O
variants NNS O
. . O

METHODS NNS O
: : O
We PRP O
did VBD O
whole-exome JJ O
sequencing NN O
on IN O
DNA NNP O
extracted VBN O
from IN O
the DT O
blood NN O
of IN O
39 CD O
individuals NNS O
( -LRB- O
28 CD O
individuals NNS O
diagnosed VBN O
with IN O
hereditary JJ O
diffuse NN O
gastric JJ O
cancer NN O
and CC O
11 CD O
unaffected JJ O
first-degree JJ O
relatives NNS O
) -RRB- O
in IN O
22 CD O
families NNS O
without IN O
pathogenic JJ O
CDH1 NNP O
variants NNS O
. . O

Genes NNS O
with IN O
loss-of-function NN O
variants NNS O
were VBD O
prioritised VBN O
using VBG O
gene-interaction NN O
analysis NN O
to TO O
identify VB O
clusters NNS O
of IN O
genes NNS O
that WDT O
could MD O
be VB O
involved VBN O
in IN O
predisposition NN O
to IN O
hereditary JJ O
diffuse NN O
gastric JJ O
cancer NN O
. . O

FINDINGS NNP O
: : O
Protein-affecting NN O
germline NN O
variants NNS O
were VBD O
identified VBN O
in IN O
probands NNS O
from IN O
six CD O
families NNS O
with IN O
hereditary JJ O
diffuse NN O
gastric JJ O
cancer NN O
; : O
variants NNS O
were VBD O
found VBN O
in IN O
genes NNS O
known VBN O
to TO O
predispose VB O
to IN O
cancer NN O
and CC O
in IN O
lesser-studied JJR O
DNA NN O
repair NN O
genes NNS O
. . O

A DT O
frameshift NN B-Var
deletion NN I-Var
in IN O
PALB2 NN B-Gene
was VBD O
found VBN B-Reg
in IN O
one CD O
member NN O
of IN O
a DT O
family NN O
with IN O
a DT O
history NN O
of IN O
gastric JJ B-Disease
and CC O
breast NN B-Disease
cancer NN I-Disease
Melanocortin NNP O
4 CD O
Receptor NNP O
Pathway NNP O
Dysfunction NNP O
in IN O
Obesity NNP O
: : O
Patient NNP O
Stratification NNP O
Aimed VBN O
at IN O
MC4R NNP O
Agonist NNP O
Treatment NNP O
. . O

Context NNP O
: : O
The DT O
hypothalamic JJ O
melanocortin NN O
4 CD O
receptor NN O
( -LRB- O
MC4R NN O
) -RRB- O
pathway NN O
serves VBZ O
a DT O
critical JJ O
role NN O
in IN O
regulating VBG O
body NN O
weight NN O
. . O

Loss NN B-NegReg
of IN I-NegReg
function NN I-NegReg
( -LRB- O
LoF NN O
) -RRB- O
mutations NNS B-Var
in IN O
the DT O
MC4R NNP B-Pathway
pathway NN I-Pathway
, , O
including VBG O
mutations NNS O
in IN O
the DT O
pro-opiomelanocortin JJ O
( -LRB- O
POMC NN B-Gene
) -RRB- O
, , O
prohormone NN O
convertase VBP O
1 CD O
( -LRB- O
PCSK1 NNP B-Gene
) -RRB- O
, , O
leptin NN O
receptor NN O
( -LRB- O
LEPR NN B-Gene
) -RRB- O
, , O
or CC O
MC4R JJ B-Gene
genes NNS O
, , O
have VBP O
been VBN O
shown VBN O
to TO O
cause VB O
early-onset JJ B-Disease
severe JJ I-Disease
obesity NN I-Disease
Mutations NNS B-Var
in IN O
C11orf70 JJ B-Gene
Cause NNP B-Reg
Primary NNP B-Disease
Ciliary NNP I-Disease
Dyskinesia NNP I-Disease
with IN O
Randomization NNP O
of IN O
Left NNP O
/ SYM O
Right NNP O
Body NN O
Asymmetry NNP O
Due IN O
to IN O
Defects NNS B-NegReg
of IN O
Outer NNP B-Protein
and CC I-Protein
Inner NNP I-Protein
Dynein NNP I-Protein
Arms NNP I-Protein
. . O

Primary NNP O
ciliary NN O
dyskinesia NN O
( -LRB- O
PCD NNP O
) -RRB- O
is VBZ O
characterized VBN O
by IN O
chronic JJ O
airway NN O
disease NN O
, , O
male JJ O
infertility NN O
, , O
and CC O
randomization NN O
of IN O
the DT O
left JJ O
/ SYM O
right JJ O
body NN O
axis VBD O
as IN O
a DT O
result NN O
of IN O
defects NNS O
of IN O
motile JJ O
cilia NNS O
and CC O
sperm VB O
flagella NN O
. . O

We PRP O
identified VBD O
loss-of-function NN O
mutations NNS O
in IN O
the DT O
open-reading JJ O
frame NN O
C11orf70 NN O
in IN O
PCD NNP O
individuals NNS O
from IN O
five CD O
distinct JJ O
families NNS O
. . O

Transmission NN O
electron NN O
microscopy VBD O
analyses NNS O
and CC O
high-resolution JJ O
immunofluorescence NN O
microscopy VBD O
demonstrate VBP O
that IN O
loss-of-function NN B-NegReg
mutations NNS B-Var
in IN O
C11orf70 JJ B-Gene
cause NN O
immotility NN B-CPA
of IN O
respiratory JJ B-CPA
cilia NNS I-CPA
and CC O
sperm VB B-CPA
flagella NN I-CPA
, , O
respectively RB O
, , O
as IN O
a DT O
result NN O
of IN O
the DT O
loss NN B-NegReg
of IN O
axonemal JJ B-Protein
outer NN I-Protein
( -LRB- O
ODAs NNS O
) -RRB- O
and CC O
inner JJ B-Protein
dynein NN I-Protein
arms NNS I-Protein
De NNP O
novo NN O
and CC O
inherited VBD O
private JJ O
variants NNS B-Var
in IN O
MAP1B NNP B-Gene
in IN O
periventricular JJ B-Disease
nodular JJ I-Disease
heterotopia NN I-Disease
. . O

Periventricular NNP O
nodular JJ O
heterotopia NN O
( -LRB- O
PVNH NNP O
) -RRB- O
is VBZ O
a DT O
malformation NN O
of IN O
cortical JJ O
development NN O
commonly RB O
associated VBN O
with IN O
epilepsy NN O
. . O

We PRP O
exome VBP O
sequenced VBD O
202 CD O
individuals NNS O
with IN O
sporadic JJ O
PVNH NN O
to TO O
identify VB O
novel JJ O
genetic JJ O
risk NN O
loci NN O
. . O

We PRP O
first RB O
performed VBD O
a DT O
trio-based NN O
analysis NN O
and CC O
identified VBD O
219 CD O
de IN O
novo NN O
variants NNS O
. . O

Although IN O
no DT O
novel JJ O
genes NNS O
were VBD O
implicated VBN O
in IN O
this DT O
initial JJ O
analysis NN O
, , O
PVNH NN O
cases NNS O
were VBD O
found VBN O
overall RB O
to TO O
have VB O
a DT O
significant JJ O
excess NN O
of IN O
nonsynonymous JJ O
de FW O
novo NN O
variants NNS O
in IN O
intolerant JJ O
genes NNS O
( -LRB- O
p NN O
= SYM O
3.27x10-7 CD O
) -RRB- O
, , O
suggesting VBG O
a DT O
role NN O
for IN O
rare JJ O
new JJ O
alleles NNS O
in IN O
genes NNS O
yet RB O
to TO O
be VB O
associated VBN O
with IN O
the DT O
condition NN O
. . O

Using VBG O
a DT O
gene-level NN O
collapsing VBG O
analysis NN O
comparing VBG O
cases NNS O
and CC O
controls NNS O
, , O
we PRP O
identified VBD O
a DT O
genome-wide RB O
significant JJ O
signal NN O
driven VBN O
by IN O
four CD O
ultra-rare JJ O
loss-of-function NN B-NegReg
heterozygous JJ O
variants NNS B-Var
in IN O
MAP1B NNP B-Gene
, , O
including VBG O
one CD O
de FW O
novo NN O
variant NN O
. . O

In IN O
at RB O
least RBS O
one CD O
instance NN O
, , O
the DT O
MAP1B JJ B-Gene
variant NN B-Var
was VBD O
inherited VBN B-Reg
from IN I-Reg
a DT O
parent NN O
with IN O
previously RB O
undiagnosed VBN O
PVNH NN B-Disease
Protein NN B-Enzyme
kinase VBP I-Enzyme
Cα NNP I-Enzyme
gain-of-function JJ B-PosReg
variant NN B-Var
in IN O
Alzheimer NNP B-Disease
's POS I-Disease
disease NN O
displays NNS O
enhanced VBN B-PosReg
catalysis NN B-MPA
by IN O
a DT O
mechanism NN O
that WDT O
evades VBZ O
down-regulation IN O
. . O

Conventional JJ O
protein NN O
kinase NN O
C NNP O
( -LRB- O
PKC NNP O
) -RRB- O
family NN O
members NNS O
are VBP O
reversibly RB O
activated VBN O
by IN O
binding VBG O
to IN O
the DT O
second JJ O
messengers NNS O
Ca2 NN O
+ SYM O
and CC O
diacylglycerol NN O
, , O
events NNS O
that WDT O
break VBP O
autoinhibitory JJ O
constraints NNS O
to TO O
allow VB O
the DT O
enzyme NN O
to TO O
adopt VB O
an DT O
active JJ O
, , O
but CC O
degradation-sensitive NN O
, , O
conformation NN O
. . O

Perturbing VBG O
these DT O
autoinhibitory JJ O
constraints NNS O
, , O
resulting VBG O
in IN O
protein NN O
destabilization NN O
, , O
is VBZ O
one CD O
of IN O
many JJ O
mechanisms NNS O
by IN O
which WDT O
PKC NNP O
function NN O
is VBZ O
lost VBN O
in IN O
cancer NN O
. . O

Here RB O
, , O
we PRP O
address VBP O
how WRB O
a DT O
gain-of-function JJ B-PosReg
germline NN B-Var
mutation NN I-Var
in IN O
PKCα NNS B-Enzyme
in IN O
Alzheimer NNP B-Disease
's POS I-Disease
disease NN O
( -LRB- O
AD NN O
) -RRB- O
enhances VBZ B-PosReg
signaling VBG B-MPA
without IN O
increasing VBG O
vulnerability NN O
to IN O
down-regulation IN O
. . O

Biochemical JJ O
analyses NNS O
of IN O
purified JJ O
protein NN O
demonstrate VBP O
that IN O
this DT O
mutation NN B-Var
results VBZ O
in IN O
an DT O
∼30 JJ O
% NN O
increase NN B-PosReg
in IN O
the DT O
catalytic JJ B-MPA
rate NN O
of IN O
the DT O
activated VBN O
enzyme NN O
, , O
with IN O
no DT O
changes NNS O
in IN O
the DT O
concentrations NNS O
of IN O
Ca2 NN O
+ SYM O
or CC O
lipid NN O
required VBN O
for IN O
half-maximal JJ O
activation NN O
. . O

Molecular JJ O
dynamics NNS O
simulations NNS O
reveal VBP O
that IN O
this DT O
mutation NN B-Var
has VBZ O
both CC O
localized VBN O
and CC O
allosteric JJ O
effects NNS O
, , O
most RBS O
notably RB O
decreasing VBG B-NegReg
the DT O
dynamics NNS B-MPA
of IN I-MPA
the DT I-MPA
C-helix NN I-MPA
, , O
a DT O
key JJ O
determinant NN O
in IN O
the DT O
catalytic JJ O
turnover NN O
of IN O
kinases NNS O
. . O

Consistent JJ O
with IN O
this DT O
mutation NN O
not RB O
altering VBG O
autoinhibitory JJ O
constraints NNS O
, , O
live-cell JJ O
imaging NN O
studies NNS O
reveal VBP O
that IN O
the DT O
basal NN O
signaling VBG O
output NN O
of IN O
PKCα-M489V NNP O
is VBZ O
unchanged JJ O
. . O

However RB O
, , O
the DT O
mutant JJ B-Var
enzyme NN B-Enzyme
in IN O
cells NNS O
displays NNS O
increased VBD B-PosReg
sensitivity NN B-MPA
to IN O
an DT O
inhibitor NN O
that WDT O
is VBZ O
ineffective JJ O
toward IN O
scaffolded VBD O
PKC NNP O
, , O
suggesting VBG O
the DT O
altered JJ O
dynamics NNS O
of IN O
the DT O
kinase NN O
domain NN O
may MD O
influence VB B-Reg
protein NN B-Protein
interactions NNS B-Interaction
. . O

Finally RB O
, , O
we PRP O
show VBP O
that IN O
phosphorylation NN B-MPA
of IN O
a DT O
key JJ O
PKC NNP O
substrate NN O
, , O
myristoylated VBD B-MPA
alanine-rich NN I-MPA
C-kinase NN I-MPA
substrate NN I-MPA
, , O
is VBZ O
increased VBN B-PosReg
in IN O
brains NNS O
of IN O
CRISPR-Cas9 NNP O
genome-edited NN O
mice NNS O
containing VBG O
the DT O
PKCα-M489V NNP B-Enzyme
mutation NN O
. . O

Our PRP$ O
results NNS O
unveil VBP O
how WRB O
an DT O
AD-associated NN O
mutation NN O
in IN O
PKCα NNS O
permits NNS O
enhanced VBN O
agonist-dependent JJ O
signaling NN O
via IN O
a DT O
mechanism NN O
that WDT O
evades VBZ O
the DT O
cell NN O
's POS O
homeostatic JJ O
down-regulation RP O
of IN O
constitutively RB O
active JJ O
PKCα. NN O
Gain-of-function NN B-PosReg
KCNJ6 VBD B-Gene
Mutation NNP B-Var
in IN O
a DT O
Severe NNP B-Disease
Hyperkinetic NNP I-Disease
Movement NNP I-Disease
Disorder NNP I-Disease
Phenotype NNP O
. . O

Here RB O
, , O
we PRP O
describe VBP O
a DT O
fourth JJ O
case NN O
of IN O
a DT O
human NN O
with IN O
a DT O
de FW O
novo NN O
KCNJ6 NNP B-Gene
( -LRB- O
GIRK2 NNP O
) -RRB- O
mutation NN B-Var
, , O
who WP O
presented VBD B-Reg
with IN O
clinical JJ O
findings NNS O
of IN O
severe JJ B-Disease
hyperkinetic JJ I-Disease
movement NN I-Disease
disorder NN I-Disease
and CC O
developmental JJ B-CPA
delay NN I-CPA
, , O
similar JJ O
to IN O
the DT O
Keppen-Lubinsky NNP O
syndrome NN O
but CC O
without IN O
lipodystrophy NN O
. . O

Whole-exome JJ O
sequencing NN O
of IN O
the DT O
patient NN O
's POS O
DNA NNP O
revealed VBD O
a DT O
heterozygous JJ O
de FW O
novo NN O
variant NN O
in IN O
the DT O
KCNJ6 NNP B-Gene
( -LRB- O
c.512T NNP B-Var
> XX O
G NN O
, , O
p NN B-Var
. . O

Leu171Arg NNP O
) -RRB- O
. . O

We PRP O
conducted VBD O
in IN O
vitro FW O
functional JJ O
studies NNS O
to TO O
determine VB O
if IN O
this DT O
Leu-to-Arg NNP O
mutation NN O
alters VBZ O
the DT O
function NN O
of IN O
GIRK2 NNP O
channels NNS O
. . O

Heterologous JJ O
expression NN O
of IN O
the DT O
mutant JJ B-Var
GIRK2 NNP B-Gene
channel NN O
alone RB O
produced VBD B-PosReg
an DT O
aberrant NN O
basal NN B-MPA
inward IN I-MPA
current NN I-MPA
that WDT O
lacked VBD B-NegReg
G NN B-Protein
protein NN I-Protein
activation NN B-MPA
, , O
lost VBD B-NegReg
K+ VBN B-MPA
selectivity NN I-MPA
and CC O
gained VBD B-PosReg
Ca2 NN B-MPA
+ SYM I-MPA
permeability NN O
. . O

Notably RB O
, , O
the DT O
inward JJ O
current NN O
was VBD O
inhibited VBN O
by IN O
the DT O
Na+ JJ O
channel NN O
blocker NN O
QX-314 NNP O
, , O
similar JJ O
to IN O
the DT O
previously RB O
reported VBN O
weaver JJ O
mutation NN O
in IN O
murine NN O
GIRK2 NNP O
. . O

Expression NN O
of IN O
a DT O
tandem NN O
dimer NN O
containing VBG O
GIRK1 NNP O
and CC O
GIRK2(p NNP O
. . O

Leu171Arg NNP O
) -RRB- O
did VBD O
not RB O
lead VB O
to IN O
any DT O
currents NNS O
, , O
suggesting VBG O
heterotetramers NNS O
are VBP O
not RB O
functional JJ O
. . O

In IN O
neurons NNS O
expressing VBG O
p XX B-Var
. . O

Leu171Arg NNP O
GIRK2 NNP B-Gene
channels NNS O
, , O
these DT O
changes NNS O
in IN O
channel NN O
properties NNS O
would MD O
be VB O
expected VBN O
to TO O
generate VB O
a DT O
sustained JJ O
depolarization NN B-NegReg
, , O
instead RB O
of IN O
the DT O
normal JJ O
G NN B-MPA
protein-gated NN I-MPA
inhibitory JJ I-MPA
response NN I-MPA
De NNP O
Novo NNP O
and CC O
Inherited NNP O
Loss-of-Function NNP B-NegReg
Variants NNP B-Var
in IN O
TLK2 NNP B-Gene
: : O
Clinical NNP O
and CC O
Genotype-Phenotype NNP O
Evaluation NNP O
of IN O
a DT O
Distinct NNP B-Disease
Neurodevelopmental NNP I-Disease
Disorder NNP I-Disease
Progranulin NNP O
as IN O
a DT O
therapeutic JJ O
target NN O
for IN O
dementia NN O
. . O

INTRODUCTION NN O
: : O
Progranulin NNP O
( -LRB- O
PGRN NNP O
) -RRB- O
is VBZ O
an DT O
acrosomal NN O
glycoprotein NN O
that WDT O
is VBZ O
synthesized VBN O
during IN O
spermatogenesis NN O
. . O

It PRP O
is VBZ O
overexpressed VBN O
in IN O
tumors NNS O
and CC O
has VBZ O
anti-inflammatory RB O
properties NNS O
. . O

The DT O
protein NN O
may MD O
be VB O
cleaved VBN O
into IN O
granulins NNS O
which WDT O
display NN O
pro-inflammatory JJ O
properties NNS O
. . O

In IN O
2006 CD O
, , O
mutations NNS B-Var
in IN O
progranulin JJ O
gene NN O
( -LRB- O
GRN NNP B-Gene
) -RRB- O
that WDT O
cause VBP O
haploinsufficiency NN O
were VBD O
found VBN O
in IN O
familial JJ O
cases NNS B-Reg
of IN O
frontotemporal JJ B-Disease
dementia NN I-Disease
Quantitative JJ O
phosphoproteomic JJ O
analysis NN O
of IN O
the DT O
molecular JJ O
substrates NNS O
of IN O
sleep NN O
need NN O
. . O

Sleep NN O
and CC O
wake VBP O
have VBP O
global JJ O
effects NNS O
on IN O
brain NN O
physiology NN O
, , O
from IN O
molecular JJ O
changes1-4 NN O
and CC O
neuronal JJ O
activities NNS O
to IN O
synaptic JJ O
plasticity3-7 NN O
. . O

Sleep-wake VB O
homeostasis NN O
is VBZ O
maintained VBN O
by IN O
the DT O
   O
generation NN O
of IN O
a DT O
sleep NN O
need NN O
that WDT O
accumulates NNS O
during IN O
waking NN O
and CC O
dissipates NNS O
during IN O
sleep8-11 NN O
. . O

Here RB O
we PRP O
investigate VBP O
the DT O
molecular JJ O
basis NN O
of IN O
sleep NN O
need NN O
using VBG O
quantitative JJ O
phosphoproteomic JJ O
analysis NN O
of IN O
the DT O
sleep-deprived NN O
and CC O
Sleepy NNP O
mouse NN O
models NNS O
of IN O
increased VBN O
sleep NN O
need NN O
. . O

Sleep VB O
deprivation NN O
induces VBZ O
cumulative JJ O
phosphorylation NN O
of IN O
the DT O
brain NN O
proteome NN O
, , O
which WDT O
dissipates VBZ O
during IN O
sleep NN O
. . O

Sleepy JJ O
mice NNS O
, , O
owing VBG O
to IN O
a DT O
gain-of-function JJ B-PosReg
mutation NN B-Var
in IN O
the DT O
Sik3 NNP B-Gene
gene NN O
12 CD O
, , O
have VB O
a DT O
constitutively RB O
high JJ O
sleep NN O
need NN O
despite IN O
increased VBN O
sleep NN O
amount NN O
. . O

The DT O
brain NN B-Protein
proteome NN I-Protein
of IN O
these DT O
mice NNS O
exhibits VBZ O
hyperphosphorylation NN B-MPA
, , O
similar JJ O
to IN O
that DT O
seen VBN O
in IN O
the DT O
brain NN O
of IN O
sleep-deprived NN O
mice NNS O
. . O

Comparison NNP O
of IN O
the DT O
two CD O
models NNS O
identifies VBZ O
80 CD O
mostly RB O
synaptic JJ O
sleep-need-index NN O
phosphoproteins NNS O
( -LRB- O
SNIPPs NNPS O
) -RRB- O
, , O
in IN O
which WDT O
phosphorylation NN O
states NNS O
closely RB O
parallel JJ O
changes NNS O
of IN O
sleep NN O
need NN O
. . O

SLEEPY NNP O
, , O
the DT O
mutant JJ B-Var
SIK3 NNP B-Gene
protein NN B-Protein
, , O
preferentially RB B-PosReg
associates VBZ B-Interaction
with IN I-Interaction
and CC O
phosphorylates VBZ B-MPA
SNIPPs NNS B-Protein
Germline JJ O
mutations NNS O
and CC O
somatic JJ O
inactivation NN O
of IN O
TRIM28 NNP O
in IN O
Wilms NNPS O
tumour NN O
. . O

Wilms NNPS O
tumour NN O
is VBZ O
a DT O
childhood NN O
tumour NN O
that WDT O
arises VBZ O
as IN O
a DT O
consequence NN O
of IN O
somatic JJ O
and CC O
rare JJ O
germline NN O
mutations NNS O
, , O
the DT O
characterisation NN O
of IN O
which WDT O
has VBZ O
refined VBN O
our PRP$ O
understanding NN O
of IN O
nephrogenesis NN O
and CC O
carcinogenesis NN O
. . O

Here RB O
we PRP O
report VBP O
that IN O
germline JJ O
loss NN B-NegReg
of IN I-NegReg
function NN I-NegReg
mutations NNS B-Var
in IN O
TRIM28 NNP B-Gene
predispose NN O
children NNS O
to IN O
Wilms NNS B-Disease
tumour NN I-Disease
. . O

Loss NN O
of IN O
function NN O
of IN O
this DT O
transcriptional JJ O
co-repressor NN O
, , O
which WDT O
has VBZ O
a DT O
role NN O
in IN O
nephrogenesis NN O
, , O
has VBZ O
not RB O
previously RB O
been VBN O
associated VBN O
with IN O
cancer NN O
. . O

Inactivation NN B-NegReg
of IN O
TRIM28 NNP B-Gene
, , O
either CC O
germline JJ O
or CC O
somatic JJ O
, , O
occurred VBD O
through IN O
inactivating VBG B-Var
mutations NNS I-Var
, , O
loss NN B-Var
of IN I-Var
heterozygosity NN I-Var
or CC O
epigenetic JJ B-Var
silencing NN I-Var
Mutational JJ O
and CC O
functional JJ O
studies NNS O
on IN O
NR5A1 NNP B-Gene
gene NN O
in IN O
46,XY CD B-Disease
disorders NNS I-Disease
of IN I-Disease
sex NN I-Disease
development NN I-Disease
: : O
identification NN O
of IN O
six CD O
novel JJ O
loss NN B-NegReg
of IN I-NegReg
function NN I-NegReg
mutations NNS B-Var
. . O

OBJECTIVE NN O
: : O
To TO O
study VB O
the DT O
functional JJ O
properties NNS O
of IN O
six CD O
novel JJ O
missense NN O
mutations NNS O
of IN O
the DT O
NR5A1 NNP O
gene NN O
encoding VBG O
the DT O
steroidogenic JJ O
factor NN O
1 CD O
( -LRB- O
SF-1 NNP O
) -RRB- O
identified VBN O
in IN O
six CD O
patients NNS O
with IN O
46,XY CD O
disorders NNS O
of IN O
sex NN O
development NN O
( -LRB- O
DSD NNP O
) -RRB- O
and CC O
to TO O
describe VB O
their PRP$ O
relative JJ O
phenotype-genotype NN O
relationship NN O
. . O

DESIGN NNP O
: : O
Genetic JJ O
and CC O
functional JJ O
studies NNS O
. . O

SETTING NNP O
: : O
University NNP O
department NN O
. . O

PATIENT(S NNP O
) -RRB- O
: : O
Six CD O
46,XY CD O
DSD NNP O
patients NNS O
. . O

INTERVENTION(S NN O
) -RRB- O
: : O
None NN O
. . O

MAIN NNP O
OUTCOME NNP O
MEASURE(S NNP O
) -RRB- O
: : O
Sanger NN O
sequencing NN O
and CC O
multiplex JJ O
ligation-dependent NN O
probe NN O
amplification NN O
analysis NN O
to TO O
identify VB O
the DT O
mutations NNS O
or CC O
deletions NNS O
/ SYM O
duplications NNS O
of IN O
the DT O
NR5A1 NNP O
gene NN O
. . O

Functional JJ O
studies NNS O
by IN O
transactivation NN O
assays NNS O
to TO O
predict VB O
the DT O
impact NN O
of IN O
mutations NNS O
on IN O
molecular JJ O
function NN O
. . O

RESULT(S NN O
) -RRB- O
: : O
NR5A1 NN B-Gene
exons NNS O
sequencing NN O
identified VBN B-Reg
in IN I-Reg
six CD O
46,XY CD B-Disease
DSD NNP I-Disease
patients NNS O
six CD O
novel JJ O
mutations NNS O
: : O
p LS B-Var
. . O

T40R NNS O
, , O
p NN B-Var
. . O

T47C NNP O
, , O
p NN B-Var
. . O

G328W NN O
, , O
p NN B-Var
. . O

A351E UH O
, , O
p NN B-Var
. . O

R427W NN O
, , O
and CC O
p LS B-Var
. . O

Q460R. NNP O
Five CD O
missense NN O
variants NNS O
were VBD O
heterozygous JJ O
, , O
and CC O
one CD O
was VBD O
homozygous JJ O
( -LRB- O
p NN O
. . O

R427W NN O
) -RRB- O
. . O

Functional JJ O
analysis NN O
revealed VBD O
a DT O
significant JJ O
loss NN B-NegReg
of IN O
DNA-binding NN B-Interaction
and CC O
transactivation NN B-MPA
ability NN O
for IN O
all DT O
variants NNS O
, , O
except IN O
for IN O
p NN O
. . O

Q460R NNP O
, , O
which WDT O
showed VBD O
a DT O
modest JJ O
reduced JJ O
activity NN O
compared VBN O
with IN O
that DT O
of IN O
the DT O
wild-type JJ O
protein NN O
. . O

Phenotypes NNS O
associated VBN O
with IN O
these DT O
mutations NNS O
varied VBN O
from IN O
males NNS O
with IN O
spontaneous JJ O
puberty NN O
, , O
substantial JJ O
T NNP O
production NN O
, , O
and CC O
possible JJ O
fertility NN O
, , O
to IN O
females NNS O
with IN O
and CC O
without IN O
müllerian JJ O
structures NNS O
and CC O
primary JJ O
amenorrhea NN O
. . O

CONCLUSION(S NNP O
) -RRB- O
: : O
We PRP O
describe VBP O
six CD O
novel JJ O
mutations NNS B-Var
in IN O
NR5A1 NNP B-Gene
gene NN O
and CC O
showed VBD O
that IN O
they PRP O
might MD O
affect VB B-Reg
protein NN B-MPA
structure NN I-MPA
, , O
therefore RB O
compromising VBG B-NegReg
seriously RB O
the DT O
SF-1 NNP B-MPA
role NN O
in IN O
regulating VBG O
gonadal JJ B-CPA
development NN I-CPA
Multiple JJ O
regions NNS O
in IN O
the DT O
extracellular JJ O
domain NN O
of IN O
the DT O
glycine NN O
receptor NN O
determine JJ O
receptor NN O
activity NN O
. . O

Glycine NNP O
receptors NNS O
( -LRB- O
GlyRs NNS O
) -RRB- O
are VBP O
Cys-loop NNP O
receptors NNS O
that WDT O
mediate VBP O
fast JJ O
synaptic JJ O
inhibition NN O
in IN O
the DT O
brain NN O
stem NN O
and CC O
spinal JJ O
cord NN O
. . O

They PRP O
are VBP O
involved VBN O
in IN O
the DT O
generation NN O
of IN O
motor NN O
rhythm NN O
, , O
reflex JJ O
circuit NN O
coordination NN O
, , O
and CC O
sensory JJ O
signal NN O
processing NN O
and CC O
therefore RB O
represent VBP O
targets NNS O
for IN O
therapeutic JJ O
interventions NNS O
. . O

The DT O
extracellular JJ O
domains NNS O
( -LRB- O
ECDs NNP O
) -RRB- O
of IN O
Cys-loop NNP O
receptors NNS O
typically RB O
contain VBP O
many JJ O
aromatic JJ O
amino NN O
acids NNS O
, , O
but CC O
only RB O
those DT O
in IN O
the DT O
receptor NN O
binding JJ O
pocket NN O
have VBP O
been VBN O
extensively RB O
studied VBN O
. . O

Here RB O
, , O
we PRP O
show VBP O
that IN O
many JJ O
Phe NNP O
residues NNS O
in IN O
the DT O
ECD NNP O
that WDT O
are VBP O
not RB O
located VBN O
in IN O
the DT O
binding JJ O
pocket NN O
are VBP O
also RB O
involved VBN O
in IN O
GlyR NNP O
function NN O
. . O

We PRP O
examined VBD O
these DT O
Phe NNP O
residues NNS O
by IN O
creating VBG O
several JJ O
GlyR NN O
variants NNS O
, , O
characterizing VBG O
these DT O
variants NNS O
with IN O
the DT O
two-electrode CD O
voltage NN O
clamp NN O
technique NN O
in IN O
Xenopus NNP O
oocytes NNS O
, , O
and CC O
interpreting VBG O
changes NNS O
in IN O
receptor NN O
parameters NNS O
by IN O
using VBG O
currently RB O
available JJ O
structural JJ O
information NN O
on IN O
the DT O
open JJ O
and CC O
closed JJ O
states NNS O
of IN O
the DT O
GlyR. NNP O
Substitution NNP B-Var
of IN I-Var
six CD I-Var
of IN I-Var
the DT I-Var
eight CD I-Var
Phe NNP I-Var
residues NNS I-Var
in IN I-Var
the DT I-Var
ECD NNP I-Var
with IN I-Var
Ala NNP I-Var
resulted VBD O
in IN O
loss NN B-NegReg
of IN O
function NN B-MPA
or CC O
significantly RB O
increased VBD B-PosReg
the DT O
EC50 NNP B-MPA
and CC O
also RB O
altered VBD B-Reg
the DT O
maximal JJ B-MPA
response NN I-MPA
to IN I-MPA
the DT I-MPA
partial JJ I-MPA
GlyR VBD I-MPA
agonist JJ I-MPA
taurine NN I-MPA
RES NNP O
complex NN O
is VBZ O
associated VBN O
with IN O
intron NN O
definition NN O
and CC O
required VBN O
for IN O
zebrafish JJ O
early JJ O
embryogenesis NN O
. . O

Pre-mRNA NN O
splicing NN O
is VBZ O
a DT O
critical JJ O
step NN O
of IN O
gene NN O
expression NN O
in IN O
eukaryotes NNS O
. . O

Transcriptome-wide VB O
splicing NN O
patterns NNS O
are VBP O
complex JJ O
and CC O
primarily RB O
regulated VBN O
by IN O
a DT O
diverse JJ O
set NN O
of IN O
recognition NN O
elements NNS O
and CC O
associated VBN O
RNA-binding NNP O
proteins NNS O
. . O

The DT O
retention NN O
and CC O
splicing NN O
( -LRB- O
RES NNP O
) -RRB- O
complex NN O
is VBZ O
formed VBN O
by IN O
three CD O
different JJ O
proteins NNS O
( -LRB- O
Bud13p NNP O
, , O
Pml1p NNPS O
and CC O
Snu17p NNP O
) -RRB- O
and CC O
is VBZ O
involved VBN O
in IN O
splicing NN O
in IN O
yeast NN O
. . O

However RB O
, , O
the DT O
importance NN O
of IN O
the DT O
RES NNP O
complex NN O
for IN O
vertebrate NN O
splicing NN O
, , O
the DT O
intronic JJ O
features NNS O
associated VBN O
with IN O
its PRP$ O
activity NN O
, , O
and CC O
its PRP$ O
role NN O
in IN O
development NN O
are VBP O
unknown JJ O
. . O

In IN O
this DT O
study NN O
, , O
we PRP O
have VBP O
generated VBN O
loss-of-function NN B-NegReg
mutants NNS B-Var
for IN O
the DT O
three CD O
components NNS O
of IN O
the DT O
RES NNP O
complex NN O
in IN O
zebrafish NN O
and CC O
showed VBD O
that IN O
they PRP O
are VBP O
required VBN O
during IN O
early JJ O
development NN O
. . O

The DT O
mutants NNS O
showed VBD O
a DT O
marked JJ O
neural JJ O
phenotype NN O
with IN O
increased VBN B-PosReg
cell NN B-CPA
death NN I-CPA
in IN I-CPA
the DT I-CPA
brain NN I-CPA
and CC O
a DT O
decrease NN B-NegReg
in IN O
differentiated VBN B-CPA
neurons NNS I-CPA
. . O

Transcriptomic JJ O
analysis NN O
of IN O
bud13 NNP B-Gene
, , O
snip1 NNP B-Gene
( -LRB- I-Gene
pml1 NNP O
) -RRB- O
and CC O
rbmx2 NN B-Gene
( -LRB- I-Gene
snu17 NNP O
) -RRB- O
mutants NNS B-Var
revealed VBD O
a DT O
global JJ O
defect NN B-NegReg
in IN O
intron NN B-MPA
splicing NN I-MPA
, , O
with IN O
strong JJ O
mis-splicing NN B-MPA
of IN I-MPA
a DT I-MPA
subset NN I-MPA
of IN I-MPA
introns NNS I-MPA
Mutant JJ B-Var
p53 VBP B-Gene
gain NN B-PosReg
of IN I-PosReg
function NN I-PosReg
induces VBZ B-Reg
HER2 NNP B-Protein
over-expression IN B-MPA
in IN O
cancer NN O
cells NNS O
. . O

BACKGROUND NNP O
: : O
HER2 NNP O
over-expression IN O
is VBZ O
related VBN O
with IN O
a DT O
poor JJ O
prognosis NN O
in IN O
patients NNS O
with IN O
invasive JJ O
breast NN O
cancer NN O
tumors NNS O
. . O

Clinical JJ O
associations NNS O
have VBP O
reported VBN O
that IN O
somatic JJ O
mutations NNS O
of IN O
p53 NN O
more RBR O
frequently RB O
detected VBN O
in IN O
cases NNS O
of IN O
sporadic JJ O
breast NN O
cancer NN O
of IN O
the DT O
HER2 NNP O
subtypes NNS O
, , O
besides IN O
a DT O
high JJ O
percentage NN O
of IN O
HER2-amplifying VBG O
tumors NNS O
carry VBP O
germline NN O
mutations NNS O
of IN O
p53 NN O
. . O

The DT O
mechanisms NNS O
responsible JJ O
for IN O
the DT O
acquisition NN O
of IN O
oncogenic JJ O
functions NNS O
of IN O
p53 NN O
mutant JJ O
proteins NNS O
( -LRB- O
mtp53 NN O
) -RRB- O
, , O
known VBN O
as IN O
Gain NN O
of IN O
Function NNP O
( -LRB- O
GOF NNP O
) -RRB- O
, , O
over IN O
HER2 NNP O
expression NN O
have VBP O
not RB O
been VBN O
reported VBN O
. . O

The DT O
objective NN O
of IN O
this DT O
study NN O
was VBD O
to TO O
evaluate VB O
a DT O
possible JJ O
relationship NN O
between IN O
p53 NN O
mutants NNS O
and CC O
HER2 NNP O
regulation NN O
. . O

METHODS NNS O
: : O
HER2 NNP O
expression NN O
( -LRB- O
transcription NN O
and CC O
protein NN O
) -RRB- O
, , O
as RB O
well RB O
as IN O
HER2 NNP O
protein NN O
stabilization NN O
have VBP O
been VBN O
evaluated VBN O
after IN O
inducing VBG O
or CC O
silencing VBG O
of IN O
p53 NN O
mutants NNS O
' POS O
expression NN O
in IN O
cell NN O
lines NNS O
. . O

Finally RB O
, , O
we PRP O
evaluated VBD O
the DT O
interaction NN O
of IN O
the DT O
p53 NN O
mutants NNS O
over IN O
the DT O
HER2 NNP O
receptor NN O
promoter NN O
. . O

RESULTS NNS O
: : O
Higher JJR B-PosReg
HER2 NNP B-Protein
expression NN B-MPA
in IN O
cell NN O
lines NNS O
harboring VBG O
endogenous JJ O
mtp53 NN B-Var
compared VBN O
with IN O
wt CD O
or CC O
null JJ O
expression NN O
of IN O
p53 NN O
cell NN O
lines NNS O
. . O

Transfection NN O
of IN O
p53 NN B-Gene
mutants NNS O
( -LRB- O
R248Q FW B-Var
and CC O
R273C VBD B-Var
) -RRB- O
in IN O
cell NN O
lines NNS O
increased VBD B-PosReg
the DT O
expression NN B-MPA
of IN O
HER2 NNP B-Protein
. . O

Silencing VBG O
of IN O
p53 NN O
mutants NNS O
, , O
decrease VB O
HER2 NNP O
expression NN O
. . O

The DT O
p53 NN B-Gene
mutants NNS O
R248Q XX B-Var
and CC O
R273C VBD B-Var
significantly RB O
increase VB B-PosReg
the DT O
luciferase NN B-Enzyme
activity NN B-MPA
on IN O
the DT O
HER2 NNP O
promoter NN O
, , O
and CC O
both DT O
mutants NNS O
also RB O
promote VBP B-PosReg
acetylation NN B-MPA
of IN O
H3 NNP B-Protein
and CC O
H4 NNP B-Protein
histones NNS I-Protein
binding VBG B-Interaction
in IN O
it PRP O
. . O

CONCLUSIONS NNS O
: : O
These DT O
findings NNS O
show VBP O
for IN O
the DT O
first JJ O
time NN O
that WDT O
p53 VBP B-Gene
mutants NNS B-Var
induce VBP B-Reg
over-expression IN B-MPA
of IN O
HER2 NNP B-Protein
Mice NNS O
harboring VBG O
the DT O
human JJ O
SLC30A8 NNP B-Gene
R138X JJ O
loss-of-function NN B-NegReg
mutation NN B-Var
have VBP O
increased VBN B-PosReg
insulin NN B-MPA
secretory NN I-MPA
capacity NN I-MPA
. . O

SLC30A8 NNP O
encodes NNS O
a DT O
zinc NN O
transporter NN O
that WDT O
is VBZ O
primarily RB O
expressed VBN O
in IN O
the DT O
pancreatic JJ O
islets NNS O
of IN O
Langerhans NNP O
. . O

In IN O
β-cells NNS O
it PRP O
transports VBZ O
zinc NN O
into IN O
insulin-containing NN O
secretory NN O
granules NNS O
. . O

Loss-of-function NN O
( -LRB- O
LOF NNP O
) -RRB- O
mutations NNS O
in IN O
SLC30A8 JJ O
protect NN O
against IN O
type NN O
2 CD O
diabetes NNS O
in IN O
humans NNS O
. . O

In IN O
this DT O
study NN O
, , O
we PRP O
generated VBD O
a DT O
knockin NN O
mouse NN O
model NN O
carrying VBG O
one CD O
of IN O
the DT O
most RBS O
common JJ O
human NN O
LOF NNP O
mutations NNS O
for IN O
SLC30A8 CD O
, , O
R138X. NNP O
The DT O
R138X JJ O
mice NNS O
had VBD O
normal JJ O
body NN O
weight NN O
, , O
glucose NN O
tolerance NN O
, , O
and CC O
pancreatic JJ O
β-cell NN O
mass NN O
. . O

Interestingly RB O
, , O
in IN O
hyperglycemic JJ O
conditions NNS O
induced VBN O
by IN O
the DT O
insulin NN O
receptor NN O
antagonist NN O
S961 NNP O
, , O
the DT O
R138X JJ B-Var
mice NNS O
showed VBD O
a DT O
50 CD O
% NN O
increase NN B-PosReg
in IN O
insulin NN B-MPA
secretion NN I-MPA
. . O

This DT O
effect NN O
was VBD O
not RB O
associated VBN O
with IN O
enhanced JJ O
β-cell NN O
proliferation NN O
or CC O
mass NN O
. . O

Our PRP$ O
data NNS O
suggest VBP O
that IN O
the DT O
SLC30A8 JJ B-Gene
R138X NNP O
LOF NNP B-NegReg
mutation NN B-Var
may MD O
exert VB O
beneficial JJ B-PosReg
effects NNS I-PosReg
on IN O
glucose NN B-MPA
metabolism NN I-MPA
by IN O
increasing VBG B-PosReg
the DT O
capacity NN O
of IN O
β-cells NNS O
to TO O
secrete VB B-MPA
insulin NN I-MPA
The DT O
lateral JJ O
meningocele NN O
syndrome NN O
mutation NN O
causes VBZ O
marked VBN O
osteopenia NN O
in IN O
mice NNS O
. . O

Lateral JJ O
meningocele NN O
syndrome NN O
( -LRB- O
LMS NNP O
) -RRB- O
is VBZ O
a DT O
rare JJ O
genetic JJ O
disorder NN O
characterized VBN O
by IN O
neurological JJ O
complications NNS O
and CC O
osteoporosis NN O
. . O

LMS NNP B-Disease
is VBZ O
associated VBN O
with IN O
mutations NNS B-Var
in IN I-Var
exon NN I-Var
33 CD I-Var
of IN O
NOTCH3 NNP B-Gene
leading VBG O
to IN O
a DT O
truncated VBN B-MPA
protein NN B-Protein
lacking VBG B-NegReg
sequences NNS B-MPA
for IN I-MPA
NOTCH3 JJ I-MPA
degradation NN I-MPA
and CC O
presumably RB O
causing VBG O
NOTCH3 JJ B-Gene
gain NN B-PosReg
of IN I-PosReg
function NN I-PosReg
. . O

To TO O
create VB O
a DT O
mouse NN O
model NN O
reproducing VBG O
human JJ O
LMS-associated NNP O
mutations NNS O
, , O
we PRP O
utilized VBD O
CRISPR NNP O
/ SYM O
Cas9 VBZ O
to TO O
introduce VB O
a DT O
tandem NN O
termination NN O
codon VBN O
at IN O
bases NNS O
6691-6696 CD O
( -LRB- O
ACCAAG→TAATGA NNS O
) -RRB- O
and CC O
verified VBD O
this DT O
mutation NN O
( -LRB- O
Notch3tm1.1Ecan NNP O
) -RRB- O
by IN O
DNA NN O
sequencing NN O
of IN O
F1 NNP O
mice NNS O
. . O

One-month-old CD O
male NN O
and CC O
female JJ O
heterozygous JJ O
Notch3tm1.1Ecan JJ B-Var
mice NNS O
had VBD O
cancellous JJ B-CPA
and CC I-CPA
cortical JJ I-CPA
bone NN I-CPA
osteopenia NN B-NegReg
but CC O
exhibited VBD O
no DT O
obvious JJ O
neurological JJ O
alterations NNS O
, , O
and CC O
histopathology NN O
of IN O
multiple JJ O
organs NNS O
revealed VBD O
no DT O
abnormalities NNS O
. . O

Microcomputed JJ O
tomography NN O
of IN O
these DT O
mutants NNS B-Var
revealed VBD O
a DT O
35-60 CD O
% NN O
decrease NN B-NegReg
in IN O
cancellous JJ B-CPA
bone NN I-CPA
volume NN I-CPA
associated VBN O
with IN O
a DT O
reduction NN B-NegReg
in IN O
trabecular NN B-CPA
number NN I-CPA
and CC O
decreased VBD B-NegReg
connectivity NN B-CPA
. . O

During IN O
maturation NN O
, , O
cancellous JJ O
and CC O
cortical JJ O
bones NNS O
were VBD O
restored VBN O
in IN O
female NN O
but CC O
not RB O
in IN O
male JJ O
mice NNS O
, , O
which WDT O
exhibited VBD O
cancellous JJ O
bone NN O
osteopenia NN O
at IN O
4 CD O
months NNS O
. . O

Cancellous JJ O
bone NN O
histomorphometry NN O
revealed VBD O
increased VBN O
osteoblast NN O
and CC O
osteocyte JJ O
numbers NNS O
and CC O
a DT O
modest JJ O
increase NN O
in IN O
osteoclast JJ O
surface NN O
and CC O
bone NN O
formation NN O
rate NN O
. . O

Notch3tm1.1Ecan JJ B-Var
calvarial JJ B-CPA
osteoblasts NNS I-CPA
had VBD O
increased VBN B-PosReg
proliferation NN O
and CC O
increased VBN B-PosReg
bone NN B-Protein
γ-carboxyglutamate NN I-Protein
protein NN I-Protein
( -LRB- I-Protein
Bglap NNP O
) -RRB- O
and CC O
TNF NNP B-Gene
superfamily JJ I-Gene
member NN I-Gene
11 CD I-Gene
( -LRB- I-Gene
Tnfsf11 NN O
) -RRB- O
mRNA NN B-MPA
levels NNS I-MPA
and CC O
lower JJR B-NegReg
Tnfrsf11b NNP B-MPA
levels NNS I-MPA
. . O

Tnfsf11 NN O
mRNA NNS O
was VBD O
increased VBN O
in IN O
osteocyte-rich JJ O
femora NN O
from IN O
Notch3tm1.1Ecan JJ O
mice NNS O
. . O

Cultures NNS O
of IN O
bone NN O
marrow-derived NN O
macrophages NNS O
from IN O
Notch3tm1.1Ecan JJ O
mice NNS O
revealed VBD O
increased VBN O
osteoclast JJ O
formation NN O
, , O
particularly RB O
in IN O
cocultures NNS O
with IN O
osteoblasts NNS O
from IN O
Notch3tm1.1Ecan JJ O
mice NNS O
. . O

In IN O
conclusion NN O
, , O
the DT O
Notch3tm1.1Ecan JJ B-Var
mutation NN I-Var
causes VBZ O
osteopenia NN B-Disease
despite IN O
an DT O
increase NN B-PosReg
in IN O
osteoblast NN B-CPA
proliferation NN I-CPA
and CC O
function NN B-CPA
and CC O
is VBZ O
associated VBN O
with IN O
enhanced JJ B-PosReg
Tnfsf11 NNP B-Gene
expression NN B-MPA
Heterogeneous JJ O
nature NN O
of IN O
diabetes NNS B-Disease
in IN O
a DT O
family NN O
with IN O
a DT O
gain-of-function JJ B-PosReg
mutation NN B-Var
in IN O
the DT O
ATP-binding NNP O
cassette NN O
subfamily NN O
C NN O
member NN O
8 CD O
( -LRB- O
ABCC8 NN B-Gene
) -RRB- O
gene NN O
. . O

Gain-of-function NN B-PosReg
ATP-binding NNP O
cassette NN O
subfamily NN O
C NN O
member NN O
8 CD O
( -LRB- O
ABCC8 NN B-Gene
) -RRB- O
mutations NNS B-Var
are VBP O
known VBN O
to TO O
cause VB B-Reg
neonatal JJ B-Disease
diabetes NN I-Disease
mellitus NN I-Disease
and CC O
maturity-onset NN B-Disease
diabetes NNS I-Disease
Activating VBG O
human JJ O
epidermal JJ O
growth NN O
factor NN O
receptor NN O
2 CD O
( -LRB- O
HER2 NNP O
) -RRB- O
gene NN O
mutation NN O
in IN O
bone NN O
metastases NNS O
from IN O
breast NN O
cancer NN O
. . O

In IN O
addition NN O
to IN O
amplification NN O
, , O
point NN B-Var
mutations NNS I-Var
of IN O
the DT O
human JJ O
epidermal JJ O
growth NN O
factor NN O
receptor NN O
2 CD O
( -LRB- O
HER2 NNP O
) -RRB- O
gene NN O
( -LRB- O
ERBB2 NN B-Gene
) -RRB- O
have VBP O
been VBN O
shown VBN O
to TO O
activate VB B-PosReg
the DT O
corresponding VBG O
signaling NN B-Pathway
pathway NN I-Pathway
in IN O
breast NN B-Disease
cancer NN I-Disease
. . O

The DT O
prevalence NN O
of IN O
ERBB2/HER2 NNS O
mutation NN O
in IN O
bone NN O
metastasis NN O
of IN O
breast NN O
cancer NN O
and CC O
the DT O
associated JJ O
phenotype NN O
are VBP O
not RB O
known VBN O
. . O

In IN O
this DT O
study NN O
, , O
bone NN O
metastases NNS O
from IN O
breast NN O
cancer NN O
patients NNS O
( -LRB- O
n CC O
  _SP O
= SYM O
  _SP O
231 CD O
) -RRB- O
were VBD O
analyzed VBN O
for IN O
ERBB2/HER2 NNS O
mutation NN O
. . O

In IN O
7 CD O
patients NNS O
( -LRB- O
3 CD O
% NN O
; , O
median JJ O
age NN O
70 CD O
   O
years NNS O
, , O
range VBP O
50-83 CD O
   O
years NNS O
) -RRB- O
, , O
gain-of-function NN O
mutations NNS O
of IN O
ERBB2/HER2 NNS O
were VBD O
detected VBN O
. . O

The DT O
most RBS O
frequent JJ O
mutation NN O
was VBD O
p NN O
. . O

L755S JJ O
( -LRB- O
71 CD O
% NN O
) -RRB- O
. . O

In IN O
29 CD O
% NN O
of IN O
mutated JJ O
cases NNS O
, , O
p XX O
. . O

V777L NNP O
was VBD O
found VBN O
. . O

Lobular JJ O
breast NN O
cancer NN O
was VBD O
present JJ O
in IN O
71 CD O
% NN O
of IN O
mutated JJ O
cases NNS O
( -LRB- O
n CC O
  _SP O
= SYM O
  _SP O
5 CD O
) -RRB- O
and CC O
in IN O
49 CD O
% NN O
of IN O
all DT O
samples NNS O
( -LRB- O
n CC O
  _SP O
= SYM O
  _SP O
231 CD O
; : O
p DT O
  _SP O
= SYM O
  _SP O
0.275 CD O
) -RRB- O
. . O

Mutation NNP O
frequency NN O
was VBD O
4.4 CD O
% NN O
in IN O
the DT O
lobular JJ O
subgroup NN O
and CC O
17.4 CD O
% NN O
in IN O
the DT O
pleomorphic JJ O
subtype NN O
of IN O
lobular JJ O
cancer NN O
( -LRB- O
n CC O
  _SP O
= SYM O
  _SP O
23 CD O
) -RRB- O
, , O
respectively RB O
. . O

All DT O
but CC O
one CD O
mutated VBD O
lobular JJ O
cancers NNS O
were VBD O
of IN O
the DT O
pleomorphic JJ O
subtype NN O
( -LRB- O
p FW O
  _SP O
= SYM O
  _SP O
0.006 CD O
) -RRB- O
. . O

Mutated JJ O
cancers NNS O
belonged VBD O
either CC O
to IN O
the DT O
luminal JJ O
( -LRB- O
n CC O
  _SP O
= SYM O
  _SP O
4 CD O
) -RRB- O
or CC O
to IN O
the DT O
triple-negative JJ O
types NNS O
( -LRB- O
n CC O
  _SP O
= SYM O
  _SP O
3 CD O
) -RRB- O
. . O

With IN O
regard NN O
to IN O
protein NN O
expression NN O
and CC O
gene NN O
amplification NN O
, , O
HER2 NNP O
was VBD O
negative JJ O
in IN O
all DT O
mutated VBN O
cases NNS O
. . O

Among IN O
the DT O
14 CD O
% NN O
of IN O
metastatic JJ O
luminal JJ O
cancers NNS O
with IN O
estrogen NN O
receptor NN O
gene NN O
( -LRB- O
ESR1 NNP O
) -RRB- O
mutation NN O
, , O
conveying VBG O
resistance NN O
against IN O
aromatase NN O
inhibitors NNS O
, , O
no DT O
concomitant JJ O
ERBB2/HER2 VBZ O
mutation NN O
occurred VBD O
. . O

We PRP O
conclude VBP O
that IN O
activating VBG B-PosReg
HER2 NNP B-Gene
mutation NN B-Var
is VBZ O
present JJ O
in IN O
about IN O
3 CD O
% NN O
of IN O
bone NN B-CPA
metastases NNS I-CPA
from IN O
breast NN B-Disease
cancers NNS I-Disease
, , O
with IN O
significantly RB O
higher JJR B-PosReg
rates NNS I-PosReg
Altered NNP O
ER-mitochondria NNP O
contact NN O
impacts VBZ O
mitochondria VBP O
calcium NN O
homeostasis NN O
and CC O
contributes VBZ O
to IN O
neurodegeneration NN O
in IN O
vivo NN O
in IN O
disease NN O
models NNS O
. . O

Calcium NNP O
( -LRB- O
Ca2 NN O
+ SYM O
) -RRB- O
homeostasis NN O
is VBZ O
essential JJ O
for IN O
neuronal JJ O
function NN O
and CC O
survival NN O
. . O

Altered JJ O
Ca2 NN O
+ SYM O
homeostasis NN O
has VBZ O
been VBN O
consistently RB O
observed VBN O
in IN O
neurological JJ O
diseases NNS O
. . O

How WRB O
Ca2 NN O
+ SYM O
homeostasis NN O
is VBZ O
achieved VBN O
in IN O
various JJ O
cellular JJ O
compartments NNS O
of IN O
disease-relevant NN O
cell NN O
types NNS O
is VBZ O
not RB O
well RB O
understood VBN O
. . O

Here RB O
we PRP O
show VBP O
in IN O
Drosophila NNP O
Parkinson NNP O
's POS O
disease NN O
( -LRB- O
PD NNP O
) -RRB- O
models NNS O
that IN O
Ca2 NN O
+ SYM O
transport NN O
from IN O
the DT O
endoplasmic JJ O
reticulum NN O
( -LRB- O
ER NNP O
) -RRB- O
to TO O
mitochondria VB O
through IN O
the DT O
ER-mitochondria NNP O
contact NN O
site NN O
( -LRB- O
ERMCS NNP O
) -RRB- O
critically RB O
regulates VBZ O
mitochondrial JJ O
Ca2 NN O
+ CC O
( -LRB- O
mito-Ca2 JJ O
+ SYM O
) -RRB- O
homeostasis NN O
in IN O
dopaminergic JJ O
( -LRB- O
DA NNP O
) -RRB- O
neurons NNS O
, , O
and CC O
that IN O
the DT O
PD-associated NNP O
PINK1 NNP O
protein NN O
modulates VBZ O
this DT O
process NN O
. . O

In IN O
PINK1 NNP B-Gene
mutant JJ B-Var
DA NNP O
neurons NNS O
, , O
the DT O
ERMCS NNP B-MPA
is VBZ O
strengthened VBN B-PosReg
and CC O
mito-Ca2 JJ B-MPA
+ SYM I-MPA
level NN O
is VBZ O
elevated JJ B-PosReg
, , O
resulting VBG O
in IN O
mitochondrial JJ B-MPA
enlargement JJ B-PosReg
and CC O
neuronal JJ B-CPA
death NN B-NegReg
Bronchiectasis NN B-Disease
and CC O
Recurrent NNP B-Disease
Respiratory NNP I-Disease
Infections NNPS I-Disease
with IN O
a DT O
De NNP O
Novo NNP O
STAT1 NNP B-Gene
Gain-of-Function NNP B-PosReg
Variant NNP B-Var
: : O
First NNP O
Case NNP O
in IN O
Korea NNP O
. . O

Bronchiectasis NNP O
is VBZ O
a DT O
chronic JJ O
disease NN O
characterized VBN O
by IN O
airway NN O
infection NN O
and CC O
inflammation NN O
, , O
leading VBG O
to IN O
permanent JJ O
dilation NN O
of IN O
the DT O
bronchi NN O
. . O

Evaluation NN O
of IN O
underlying VBG O
etiology NN O
is VBZ O
important JJ O
in IN O
managing VBG O
young JJ O
bronchiectasis NN O
patients NNS O
with IN O
recurrent JJ O
infections NNS O
caused VBN O
by IN O
unusual JJ O
pathogens NNS O
. . O

The DT O
signal NN O
transducer NN O
and CC O
activator NN O
of IN O
transcription NN O
1 CD O
( -LRB- O
STAT1 NNP O
) -RRB- O
protein NN O
plays VBZ O
a DT O
key JJ O
role NN O
in IN O
STAT NNP O
signaling NN O
and CC O
immune JJ O
system NN O
regulation NN O
. . O

Heterozygotes NNS O
for IN O
gain-of-function NN B-PosReg
( -LRB- O
GOF NN O
) -RRB- O
alleles NNS B-Var
of IN O
the DT O
STAT1 NNP B-Gene
gene NN O
usually RB O
display VBP O
autosomal NN B-Disease
dominant JJ I-Disease
chronic JJ I-Disease
mucocutaneous JJ I-Disease
candidiasis NN I-Disease
( -LRB- O
CMC NNP O
) -RRB- O
and CC O
a DT O
wide JJ O
range NN O
of IN O
clinical JJ O
features NNS O
, , O
such JJ O
as IN O
bronchiectasis NN B-Disease
. . O

Here RB O
, , O
we PRP O
report VBP O
on IN O
a DT O
patient NN O
with IN O
CMC NNP O
and CC O
bronchiectasis NN O
with IN O
various JJ O
types NNS O
of IN O
infections NNS O
who WP O
carried VBD O
a DT O
pathogenic JJ O
variant NN O
of IN O
the DT O
STAT1 NNP O
gene NN O
. . O

The DT O
24-year-old CD O
female NN O
presented VBN O
with IN O
recurrent JJ O
respiratory JJ B-Disease
bacterial JJ I-Disease
and CC I-Disease
nontuberculous JJ I-Disease
mycobacterial JJ I-Disease
infections NNS I-Disease
complicated VBN O
by IN O
severe JJ O
bronchiectasis NN B-Disease
and CC O
CMC NNP B-Disease
. . O

Whole-exome JJ O
sequencing NN O
revealed VBD B-Reg
a DT O
c.800C NN B-Var
> XX O
T NNP O
( -LRB- O
p NN O
. . O

Ala267Val NNP O
) -RRB- O
heterozygous JJ O
mutation NN O
in IN O
the DT O
STAT1 NNP B-Gene
Single JJ O
copy NN O
/ SYM O
knock-in VB O
models NNS O
of IN O
ALS NNP O
SOD1 NNP O
in IN O
C. NNP O
elegans NNS O
suggest VBP O
loss NN O
and CC O
gain NN O
of IN O
function NN O
have VBP O
different JJ O
contributions NNS O
to IN O
cholinergic NN O
and CC O
glutamatergic JJ O
neurodegeneration NN O
. . O

Mutations NNPS B-Var
in IN O
Cu NNP O
/ SYM O
Zn NNP O
superoxide JJ O
dismutase NN O
1 CD O
( -LRB- O
SOD1 NNP B-Gene
) -RRB- O
lead VBP B-Reg
to IN I-Reg
Amyotrophic NNP B-Disease
Lateral NNP I-Disease
Sclerosis NNP I-Disease
A DT O
homozygous JJ O
loss-of-function NN B-NegReg
mutation NN B-Var
leading VBG O
to IN O
CYBC1 VB B-Gene
deficiency NN O
causes VBZ B-Reg
chronic JJ B-Disease
granulomatous JJ I-Disease
disease NN I-Disease
. . O

Mutations NNPS B-Var
in IN O
genes NNS B-Gene
encoding NN I-Gene
subunits NNS I-Gene
of IN I-Gene
the DT I-Gene
phagocyte NN I-Gene
NADPH NNP I-Gene
oxidase NN I-Gene
complex NN I-Gene
are VBP O
recognized VBN O
to TO O
cause VB B-Reg
chronic JJ B-Disease
granulomatous JJ I-Disease
disease NN I-Disease
( -LRB- O
CGD NNP O
) -RRB- O
, , O
a DT O
severe JJ O
primary JJ O
immunodeficiency NN O
. . O

Here RB O
we PRP O
describe VBP O
how WRB O
deficiency NN B-NegReg
of IN O
CYBC1 NN B-Gene
, , O
a DT O
previously RB O
uncharacterized JJ O
protein NN O
in IN O
humans NNS O
( -LRB- O
C17orf62 NNP O
) -RRB- O
, , O
leads VBZ O
to IN O
reduced JJ B-NegReg
expression NN B-MPA
of IN I-MPA
NADPH NNP I-MPA
oxidase NN I-MPA
's POS I-MPA
main JJ I-MPA
subunit NN O
( -LRB- O
gp91phox NN O
) -RRB- O
and CC O
results NNS B-Reg
in IN O
CGD NNP B-Disease
Loss NNP O
of IN O
Function NNP O
in IN O
Zeaxanthin NNP O
Epoxidase NNP O
of IN O
Dunaliella NNP O
tertiolecta NN O
Caused VBN O
by IN O
a DT O
Single NNP O
Amino NNP O
Acid NNP O
Mutation NNP O
within IN O
the DT O
Substrate-Binding NN O
Site NNP O
. . O

The DT O
zea1 NNP O
mutant NN O
of IN O
marine JJ O
microalga NN O
Dunaliella NNP O
tertiolecta NN O
accumulates VBZ O
zeaxanthin CD O
under IN O
normal JJ O
growth NN O
conditions NNS O
, , O
and CC O
its PRP$ O
phenotype NN O
has VBZ O
been VBN O
speculated VBN O
to TO O
be VB O
related VBN O
to IN O
zeaxanthin CD O
epoxidase NN O
( -LRB- O
ZEP NNP O
) -RRB- O
. . O

In IN O
this DT O
study NN O
, , O
we PRP O
isolated VBD O
the DT O
ZEP NNP O
gene NN O
from IN O
both CC O
wild-type JJ O
D. NNP O
tertiolecta NN O
and CC O
the DT O
mutant NN O
. . O

We PRP O
found VBD O
that IN O
the DT O
zea1 NNP O
mutant NN O
has VBZ O
a DT O
point NN B-Var
mutation NN I-Var
of IN O
the DT O
1337th CD O
nucleotide NN O
of IN O
the DT O
ZEP NNP B-Gene
sequence NN O
( -LRB- O
a DT O
change NN O
from IN O
guanine NN O
to IN O
adenine JJ O
) -RRB- O
, , O
resulting VBG O
in IN O
a DT O
change NN B-Reg
of IN O
glycine NN B-MPA
to TO I-MPA
aspartate VB I-MPA
in IN I-MPA
a DT I-MPA
highly RB I-MPA
conserved JJ I-MPA
region NN I-MPA
in IN I-MPA
the DT I-MPA
catalytic JJ I-MPA
domain NN I-MPA
. . O

Similar JJ O
expression NN O
levels NNS O
of IN O
ZEP NNP O
mRNA NNS O
and CC O
protein NN O
in IN O
both CC O
wild-type JJ O
and CC O
zea1 NNP O
were VBD O
confirmed VBN O
by IN O
using VBG O
qRT-PCR JJ O
and CC O
western JJ O
blot NN O
analysis NN O
, , O
respectively RB O
. . O

Additionally RB O
, , O
the DT O
enzyme NN O
activity NN O
analysis NN O
of IN O
ZEPs NNPS O
in IN O
the DT O
presence NN O
of IN O
cofactors NNS O
showed VBD O
that IN O
the DT O
inactivation NN O
of IN O
ZEP NNP O
in IN O
zea1 NNP O
was VBD O
not RB O
caused VBN O
by IN O
deficiency NN O
in IN O
the DT O
levels NNS O
of IN O
cofactors NNS O
. . O

From IN O
the DT O
predicted VBN O
three-dimensional CD O
ZEP NNP O
structure NN O
of IN O
zea1 NNP O
, , O
we PRP O
observed VBD O
a DT O
conformational JJ O
change NN O
on IN O
the DT O
substrate-binding NN O
site NN O
in IN O
the DT O
ZEP NNP O
. . O

A DT O
comparative JJ O
analysis NN O
of IN O
the DT O
ZEP NNP B-Enzyme
structures NNS O
suggested VBD O
that IN O
the DT O
conformational JJ B-MPA
change NN I-MPA
induced VBN O
by IN O
a DT O
single JJ B-Var
amino NN I-Var
acid NN I-Var
mutation NN I-Var
might MD O
impact VB B-NegReg
the DT O
interaction NN B-Interaction
between IN I-Interaction
the DT I-Interaction
substrate NN I-Interaction
and CC I-Interaction
substrate-binding NN I-Interaction
site NN I-Interaction
, , O
resulting VBG O
in IN O
loss NN B-NegReg
of IN O
zeaxanthin NN B-Enzyme
epoxidase NN I-Enzyme
function NN B-MPA
LZTR1 NN O
is VBZ O
a DT O
regulator NN O
of IN O
RAS NNP O
ubiquitination NN O
and CC O
signaling NN O
. . O

In IN O
genetic JJ O
screens NNS O
aimed VBN O
at IN O
understanding VBG O
drug NN O
resistance NN O
mechanisms NNS O
in IN O
chronic JJ O
myeloid NN O
leukemia NN O
cells NNS O
, , O
inactivation NN B-Var
of IN O
the DT O
cullin NN O
3 CD O
adapter NN O
protein-encoding NN O
leucine NN B-Gene
zipper-like NN I-Gene
transcription NN I-Gene
regulator NN I-Gene
1 CD I-Gene
( -LRB- I-Gene
LZTR1 NN O
) -RRB- O
gene NN O
led VBD O
to IN O
enhanced VBN B-PosReg
mitogen-activated NN B-Pathway
protein NN I-Pathway
kinase NN I-Pathway
( -LRB- I-Pathway
MAPK NN I-Pathway
) -RRB- O
pathway NN O
activity NN B-MPA
and CC O
reduced VBN B-NegReg
sensitivity NN B-MPA
to TO I-MPA
tyrosine VB I-MPA
kinase NN I-MPA
inhibitors NNS I-MPA
. . O

Knockdown NNP O
of IN O
the DT O
Drosophila NNP O
LZTR1 NNP O
ortholog NN O
CG3711 NNP O
resulted VBD O
in IN O
a DT O
Ras-dependent NNP O
gain-of-function NN O
phenotype NN O
. . O

Endogenous JJ O
human JJ O
LZTR1 NN O
associates NNS O
with IN O
the DT O
main JJ O
RAS NNP O
isoforms NNS O
. . O

Inactivation NN B-Var
of IN O
LZTR1 NNP B-Gene
led VBD O
to IN O
decreased VBN B-NegReg
ubiquitination NN B-MPA
and CC O
enhanced JJ B-PosReg
plasma NN B-MPA
membrane JJ I-MPA
localization NN I-MPA
of IN I-MPA
endogenous JJ I-MPA
KRAS NNP I-MPA
Association NN O
Between IN O
Titin NNP O
Loss-of-Function NNP O
Variants NNPS O
and CC O
Early-Onset NNP O
Atrial NNP O
Fibrillation NNP O
. . O

Importance NN O
: : O
Atrial JJ O
fibrillation NN O
( -LRB- O
AF NNP O
) -RRB- O
is VBZ O
the DT O
most RBS O
common JJ O
arrhythmia NN O
affecting VBG O
1 CD O
% NN O
of IN O
the DT O
population NN O
. . O

Young JJ O
individuals NNS O
with IN O
AF NNP O
have VBP O
a DT O
strong JJ O
genetic JJ O
association NN O
with IN O
the DT O
disease NN O
, , O
but CC O
the DT O
mechanisms NNS O
remain VBP O
incompletely RB O
understood VBN O
. . O

Objective NNP O
: : O
To TO O
perform VB O
large-scale JJ O
whole-genome JJ O
sequencing NN O
to TO O
identify VB O
genetic JJ O
variants NNS O
related VBN O
to IN O
AF NNP O
. . O

Design NNP O
, , O
Setting NN O
, , O
and CC O
Participants NNS O
: : O
The DT O
National NNP O
Heart NNP O
, , O
Lung NNP O
, , O
and CC O
Blood NNP O
Institute NNP O
's POS O
Trans-Omics NNP O
for IN O
Precision NNP O
Medicine NNP O
Program NNP O
includes VBZ O
longitudinal JJ O
and CC O
cohort NN O
studies NNS O
that WDT O
underwent VBD O
high-depth JJ O
whole-genome JJ O
sequencing NN O
between IN O
2014 CD O
and CC O
2017 CD O
in IN O
18 CD O
  _SP O
526 CD O
individuals NNS O
from IN O
the DT O
United NNP O
States NNP O
, , O
Mexico NNP O
, , O
Puerto NNP O
Rico NNP O
, , O
Costa NNP O
Rica NNP O
, , O
Barbados NNP O
, , O
and CC O
Samoa NNP O
. . O

This DT O
case-control NN O
study NN O
included VBD O
2781 CD O
patients NNS O
with IN O
early-onset JJ O
AF NN O
from IN O
9 CD O
studies NNS O
and CC O
identified VBD O
4959 CD O
controls NNS O
of IN O
European JJ O
ancestry NN O
from IN O
the DT O
remaining VBG O
participants NNS O
. . O

Results NNS O
were VBD O
replicated VBN O
in IN O
the DT O
UK NNP O
Biobank NNP O
( -LRB- O
346 CD O
  _SP O
546 CD O
participants NNS O
) -RRB- O
and CC O
the DT O
MyCode NNP O
Study NNP O
( -LRB- O
42 CD O
  _SP O
782 CD O
participants NNS O
) -RRB- O
. . O

Exposures NNPS O
: : O
Loss-of-function NN O
( -LRB- O
LOF NNP O
) -RRB- O
variants NNS O
in IN O
genes NNS O
at IN O
AF NN O
loci NN O
and CC O
common JJ O
genetic JJ O
variation NN O
across IN O
the DT O
whole JJ O
genome NN O
. . O

Main NNP O
Outcomes NNP O
and CC O
Measures NNPS O
: : O
Early-onset JJ O
AF NN O
( -LRB- O
defined VBN O
as IN O
AF NN O
onset NN O
in IN O
persons NNS O
< XX O
66 CD O
years NNS O
of IN O
age NN O
) -RRB- O
. . O

Due IN O
to IN O
multiple JJ O
testing NN O
, , O
the DT O
significance NN O
threshold NN O
for IN O
the DT O
rare JJ O
variant NN O
analysis NN O
was VBD O
P NN O
  _SP O
= SYM O
  _SP O
4.55 CD O
  _SP O
× NNS O
  _SP O
10-3 CD O
. . O

Results NNS O
: : O
Among IN O
2781 CD O
participants NNS O
with IN O
early-onset JJ O
AF NN O
( -LRB- O
the DT O
case NN O
group NN O
) -RRB- O
, , O
72.1 CD O
% NN O
were VBD O
men NNS O
, , O
and CC O
the DT O
mean JJ O
( -LRB- O
SD NN O
) -RRB- O
age NN O
of IN O
AF NNP O
onset NN O
was VBD O
48.7 CD O
( -LRB- O
10.2 CD O
) -RRB- O
years NNS O
. . O

Participants NNS O
underwent VBD O
whole-genome JJ O
sequencing NN O
at IN O
a DT O
mean JJ O
depth NN O
of IN O
37.8 CD O
fold NN O
and CC O
mean VB O
genome JJ O
coverage NN O
of IN O
99.1 CD O
% NN O
. . O

At IN O
least JJS O
1 CD O
LOF NNP O
variant NN O
in IN O
TTN NNP O
, , O
the DT O
gene NN O
encoding VBG O
the DT O
sarcomeric JJ O
protein NN O
titin NN O
, , O
was VBD O
present JJ O
in IN O
2.1 CD O
% NN O
of IN O
case NN O
participants NNS O
compared VBN O
with IN O
1.1 CD O
% NN O
in IN O
control NN O
participants NNS O
( -LRB- O
odds NNS O
ratio NN O
[ -LRB- O
OR CC O
] -RRB- O
, , O
1.76 CD O
[ -LRB- O
95 CD O
% NN O
CI NN O
, , O
1.04-2.97 CD O
] -RRB- O
) -RRB- O
. . O

The DT O
proportion NN O
of IN O
individuals NNS O
with IN O
early-onset JJ B-Disease
AF NN I-Disease
who WP O
carried VBD O
a DT O
LOF NNP B-PosReg
variant NN B-Var
in IN O
TTN NNP B-Gene
increased VBD B-PosReg
with IN O
an DT O
earlier JJR O
age NN O
of IN O
AF NNP O
onset NN O
( -LRB- O
P NN O
value NN O
for IN O
trend NN O
, , O
4.92 CD O
  _SP O
× NNS O
  _SP O
10-4 CD O
) -RRB- O
, , O
and CC O
6.5 CD O
% NN O
of IN O
individuals NNS O
with IN O
AF NN O
onset NN O
prior RB O
to IN O
age NN O
30 CD O
carried VBD O
a DT O
TTN NN O
LOF NNP O
variant NN O
( -LRB- O
OR CC O
, , O
5.94 CD O
[ -LRB- O
95 CD O
% NN O
CI NN O
, , O
2.64-13.35 CD O
] -RRB- O
; : O
P NN O
  _SP O
= SYM O
  _SP O
1.65 CD O
  _SP O
× NNS O
  _SP O
10-5 CD O
) -RRB- O
. . O

The DT O
association NN O
between IN O
TTN NNP O
LOF NNP O
variants NNS O
and CC O
AF NNP O
was VBD O
replicated VBN O
in IN O
an DT O
independent JJ O
study NN O
of IN O
1582 CD O
patients NNS O
with IN O
early-onset JJ O
AF NN O
( -LRB- O
cases NNS O
) -RRB- O
and CC O
41 CD O
  _SP O
200 CD O
control NN O
participants NNS O
( -LRB- O
OR CC O
, , O
2.16 CD O
[ -LRB- O
95 CD O
% NN O
CI NN O
, , O
1.19-3.92 CD O
] -RRB- O
; : O
P NN O
  _SP O
= SYM O
  _SP O
.01 CD O
) -RRB- O
. . O

Conclusions NNPS O
and CC O
Relevance NNP O
: : O
In IN O
a DT O
case-control NN O
study NN O
, , O
there EX O
was VBD O
a DT O
statistically RB O
significant JJ B-Reg
association NN I-Reg
between IN O
an DT O
LOF NNP B-NegReg
variant NN B-Var
in IN O
the DT O
TTN NNP B-Gene
gene NN O
and CC O
early-onset JJ B-Disease
AF NN I-Disease
HDX-MS NNP O
reveals VBZ O
dysregulated VBN O
checkpoints NNS O
that WDT O
compromise VBP O
discrimination NN O
against IN O
self NN O
RNA NNP O
during IN O
RIG-I NNP O
mediated VBN O
autoimmunity NN O
. . O

Retinoic NNP O
acid NN O
inducible JJ O
gene-I NN O
( -LRB- O
RIG-I NNP O
) -RRB- O
ensures VBZ O
immune JJ O
surveillance NN O
of IN O
viral JJ O
RNAs NNS O
bearing VBG O
a DT O
5'-triphosphate CD O
( -LRB- O
5'ppp CD O
) -RRB- O
moiety NN O
. . O

Mutations NNS O
in IN O
RIG-I NNP B-Gene
( -LRB- O
C268F NNS B-Var
and CC O
E373A NNS B-Var
) -RRB- O
lead VBP O
to IN O
impaired JJ B-NegReg
ATPase NNP B-Protein
activity NN B-MPA
, , O
thereby RB O
driving VBG O
hyperactive JJ B-PosReg
signaling NN B-MPA
associated VBN O
with IN O
autoimmune JJ O
diseases NNS O
. . O

Here RB O
we PRP O
report VBP O
, , O
using VBG O
hydrogen NN O
/ SYM O
deuterium NN O
exchange NN O
, , O
mechanistic JJ O
models NNS O
for IN O
dysregulated JJ O
RIG-I NNP O
proofreading VBG O
that DT O
ultimately RB O
result VBP O
in IN O
the DT O
improper JJ O
recognition NN O
of IN O
cellular JJ O
RNAs NNS O
bearing VBG O
7-methylguanosine NN O
and CC O
N1-2'-O-methylation NNP O
( -LRB- O
Cap1 NNP O
) -RRB- O
on IN O
the DT O
5 CD O
' `` O
end NN O
. . O

Cap1-RNA NNS O
compromises VBZ O
its PRP$ O
ability NN O
to TO O
stabilize VB O
RIG-I NNP O
helicase VBP O
and CC O
blunts NNS O
caspase JJ O
activation NN O
and CC O
recruitment NN O
domains NNS O
( -LRB- O
CARD NNP O
) -RRB- O
partial JJ O
opening NN O
by IN O
threefold NN O
. . O

RIG-I NNP B-Gene
H830A VBP B-Var
mutation NN I-Var
restores VBZ B-PosReg
Cap1-helicase NNP B-Protein
engagement NN B-MPA
as RB O
well RB O
as IN O
CARDs NNS B-MPA
partial JJ I-MPA
opening NN I-MPA
event NN I-MPA
to IN O
a DT O
level NN O
comparable JJ O
to IN O
that DT O
of IN O
5'ppp CD O
. . O

However RB O
, , O
E373A NNP B-Var
RIG-I NNP B-Gene
locks VBZ O
the DT O
receptor NN O
in IN O
an DT O
ATP-bound NNP O
state NN O
, , O
resulting VBG O
in IN O
enhanced JJ B-PosReg
Cap1-helicase NNP B-Protein
engagement NN B-MPA
and CC O
a DT O
sequential JJ B-MPA
CARDs NNS I-MPA
stimulation NN I-MPA
. . O

C268F NNS B-Var
mutation NN I-Var
renders VBZ O
a DT O
more RBR B-PosReg
tethered JJ B-MPA
ring NN I-MPA
architecture NN I-MPA
and CC O
results NNS B-Reg
in IN I-Reg
constitutive JJ B-MPA
CARDs NNS I-MPA
signaling VBG I-MPA
Variant NNP O
Prolactin NNP O
Receptor NNP O
in IN O
Agalactia NNP O
and CC O
Hyperprolactinemia NNP O
. . O

A DT O
loss-of-function NN O
variant NN O
in IN O
the DT O
gene NN O
encoding VBG O
the DT O
prolactin NN O
receptor NN O
( -LRB- O
PRLR NNP O
) -RRB- O
was VBD O
reported VBN O
previously RB O
in IN O
a DT O
woman NN O
with IN O
persistent JJ O
postpartum NN O
galactorrhea NN O
; : O
however RB O
, , O
this DT O
paradoxical JJ O
phenotype NN O
is VBZ O
not RB O
completely RB O
understood VBN O
. . O

Here RB O
we PRP O
describe VBP O
a DT O
35-year-old CD O
woman NN O
who WP O
presented VBD O
with IN O
idiopathic JJ O
hyperprolactinemia NN B-Disease
that WDT O
was VBD O
associated VBN O
with IN O
a DT O
complete JJ O
lack NN O
of IN O
lactation NN O
after IN O
each DT O
of IN O
her PRP$ O
two CD O
deliveries NNS O
. . O

She PRP O
is VBZ O
a DT O
compound JJ O
heterozygote NN O
for IN O
loss-of-function NN B-NegReg
variants NNS B-Var
of IN O
PRLR NNP B-Gene
. . O

Her PRP$ O
unaffected JJ O
parents NNS O
are VBP O
heterozygotes NNS O
. . O

These DT O
findings NNS O
are VBP O
consistent JJ O
with IN O
previous JJ O
work NN O
showing VBG O
that DT O
mice NNS O
deficient JJ O
in IN O
functional JJ O
Prlr NNP O
do VBP O
not RB B-NegReg
lactate VB B-CPA
WRKY12 NN O
represses VBZ O
GSH1 JJ O
expression NN O
to TO O
negatively RB O
regulate VB O
cadmium NN O
tolerance NN O
in IN O
Arabidopsis NNP O
. . O

KEY JJ O
MESSAGE NN O
: : O
The DT O
WRKY NNP O
transcription NN O
factor NN O
WRKY12 NN O
negatively RB O
regulates VBZ O
Cd NNP O
tolerance NN O
in IN O
Arabidopsis NNP O
via IN O
the DT O
glutathione-dependent NN O
phytochelatin NN O
synthesis NN O
pathway NN O
by IN O
directly RB O
targeting VBG O
GSH1 : O
and CC O
indirectly RB O
repressing VBG O
phytochelatin NN O
synthesis-related NN O
gene NN O
expression NN O
. . O

Cadmium NN O
( -LRB- O
Cd NNP O
) -RRB- O
is VBZ O
a DT O
widespread JJ O
pollutant NN O
toxic JJ O
to IN O
plants NNS O
. . O

The DT O
glutathione NN O
( -LRB- O
GSH)-dependent NN O
phytochelatin NN O
( -LRB- O
PC NN O
) -RRB- O
synthesis NN O
pathway NN O
plays VBZ O
key JJ O
roles NNS O
in IN O
Cd NNP O
detoxification NN O
. . O

However RB O
, , O
its PRP$ O
regulatory JJ O
mechanism NN O
remains VBZ O
largely RB O
unknown JJ O
. . O

Here RB O
, , O
we PRP O
showed VBD O
a DT O
previously RB O
unknown JJ O
function NN O
of IN O
the DT O
WRKY NNP O
transcription NN O
factor NN O
WRKY12 NN O
in IN O
the DT O
regulation NN O
of IN O
Cd NNP O
tolerance NN O
by IN O
repressing VBG O
the DT O
expression NN O
of IN O
PC NN O
synthesis-related NN O
genes NNS O
. . O

The DT O
expression NN O
of IN O
WRKY12 NNP O
was VBD O
inhibited VBN O
by IN O
Cd NNP O
stress NN O
. . O

Enhanced NNP B-PosReg
Cd NNP B-CPA
tolerance NN I-CPA
was VBD O
observed VBN O
in IN O
the DT O
WRKY12 JJ B-Gene
loss-of-function NN B-NegReg
mutants NNS B-Var
, , O
whereas IN O
increased VBD O
Cd NNP O
sensitivity NN O
was VBD O
found VBN O
in IN O
the DT O
WRKY12-overexpressing VBG O
plants NNS O
. . O

Overexpression NN O
and CC O
loss-of-function NN B-NegReg
of IN O
WRKY12 NNP B-Gene
were VBD O
associated VBN O
respectively RB O
with IN O
increased VBN O
and CC O
decreased VBD B-NegReg
Cd NN B-CPA
accumulation NN I-CPA
by IN O
repressing VBG O
or CC O
releasing VBG B-PosReg
the DT O
expression NN B-MPA
of IN O
the DT O
genes NNS O
involved VBN O
in IN O
the DT O
PC NN O
synthesis NN O
pathway NN O
. . O

Transient JJ O
expression NN O
assay VBP O
showed VBD O
that IN O
WRKY12 NNP O
repressed VBD O
the DT O
expression NN O
of IN O
GSH1 NNP B-Gene
, , O
GSH2 NNP B-Gene
, , O
PCS1 NNP B-Gene
, , O
and CC O
PCS2 NNP B-Gene
Loss-of-function NN B-NegReg
mutations NNS B-Var
in IN O
QRICH2 NNP B-Gene
cause IN B-Reg
male JJ B-Disease
infertility NN I-Disease
with IN O
multiple JJ O
morphological JJ O
abnormalities NNS O
of IN O
the DT O
sperm JJ O
flagella NN O
. . O

Aberrant NNP B-Var
sperm NN B-CPA
flagella NN I-CPA
impair NN B-NegReg
sperm NN B-CPA
motility NN I-CPA
and CC O
cause VB B-Reg
male JJ B-Disease
infertility NN I-Disease
, , O
yet CC O
the DT O
genes NNS O
which WDT O
have VBP O
been VBN O
identified VBN O
in IN O
multiple JJ O
morphological JJ O
abnormalities NNS O
of IN O
the DT O
flagella NN O
( -LRB- O
MMAF NN O
) -RRB- O
can MD O
only RB O
explain VB O
the DT O
pathogenic JJ O
mechanisms NNS O
of IN O
MMAF NN O
in IN O
a DT O
small JJ O
number NN O
of IN O
cases NNS O
. . O

Here RB O
, , O
we PRP O
identify VBP O
and CC O
functionally RB O
characterize VB O
homozygous JJ O
loss-of-function NN O
mutations NNS O
of IN O
QRICH2 NNP O
in IN O
two CD O
infertile JJ O
males NNS O
with IN O
MMAF NN O
from IN O
two CD O
consanguineous JJ O
families NNS O
. . O

Remarkably RB O
, , O
Qrich2 NNP O
knock-out VB O
( -LRB- O
KO NNP O
) -RRB- O
male JJ O
mice NNS O
constructed VBN O
by IN O
CRISPR-Cas9 NNP O
technology NN O
present JJ O
MMAF NNP O
phenotypes NNS O
and CC O
sterility NN O
. . O

To TO O
elucidate VB O
the DT O
mechanisms NNS O
of IN O
Qrich2 NNP O
functioning VBG O
in IN O
sperm JJ O
flagellar JJ O
formation NN O
, , O
we PRP O
perform VBP O
proteomic JJ O
analysis NN O
on IN O
the DT O
testes NNS O
of IN O
KO NNP O
and CC O
wild-type JJ O
mice NNS O
. . O

Furthermore RB O
, , O
in IN O
vitro FW O
experiments NNS O
indicate VBP O
that IN O
QRICH2 NNP O
is VBZ O
involved VBN O
in IN O
sperm JJ O
flagellar JJ O
development NN O
through IN O
stabilizing VBG O
and CC O
enhancing VBG O
the DT O
expression NN O
of IN O
proteins NNS O
related VBN O
to IN O
flagellar JJ O
development NN O
. . O

Our PRP$ O
findings NNS O
strongly RB O
suggest VBP O
that IN O
the DT O
genetic JJ O
mutations NNS B-Var
of IN O
human NN O
QRICH2 NNP B-Gene
can MD O
lead VB B-Reg
to IN I-Reg
male JJ B-Disease
infertility NN I-Disease
with IN O
MMAF NN B-CPA
